rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGTTCAGGGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	34	9.433203210618458E-5		41	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	6	4	1	18	32	42	36	43														X+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGAGGTTTCGGACTAGCGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLRFRTSGYNEQFF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	4	4	8	0	18	32	-1	40	51						01,02								CASSLRFRTSGYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCATCAGGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSHQGLNTEAFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-01	01	5	0	7	0	5	0	18	30	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHQGLNTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGACAGGGGGCGAAAACTGAAGCTTTCTTTGGACAA	CASSLGQGAKTEAFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	0	5	0	4	18	-1	44	34	48														CASSLGQGAKTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTCGCAGCGGGAAGTTCTGAGCAGTTCTTCGGGCCA	CASSLVAAGSSEQFF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	3	9	4	5	18	34	45	38	50														CASSLVAAGSSEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGGGGGACAGGGGGCGTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRGTGGVSGANVLTF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	54	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	0	1	3	3	18	30	45	33	48														CASSRGTGGVSGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTCTTCACAGGCCGGGTGTCTACGAGCAGTACTTCGGGCCG	CASSFLHRPGVYEQYF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	4	3	5	8	19	33	43	38	51														CASSFLHRPGVYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGTCAAGAATCCTACGAGCAGTACTTCGGGCCG	CASSLGQESYEQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-07	01	0	2	8	1	5	1	19	35	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQESYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGTGGGCTAGCGGGGGGAAAATGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	39	1.0820438976885877E-4		53	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	9	5	8	19	35	51	40	59														X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAAACCCAGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSLNPGMNTEAFF	In	VDJ	1	116	3.2183869777404147E-4	3.628412975955508E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	0	4	2	19	34	42	38	44														CASSLNPGMNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCACCGGGGAGGCCCCACGGCCCTCTCACCTGTGGAGAAACATTCAGTACTTCGGCGCC	CATGEAPRPSHLWRNIQYF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	57	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	9	9	1	6	3	25	23	30	39	33	64			01,02										Vb 1	CATGEAPRPSHLWRNIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGAACAGGGCTTTGAACACTGAAGCTTTCTTTGGACAA	CASSGNRALNTEAFF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	0	3	3	23	36	45	39	48			01,02										Vb 1	CASSGNRALNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATTCCCGAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVFPRGNTGELFF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	1	5	2	1	6	0	23	38	-1	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVFPRGNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAACCCTTTTTGGGCTATACCTTCGGTTCG	CASSQPFLGYTF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	8	0	14	11	3	23	35	50	46	53			01,02										Vb 1	CASSQPFLGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTCCAGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSVGPGGQETQYF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	2	3	1	23	39	49	42	50			01,02										Vb 1	CASSVGPGGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGTCAGGGGACAATCAGCCCCAGCATTTTGGTGAT	CASSVSGDNQPQHF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	3	2	1	23	37	45	39	46			01,02										Vb 1	CASSVSGDNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAGGACTAAAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	47	1.304001620291375E-4		41	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	9	3	2	3	23	36	44	38	47			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGAGGGGCCATACCAATGAGCAGTTCTTCGGGCCA	CASSVRGHTNEQFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	2	5	2	6	1	6	23	37	43	38	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVRGHTNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAAGGGACTTTGGGCAAAAACATTCAGTACTTCGGCGCC	CASSEGTLGKNIQYF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	0	10	3	2	5	23	36	44	38	49			01,02			01,02							Vb 1	CASSEGTLGKNIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTCGGGCGGGAGTGGTACGAGCAGTACTTCGGGCCG	CASSVGREWYEQYF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	2	4	6	3	23	34	47	40	50			01,02										Vb 1	CASSVGREWYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTGGGACAGGGGTCGTGTTTTTCTACGAGCAGTACTTCGGGCCG	CASSPGTGVVFFYEQYF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	3	3	10	23	35	48	38	58			01,02										Vb 1	CASSPGTGVVFFYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCGTGGCCATGACTTTCAGTTCTTCGGGCCA	CASSPRGHDFQFF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	13	12	2	23	35	51	47	53			01,02			01,02							Vb 1	CASSPRGHDFQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTACGGGGGGGCCTCTACAAGAGACCCAGTACTTCGGGCCA	CASSVATGGPLQETQYF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	0	2	3	6	23	39	50	42	56			01,02										Vb 1	CASSVATGGPLQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTTGGGGGGGTACTGAAGCTTTCTTTGGACAA	CASSVAWGGTEAFF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	5	3	1	23	39	49	42	50			01,02										Vb 1	CASSVAWGGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGACCGTTGGGGTACTACAATGAGCAGTTCTTCGGGCCA	CASSVGPLGYYNEQFF	In	VDJ	1	106	2.940939824486931E-4	3.315618753890378E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	6	2	3	7	2	23	39	50	46	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGPLGYYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCCCAAGATATAGGAAAGTCATTCAGTACTTCGGCGCC		Out	VDJ	1	121	3.357110554367157E-4		40	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-04	01	7	1	8	9	11	4	23	32	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-04	TCRBV09-01		TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGCCAGGGTCTTCCTACGAGCAGTACTTCGGGCCG	CASSVEPGSSYEQYF	In	VDJ	2	189	5.243751196490848E-4	5.911810797030958E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	1	3	3	23	39	47	42	50			01,02										Vb 1	CASSVEPGSSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTTGGACTAGGCCCCAATACGCAGTATTTTGGCCCA	CASSVVGLGPNTQYF	In	VDJ	3	267	7.407838991868023E-4	8.351605729138971E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	8	7	2	6	23	39	48	41	54			01,02			01,02							Vb 1	CASSVVGLGPNTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGTATCAGTAATCCAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	27	7.491073137844069E-5		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	4	5	5	5	12	28	41	49	46	61													Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACATGCAGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSQHAGLNTEAFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	0	4	2	29	44	52	48	54													Vb 16	CASSQHAGLNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACCACGGGGGGGAGCAGTTCTTCGGGCCA	CASSQDHGGEQFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	1	10	3	0	29	46	-1	49	56													Vb 16	CASSQDHGGEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAGACCATAGCCAAGCTTTCTTTGGACAA	CASSRDHSQAFF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	36	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	5	7	9	3	1	29	46	53	49	54						01,02							Vb 16	CASSRDHSQAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGGGACAGGGGTTCGGCGGCTACACCTTCGGTTCG	CASSPGQGFGGYTF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	8	1	6	29	42	53	43	59													Vb 16	CASSPGQGFGGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCGGTTGGGACCCAGTACTTCGGGCCA	CASSQAVGTQYF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	36	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	5	7	0	4	29	-1	48	45	52						01,02							Vb 16	CASSQAVGTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCCGTCCAGATCTATTAAGGGCTACACCTTCGGTTCG		Out	VDJ	1	70	1.9421300727743884E-4		38	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	8	4	5	8	4	10	29	38	45	42	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCACAGGGGTCCCTCCAGTGAAGCTTTCTTTGGACAA	CASSHRGPSSEAFF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	7	2	9	29	40	49	42	58													Vb 16	CASSHRGPSSEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCGCCGGAACTAGCGGGAGGGCCACGCAGTATTTTGGCCCA	CASSLAGTSGRATQYF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	0	9	8	2	29	42	63	50	65													Vb 16	CASSLAGTSGRATQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATATTACCGGGTCTACAGATACGCAGTATTTTGGCCCA	CASSHITGSTDTQYF	In	VDJ	1	90	2.497024379281356E-4	2.81514799858617E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	3	6	3	29	43	53	49	56						01,02							Vb 16	CASSHITGSTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAAACTGGGCGGTCGATGAGCAGTTCTTCGGGCCA	CASSQENWAVDEQFF	In	VDJ	1	112	3.1074081164390215E-4	3.5032952871294563E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	0	8	0	8	5	5	29	46	55	51	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQENWAVDEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAATAAGAGGCGAGCAGTACTTCGGGCCG	CASSQGIRGEQYF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	11	1	6	6	0	29	45	-1	51	55													Vb 16	CASSQGIRGEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGATTTTTAGCGAGCAGTACTTCGGGCCG	CASSQVIFSEQYF	In	VDJ	1	121	3.357110554367157E-4	3.784810086988073E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	5	8	6	7	0	29	45	-1	52	55						01,02							Vb 16	CASSQVIFSEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTGCATCAGCCCCAGCATTTTGGTGAT	CASSQDLHQPQHF	In	VDJ	1	127	3.523578846319247E-4	3.9724866202271513E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-05	01	0	10	0	5	3	0	29	46	-1	49	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDLHQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATACACTAGCGGGAGGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	146	4.050728437500867E-4		47	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	0	7	3	1	29	44	60	47	61													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCTTCCAAGAGACCCAGTACTTCGGGCCA	CASSRFQETQYF	In	VDJ	1	151	4.189452014127609E-4	4.723192753183463E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	4	10	0	1	0	2	29	-1	44	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSRFQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTCTCAGGGCGTTGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	155	4.3004308754290025E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	7	4	6	29	42	51	46	57													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATGTCTGGACCGGGGAGCTGTTTTTTGGAGAA	CASSHVWTGELFF	In	VDJ	1	157	4.3559203060796993E-4	4.910869286422541E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	3	0	10	5	5	0	29	43	-1	48	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSHVWTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAACTTTGACAGGGACGAGCAGTACTTCGGGCCG	CASNFDRDEQYF	In	VDJ	2	173	4.799835751285274E-4	5.411340041726749E-4	36	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	5	5	0	29	39	-1	44	51													Vb 16	CASNFDRDEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCAACTCCCTCAAATAGCGGGAGGCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	176	4.883069897261319E-4		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	1	5	12	2	28	40	62	52	64													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAATTAGTAGGGGAGCAGTTCTTCGGGCCA	CASSQELVGEQFF	In	VDJ	2	223	6.187071517552694E-4	6.975311152052399E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	0	5	3	10	6	0	29	46	-1	52	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQELVGEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCGTGGGGGGTCTCGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSQAWGVSGAYEQYF	In	VDJ	2	237	6.575497532107572E-4	7.413223062943581E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	9	1	2	3	9	29	45	54	48	63						01,02							Vb 16	CASSQAWGVSGAYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGTAAGACTCGTGTGCGGGAGGGTGTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	241	6.686476393408965E-4		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	0	7	13	3	28	41	63	54	66													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGATCCGGGGTACGCAGTATTTTGGCCCA		Out	VDJ	3	330	9.155756057364974E-4		40	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	8	5	0	29	46	-1	51	56													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAAGGCCAGGGTTCGCCACTGAAGCTTTCTTTGGACAA	CASSRRPGFATEAFF	In	VDJ	3	338	9.37771377996776E-4	0.0010572444705801395	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	4	6	5	29	42	53	48	58													Vb 16	CASSRRPGFATEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGTCCGGAACAGGGGGCAACGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	363	0.001007133166310147		52	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	0	4	8	3	29	43	60	51	63													Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGATCGACAGGGGGCAGGTCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	5	483	0.0013400697502143279		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	0	6	5	5	29	42	57	47	62													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCTTACACAGATACGCAGTATTTTGGCCCA	CASSVAYTDTQYF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	7	2	1	3	24	36	41	37	44						01,02								CASSVAYTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCACAGAGGTACCGAGCAGTACTTCGGGCCG	CASSHRGTEQYF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	5	3	5	6	1	6	24	36	41	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRGTEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGTCGGTGATCAGATGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	8.600861750858006E-5		56	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	10	2	7	4	30	0	24	31	-1	61	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSVAGNTEAFF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	5	4	1	1	0	24	36	-1	37	44						01,02								CASSVAGNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTACAATTTCAAGGGCCGAACACTGAAGCTTTCTTTGGACAA	CASSLQFQGPNTEAFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	5	3	1	11	2	24	36	51	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQFQGPNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCACTACGCGGACTAGCTGGACCGGGGAGCTGTTTTTTGGAGAA	CATTRTSWTGELFF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	1	7	5	6	3	24	31	45	37	48						01,02								CATTRTSWTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCAGCGGTACCGGAGGTGGAAACACCATATATTTTGGAGAG	CASSVSGTGGGNTIYF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	6	5	3	3	9	24	36	44	39	53						01,02								CASSVSGTGGGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGACAGGGGTACTGAAGCTTTCTTTGGACAA	CASSLDRGTEAFF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	5	3	1	24	36	47	39	48														CASSLDRGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGCTGATGGGGTGGTTACTGAAGCTTTCTTTGGACAA	CASSLADGVVTEAFF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	6	2	5	10	5	24	35	49	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLADGVVTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTGAGTGCTCCCGGACTAGCGGGAGGAGACGAGCAGTACTTCGGGCCG	CASSLSAPGLAGGDEQYF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	1	5	13	2	24	35	62	48	64														CASSLSAPGLAGGDEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCATCGGCCCCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	44	1.2207674743153297E-4		41	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	9	0	2	5	3	24	36	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACTTTCGACAGCCCAGGGGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSTFDSPGGLNTEAFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	0	12	2	24	37	56	49	58														CASSTFDSPGGLNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGGGACTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CASSAGTSGGYEQYF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	3	3	0	24	36	-1	39	53														CASSAGTSGGYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGAATCTTGGGGATTCAGTACTTCGGCGCC	CASSLGILGIQYF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-04	01	5	6	2	10	11	0	24	36	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGILGIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01		TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAAAACAGGGGAGCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSENRGAAKNIQYF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	2	0	4	3	24	36	47	40	50														CASSENRGAAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCGGACAGGGTATCTATGGCTACACCTTCGGTTCG	CASSGGQGIYGYTF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	3	3	24	36	47	39	50														CASSGGQGIYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGGGGACTAGCGGGAGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	58	1.6091934888702074E-4		49	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	1	1	1	0	24	37	-1	38	53														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGCGGGGAAGAAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	60	1.6646829195209043E-4		41	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	0	0	8	7	1	4	24	41	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGGGGCTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVGGAGTGELFF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	9	0	4	3	4	24	36	46	39	50														CASSVGGAGTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGTGCTAAAAAAGACCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	74	2.053108934075782E-4		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	12	13	24	35	50	47	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGACTAGCTCTTAACGAGCAGTACTTCGGGCCG	CASSVGLALNEQYF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	7	5	3	5	24	36	47	39	52						01,02								CASSVGLALNEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCTTTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSGFLAKNIQYF	In	VDJ	1	94	2.60800324058275E-4	2.940265687412222E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	9	0	0	0	5	24	-1	39	36	44														CASSGFLAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCCTCGGGCAAGCGGGAAAGCCTTAATGAGCAGTTCTTCGGGCCA	CASSVASGKRESLNEQFF	In	VDJ	1	149	4.1339625834769123E-4	4.6606339087704374E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	3	7	13	7	24	36	56	49	63														CASSVASGKRESLNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGCGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPRTGGTDTQYF	In	VDJ	2	189	5.243751196490848E-4	5.911810797030958E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	1	4	0	24	36	-1	40	49														CASSPRTGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSVVYTGELFF	In	VDJ	3	262	7.269115415241282E-4	8.195208618106407E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	8	3	1	3	24	36	40	37	43						01,02								CASSVVYTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGATCCCGGGTGTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	381	0.0010570736538957743		37	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	8	4	1	5	3	24	31	40	36	43						01,02								X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGAGGACGGATCCTCCTACGAACAGTACTTCGGGCCG	CASSEEDGSSYEQYF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	45	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-07	01	1	1	7	10	1	15	24	40	45	41	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEDGSSYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTACCGGGACAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSEATGTGQETQYF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	3	2	4	0	23	40	-1	44	53														CASSEATGTGQETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGCTAGGGGACTAGCGGGAGGGGATACGCAGTATTTTGGCCCA	CASSEGARGLAGGDTQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	0	0	6	7	0	23	39	-1	46	62														CASSEGARGLAGGDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGACGGTGGGACTAGCGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSEGTVGLAGEETQYF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	0	2	3	7	0	23	39	-1	46	60														CASSEGTVGLAGEETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTGAGGGGGCGCACAGATACGCAGTATTTTGGCCCA	CASSEVRGRTDTQYF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	5	0	1	2	0	23	39	-1	41	48														CASSEVRGRTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGTCGGGAGGGAACTTTCTCCGGTCGTGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	1.581448773544859E-4		61	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	0	7	2	19	20	37	47	39	66														X+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGTCAAGGGGGTATTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGVKGVFGANVLTF	In	VDJ	1	94	2.60800324058275E-4	2.940265687412222E-4	54	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	5	1	3	6	4	23	39	51	45	55														CASSEGVKGVFGANVLTF+TCRBV06-01+TCRBJ02-06	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCAGGCATGAGGGCTCAGAACGAAGCTTTCTTTGGACAA	CASSEAGMRAQNEAFF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	0	8	6	8	23	40	51	46	59														CASSEAGMRAQNEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCAGTGAGGGGACTAGCGGGAGGGGATACGCAGTATTTTGGCCCA	CASSEAVRGLAGGDTQYF	In	VDJ	1	108	2.9964292551376277E-4	3.3781775983034043E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	0	0	6	6	0	23	40	-1	46	62														CASSEAVRGLAGGDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGAGCACAATGAGCAGTTCTTCGGGCCA	CASSEEEHNEQFF	In	VDJ	1	125	3.468089415668551E-4	3.909927775814125E-4	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	10	2	5	1	1	23	39	44	40	45														CASSEEEHNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGAACCCTAGGACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSEGTLGLAGGETQYF	In	VDJ	1	128	3.5513235616445955E-4	4.003766042433664E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	1	1	4	8	0	23	39	-1	47	61														CASSEGTLGLAGGETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCAAGTCGGGACACCTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEASRDTYSGANVLTF	In	VDJ	3	315	8.739585327484748E-4	9.853017995051596E-4	57	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	0	6	0	5	4	23	40	51	45	55														CASSEASRDTYSGANVLTF+TCRBV06-01+TCRBJ02-06	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGAGGGGGAATCCCACGAGCAGTACTTCGGGCCG	CASSEEEGESHEQYF	In	VDJ	3	352	9.766139794522637E-4	0.0011010356616692576	45	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-07	01	1	5	1	5	3	6	23	39	48	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEEGESHEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAGGTCAGGCCAAAAACATTCAGTACTTCGGCGCC	CAISEGQAKNIQYF	In	VDJ	4	394	0.001093141783818727	0.0012324092349366123	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	5	1	2	0	23	39	-1	41	44														CAISEGQAKNIQYF+TCRBV06-01+TCRBJ02-04	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGTAGCGGGAGCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGSGSSNTGELFF	In	VDJ	6	668	0.0018533469837332733	0.0020894654033950686	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	5	2	0	1	2	23	39	49	40	51														CASSEGSGSSNTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCGAGGACAGGGACATGAAAAACTGTTTTTTGGCAGT	CASSEARGQGHEKLFF	In	VDJ	20	2140	0.005937369079624558	0.006693796352193782	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	3	6	4	2	23	40	52	44	54														CASSEARGQGHEKLFF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCACAACTAGTAAATGAGCAGTTCTTCGGGCCA	CASSSQLVNEQFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	39	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	8	7	4	2	22	35	44	39	46						01,02								CASSSQLVNEQFF+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAATCCAAATCGGGACAGCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	8.600861750858006E-5		47	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	1	9	2	22	32	48	41	50														X+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGTAGGCAGGGGGCAACCCACAGATACGTAGTATTTTGGCCCA	CASSLVGRGQPTDT*YF	Stop	VDJ	1	74	2.053108934075782E-4		51	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	0	13	4	15	22	38	50	42	65														CASSLVGRGQPTDT*YF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCCTGACAGGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	79	2.191832510702524E-4		41	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	3	3	1	22	35	46	38	47														X+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTGCCAGCAGCTTATCCAGGGGGCCCTAACCGGGACTAGCGGGAGGAGGTGCAGATACGCAGTATTTTGGCCCA	CASSLSRGP*PGLAGGGADTQYF	Stop	VDJ	1	93	2.5802585252574016E-4		69	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	1	4	17	5	0	15	47	32	52														CASSLSRGP*PGLAGGGADTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGGGCGACTGAAGCTTTCTTTGGACAA	CAWSRATEAFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	2	8	0	5	1	1	26	38	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSRATEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGGGCCACCCGGGACCGTGGCTACACCTTCGGTTCG	CARATRDRGYTF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	8	0	7	7	10	2	26	32	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CARATRDRGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATCCGGGACAGGGTTACGGCTACACCTTCGGTTCG	CAWNPGQGYGYTF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	8	4	4	26	36	49	40	53			unresolved										Vb 20	CAWNPGQGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGACAGATACGCAGTATTTTGGCCCA	CAWSVRTDTQYF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	8	5	3	1	0	26	40	-1	41	44						01,02							Vb 20	CAWSVRTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGAGAGGTGGGCGCAGATACGCAGTATTTTGGCCCA	CAREVGADTQYF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	8	8	0	4	8	1	26	32	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAREVGADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGACACTAATCAGCCCCAGCATTTTGGTGAT	CAWSPDTNQPQHF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	6	4	2	2	26	38	45	40	47													Vb 20	CAWSPDTNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGCGATGGGGGGCGGTGCCTACAATGAGCAGTTCTTCGGGCCA	CAWRAMGGGAYNEQFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	48	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-01	01	3	6	0	2	7	4	26	37	50	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRAMGGGAYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACCAGGGCCCTATGGCTACACCTTCGGTTCG	CAWRPGPYGYTF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	4	2	2	26	37	44	39	46													Vb 20	CAWRPGPYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTATGGAGTCGGACGGGCTCACATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	9.710650363871942E-5		49	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	0	1	7	7	9	8	26	40	53	49	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATACAGGGGCGGTCTGAAGCTTTCTTTGGACAA	CAWSIQGRSEAFF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	2	6	2	4	26	38	47	40	51													Vb 20	CAWSIQGRSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTACAGTAATGAAAAACTGTTTTTTGGCAGT	CAWSYSNEKLFF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	5	4	1	0	26	38	-1	39	43			unresolved										Vb 20	CAWSYSNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGATGATCGGCCGGAGGAGTCCTACGAGCAGTACTTCGGGCCG	CAWNDDRPEESYEQYF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	1	1	13	2	26	36	54	49	56													Vb 20	CAWNDDRPEESYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATATCCGGGACCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWISGTGSSYNEQFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	0	10	0	26	36	-1	46	52													Vb 20	CAWISGTGSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGAGGGCGGGACAGGGCGCCCGGGGCTACACCTTCGGTTCG	CAWKRAGQGARGYTF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	8	7	7	26	36	52	43	59			unresolved										Vb 20	CAWKRAGQGARGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCGACAGGAATTTAGCACTGAAGCTTTCTTTGGACAA	CAWTRQEFSTEAFF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	4	3	7	26	36	45	39	52													Vb 20	CAWTRQEFSTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGGGACAGGGCAGACAGATACGCAGTATTTTGGCCCA	CAWSAGTGQTDTQYF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	3	2	3	26	39	50	41	53			unresolved										Vb 20	CAWSAGTGQTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGGGCCCAGGCTATACCTTCGGTTCG	CAWSEGPGYTF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	1	4	4	14	6	4	26	39	49	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEGPGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGCCGGGACAGGGTGGAACACTGAAGCTTTCTTTGGACAA	CAWRAGTGWNTEAFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	1	4	2	26	37	50	41	52													Vb 20	CAWRAGTGWNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCTTTCCAGCGAGACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	47	1.304001620291375E-4		50	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	6	2	9	3	26	40	53	49	56						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTAGGCGCTCTGGAAACACCATATATTTTGGAGAG	CAWSPRRSGNTIYF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	4	8	0	1	3	26	38	43	39	46			unresolved			01,02							Vb 20	CAWSPRRSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACTAGCGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CAWSGLAGDTGELFF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	2	2	3	0	0	26	-1	-1	39	51													Vb 20	CAWSGLAGDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSLDSNQPQHF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	2	1	8	0	2	0	26	38	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSLDSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCGACAGAGCAAGAGACCCAGTACTTCGGGCCA	CAWTPTEQETQYF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	5	2	4	2	26	36	45	40	47			unresolved										Vb 20	CAWTPTEQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGAAGTCTAGGCTACAATGAGCAGTTCTTCGGGCCA	CAWSRSLGYNEQFF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	8	3	6	1	26	38	48	44	49			unresolved			01,02							Vb 20	CAWSRSLGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGATTGGGTCCCGGGACTAGCTTACGAGCAGTACTTCGGGCCG	CAWSDWVPGLAYEQYF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	7	4	10	1	26	39	58	49	59			unresolved			01,02							Vb 20	CAWSDWVPGLAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCACCGGGACAGGGGTCAATGGCTACACCTTCGGTTCG	CAWTTGTGVNGYTF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	6	5	3	26	36	51	41	54													Vb 20	CAWTTGTGVNGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVQSNQPQHF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	5	1	0	0	26	-1	-1	40	44													Vb 20	CAWSVQSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTTTATGGGGTGGTGGCTACACCTTCGGTTCG	CAWILWGGGYTF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	4	6	2	7	6	3	26	36	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWILWGGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGAGGAGCGGGAACCTACGAGCAGTACTTCGGGCCG	CAWSVGGAGTYEQYF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	3	2	6	1	26	40	53	46	54													Vb 20	CAWSVGGAGTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGGGAGAAGGGGGCTTCGGATGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	65	1.8034064961476462E-4		52	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	1	7	8	26	37	51	44	59			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGGGGGTCCACACCGGGGAGCTGTTTTTTGGAGAA	CAWSVGGVHTGELFF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	0	3	1	3	26	40	48	41	51			unresolved										Vb 20	CAWSVGGVHTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGCGGCGGATACGCAGTATTTTGGCCCA	CAWNAADTQYF	In	VDJ	1	75	2.0808536494011304E-4	2.3459566654884752E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	6	2	2	26	36	42	38	44						01,02							Vb 20	CAWNAADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCCACATAGGAGGGACCCAAGGCGGCCAGCCCCAGCATTTTGGTGAT	CAWSAHIGGTQGGQPQHF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	54	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	10	0	7	8	12	26	39	53	47	65													Vb 20	CAWSAHIGGTQGGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAACAGGGACCTACGAGCAGTACTTCGGGCCG	CAWKTGTYEQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	2	2	1	26	36	44	38	45													Vb 20	CAWKTGTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGCCGACGGACAGTACTTCGGGCCG	CAWSVADGQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	0	1	8	10	7	0	26	40	-1	47	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVADGQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAAAACCCCCGACAGTGAAGCTTTCTTTGGACAA	CAWTKTPDSEAFF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	7	11	0	26	36	-1	47	52			unresolved										Vb 20	CAWTKTPDSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGTGGTAGTACGCGCTGCCCAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	88	2.4415349486306594E-4		47	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	9	18	0	26	37	-1	55	60			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTCAGACTGCCCAGGCCCAGTACTTCGGGCCA	CAWSVQTAQAQYF	In	VDJ	1	91	2.5247690946067047E-4	2.846427420792683E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	0	4	4	9	10	0	26	40	-1	50	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVQTAQAQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTGGGAATTGAACACTGAAGCTTTCTTTGGACAA	CAWWELNTEAFF	In	VDJ	1	91	2.5247690946067047E-4	2.846427420792683E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	5	0	8	0	1	2	26	35	40	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWWELNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGAACAGCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	100	2.7744715325348407E-4		43	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	5	0	4	1	26	40	48	44	49			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTCGAGGGGGGGATACGCAGTATTTTGGCCCA	CAWTRGGDTQYF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	4	5	1	6	4	1	26	36	46	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTRGGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCGACCGGGACAGGGGAGGGAAGCTTTCTTTGGACAA	CAWRPGQGREAFF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	8	5	3	26	35	50	40	53													Vb 20	CAWRPGQGREAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACAGGGAGAACACTGAAGCTTTCTTTGGACAA	CAWSDRENTEAFF	In	VDJ	1	112	3.1074081164390215E-4	3.5032952871294563E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	1	0	1	26	-1	45	39	46			unresolved										Vb 20	CAWSDRENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGGCCCAAAAAGCTCCTACGAGCAGTACTTCGGGCCG	CAWSGGPKSSYEQYF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	7	0	0	0	8	26	-1	44	39	52			unresolved										Vb 20	CAWSGGPKSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGGCTAGCGGGAGGTAGCTACGAGCAGTACTTCGGGCCG	CAWSWLAGGSYEQYF	In	VDJ	1	116	3.2183869777404147E-4	3.628412975955508E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	1	3	3	3	26	38	52	41	55													Vb 20	CAWSWLAGGSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCGACAGGGGCTTGGGACTGAAGCTTTCTTTGGACAA	CAWRRQGLGTEAFF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	5	2	6	26	37	47	39	53			unresolved										Vb 20	CAWRRQGLGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCTAACGGGAGAAGTTTCCGAGAGCAGTTCTTCGGGCCA	CAWSANGRSFREQFF	In	VDJ	1	119	3.30162112371646E-4	3.7222512425750474E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	2	10	6	10	26	37	49	43	59			unresolved										Vb 20	CAWSANGRSFREQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTATCTGTGTTATAGAAAGACCTATGGCTACACCTTCGGTTCG	CAWSYLCYRKTYGYTF	In	VDJ	1	121	3.357110554367157E-4	3.784810086988073E-4	48	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	2	2	7	4	17	0	26	38	-1	55	58			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSYLCYRKTYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGCAAGGGACGGCGGGTCGCAGATACGCAGTATTTTGGCCCA	CAGKGRRVADTQYF	In	VDJ	1	121	3.357110554367157E-4	3.784810086988073E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	8	0	7	4	5	9	26	32	42	37	51			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAGKGRRVADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACTGGGGGGGACTGAACACTGAAGCTTTCTTTGGACAA	CAWNWGGLNTEAFF	In	VDJ	1	126	3.495834130993899E-4	3.941207198020638E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	0	3	2	26	36	46	39	48			unresolved										Vb 20	CAWNWGGLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATCCGGGACAGGGGTATGGCTACACCTTCGGTTCG	CAWNPGQGYGYTF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	5	4	0	26	36	-1	40	50			unresolved										Vb 20	CAWNPGQGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCCCAGGGACGAACACCATATATTTTGGAGAG	CAWSTPGTNTIYF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	2	0	7	7	6	1	26	38	49	44	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSTPGTNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTTCGGAGGGGGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CAFRRGGTNEKLFF	In	VDJ	1	141	3.912004860874125E-4	4.410398531118333E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	9	0	2	6	1	26	33	46	39	47													Vb 20	CAFRRGGTNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCACCGGGGCCAGCCTTCGCTACACCTTCGGTTCG	CAWSTGASLRYTF	In	VDJ	1	152	4.2171967294529577E-4	4.754472175389976E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	3	7	0	9	4	8	26	37	46	41	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSTGASLRYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGACCGGGACAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWMTGTVNTGELFF	In	VDJ	1	153	4.244941444778306E-4	4.7857515975964894E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	1	5	1	26	36	48	41	49			unresolved										Vb 20	CAWMTGTVNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAGGTGGGGAGCTGTTTTTTGGAGAA	CAWSGGGELFF	In	VDJ	1	157	4.3559203060796993E-4	4.910869286422541E-4	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	11	1	8	0	1	26	-1	43	39	44			unresolved										Vb 20	CAWSGGGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTATCTCTGTGCCTGGAGTGTATACCGGGGTGGCAGGGTTGGCGGAGCGGACTCCTACGAGCAGTACTTCGGGCCG	CAWSVYRGGRVGGADSYEQYF	In	VDJ	2	165	4.577878028682487E-4	5.161104664074645E-4	63	TCRBV30	TCRBV30-01					TCRBJ02	TCRBJ02-07	01	0	4	3	0	12	13	9	23	40	35	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVYRGGRVGGADSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCCAATACGAGCAGTACTTCGGGCCG	CAWSFQYEQYF	In	VDJ	2	189	5.243751196490848E-4	5.911810797030958E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	6	4	3	1	26	38	43	41	44			unresolved										Vb 20	CAWSFQYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGCCAGGGGACGCAGTATTTTGGCCCA	CAWSVSQGTQYF	In	VDJ	2	193	5.354730057792242E-4	6.036928485857009E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	9	4	0	26	40	-1	44	50			unresolved										Vb 20	CAWSVSQGTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCCTCTACGACAAAACGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CALYDKTTGDTGELFF	In	VDJ	2	196	5.437964203768288E-4	6.130766752476548E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	2	3	14	0	26	32	-1	46	54													Vb 20	CALYDKTTGDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTTTGACGTAGGGCTTGCATTTTCTGAAGCTTTCTTTGGACAA	CAWFDVGLAFSEAFF	In	VDJ	2	196	5.437964203768288E-4	6.130766752476548E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	5	5	3	6	8	10	26	35	47	43	57			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWFDVGLAFSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCACGACAGTCCTAATGAAAAACTGTTTTTTGGCAGT	CAWHDSPNEKLFF	In	VDJ	2	197	5.465708919093636E-4	6.162046174683062E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	3	3	2	26	35	43	38	45			unresolved										Vb 20	CAWHDSPNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCACGACCCTAGCGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CATTLAGSYNEQFF	In	VDJ	2	200	5.548943065069681E-4	6.255884441302601E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	4	3	1	6	0	26	32	-1	38	47			unresolved										Vb 20	CATTLAGSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGTAGGGGCTACACCTTCGGTTCG	CAWSVGRGYTF	In	VDJ	2	215	5.965113794949906E-4	6.725075774400295E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	0	0	9	8	0	4	26	-1	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGRGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATCGGGACAGATGCCGGGGAGCTGTTTTTTGGAGAA	CAWSIGTDAGELFF	In	VDJ	2	218	6.048347940925952E-4	6.818914041019834E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	5	6	3	3	26	38	48	41	51			unresolved										Vb 20	CAWSIGTDAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTAGGATCGGACGTCAGCCCCAGCATTTTGGTGAT	CAWSARIGRQPQHF	In	VDJ	2	224	6.214816232878043E-4	7.006590574258913E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	1	1	7	6	8	1	26	39	51	47	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSARIGRQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATAACTAGCGGGCCATCCTACAATGAGCAGTTCTTCGGGCCA	CAWITSGPSYNEQFF	In	VDJ	2	229	6.353539809504785E-4	7.162987685291477E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	4	1	2	3	26	36	47	38	50						01,02							Vb 20	CAWITSGPSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTCCGGAAACTACAATGAGCAGTTCTTCGGGCCA	CAWSSGNYNEQFF	In	VDJ	3	262	7.269115415241282E-4	8.195208618106407E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	3	1	8	3	4	2	26	37	44	41	46			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSSGNYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGGGACTAGCGGGAAGTGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	273	7.574307283820114E-4		50	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	3	2	2	7	26	35	50	37	57													Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAACTTAGGGCTTGGGGGAGGAAACACCATATATTTTGGAGAG	CAWSVNLGLGGGNTIYF	In	VDJ	3	315	8.739585327484748E-4	9.853017995051596E-4	51	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	0	6	1	4	13	1	26	40	58	53	59			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVNLGLGGGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGACTTCGATGAGCAGTTCTTCGGGCCA	CAWSVRDFDEQFF	In	VDJ	3	335	9.294479633991715E-4	0.0010478606439181855	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	8	2	3	26	40	48	42	51						01,02							Vb 20	CAWSVRDFDEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGCAGGGTTCTAGGGGCTGAAGCTTTCTTTGGACAA	CAWSGRVLGAEAFF	In	VDJ	3	362	0.0010043586947776123	0.0011323150838757708	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	6	1	9	26	39	45	40	54													Vb 20	CAWSGRVLGAEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAATCCAGGCGAATAACAGATACGCAGTATTTTGGCCCA	CAWKSRRITDTQYF	In	VDJ	3	363	0.001007133166310147	0.001135443026096422	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	4	3	4	6	26	36	44	40	50			unresolved										Vb 20	CAWKSRRITDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGTCCGAATCAGCCCCAGCATTTTGGTGAT	CAWSVGPNQPQHF	In	VDJ	4	375	0.0010404268247005651	0.0011729783327442376	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	0	5	4	4	0	4	26	-1	43	40	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGPNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATTACGGCCTCAACCGAGCAGTACTTCGGGCCG	CAWSITASTEQYF	In	VDJ	4	381	0.0010570736538957743	0.0011917459860681455	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	2	9	0	6	5	6	26	38	46	43	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSITASTEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGACATCTTTAAAGAAGCTTTCTTTGGACAA	CAWSVDIFKEAFF	In	VDJ	5	508	0.0014094315385276988	0.0015889946480908605	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	6	8	1	8	26	40	45	41	53			unresolved										Vb 20	CAWSVDIFKEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	31	8.600861750858006E-5		38	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	3	6	5	1	5	23	32	36	33	41														X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAATCCGGGACATCGGGAGGGATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQSGTSGGISNQPQHF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	57	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	8	0	0	10	2	23	38	56	48	58														CASSQSGTSGGISNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAGTTAGCGGGAGATTTTGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	1.1652780436646329E-4		50	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	3	2	7	23	37	48	39	55														X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATCAAGTTCGGCTAGTTGTAGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	43	1.1930227589899814E-4		58	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	8	1	10	6	23	40	54	50	60						01,02								X+TCRBV01-01+TCRBJ02-04	TCRBV01-01*01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCGGGACAGCTTTCCTCGAGAGCAGTACTTCGGGCCG	CASSPRDSFPREQYF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	7	3	10	23	36	46	39	56														CASSPRDSFPREQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCATGGAAGACTAGCGGCCTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	49	1.359491050942072E-4		49	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	5	2	5	3	23	37	51	42	54						01,02								X+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGACCCAGGGCCCCAGCCCCAGCATTTTGGTGAT	CASSDPGPQPQHF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	7	4	3	23	35	44	39	47														CASSDPGPQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGAACGGGGGCTTAGAAGCTTTCTTTGGACAA	CASSQNGGLEAFF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	3	6	0	8	4	3	23	37	47	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNGGLEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATAGCGGGAGGGCGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDSGRASGANVLTF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	5	0	1	0	2	23	-1	51	40	53														CASSQDSGRASGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGAGGGACAGGGTTTGAGCTGCAGCCCCAGCATTTTGGTGAT	CASSQGGTGFELQPQHF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	3	7	2	9	23	39	50	41	59														CASSQGGTGFELQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACCCGGACTCTCACAATGAGCAGTTCTTCGGGCCA	CASSQDPDSHNEQFF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	10	5	3	3	23	40	48	43	51						01,02								CASSQDPDSHNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCTTAGCGGGAGGGCCGAATGAGCAGTTCTTCGGGCCA	CASSLLAGGPNEQFF	In	VDJ	1	82	2.2750666566785692E-4	2.564912620934066E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	7	3	3	23	36	50	39	53														CASSLLAGGPNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAAGGACTAGCAGTTTCACAGATACGCAGTATTTTGGCCCA	CASSQERTSSFTDTQYF	In	VDJ	1	92	2.552513809932053E-4	2.877706842999196E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	7	2	2	5	23	40	50	42	55						01,02								CASSQERTSSFTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGGGACAAGTCTGGAAACACCATATATTTTGGAGAA	CASSQGDKSGNTIYF	In	VDJ	1	98	2.718982101884144E-4	3.065383376238274E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	6	19	2	19	23	37	45	39	64														CASSQGDKSGNTIYF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCTGACTGCTGAGCAGTTCTTCGGGCCA	CASSQDLTAEQFF	In	VDJ	1	102	2.829960963185537E-4	3.190501065064326E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	10	9	3	2	23	40	47	43	49						01,02								CASSQDLTAEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGACTACCCGGGACCCTACGAGCAGTACTTCGGGCCG	CASSQDYPGPYEQYF	In	VDJ	1	102	2.829960963185537E-4	3.190501065064326E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	9	2	0	8	23	-1	43	37	51						01,02								CASSQDYPGPYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGCGAGGGGGTTTCCTAGATACGCAGTATTTTGGCCCA	CASSPRGGFLDTQYF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	1	5	4	6	23	36	46	40	52														CASSPRGGFLDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCGAGGTGGGTTTGTCAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	256	7.102647123289191E-4		52	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	11	1	5	0	16	23	-1	39	35	55														X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTAGGGACGCTCAACGAGCAGTACTTCGGGCCG	CASSQVGTLNEQYF	In	VDJ	5	574	0.0015925466596749985	0.0017954388346538464	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	1	0	7	5	2	5	23	39	46	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGTLNEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGACCCCGGGGGCAGGGAGCAGTACTTCGGGCCG	CASSQDPGGREQYF	In	VDJ	6	641	0.0017784362523548328	0.002005010963437483	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	3	6	0	7	7	3	23	37	50	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPGGREQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTATTCTATACGGTTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	7.491073137844069E-5		47	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	7	2	7	4	19	0	19	28	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCACACCCAAGATCGGTATATACAATGAGCAGTTCTTCGGGCCA	CASSPTPKIGIYNEQFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	51	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	4	3	6	4	3	15	19	31	37	34	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPTPKIGIYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTGAGGGGACGGGTTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	7.768520291097554E-5		44	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	4	5	6	19	31	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTCGGGGGGCGAATCTCAAATGAGCAGTTCTTCGGGCCA	CASSLVGGRISNEQFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	1	7	1	9	19	35	43	36	52													Vb 5.1	CASSLVGGRISNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCGAGAGACAGGGTCGGAAATGCTTTCTTTGGACAA		Out	VDJ	1	28	7.768520291097554E-5		41	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	11	6	8	19	30	43	36	51													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGTTCGTTGGCGGGAACTTACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	8.045967444351037E-5		52	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	3	3	10	5	19	31	47	41	52													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGTCCTTCCAAGAGACCCAGTACTTCGGGCCA	CASSPGSFQETQYF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	4	1	2	5	19	31	37	33	42						01,02							Vb 5.1	CASSPGSFQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGACCAGGGTCTTTGGACGGGGAGCTGTTTTTTGGAGAA	CASSGPGSLDGELFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	7	4	8	19	31	40	35	48													Vb 5.1	CASSGPGSLDGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAAGGGACTAGCCTTAGCACAGATACGCAGTATTTTGGCCCA	CASSEGTSLSTDTQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	7	0	3	3	19	31	43	34	46						01,02							Vb 5.1	CASSEGTSLSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGCGGGAGCAGCACAGATACGCAGTATTTTGGCCCA	CASSFGGSSTDTQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	2	0	2	1	19	33	42	35	43													Vb 5.1	CASSFGGSSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTGGGGGAGCGGGCTACGAGCAGTACTTCGGGCCG	CASSLVGGAGYEQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	4	3	7	0	19	35	-1	42	48						01,02							Vb 5.1	CASSLVGGAGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTAAAGGGGATGGAAGTCGCGAGCAGTACTTCGGGCCG	CASSKGDGSREQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	6	3	10	19	30	38	33	48													Vb 5.1	CASSKGDGSREQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCACCGTTCAGGGGCCAGGTGGGGAGCTGTTTTTTGGAGAA	CASSPTVQGPGGELFF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	8	9	6	19	31	46	40	52													Vb 5.1	CASSPTVQGPGGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTTGTTAGCCGTCGACTATGGCTACACCTTCGGTTCG	CASSLLAVDYGYTF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	5	7	3	1	5	19	34	39	35	44						01,02							Vb 5.1	CASSLLAVDYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATACGGGAGGGCCTGCCGGGGAGCTGTTTTTTGGAGAA	CASSLDTGGPAGELFF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	8	0	6	3	4	19	35	46	38	50													Vb 5.1	CASSLDTGGPAGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAAGACCGGGACGACAGAAAAAAAACTGTTTTTTGGCAGT	CASKTGTTEKKLFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	6	0	7	9	5	8	19	29	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASKTGTTEKKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCGGGAAGACAAGTCTAGCATTCAGTACTTCGGCGCC	CASSLREDKSSIQYF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	8	3	9	0	12	19	-1	39	34	51													Vb 5.1	CASSLREDKSSIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCTCCGGGTTAGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	41	1.1375333283392846E-4		40	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	8	4	7	4	5	19	30	38	34	43						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCTTTCGACAGGGAATTTAGTGTACACTGAAGCTTTCTTTGGACAA	CASSLSTGNLVYTEAFF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	3	6	10	19	30	43	36	53													Vb 5.1	CASSLSTGNLVYTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGAGAACCGGGAGGCGCCTACGAGCAGTACTTCGGGCCG	CASSREPGGAYEQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	1	2	7	2	19	31	45	38	47													Vb 5.1	CASSREPGGAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGPNTGELFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	2	7	0	0	0	19	-1	-1	35	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGPNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCATAGGGGTGTGGGGGCCAACGTCCTGACTTTCGGGGCC	CASHRGVGANVLTF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	5	2	4	3	4	19	28	36	31	40													Vb 5.1	CASHRGVGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCCGGGACAGGGTAACGGGGAAAACTATGGCTACACCTTCGGTTCG	CASSSPGQGNGENYGYTF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	2	4	10	19	32	45	36	55													Vb 5.1	CASSSPGQGNGENYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCGACAGCAACCACTGAAGCTTTCTTTGGACAA	CASSLSTATTEAFF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	4	2	4	19	34	41	36	45													Vb 5.1	CASSLSTATTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCAGGGGGGCGGGAGGGCCCCATATGAGCAGTTCTTCGGGCCA	CASSSQGGGRAPYEQFF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	0	8	9	6	19	32	50	41	56													Vb 5.1	CASSSQGGGRAPYEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGACAGTTGGGAGGTTGCTAATGAAAAACTGTTTTTTGGCAGT	CASSPDSWEVANEKLFF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	4	1	5	3	2	11	19	31	39	33	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPDSWEVANEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGACAAGATCCCGGGACGCGCCCGCTGTTTTTTGGAGAA	CASRQDPGTRPLFF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	5	0	7	13	10	6	19	30	45	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASRQDPGTRPLFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTATACCACCAAGCCGAACCATATGGGAGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	76	2.1085983647264788E-4		62	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	1	1	22	0	19	33	-1	55	61													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCTACGGGACAGGGGTTAGCAACGAGCAGTACTTCGGGCCG	CASSSYGTGVSNEQYF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	5	5	6	19	32	47	37	53													Vb 5.1	CASSSYGTGVSNEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACCCGCGCCAGGGTTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	91	2.5247690946067047E-4		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	4	8	2	19	31	44	39	46													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGGAGGGACGGCAGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	98	2.718982101884144E-4		52	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	0	2	1	10	19	33	41	34	51													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTCACCCAAGGACAGGGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVTQGQGANTGELFF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	57	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	0	2	8	1	19	35	54	43	55													Vb 5.1	CASSLVTQGQGANTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGTGGGACTAGGGTATTACAATGAGCAGTTCTTCGGGCCA	CASSVGLGYYNEQFF	In	VDJ	3	275	7.629796714470811E-4	8.601841106791075E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	8	4	0	5	19	-1	41	35	46						01,02							Vb 5.1	CASSVGLGYYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGAGACTAGCCCACAATGAGCAGTTCTTCGGGCCA	CASSGRLAHNEQFF	In	VDJ	4	453	0.0012568356042382827	0.001416957825955039	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	7	5	4	2	19	31	42	35	44						01,02							Vb 5.1	CASSGRLAHNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTACATGGACACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	6	635	0.0017617894231596236		43	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	2	1	7	2	4	0	19	33	-1	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGACTAGCGGGGGACAATAAGCAGTTCTTCGGGCCA	CASSRLAGDNKQFF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	11	2	6	25	36	50	38	56													Vb 3	CASSRLAGDNKQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCGACTAGTTCGGGGCTCACAGATACGCAGTATTTTGGCCCA	CASSPSTSSGLTDTQYF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	8	2	5	9	25	37	48	42	57						01,02							Vb 3	CASSPSTSSGLTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTCACGGGGTGGGGGGCGCGAGATACGCAGTATTTTGGCCCA	CASLTGWGARDTQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	8	6	0	5	11	3	25	34	51	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASLTGWGARDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAAGGGAGGACAGGGTGAGAAGGAGCAGTTCTTCGGGCCA	CASSKGGQGEKEQFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	10	6	7	25	37	51	43	58													Vb 3	CASSKGGQGEKEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGGGGACAGAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGGTETNTGELFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	5	0	3	3	25	34	44	37	47													Vb 3	CASGGTETNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCTATGTACCTCTGTGCCAGCAGTTTATGAACAAATAGGGACAGGGGAAGAGGTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	9.433203210618458E-5		61	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	2	2	8	7	12	29	47	37	54													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGCCTCCGGGACAGTGGGTCTAGCACCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	9.710650363871942E-5		55	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	4	8	12	25	36	51	44	63													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCAGTGGACTAGCGGGAGGAGTGGCCAAAAACATTCAGTACTTCGGCGCC	CASSGLAGGVAKNIQYF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	1	1	1	0	4	25	-1	51	37	55													Vb 3	CASSGLAGGVAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCGGGACACAACCCATATACGCAGTATTTTGGCCCA	CASRPGHNPYTQYF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	6	7	3	8	25	36	45	39	53													Vb 3	CASRPGHNPYTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGCAAAGTGAGCAGTTCTTCGGGCCA	CASSLLQSEQFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	1	4	6	9	2	3	25	41	45	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLQSEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACCAGCCGGGGACTAGCCGCTACGAGCAGTACTTCGGGCCG	CASNQPGTSRYEQYF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	7	3	8	2	25	35	52	43	54						01,02							Vb 3	CASNQPGTSRYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTTGGGGGAGGGACTCGACTTATGGCTACACCTTCGGTTCG	CASWGRDSTYGYTF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	9	9	0	5	4	8	25	33	44	37	52													Vb 3	CASWGRDSTYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACCCCTAACTATGGCTACACCTTCGGTTCG	CASRTPNYGYTF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	2	7	0	0	2	25	-1	39	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRTPNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGGATAACTATGGCTACACCTTCGGTTCG	CASSLQDNYGYTF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	1	0	1	25	-1	44	40	45													Vb 3	CASSLQDNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTTGGGAGAACCCCGGGGGAAAAACTGTTTTTTGGCAGT	CASSFFGRTPGEKLFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	8	3	8	14	0	25	39	-1	53	58						01,02							Vb 3	CASSFFGRTPGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAGACTAGCGATCCCTACAATGAGCAGTTCTTCGGGCCA	CASSQTSDPYNEQFF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	6	2	3	3	25	36	47	39	50						01,02							Vb 3	CASSQTSDPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGCAAGTGGACAGCACACAGCTAACTATGGCTACACCTTCGGTTCG	CAASGQHTANYGYTF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	1	5	0	6	7	25	31	43	37	50													Vb 3	CAASGQHTANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGCCACGGGGTACTATGGCTACACCTTCGGTTCG	CASRATGYYGYTF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	3	5	1	25	36	46	41	47													Vb 3	CASRATGYYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAATACCAGGGGTCGCCCAATCAGCCCCAGCATTTTGGTGAT	CASSEYQGSPNQPQHF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	3	6	5	25	37	49	43	54													Vb 3	CASSEYQGSPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAATTCGCGACTATGAGCAGTTCTTCGGGCCA	CASSSIRDYEQFF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	8	8	0	25	38	-1	46	50						01,02							Vb 3	CASSSIRDYEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTTCAGGGCGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGRSNQPQHF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	4	3	1	2	3	25	33	40	35	43													Vb 3	CASSGRSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGGACTACCAGAAACTATGGCTACACCTTCGGTTCG	CASSPGTTRNYGYTF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	9	2	3	5	25	37	47	40	52						01,02							Vb 3	CASSPGTTRNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCCACACCTCCTTCTCTGGAAACACCATATATTTTGGAGAG	CASSLPHTSFSGNTIYF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	6	0	4	7	25	40	47	44	54													Vb 3	CASSLPHTSFSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCCCAGGGCTTTGGCAATCAGCCCCAGCATTTTGGTGAT	CASRPQGFGNQPQHF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	2	4	5	25	36	45	40	50													Vb 3	CASRPQGFGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	56	1.5537040582195107E-4		38	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	0	9	0	0	1	25	-1	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGGGGACAGCAGCTCCGAAAAACTGTTTTTTGGCAGT	CASSPGDSSSEKLFF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	8	5	7	25	36	48	41	55													Vb 3	CASSPGDSSSEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCCTGGGACAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSSLGQGSYEQYF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	0	6	0	25	36	-1	42	51													Vb 3	CASSSLGQGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGGCGGGGGGCGAAGGTCAGCCCCAGCATTTTGGTGAT	CASSLRAGGEGQPQHF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	7	1	6	3	6	25	40	51	43	57													Vb 3	CASSLRAGGEGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAATGGGGCTGGGAAGAACACTGAAGCTTTCTTTGGACAA	CASNGAGKNTEAFF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	7	0	1	2	6	25	35	42	37	48													Vb 3	CASNGAGKNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGGGGGGGACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	61	1.6924276348462527E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	0	0	0	1	25	-1	48	40	49													Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGCCTCCTATAAACAATGAGCAGTTCTTCGGGCCA	CASSLEPPINNEQFF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	9	5	7	3	25	40	50	47	53						01,02							Vb 3	CASSLEPPINNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCCAGGGTTCTGGACTACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSTQGSGLLAKNIQYF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	1	9	0	12	2	25	37	55	49	57						01,02							Vb 3	CASSTQGSGLLAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTACAGGGGCTAACTATGGCTACACCTTCGGTTCG	CASTGANYGYTF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	2	0	1	0	25	33	-1	34	41													Vb 3	CASTGANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCCTCGGCACTGAAGCTTTCTTTGGACAA	CASTPLGTEAFF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	8	5	4	7	0	25	35	-1	42	45						01,02							Vb 3	CASTPLGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTGGCGGGAGGGCCTCCTGCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	68	1.8866406421236915E-4		52	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	0	4	3	9	25	41	53	44	62													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGTTAGGGGGCGAGGGAACACTGAAGCTTTCTTTGGACAA	CASSFVRGRGNTEAFF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	1	4	4	25	39	50	43	54													Vb 3	CASSFVRGRGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCGAACGGGACAAGGCGTCCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSTERDKASLSGNTIYF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	6	0	7	10	24	36	49	43	59													Vb 3	CASSTERDKASLSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGAGACCGGGGCAGATACGCAGTATTTTGGCCCA	CASSSETGADTQYF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	3	4	7	0	25	38	-1	45	50													Vb 3	CASSSETGADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGCACAGGGCTATAGTGGCTACACCTTCGGTTCG	CASSSAQGYSGYTF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	7	4	6	25	38	48	42	54													Vb 3	CASSSAQGYSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCCGAGGGGGATGGAACATTCAGTACTTCGGCGCC	CASSRGGWNIQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	5	1	7	5	4	25	34	45	39	49													Vb 3	CASSRGGWNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCACACTCGGGACAGGCGGATCAGCCCCAGCATTTTGGTGAT	CASSPHSGQADQPQHF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	4	5	8	3	25	37	53	45	56													Vb 3	CASSPHSGQADQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCTATCCCGGGGGGCTGGAGAGACCCAGTACTTCGGGCCA	CASSFLSRGAGETQYF	In	VDJ	1	76	2.1085983647264788E-4	2.377236087694988E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	1	4	7	4	25	39	53	46	57													Vb 3	CASSFLSRGAGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGAGGGACAGGGGGCTGGTGAAGCTTTCTTTGGACAA	CASSPEGQGAGEAFF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	0	7	5	3	25	37	54	42	57													Vb 3	CASSPEGQGAGEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGACTAGCGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSWTSGSTDTQYF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	5	0	0	1	25	-1	48	38	49						01,02							Vb 3	CASSWTSGSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCACCTGCTTACAATGAGCAGTTCTTCGGGCCA	CASSPPAYNEQFF	In	VDJ	1	78	2.1640877953771754E-4	2.439794932108014E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	6	3	7	4	3	5	25	36	41	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPPAYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTGACAGGCCCCAGGGCTGAAGCTTTCTTTGGACAA	CASSLTGPRAEAFF	In	VDJ	1	78	2.1640877953771754E-4	2.439794932108014E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	6	3	8	25	36	45	39	53													Vb 3	CASSLTGPRAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAGGGGGTACACTGAAGCTTTCTTTGGACAA	CASRRGYTEAFF	In	VDJ	1	78	2.1640877953771754E-4	2.439794932108014E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	3	1	1	25	36	43	37	44													Vb 3	CASRRGYTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCAGACATCTATGTACCTCTGTGCCAGCAGTCTACCACCGGGACTAGCGGACCTCGTCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLPPGLADLVPYNEQFF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	60	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	2	8	9	21	33	52	41	61						01,02							Vb 3	CASSLPPGLADLVPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCCGGGACAGATCCGGCGGCTATGGCTACACCTTCGGTTCG	CASSARDRSGGYGYTF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	4	4	9	25	37	48	41	57													Vb 3	CASSARDRSGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGTAGCCGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVAGSGANVLTF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	5	7	0	1	3	25	37	42	38	45						01,02							Vb 3	CASSVAGSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATAGCGGGAGCCCACGAGCAGTACTTCGGGCCG	CASSLIAGAHEQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	2	5	1	3	25	40	50	41	53													Vb 3	CASSLIAGAHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCGGGACAAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	87	2.4137902333053112E-4		46	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	1	5	1	25	37	48	42	49													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGAGGTAGCGCAAGACACACAGATACGCAGTATTTTGGCCCA	CASSRGSARHTDTQYF	In	VDJ	1	94	2.60800324058275E-4	2.940265687412222E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	6	2	6	7	25	36	47	42	54						01,02							Vb 3	CASSRGSARHTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAATGGTCACCGGGAGGACGAGCAGTACTTCGGGCCG	CASSLNGHREDEQYF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	1	5	9	0	25	40	-1	49	56													Vb 3	CASSLNGHREDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCGTCCAACACTGAAGCTTTCTTTGGACAA	CASSLPSNTEAFF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	6	2	1	3	25	40	43	41	46						01,02							Vb 3	CASSLPSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCCGCGGACTAGCGGGATTGGTCGATACGCAGTATTTTGGCCCA	CASRGLAGLVDTQYF	In	VDJ	1	98	2.718982101884144E-4	3.065383376238274E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	1	3	6	3	6	25	34	49	37	55													Vb 3	CASRGLAGLVDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACCCAACTTACTAGCGGGAAGGACAGATACGCAGTATTTTGGCCCA	CASSSPNLLAGRTDTQYF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	3	3	10	3	25	38	58	48	61													Vb 3	CASSSPNLLAGRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAAATCAGGGAGGCCCCTGAAGCTTTCTTTGGACAA	CASSQIREAPEAFF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	6	8	3	25	36	50	44	53													Vb 3	CASSQIREAPEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTCAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLVRENTEAFF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	1	2	1	25	40	47	42	48													Vb 3	CASSLVRENTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCACGATATGGGGACAGCGAGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CATTIWGQRVSNQPQHF	In	VDJ	1	102	2.829960963185537E-4	3.190501065064326E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	0	5	1	10	6	25	32	49	42	55													Vb 3	CATTIWGQRVSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGGCAGGCCAGCAATCAGCCTCAGCATTTTGGTGAT	CASSLRQASNQPQHF	In	VDJ	1	102	2.829960963185537E-4	3.190501065064326E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	4	13	3	14	25	40	47	43	61													Vb 3	CASSLRQASNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCCCCGTCGGGTGAGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	106	2.940939824486931E-4		35	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	11	8	4	7	5	4	25	31	40	36	44						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGCGGGACAGGGGATCACTGAAGCTTTCTTTGGACAA	CASSPAGQGITEAFF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	4	5	2	25	37	52	42	54													Vb 3	CASSPAGQGITEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAATCCAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASRNPGDTGELFF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	3	5	0	25	36	-1	41	47													Vb 3	CASRNPGDTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGGACAGGGTGATCAGCCCCAGCATTTTGGTGAT	CASSLGGQGDQPQHF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	5	2	2	25	40	51	42	53													Vb 3	CASSLGGQGDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCCGGGGCTACTGGCGGAAAACTGTTTTTTGGCAGT	CASSSPGATGGKLFF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	4	7	0	10	5	9	25	38	48	43	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSPGATGGKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTTGGCCCGAGGTGGACTGAAGCTTTCTTTGGACAA	CASSLLGPRWTEAFF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	1	5	8	3	25	40	52	48	55													Vb 3	CASSLLGPRWTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGGGGAAGTTTAACACTGAAGCTTTCTTTGGACAA	CASSLEGKFNTEAFF	In	VDJ	1	127	3.523578846319247E-4	3.9724866202271513E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	5	2	2	1	6	25	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLEGKFNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGACTAGCGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSRTSGAYNEQFF	In	VDJ	1	128	3.5513235616445955E-4	4.003766042433664E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	2	1	0	25	37	-1	38	50													Vb 3	CASSRTSGAYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAAACTAGCGGGCCCCCGAGCGGAGATAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	141	3.912004860874125E-4		58	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	4	5	3	15	23	38	50	41	65						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGGTTAGCGGGAGTGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLEVSGSGSYNEQFF	In	VDJ	2	172	4.7720910359599255E-4	5.380060619520236E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	2	1	5	4	25	40	54	45	58													Vb 3	CASSLEVSGSGSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGACAGGGTACGAGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSPTGYEGNQPQHF	In	VDJ	2	176	4.883069897261319E-4	5.505178308346288E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	4	2	9	25	37	46	39	55													Vb 3	CASSPTGYEGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCACCTCCGGGACAGAAGCCAAAAACATTCAGTACTTCGGCGCC	CATTSGTEAKNIQYF	In	VDJ	2	183	5.077282904538758E-4	5.72413426379188E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	0	5	0	8	1	25	32	47	40	48													Vb 3	CATTSGTEAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAGGGCAATGGGGAGACCCAGTACTTCGGGCCA	CASSEGNGETQYF	In	VDJ	2	190	5.271495911816197E-4	5.94309021923747E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	11	0	5	0	7	25	-1	42	37	49													Vb 3	CASSEGNGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTGACTAGCCCCTACGAGCAGTACTTCGGGCCG	CASSLTSPYEQYF	In	VDJ	2	193	5.354730057792242E-4	6.036928485857009E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	7	2	3	1	25	36	46	39	47						01,02							Vb 3	CASSLTSPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGTAAAGGACGGTAGGGGGATCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	196	5.437964203768288E-4		49	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	5	1	1	12	1	25	34	52	46	53													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTAGGACGGGGGACCCAGTACTTCGGGCCA	CASSLGRGTQYF	In	VDJ	3	267	7.407838991868023E-4	8.351605729138971E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	3	7	3	0	25	40	-1	43	48													Vb 3	CASSLGRGTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCGGAGACTAGCGGCATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSAETSGIAKNIQYF	In	VDJ	3	294	8.156946305652431E-4	9.196150128714822E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	2	5	0	5	3	25	37	51	42	54						01,02							Vb 3	CASSAETSGIAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGCAGGGGCGTTAGCTGAAGCTTTCTTTGGACAA	CASSLAGALAEAFF	In	VDJ	3	334	9.266734918666366E-4	0.0010447327016975343	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	6	2	6	25	39	47	41	53													Vb 3	CASSLAGALAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAACAGGGGGCGGGTGAAAAACTGTTTTTTGGCAGT	CASSLEQGAGEKLFF	In	VDJ	3	346	9.599671502570548E-4	0.0010822680083453497	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	0	7	2	3	25	40	51	42	54													Vb 3	CASSLEQGAGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTTACTAGCGGACGCCTACGAGCAGTACTTCGGGCCG	CASTLLADAYEQYF	In	VDJ	3	360	9.988097517125425E-4	0.001126059199434468	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	5	2	4	3	25	35	47	39	50						01,02							Vb 3	CASTLLADAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATACGGGACAGAAAACACCTTCGGTTCG	CASSLYGTENTF	In	VDJ	3	365	0.0010126821093752168	0.0011416989105377244	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	5	12	2	3	25	41	50	43	53													Vb 3	CASSLYGTENTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCTGTCGAGGCCTGAGACAGGGGGGCGCCGAGCAGTACTTCGGGCCG	CACRGLRQGGAEQYF	In	VDJ	5	483	0.0013400697502143279	0.001510796092574578	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	2	1	6	13	4	25	31	53	44	57													Vb 3	CACRGLRQGGAEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGGGGGAGGCATAACTATGGCTACACCTTCGGTTCG	CASRRGRHNYGYTF	In	VDJ	5	556	0.0015426061720893714	0.001739135874682123	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	5	1	1	1	5	25	36	43	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRRGRHNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGTTGACAGGGGGTAGGGACAAAAACATTCAGTACTTCGGCGCC	CASSGLTGGRDKNIQYF	In	VDJ	6	631	0.0017506915370294842	0.0019737315412309705	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	1	3	5	6	25	37	51	42	57													Vb 3	CASSGLTGGRDKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGAGGGACAGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSFEGQGAYEQYF	In	VDJ	10	1082	0.0030019781982026975	0.0033844334827447067	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	2	3	2	25	39	51	42	53													Vb 3	CASSFEGQGAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGACCGGAGGGCCTCCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGPEGLPSYNEQFF	In	VDJ	14	1471	0.00408124762435875	0.004601203006578063	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	10	0	0	5	6	25	34	45	39	51													Vb 3	CASGPEGLPSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAAGCGGGAGTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGSHTGELFF	In	VDJ	25	2614	0.0072524685860460725	0.008176440964782499	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	2	3	3	2	25	37	48	40	50													Vb 3	CASSLSGSHTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTCCCCGTCGGGCAGTTCAGATACGCAGTATTTTGGCCCA	CASRSPSGSSDTQYF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	45	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-03	01	4	8	0	4	7	4	18	31	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSPSGSSDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTCTCGTAGGAACAGGCGTCCGGCACAGATACGCAGTATTTTGGCCCA	CASRFS*EQASGTDTQYF	Stop	VDJ	3	336	9.322224349317063E-4		54	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	4	1	9	6	18	32	46	41	52														CASRFS*EQASGTDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCACCTCAGCTTCCGGACTAGCGGGAGGAGGAGGTGTAACAGATACGCAGTATTTTGGCCCA	CATSASGLAGGGGVTDTQYF	In	VDJ	6	644	0.0017867596669524372	0.0020143947900994373	60	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	1	1	3	13	10	18	23	50	36	60														CATSASGLAGGGGVTDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCATTATCTCTGCAGCGTTGAGGACATCTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	7.768520291097554E-5		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	21	1	6	0	17	4	43	36	58	53	62													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGAGACTAGCGGGAGTCGGGGAGCAGTACTTCGGGCCG	CSGRLAGVGEQYF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	2	2	7	3	5	25	32	47	35	52													Vb 4	CSGRLAGVGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAATCAACCGGGACAGATTAACTATGGCTACACCTTCGGTTCG	CSVNQPGQINYGYTF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	1	8	2	25	34	49	42	51													Vb 4	CSVNQPGQINYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGACAGCCACTATGGCTACACCTTCGGTTCG	CSVEDSHYGYTF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	3	0	2	25	-1	42	36	44													Vb 4	CSVEDSHYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAGGGCCGCTAACACTGAAGCTTTCTTTGGACAA	CSVRAANTEAFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	6	5	3	2	1	5	25	33	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRAANTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGATGACAGGGCTGGAAACACCATATATTTTGGAGAG	CSGDDRAGNTIYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	3	2	5	0	25	32	-1	37	44													Vb 4	CSGDDRAGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGTCATGTGGGAGGTCAACTATGGTTACACCTTCGGTTCG	CSVVMWEVNYGYTF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	11	8	11	25	33	47	41	58													Vb 4	CSVVMWEVNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTGGGGGCCCGGGGTTCTTCTGAAGCTTTCTTTGGACAA	CSVEVGARGSSEAFF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	6	0	6	1	11	25	38	45	39	56													Vb 4	CSVEVGARGSSEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCCCCTTCCTGGGGGCAAACCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	1.0820438976885877E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	6	0	0	8	5	25	28	42	36	47													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCGTCCTAGGGACAATGAGCAGTTCTTCGGGCCA	CSVRPRDNEQFF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	6	5	3	5	7	0	25	33	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRPRDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGAGGACGGGGGAGAGCCCCAGCATTTTGGTGAT	CSVVEDGGEPQHF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	2	8	7	2	25	35	48	42	50													Vb 4	CSVVEDGGEPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTAAGGACAGCCAAGGGTACACTGAAGCTTTCTTTGGACAA	CSVVKDSQGYTEAFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	3	4	8	25	35	45	39	53													Vb 4	CSVVKDSQGYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCGGGGGCTAGCGGAAGCACAGATACGCAGTATTTTGGCCCA	CSVAGASGSTDTQYF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	5	0	8	1	25	33	48	41	49						01,02							Vb 4	CSVAGASGSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGGACTAGCGGGGTGGGAGATACGCAGTATTTTGGCCCA	CSVGTSGVGDTQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	5	1	4	25	33	47	34	51													Vb 4	CSVGTSGVGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGGGCCCCCTACAATGAGCAGTTCTTCGGGCCA	CSVRAPYNEQFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	6	8	0	2	2	2	25	33	39	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRAPYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGAATAAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CSVGISSNQPQHF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	6	0	8	0	0	5	25	-1	37	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGISSNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGACAGGGGGTTGGAAACACCATATATTTTGGAGAG	CSVEGQGVGNTIYF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	1	3	0	1	25	-1	47	36	48													Vb 4	CSVEGQGVGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGACATGCGGGGGCTTTAGAGCGATGAGCAGTTCTTCGGGCCA	CSDMRGL*SDEQFF	Stop	VDJ	1	54	1.4982146275688139E-4		42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	7	2	8	4	10	25	32	43	36	53													Vb 4	CSDMRGL*SDEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGACCGTTGGGGGCTACACCTTCGGTTCG	CSVEETVGGYTF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	0	0	9	8	7	0	25	39	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEETVGGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCAAGCCACGTTTGGTGGCCCTGAAGACAGCAGCAATATCTCTGCAGCGTTGAGGACATCTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	61	1.6924276348462527E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	22	1	6	0	18	4	43	35	58	53	62													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCCGAGGTGGGGGCGCGTAACGAGCAGTACTTCGGGCCA	CSVVPEVGARNEQYF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	11	10	10	25	35	51	45	61													Vb 4	CSVVPEVGARNEQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGGGGGGACTGGAACCCTACGAGCAGTACTTCGGGCCG	CSAGGLEPYEQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	1	2	0	8	25	-1	39	32	47													Vb 4	CSAGGLEPYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCAACAGGGGCGAACTGAAGCTTTCTTTGGACAA	CSAQQGRTEAFF	In	VDJ	1	94	2.60800324058275E-4	2.940265687412222E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	2	5	4	3	25	32	43	36	46													Vb 4	CSAQQGRTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCCGAGGGGGGGCTTAGGGACATTCAGTACTTCGGCGCC	CSVEAEGGLRDIQYF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	1	9	0	8	4	7	25	38	49	42	56													Vb 4	CSVEAEGGLRDIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGACTAGCGGGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	104	2.885450393836234E-4		50	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	4	0	0	4	25	-1	49	38	53						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCTGGAATGAACACTGAAGCTTTCTTTGGACAA	CSVGAGMNTEAFF	In	VDJ	1	109	3.024173970462976E-4	3.409457020509917E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	0	0	5	25	-1	39	35	44													Vb 4	CSVGAGMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGGCGGTATGAACACTGAAGCTTTCTTTGGACAA	CSVVGGMNTEAFF	In	VDJ	1	126	3.495834130993899E-4	3.941207198020638E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	5	0	3	2	25	35	42	38	44						01,02							Vb 4	CSVVGGMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACACCGGGACAGGCTAACACTGAAGCTTTCTTTGGACAA	CSVTPGQANTEAFF	In	VDJ	1	129	3.579068276969944E-4	4.035045464640177E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	2	6	2	25	33	47	39	49													Vb 4	CSVTPGQANTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCGGCGGGCCCGGGGAGCTGTTTTTTGGAGAA	CSVLGGPGELFF	In	VDJ	1	134	3.717791853596686E-4	4.1914425756727424E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	4	6	4	1	25	34	43	38	44						01,02							Vb 4	CSVLGGPGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAAGGGGCAGGGGGCGCCTACGAGCAGTACTTCGGGCCG	CSVEEGAGGAYEQYF	In	VDJ	1	151	4.189452014127609E-4	4.723192753183463E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	2	5	1	25	39	52	44	53													Vb 4	CSVEEGAGGAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGTGACTAGCGGGAGAACCCAGGCGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	153	4.244941444778306E-4		49	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	4	0	10	25	-1	46	36	56													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCACACTAGCGGGCTTCGACAATGAGCAGTTCTTCGGGCCA	CSATLAGFDNEQFF	In	VDJ	2	163	4.52238859803179E-4	5.098545819661619E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	3	4	5	4	5	25	32	45	36	50						01,02							Vb 4	CSATLAGFDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAATAGCGGGAGGGTACGAGCAGTACTTCGGGCCG	CSVIAGGYEQYF	In	VDJ	2	239	6.630986962758269E-4	7.475781907356607E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	0	4	2	0	25	33	-1	35	46													Vb 4	CSVIAGGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAGACTAGCGGAGCCATCACAGATACGCAGTATTTTGGCCCA	CSVKTSGAITDTQYF	In	VDJ	4	451	0.001251286661173213	0.0014107019415137364	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	5	2	2	6	25	34	45	36	51						01,02							Vb 4	CSVKTSGAITDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGCTGGGACAGGGAGGGTAGGAACACTGAAGCTTTCTTTGGACAA	CSVEGWDREGRNTEAFF	In	VDJ	5	551	0.001528733814426697	0.0017234961635788663	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	1	5	7	25	36	50	41	57													Vb 4	CSVEGWDREGRNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCATCGAGCGGGAGTAAGGAGACCCAGTACTTCGGGCCA	CSVSSSGSKETQYF	In	VDJ	7	733	0.0020336876333480382	0.002292781647737403	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	2	5	6	4	25	34	48	40	52													Vb 4	CSVSSSGSKETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGACTAGCGGCAGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	7	767	0.0021280196654542226		43	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	4	0	4	25	-1	46	39	50						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCCGGGACAGGGAAGGGCTACACCTTCGGTTCG	CSVVPGTGKGYTF	In	VDJ	10	1065	0.002954812182149605	0.0033312584649936344	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	8	5	3	25	35	49	40	52													Vb 4	CSVVPGTGKGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGACTAGCGGGAGGGTGAATGAGCAGTTCTTCGGGCCA	CSVEETSGRVNEQFF	In	VDJ	17	1824	0.0050606360753435485	0.005705366610467971	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	0	7	0	2	25	-1	53	39	55													Vb 4	CSVEETSGRVNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAGGGAAGACTACGAGCAGTACTTCGGGCCG	CSVDREDYEQYF	In	VDJ	19	2000	0.005548943065069681	0.0062558844413026	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	3	0	4	25	-1	41	36	45													Vb 4	CSVDREDYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGACATCTTCTCCTACGAGCAGTACTTCGGGCCG	CSVEDIFSYEQYF	In	VDJ	70	7320	0.02030913161815503	0.022896537055167518	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	6	0	0	4	25	-1	41	36	45													Vb 4	CSVEDIFSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGACAGGGCTACCAGATACGCAGTATTTTGGCCCA	CASSGTGLPDTQYF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	4	0	4	23	-1	44	36	48													Vb 22	CASSGTGLPDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCTAGCGGCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSASGLAKNIQYF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	4	5	0	0	3	23	-1	43	36	46						01,02							Vb 22	CASSASGLAKNIQYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGGGGGAGGGCCCGGAGCAGTACTTCGGGCCG	CASKGEGPEQYF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	9	0	7	3	4	23	33	43	36	47													Vb 22	CASKGEGPEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCCAGGGGGTTTAACTTCGGGGCTTTCTTTGGACAA	CASSPRGFNFGAFF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	11	3	12	23	34	44	37	56													Vb 22	CASSPRGFNFGAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCGGGACTAGCGGGAGGCTCAGATACGCAGTATTTTGGCCCA	CASSPGLAGGSDTQYF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	1	4	3	2	23	34	52	37	54													Vb 22	CASSPGLAGGSDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCCGAAGGAGGGACTTCCTACGAGCAGTACTTCGGGCCG	CASSAEGGTSYEQYF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	1	8	0	23	36	-1	44	50						01,02							Vb 22	CASSAEGGTSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGTACAGGAAACACAGATACGCAGTATTTTGGCCCA	CASTGNTDTQYF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	3	4	2	1	3	23	31	37	32	40													Vb 22	CASTGNTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCTTTGACAGCGCACGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	55	1.5259593428941623E-4		37	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	5	3	3	6	23	29	37	32	43													Vb 22	X+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCACCGGGACTAGCGGGCCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	56	1.5537040582195107E-4		46	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	10	0	4	0	2	3	23	30	44	32	47						01,02							Vb 22	X+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCACCGGGACAGGGTGGGGAACACTGAAGCTTTCTTTGGACAA	CASHRDRVGNTEAFF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	3	1	4	4	23	32	45	36	49													Vb 22	CASHRDRVGNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCTTATGGGGTTAATTAGCACAGATACGCAGTATTTTGGCCCA	CASLMGLISTDTQYF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-03	01	8	6	2	0	5	6	23	32	41	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASLMGLISTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGGCGCTTTTAGGGGGGAGAGAGACCCAGTACTTCGGGCCA	CASSEAALLGGRETQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	51	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	0	5	1	4	9	3	23	40	55	49	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEAALLGGRETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATCGAACAGGCGCTCACTATGAACACTGAAGCTTTCTTTGGACAA	CASIEQALTMNTEAFF	In	VDJ	1	86	2.3860455179799627E-4	2.690030309760118E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	4	0	4	9	23	33	42	37	51													Vb 22	CASIEQALTMNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGGGGGGGAGCATCTACGGCTACACCTTCGGTTCG	CASSEAGGSIYGYTF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	8	0	9	23	-1	47	40	56													Vb 22	CASSEAGGSIYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATTTGGGACAGGGCTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSDLGQGSTNEKLFF	In	VDJ	1	99	2.746726817209492E-4	3.096662798444787E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	0	3	2	23	37	49	40	51													Vb 22	CASSDLGQGSTNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGAGAGTTTAATGAGCAGTTCTTCGGGCCA	CASREFNEQFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	33	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	2	7	1	3	28	39	43	40	46			01,02											CASREFNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTCGGGGGAGTGAAGCTTTCTTTGGACAA	CASSRGSEAFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	33	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	2	7	0	2	28	-1	46	40	48			01,02											CASSRGSEAFF+TCRBV06-04+TCRBJ01-01	TCRBV06-04	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGACTTGACAGGGTTCGGGAGCAGTACTTCGGGCCG	CASRLDRVREQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	7	4	5	26	37	48	41	53														CASRLDRVREQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATGAGGTTTAGGGGGGGCCTGGGTCAGCCCCAGCATTTTGGTGAT	CASMRFRGGLGQPQHF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	9	0	6	9	6	26	36	52	45	58														CASMRFRGGLGQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCACTAGTAATACAGATACGCAGTATTTTGGCCCA	CATSNTDTQYF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	4	8	3	0	4	26	-1	37	33	41						01,02								CATSNTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACAGGGATGGCTACACCTTCGGTTCG	CASSYRDGYTF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-02	01	2	5	3	6	0	0	26	-1	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRDGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAGATCGGTTGGGGACTGGGAGACCCAGTACTTCGGGCCA	CASSRSVGDWETQYF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	5	10	2	26	38	54	48	56						01,02								CASSRSVGDWETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCCCAGGAGGGGTTCTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	103	2.8577056785108855E-4		34	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	10	0	8	3	5	26	32	41	35	46														X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTCCGGACTGGGATGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	105	2.9131951091615824E-4		43	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	10	4	3	6	26	39	47	42	53						01,02								X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATCGGGGTTATGGGGGCCAACGTCCTGACTTTCGGGGCC	CASIGVMGANVLTF	In	VDJ	1	119	3.30162112371646E-4	3.7222512425750474E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	7	8	3	4	1	5	26	36	42	37	47														CASIGVMGANVLTF+TCRBV06-07+TCRBJ02-06	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTATTCCGACAGGCTAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLFRQANSGANVLTF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	54	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	2	4	0	4	4	19	34	44	38	48														CASSLFRQANSGANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGAGGGCTCAAACTGGGGAGCTGTTTTTTGGAGAA	CASSLRAQTGELFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	0	8	0	8	19	-1	38	33	46														CASSLRAQTGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCAGCCATGTATCGCTGTGCCAGCCCTCCAAACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	5	487	0.0013511676363444673		40	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-06	01	8	4	6	2	4	2	19	28	34	32	36				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATTGCCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSQLPANTEAFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	42	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-01	01	1	4	5	1	3	1	29	45	51	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLPANTEAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCCACGTTTGGTGACGAAGCTTGAGGATTCAGCAGTGTATTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	36	9.988097517125425E-5		38	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-02	01	17	4	4	1	12	3	43	43	59	55	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV16-01+TCRBJ01-02	TCRBV16-01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTTTTGTGCCAGCAGCGGACTAGCCGTAGTCGGTGGGGTCGATGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	141	3.912004860874125E-4		67	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	7	0	0	24	4	-1	24	16	48			01,02			01,02								X+TCRBV16-01+TCRBJ02-02	TCRBV16-01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCCCCTACTAATCCGATTAATGGCTACACCTTCGGTTCG	CASSPPTNPINGYTF	In	VDJ	14	1485	0.004120090225814238	0.004644994197667181	45	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	3	9	6	5	9	29	42	51	47	60			01,02			01,02								CASSPPTNPINGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCAGAGAAGGGACCTTTCCCCATGAGCAGTTCTTCGGGCCA	CASSREGTFPHEQFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	45	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	5	0	7	8	6	8	19	31	42	37	50		TCRBV07-02,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSREGTFPHEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTTTCAAGAGACCCAGTACTTCGGGCCA	CASSFQETQYF	In	VJ	1	31	8.600861750858006E-5	9.69662088401903E-5	33	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	4	0	0	2	0	2	26	-1	39	-1	41		TCRBV06-04,TCRBV06-07												CASSFQETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTTCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSEFGTGELFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	8	5	4	1	0	26	42	-1	43	46		TCRBV10-01,TCRBV10-02				01,02								CASSEFGTGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGACGACAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSETTGSTDTQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	0	2	0	26	41	-1	43	50		TCRBV10-01,TCRBV10-02												CASSETTGSTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGTCAGCAGTTTTATTTTGATGGGAGTGACTGAAGCTTTCTTTGGACAA	CVSSFILMGVTEAFF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	2	5	10	2	26	39	54	49	56		TCRBV06-07,TCRBV06-08												CVSSFILMGVTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGCCCGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLARSGANVLTF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	8	6	0	1	0	18	35	-1	36	38		TCRBV07-04,TCRBV07-06				01,02								CASSLARSGANVLTF+TCRBV07-X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCTCAGGGGAGACGCCGGGGAGCTGTTTTTTGGAGAA	CASSYLRGDAGELFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	6	2	5	26	41	49	43	54		TCRBV06-07,TCRBV06-08												CASSYLRGDAGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCGGGAGGCACAGACAGATACGCAGTATTTTGGCCCA	CASSREAQTDTQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	1	3	0	5	23	-1	42	35	47		TCRBV06-07,TCRBV06-08												CASSREAQTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTATGGACAGGGTCTGGCACAGATACGCAGTATTTTGGCCCA	CASSLWTGSGTDTQYF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	3	1	1	4	18	33	42	34	46		TCRBV07-06,TCRBV07-07												CASSLWTGSGTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGGGACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSGTSGGTDTQYF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	1	0	0	28	-1	-1	41	53		TCRBV06-04,TCRBV06-08												CASSGTSGGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGAAGCTAGCGGGAGAAATGAGCAGTTCTTCGGGCCA	CASSEEASGRNEQFF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	7	5	1	23	37	52	42	53		TCRBV10-01,TCRBV10-02												CASSEEASGRNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAAACAGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLNRVTGELFF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	4	3	1	22	35	44	38	45		TCRBV07-01,TCRBV07-04												CASSLNRVTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTCCCCGGACGGATACGAGCAGTACTTCGGGCCG	CASSSPDGYEQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	39	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	4	1	7	4	4	3	18	31	39	35	42		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPDGYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGGGGCGAAGGCTACACCTTCGGTTCG	CASSYGGEGYTF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	6	0	8	0	3	26	-1	47	41	50		TCRBV06-07,TCRBV06-08												CASSYGGEGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCGGAGTGGGTAGACATTCAGTACTTCGGCGCC		Out	VDJ	1	56	1.5537040582195107E-4		34	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	8	10	2	8	0	7	28	-1	41	37	48		TCRBV06-04,TCRBV06-07												X+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCACGACAGGGAGGGGGTGAAAAACTGTTTTTTGGCAGT	CASSYSRQGGGEKLFF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	48	TCRBV06	unresolved					TCRBJ01	TCRBJ01-04	01	0	2	3	7	2	6	23	40	49	42	55		TCRBV06-05,TCRBV06-06,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRQGGGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGACGATGTTCGGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASRTMFGGSSYEQYF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	2	0	11	0	23	34	-1	45	52		TCRBV06-07,TCRBV06-08												CASRTMFGGSSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCACCTGAGGACAGGGGGCGCATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	73	2.0253642187504335E-4		49	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	0	3	7	4	26	37	55	44	59		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACGGTCTAGCGGGCTACGAGCAGTACTTCGGGCCG	CASSDGLAGYEQYF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	4	3	6	0	26	38	-1	44	52		TCRBV06-07,TCRBV06-08				01,02								CASSDGLAGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCATTGTGCCGGGCCCCAAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	75	2.0808536494011304E-4		44	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	7	8	0	5	7	6	23	33	44	40	50		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGTTTACGGAGCCCAAGGCTACACCTTCGGTTCG	CASSEVYGAQGYTF	In	VDJ	1	76	2.1085983647264788E-4	2.377236087694988E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	2	8	5	5	23	39	48	44	53		TCRBV06-01,TCRBV06-07												CASSEVYGAQGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGTTGCGGCAAACAATGAGCAGTTCTTCGGGCCA	CASSVAANNEQFF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	5	3	3	23	35	42	38	45		TCRBV06-04,TCRBV06-08				01,02								CASSVAANNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCAAAATTGGCCCAGGACAGGGTACCACCGGGGAGCTGTTTTTTGGAGAA	CASSKIGPGQGTTGELFF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	54	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	4	12	3	18	30	50	42	53		TCRBV11-01,TCRBV11-03												CASSKIGPGQGTTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTATAATCAGGCGGAATGGCGGTCTCAGCCCCAGCATTTTGGTGAT	CASSYNQAEWRSQPQHF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	51	TCRBV06	unresolved					TCRBJ01	TCRBJ01-05	01	3	4	4	6	4	13	23	37	45	41	58		TCRBV06-05,TCRBV06-06,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYNQAEWRSQPQHF+TCRBV06-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAGCTGGGACAGGGGCCGACACTGAAGCTTTCTTTGGACAA	CASRAGTGADTEAFF	In	VDJ	1	87	2.4137902333053112E-4	2.721309731966631E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	3	4	3	23	34	48	38	51		TCRBV06-07,TCRBV06-08												CASRAGTGADTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAGCTGTCAGGGGGCGGAAGCATTCAGTACTTCGGCGCC	CASSELSGGGSIQYF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	0	9	7	5	26	38	53	45	58		TCRBV06-07,TCRBV06-08												CASSELSGGGSIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGTCGAACCGGAGCAGGCTACACCTTCGGTTCG	CASRTGAGYTF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	9	10	2	8	7	2	28	36	47	43	49		TCRBV06-04,TCRBV06-07												CASRTGAGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACTAGCGGGAGTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	99	2.746726817209492E-4		40	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	7	0	1	26	-1	50	40	51		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSRSSGNTIYF	In	VDJ	1	104	2.885450393836234E-4	3.2530599094773524E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	2	0	1	0	22	34	-1	35	39		TCRBV07-01,TCRBV07-04												CASSRSSGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCGGGACAGAGCTACGAGCAATACTTCGGGCCG	CASSPGQSYEQYF	In	VDJ	1	111	3.079663401113673E-4	3.472015864922943E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	13	2	12	26	38	47	40	59		TCRBV06-07,TCRBV06-08												CASSPGQSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAATGGCTGAGCGGGCTGTACTTCGGGCCG	CASSEWLSGLYF	In	VDJ	1	112	3.1074081164390215E-4	3.5032952871294563E-4	36	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	6	4	12	7	2	26	40	53	47	55		TCRBV10-01,TCRBV10-02				01,02								CASSEWLSGLYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCTTGACCGGAGCCCCTATAATGAGCAGTTCTTCGGGCCA	CASSLDRSPYNEQFF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	2	7	7	7	18	30	41	37	48		TCRBV11-01,TCRBV11-03												CASSLDRSPYNEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTACTTSTGTGCCAGCAGTTACCCGAACTTCCGGGCTAGCGGGAGGGCCTCGGAATCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	118	3.2738764083911116E-4		65	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	0	6	13	9	8	23	48	36	57		TCRBV06-05,TCRBV06-06,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCCAGATGGGACTAGCGGGAAGGCAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	129	3.579068276969944E-4		59	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	3	0	7	7	22	32	52	39	59		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTTTCCAGGGGGACCCATGGTAATGAAAAACTGTTTTTTGGCAGT	CASSFSRGTHGNEKLFF	In	VDJ	1	138	3.82877071489808E-4	4.3165602644987944E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	1	4	4	8	26	39	50	43	58		TCRBV06-07,TCRBV06-08												CASSFSRGTHGNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCTCCGGAGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSGGNYNEQFF	In	VDJ	1	144	3.99523900685017E-4	4.504236797737872E-4	39	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	10	0	3	3	2	26	35	44	38	46		TCRBV10-01,TCRBV10-02												CASSGGNYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCTCGAAAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLENSGANVLTF	In	VDJ	1	148	4.106217868151564E-4	4.629354486563924E-4	45	TCRBV07	unresolved					TCRBJ02	TCRBJ02-06	01	5	2	8	0	3	3	22	34	39	37	42		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLENSGANVLTF+TCRBV07-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCCATTCAGGGCGGAGGCACTGAAGCTTTCTTTGGACAA	CASSPIQGGGTEAFF	In	VDJ	1	149	4.1339625834769123E-4	4.6606339087704374E-4	45	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	5	4	3	4	6	6	22	34	45	40	51		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPIQGGGTEAFF+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATATGGCTAGCGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSYMASGSTDTQYF	In	VDJ	1	155	4.3004308754290025E-4	4.848310442009515E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	5	0	5	1	23	37	49	42	50		TCRBV06-07,TCRBV06-08				01,02								CASSYMASGSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGCCGGAGAAATTTACAATGAGCAGTTCTTCGGGCCA	CASSAGEIYNEQFF	In	VDJ	2	160	4.4391544520557447E-4	5.00470755304208E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	2	4	2	5	26	39	45	41	50		TCRBV10-01,TCRBV10-02												CASSAGEIYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTCGTACGGAGGGTACGAGCAGTACTTCGGGCCG	CASSSYGGYEQYF	In	VDJ	2	167	4.633367459333183E-4	5.223663508487672E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	4	5	0	18	31	-1	36	42		TCRBV07-02,TCRBV07-08												CASSSYGGYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGGGGATCGGGGACAGATACGCAGTATTTTGGCCCA	CASRGSGTDTQYF	In	VDJ	2	186	5.160517050514803E-4	5.817972530411419E-4	39	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	3	3	5	0	23	34	-1	39	44		TCRBV10-01,TCRBV10-02												CASRGSGTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGACTTTGGATGCCCTTTCCTCCTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	200	5.548943065069681E-4		56	TCRBV06	unresolved					TCRBJ01	TCRBJ01-03	01	6	1	8	0	5	15	23	34	42	39	57		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGCTTTGACTTTGCTGGCGGGGAGCTGTTTTTTGGAGAA	CASSFDFAGGELFF	In	VDJ	2	231	6.409029240155482E-4	7.225546529704503E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	10	7	2	7	22	35	41	37	48		TCRBV07-01,TCRBV07-05				01,02								CASSFDFAGGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGTCCCTTACAATGAGCAGTTCTTCGGGCCA	CASSLVPYNEQFF	In	VDJ	3	306	8.489882889556612E-4	9.571503195192979E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	10	4	3	0	18	34	-1	37	39		TCRBV07-01,TCRBV07-02				01,02								CASSLVPYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTTTCACAGATACGCAGTATTTTGGCCCA		Out	VJ	4	403	0.0011181120276115408		37	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	1	0	0	2	0	2	26	-1	42	-1	44		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGCGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASSEAGGTDTQYF	In	VDJ	6	629	0.0017451425939644146	0.0019674756567896676	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	0	3	0	0	23	-1	-1	40	47		TCRBV06-01,TCRBV06-04												CASSEAGGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTTTAGGGGGACAGGGGGCAAATGAGCAGTTCTTCGGGCCA	YASSLGGQGANEQFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	45	TCRBV26	TCRBV26-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	7	4	1	27	40	56	44	57														YASSLGGQGANEQFF+TCRBV26-01+TCRBJ02-01	TCRBV26-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTTTTGGAGATGAGCAGTTCTTCGGGCCA	YASSFGDEQFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	33	TCRBV26	TCRBV26-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	2	8	2	0	27	40	-1	42	46														YASSFGDEQFF+TCRBV26-01+TCRBJ02-01	TCRBV26-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTCCCCAGGGTGAGCAGTTCTTCGGGCCA	YASSPQGEQFF	In	VDJ	4	441	0.0012235419458478645	0.0013794225193072235	33	TCRBV26	TCRBV26-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	9	3	0	27	39	-1	42	47														YASSPQGEQFF+TCRBV26-01+TCRBJ02-01	TCRBV26-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCACCAGTGAGCCCGGGACTTCAGTTCTTCGGGCCA		Out	VDJ	1	45	1.248512189640678E-4		34	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	13	0	10	13	15	1	25	28	49	43	50						01,02								X+TCRBV22-01+TCRBJ02-01	TCRBV22-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGGGGTTTCAGAAAGCGAGAAACCTATGGCTACACCTTCGGTTCG	CPGRGFRKRETYGYTF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	48	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	6	4	11	6	25	36	51	47	57						01,02								CPGRGFRKRETYGYTF+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGTGCGCTAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRALGSGANVLTF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	4	8	0	5	1	23	36	45	41	46						01,02							Vb 7.1	CASSRALGSGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD02-01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTAGGGGGCGGGTGAGACCCAGTACTTCGGGCCA	CASSQD*GAGETQYF	Stop	VDJ	1	28	7.768520291097554E-5		45	TCRBV04	TCRBV04-01	01	unresolved			TCRBJ02	TCRBJ02-05	01	0	6	0	5	3	4	23	40	49	43	53				TCRBD01,TCRBD02									Vb 7.1	CASSQD*GAGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	unresolved	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTGGGGGGCGGGTGAGACCCAGTACTTCGGGCCA	CASSQDWGAGETQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	45	TCRBV04	TCRBV04-01	01	unresolved			TCRBJ02	TCRBJ02-05	01	0	6	0	5	3	4	23	40	49	43	53				TCRBD01,TCRBD02									Vb 7.1	CASSQDWGAGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	unresolved	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCGACTAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTSGSSYNEQFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	2	0	1	0	23	36	-1	37	49													Vb 7.1	CASSPTSGSSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGACGAATCCGGGACGGAGTATGGCTACACCTTCGGTTCG	YASSQDESGTEYGYTF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	0	0	7	5	7	4	22	39	51	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQDESGTEYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATTGGGGGGCCGGGGAAAAACTGTTTTTTGGCAGT	XASSQDWGAGEKLFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	0	6	0	8	3	4	22	39	48	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQDWGAGEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTTCGTTTCCTCTGGCTACACCTTCGGTTCG	CASSQDFVSSGYTF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	4	10	7	9	1	23	40	51	49	52						01,02							Vb 7.1	CASSQDFVSSGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAACAGGGACAGGGGATGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSQQGQGMSNEKLFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	2	3	2	4	23	38	50	40	54													Vb 7.1	CASSQQGQGMSNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTAGGGGGGAACACTGAAGCTTTCTTTGGACAA	XASSQVGGNTEAFF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	1	1	1	0	22	38	-1	39	45													Vb 7.1	XASSQVGGNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTGGCGACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLATGSNQPQHF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	3	1	4	0	23	36	-1	40	47													Vb 7.1	CASSLATGSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGAGGGGCAAGGCTAGCGGAGAGACCCAGTACTTCGGGCCA	CASSQRGKASGETQYF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	5	4	11	0	23	37	-1	48	55						01,02							Vb 7.1	CASSQRGKASGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGAGTACCCGGGCCCCTACGAGCAGTACTTCGGGCCG	XASSQEYPGPYEQYF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	0	8	0	2	6	1	22	39	49	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQEYPGPYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAACGCGAGCGGGAGCTCTTCCCAATGAGCAGTTCTTCGGGCCA	CASSQTRAGALPNEQFF	In	VDJ	1	78	2.1640877953771754E-4	2.439794932108014E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	6	5	7	23	38	51	43	58													Vb 7.1	CASSQTRAGALPNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCAAACCTACGGGACAGGGTTGAGCAGCCCCAGCATTTTGGTGAT	CASSPNLRDRVEQPQHF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	7	9	5	23	36	54	45	59													Vb 7.1	CASSPNLRDRVEQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGGGAGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQGEDSSYEQYF	In	VDJ	1	115	3.1906422624150663E-4	3.5971335537489954E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	1	1	5	0	4	0	23	39	-1	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGEDSSYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTAGGCGGGAGGGCCCTGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQVGGRALGANVLTF	In	VDJ	1	121	3.357110554367157E-4	3.784810086988073E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	7	0	4	3	5	23	39	51	42	56													Vb 7.1	CASSQVGGRALGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGCCCTAAATGAGCAGTTCTTCGGGCCA	CASSQALNEQFF	In	VDJ	2	243	6.741965824059662E-4	7.60089959618266E-4	36	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-01	01	3	9	0	7	0	4	23	-1	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQALNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTCTGGCAGTGTACGAGCAGTACTTCGGGCCG	CASSQGLAVYEQYF	In	VDJ	4	390	0.0010820438976885877	0.001219897466054007	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	5	4	6	2	23	39	48	45	50													Vb 7.1	CASSQGLAVYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGTATATTGGGGGGCTTAAAGCAATGAGCAGTTCTTCGGGCCA	CASSVYWGA*SNEQFF	Stop	VDJ	1	38	1.0542991823632394E-4		48	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-01	01	4	6	0	6	7	6	26	39	52	46	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSVYWGA*SNEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAAACAGGGATTGAGACCCAGTACTTCGGGCCA	CASSETGIETQYF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	3	5	1	3	26	40	47	41	50			01,02										Vb 12	CASSETGIETQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGATGGACTAGCGGGAGGGCCGAGGACATTCAGTACTTCGGCGCC		Out	VDJ	1	138	3.82877071489808E-4		50	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	1	0	8	1	6	26	40	56	41	62			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-04	TCRBV10-01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTGCGCTGGCTTCAGCTTGGGATACGCAGTATTTTGGCCCA	CASSFALASAWDTQYF	In	VDJ	3	275	7.629796714470811E-4	8.601841106791075E-4	48	TCRBV12	TCRBV12-01	01				TCRBJ02	TCRBJ02-03	01	0	4	5	6	8	5	22	39	50	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFALASAWDTQYF+TCRBV12-01+TCRBJ02-03	TCRBV12-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAAACTCAGGGGCGCCCCAGCATTTTGGTGAT	CASSLNSGAPQHF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	39	TCRBV05	TCRBV05-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	9	5	1	20	34	45	39	46														CASSLNSGAPQHF+TCRBV05-08+TCRBJ01-05	TCRBV05-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTCATTAGGGGAGAGACCCAGTACTTCGGGCCA	CASSFIRGETQYF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	2	4	5	0	22	35	-1	40	45														CASSFIRGETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGTCCGGGACTGACACAATGAGCAGTTCTTCGGGCCA	CASSVRD*HNEQFF	Stop	VDJ	1	32	8.878308904111489E-5		42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	5	4	3	22	34	44	38	47						01,02								CASSVRD*HNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCCATCCGACAAGTCACGGGGAGCTGTTTTTTGGAGAA	CASSPHPTSHGELFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	45	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	6	7	8	5	22	34	46	42	51														CASSPHPTSHGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCACTACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSTTVNTEAFF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	39	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-01	01	5	3	5	0	3	0	22	34	-1	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTTVNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCGGGACATCGAACACTGAAGCTTTCTTTGGACAA	CASSPGTSNTEAFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	1	3	2	22	34	43	37	45														CASSPGTSNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCGGTAAATCAGGCGGTGAACGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	51	1.4149804815927685E-4		46	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-01	01	8	4	4	7	7	11	22	31	42	38	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCGAACAGGGGGAACTGAAGCTTTCTTTGGACAA	CASSRTGGTEAFF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	5	3	1	22	34	45	37	46														CASSRTGGTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAATCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLIGTGELFF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	5	4	4	0	22	35	-1	39	42						01,02								CASSLIGTGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCTAGAGACTAGCGGGAGCTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	94	2.60800324058275E-4		44	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	6	5	2	22	34	51	39	53														X+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCCAAGGGCGGGGCTAGCGGGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	9.710650363871942E-5		49	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	2	3	11	0	20	32	-1	43	53			01,02											X+TCRBV07-08+TCRBJ02-07	TCRBV07-08	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGAAGGCAGGGGGCGGGCAGTTCTTCGGGCCA	CASRKAGGGQFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	12	5	2	23	34	47	39	49													Vb 12	CASRKAGGGQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGAAGAGAGGGGGGGCCTATGGCTACACCTTTGGTTCG	CASRKRGGAYGYTF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	20	7	17	23	34	48	41	65													Vb 12	CASRKRGGAYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCCGGGACTACCCGCCGAGCAGTACTTCGGGCCG	CASSPGLPAEQYF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	9	6	3	5	23	34	44	37	49						01,02							Vb 12	CASSPGLPAEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRGYSNQPQHF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	8	0	0	0	2	23	-1	38	34	40													Vb 12	CASRGYSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCTCCGGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASTSGTGAYEQYF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	2	2	5	0	23	33	-1	38	48													Vb 12	CASTSGTGAYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATGAGGGAGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CASSDEGGPYNEQFF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	0	4	3	3	23	37	47	40	50													Vb 12	CASSDEGGPYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAGACAGGGCGTCTACGAGCAGTACTTCGGGCCG	CASSRQGVYEQYF	In	VDJ	1	87	2.4137902333053112E-4	2.721309731966631E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	3	1	3	23	35	43	36	46													Vb 12	CASSRQGVYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCCCGTTTCGAAAGCCCAGAGATACGCAGTATTTTGGCCCA	CASSESPFRKPRDTQYF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	51	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	0	4	5	5	15	0	23	40	-1	55	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESPFRKPRDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGCCTTAGGTTTACCGGGGAGCTGTTTTTTGGAGAA	CASSGLRFTGELFF	In	VDJ	1	108	2.9964292551376277E-4	3.3781775983034043E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	4	5	4	5	5	3	23	36	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGLRFTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCCGTCTCCCACTGGAAACACCATATATTTTGGAGAG	CASSPSPTGNTIYF	In	VDJ	1	111	3.079663401113673E-4	3.472015864922943E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	6	4	6	2	9	0	23	34	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSPSPTGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSNTGELFF	In	VJ	1	112	3.1074081164390215E-4	3.5032952871294563E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	3	0	0	0	0	2	23	-1	37	-1	39													Vb 12	CASSDSNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCACGGTACAAAGAGACCCAGTACTTCGGGCCA	CASSESRYKETQYF	In	VDJ	1	128	3.5513235616445955E-4	4.003766042433664E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-05	01	0	3	6	3	5	0	23	40	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESRYKETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGCCAGGCTGAGCAGTTCTTCGGGCCA	CASSEGQAEQFF	In	VDJ	1	146	4.050728437500867E-4	4.5667956421508983E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	4	9	3	1	23	38	45	41	46													Vb 12	CASSEGQAEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGTCGGGCTAGCAGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGLAASYNEQFF	In	VDJ	1	146	4.050728437500867E-4	4.5667956421508983E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	7	0	5	3	23	36	46	41	49						01,02							Vb 12	CASSVGLAASYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGAGTCAGGGTGGGGCGGGGAGCTGTTTTTTGGAGAA	CASSESGWGGELFF	In	VDJ	2	170	4.7166016053092286E-4	5.317501775107211E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	0	5	3	7	0	5	23	-1	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGWGGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGGGGACAGGGAGACACTGAAGCTTTCTTTGGACAA	CASSERGQGDTEAFF	In	VDJ	2	179	4.966304043237365E-4	5.599016574965827E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	3	2	2	23	38	49	40	51													Vb 12	CASSERGQGDTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGCAGGAGTACTACAATGAGCAGTTCTTCGGGCCA	CASRQEYYNEQFF	In	VDJ	2	198	5.493453634418984E-4	6.193325596889574E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	6	4	4	3	1	4	23	34	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRQEYYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTACTGGAGCGGACCCTACAATGAGCAGTTCTTCGGGCCA	CASSEYWSGPYNEQFF	In	VDJ	2	211	5.854134933648514E-4	6.599958085574243E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	5	2	5	2	23	39	49	44	51						01,02							Vb 12	CASSEYWSGPYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGGAGGCGTTAAGGGACTAGCGGGTTCAGATACGCAGTATTTTGGCCCA	CASSGGVKGLAGSDTQYF	In	VDJ	2	216	5.992858510275255E-4	6.756355196606809E-4	54	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	4	4	12	2	23	34	58	46	60						01,02							Vb 12	CASSGGVKGLAGSDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGGATCTCGTCAGGGGGCAGAAACACCATATATTTTGGAGAG	CARISSGGRNTIYF	In	VDJ	2	258	7.158136553939888E-4	8.070090929280354E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	4	0	5	8	1	23	31	47	39	48													Vb 12	CARISSGGRNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGAGCGGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	260	7.213625984590585E-4		40	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	5	0	0	1	23	-1	41	38	42						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGCCACAGGGGGAGAGACCCAGTACTTCGGGCCA	CASATGGETQYF	In	VDJ	3	343	9.516437356594503E-4	0.001072884181683396	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	3	1	4	3	0	23	32	-1	35	43													Vb 12	CASATGGETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGACAGGATACAATGAGCAGTTCTTCGGGCCA	CASSESTGYNEQFF	In	VDJ	7	779	0.0021613133238446405	0.0024366669898873627	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	4	4	0	1	23	-1	46	40	47													Vb 12	CASSESTGYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTCGGACTAGCGGGAGTGTATGAGCAGTTCTTCGGGCCA	CASSFGLAGVYEQFF	In	VDJ	8	886	0.0024581817778258686	0.002771356807497052	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	8	3	3	23	35	51	38	54													Vb 12	CASSFGLAGVYEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGACTAGCGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEGLAASYNEQFF	In	VDJ	11	1131	0.0031379273032969045	0.0035377026515566205	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	5	0	0	1	23	-1	48	38	49						01,02							Vb 12	CASSEGLAASYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAATACCGGAGCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNTGAPNTGELFF	In	VDJ	32	3327	0.009230666788743415	0.010406663768106875	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	10	2	0	5	3	23	33	42	38	45													Vb 12	CASNTGAPNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGACTAGCGGACACAGATACGCAGTATTTTGGCCCA	CAISEGLADTDTQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	5	2	0	1	23	-1	48	38	49						01,02							Vb 12	CAISEGLADTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCAGGCAATCAGCCCCAGCATTTTGGTGAT	CAISESGNQPQHF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	39	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-05	01	0	5	5	2	0	0	23	-1	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGGGGGGCGACAGATACGCAGTATTTTGGCCCA	CAIRGATDTQYF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	36	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	3	0	1	24	-1	41	35	42													Vb 12	CAIRGATDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGTGTCTGCAGATACGCAGTATTTTGGCCCA	CAISEVSADTQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	10	4	4	1	23	38	44	42	45						01,02							Vb 12	CAISEVSADTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCGTGGACAGGGTCGAGCAATCAGCCCCAGCATTTTGGTGAT	CAISESWTGSSNQPQHF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	51	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	3	1	2	3	23	40	50	42	53													Vb 12	CAISESWTGSSNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGATCGGCCGACAGGGTCGAGGCTACACCTTCGGTTCG	CAISEIGRQGRGYTF	In	VDJ	1	86	2.3860455179799627E-4	2.690030309760118E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	8	7	4	23	38	52	45	56													Vb 12	CAISEIGRQGRGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCCTGGACACGTAAACAATGAGCAGTTCTTCGGGCCA	CAISEPGHVNNEQFF	In	VDJ	1	98	2.718982101884144E-4	3.065383376238274E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	6	5	3	5	23	38	46	41	51													Vb 12	CAISEPGHVNNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGAGGGCCATGGGGAGCACTGAAGCTTTCTTTGGACAA	CAISERAMGSTEAFF	In	VDJ	2	230	6.381284524830133E-4	7.194267107497991E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	2	4	9	0	23	38	-1	47	52													Vb 12	CAISERAMGSTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGGCCAGTTGAAGCTTTCTTTGGACAA	CASSIGGPVEAFF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	6	0	7	0	4	27	-1	49	43	53			01,02										Vb 17	CASSIGGPVEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTCGGGTGGGGCAGGACTATGGCTACACCTTCGGTTCG	CASIRVGQDYGYTF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	7	0	3	7	3	27	37	49	44	52			01,02										Vb 17	CASIRVGQDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGAGGGACAGGGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	33	9.155756057364973E-5		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	3	2	2	2	27	35	46	37	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGGGACAGGGGACTATGGCTACACCTTCGGTTCG	CASTGTGDYGYTF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	3	2	0	27	37	-1	39	49			01,02										Vb 17	CASTGTGDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGAGTATGGTTAAGATGGGGGGCTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	9.433203210618458E-5		46	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	9	6	0	6	15	1	27	35	56	50	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACAGGGGAGTCGCTGGAGCCTGGAAACACCATATATTTTGGAGAG	CASSRTGESLEPGNTIYF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	2	2	0	12	27	-1	49	40	61			01,02										Vb 17	CASSRTGESLEPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCATGGGGTTGGGAGCAGTTCTTCGGGCCA	CASSIAWGWEQFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	6	2	10	3	4	27	43	50	46	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAWGWEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGGACAGGGAGGGACTGAAGCTTTCTTTGGACAA	CASSIRGQGGTEAFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	5	2	4	27	42	53	44	57			01,02										Vb 17	CASSIRGQGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTCCTGGTATAGCGGAAGAGGGAGATACGCAGTATTTTGGCCCA	CASSPPGIAEEGDTQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	5	5	10	7	27	39	55	49	62			01,02			01,02							Vb 17	CASSPPGIAEEGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGATTCGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRFDSGANVLTF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	9	2	8	0	2	5	27	35	39	37	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRFDSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACGGCGCTAACTATGGCTACACCTTCGGTTCG	CASNGANYGYTF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	9	0	0	2	1	27	37	42	39	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNGANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAGGGGGCGGTTGGGACTAGCGGGCCAAGAGACCCAGTACTTCGGGCCA	CASTRGRLGLAGQETQYF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	4	1	13	0	27	37	-1	50	62			01,02			01,02							Vb 17	CASTRGRLGLAGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TCTATCTCTGTGCCAGTAGTGCTGACAGGGGTTTGGGATACGTCTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSADRGLGYVYSGANVLTF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	63	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	2	0	3	15	8	20	31	23	46			01,02										Vb 17	CASSADRGLGYVYSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTGGCGGGGGTGGTCAGCCCCAGCATTTTGGTGAT	CASSIGGGGGQPQHF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	7	2	6	3	3	27	43	53	46	56			01,02										Vb 17	CASSIGGGGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCTTCAAGCAGGGGCAGAGAGAGGATAAATGAGCAGTTCTTCGGGCCA	CASSASSRGRERINEQFF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	7	8	13	27	39	53	47	66			01,02										Vb 17	CASSASSRGRERINEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGACAGGGGGCGGCGATCAGCCCCAGCATTTTGGTGAT	CASSLTGGGDQPQHF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	0	5	2	4	27	39	51	41	55			01,02										Vb 17	CASSLTGGGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCGGACAGGGGGCTGGAAACACCATATATTTTGGAGAG	CASIGQGAGNTIYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	1	2	2	0	27	37	-1	39	49			01,02										Vb 17	CASIGQGAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGTCAGCGGGAGGGTGGACCAATGAACAGTTCTTCGGGCCA	CASGSAGGWTNEQFF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	0	13	5	12	27	36	51	41	63			01,02										Vb 17	CASGSAGGWTNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGACGGCTACAAATCCATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSKTATNPYSNQPQHF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	2	7	0	1	15	27	40	44	41	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKTATNPYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCTTCGGGGCACTGAAGCTTTCTTTGGACAA	CASSMLRGTEAFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	4	4	0	27	41	-1	45	50			01,02										Vb 17	CASSMLRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGCCAGACAGGTTCTGAGGGAGCAGTACTTCGGGCCG	CASSIGARQVLREQYF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	7	6	8	27	43	55	49	63			01,02										Vb 17	CASSIGARQVLREQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTAGGGCCGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSIGRAGVNTEAFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	5	3	0	2	6	27	43	49	45	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGRAGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCAGGGGGCCAGTTCCCTCTCGGGCTATACCTTCGGTTCG	CASTQGASSLSGYTF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	0	14	2	19	27	37	47	39	66			01,02										Vb 17	CASTQGASSLSGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTTGGGGCAACGGGCAATGAGCAGTTCTTCGGGCCA	CASSIFGATGNEQFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	7	0	6	3	6	27	42	50	45	56			01,02										Vb 17	CASSIFGATGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGTTGGGGGAGGTCCTACGAGCAGTACTTCGGGCCG	CASSISWGRSYEQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	1	1	6	0	27	42	-1	48	54			01,02										Vb 17	CASSISWGRSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCCGGGACCCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	54	1.4982146275688139E-4		46	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	1	0	7	1	4	2	27	43	52	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGAACCATCAGCCCCAGCATTTTGGTGAT	CASSIGNHQPQHF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	3	5	0	3	27	-1	46	41	49			01,02										Vb 17	CASSIGNHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTCGCCCAGCCCCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIFRPAPSNQPQHF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	4	5	0	8	4	27	41	52	49	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIFRPAPSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCCGGTCAGGACTCAGCCCCAGCATTTTGGTGAT	CASSPPVRTQPQHF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	1	7	6	10	0	27	39	-1	49	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPPVRTQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCCCCAGGGGGGATTCACCGGGGAGCTGTTTTTTGGAGAA	CASSMPQGGFTGELFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	1	4	4	4	27	41	52	45	56			01,02										Vb 17	CASSMPQGGFTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGACAGCCCGATCCTGGGGACTGAAGCTTTCTTTGGACAA	CASKDSPILGTEAFF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	5	5	1	13	27	37	44	38	57			01,02										Vb 17	CASKDSPILGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGCCCTTCCCGCGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIDRPSRGSNQPQHF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	7	4	1	11	0	27	44	-1	55	60			01,02			01,02							Vb 17	CASSIDRPSRGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CASSLGLADNEQFF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	5	2	0	27	39	-1	41	52			01,02			01,02							Vb 17	CASSLGLADNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACAGGGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSDREGNTEAFF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	2	3	1	1	4	27	38	46	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDREGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTGCGGGACAGGGAGGTGGCTACACCTTCGGTTCG	CASTAGQGGGYTF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	7	4	3	27	37	50	41	53			01,02										Vb 17	CASTAGQGGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGACAGGGGATAGCTATACGTACTTCGGCGCC	CASSGTGDSYTYF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	2	15	0	10	27	-1	49	39	59			01,02										Vb 17	CASSGTGDSYTYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGCGGGACTAGCGGGAGGAATCAGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	64	1.7756617808222978E-4		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	0	1	4	4	7	26	36	55	40	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAACTAGGCTATGGCTACACCTTCGGTTCG	CASSIQLGYGYTF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	3	8	4	2	1	27	42	49	44	50			01,02			01,02							Vb 17	CASSIQLGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGCGGGGCTATGAACACTGAAGCTTTCTTTGGACAA	CASSMSGAMNTEAFF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	6	3	0	1	3	27	41	49	42	52			01,02										Vb 17	CASSMSGAMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAAACTCGGACTCTCAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSKNSDSQSSYNEQFF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	10	0	7	7	27	40	52	47	59			01,02			01,02							Vb 17	CASSKNSDSQSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGGGACAGGGAATCCAAGAGACCCAGTACTTCGGGCCA	CASSIKGQGIQETQYF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	3	1	2	3	27	42	53	44	56			01,02										Vb 17	CASSIKGQGIQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACGGTTCCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	71	1.9698747880997366E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	5	4	1	5	27	42	46	43	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGGAATAGGGGACACTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	75	2.0808536494011304E-4		49	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	6	0	8	2	27	38	52	46	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACGTCGCAATCAGCCCCAGCATTTTGGTGAT	CASSIGRRNQPQHF	In	VDJ	1	76	2.1085983647264788E-4	2.377236087694988E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	1	7	2	1	3	27	41	46	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGRRNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCTACGGGTGTCGGGGCCCAATGATATGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	78	2.1640877953771754E-4		53	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	10	7	0	3	13	9	27	34	52	47	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGGGGGGGACAACAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	78	2.1640877953771754E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	8	0	0	0	8	27	-1	43	35	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTCGGGACTAGCGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	78	2.1640877953771754E-4		38	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	5	7	5	0	27	37	-1	42	53			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGGGGCTAACTATGGCTACACCTTCGGTTCG	CASNGANYGYTF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	6	2	0	2	0	27	37	-1	39	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNGANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGGACCCAACAAGAGATCCAGTACTTCGGGCCA	CASSIEGTQQEIQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	0	7	10	1	12	27	44	50	45	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGTQQEIQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTTTAAACCGGGACCGCCGCGCAATCAGCCCCAGCATTTTGGTGAT	CASSTFKPGPPRNQPQHF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	7	2	10	6	27	40	55	50	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTFKPGPPRNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTGTGAAACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASCETGGTEAFF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	3	1	4	7	0	27	35	-1	42	50			01,02										Vb 17	CASCETGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTCAAATACGAACACTGAAGCTTTCTTTGGACAA	CASSTSNTNTEAFF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	3	7	1	8	0	27	40	-1	48	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTSNTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGACCCGGCTGACCAGCGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	96	2.663492671233447E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	9	6	6	5	13	0	27	35	-1	48	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCGTTTTTGGCCGAGACTGAAGCTTTCTTTGGACAA	CASRPFLAETEAFF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	9	0	5	9	4	27	38	50	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPFLAETEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSIGEGSYEQYF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	0	1	2	1	27	41	50	43	51			01,02										Vb 17	CASSIGEGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCAAAAGGACTAGCGGGCATATCCTACGAGCAGTACTTCGGGCCG	CASSAKGLAGISYEQYF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	4	1	6	4	27	39	56	45	60			01,02			01,02							Vb 17	CASSAKGLAGISYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGCGGGGACAGGGGCGATGAGACCCAGTACTTCGGGCCA	CASSRGDRGDETQYF	In	VDJ	1	98	2.718982101884144E-4	3.065383376238274E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	5	4	4	27	39	53	43	57			01,02										Vb 17	CASSRGDRGDETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACCGGGACCGTGAAACTTTCTTTGGACAA	CASSNRDRETFF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	0	7	12	3	7	27	40	48	43	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSNRDRETFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGACAGGGTAAAGTGCTGAAGCTTTCTTTGGACAA	CASSTPTG*SAEAFF	Stop	VDJ	1	103	2.8577056785108855E-4		45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	6	4	7	27	40	51	44	58			01,02										Vb 17	CASSTPTG*SAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGANVLTF	In	VJ	1	109	3.024173970462976E-4	3.409457020509917E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	6	0	0	3	0	0	27	-1	-1	-1	38			01,02										Vb 17	CASSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGTAACAGGGAACACTGAAGCTTTCTTTGGACAA	CASRVTGNTEAFF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	1	4	0	27	38	-1	42	47			01,02										Vb 17	CASRVTGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTCTTTGTTCCGGGGAGGGTACGAAAAACTGTTTTTTGGCAGT	CASRSLFRGGYEKLFF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	9	0	8	12	3	27	38	57	50	60			01,02										Vb 17	CASRSLFRGGYEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGTTTCGCAATCAGCCCCAGCATTTTGGTGAT	CASTFRNQPQHF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	6	2	0	4	27	-1	39	37	43			01,02			01,02							Vb 17	CASTFRNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAATAGGGGGGTCGACTGAAGCTTTCTTTGGACAA	CASSKIGGSTEAFF	In	VDJ	1	115	3.1906422624150663E-4	3.5971335537489954E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	5	1	5	4	4	27	40	50	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKIGGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTACGACAGGGGGTAGGAGTCAAGCTTTCTTTGGACAA	CASSTTTGGRSQAFF	In	VDJ	1	115	3.1906422624150663E-4	3.5971335537489954E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	1	9	4	8	27	40	53	44	61			01,02										Vb 17	CASSTTTGGRSQAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATTCTAAGGGACAACACTGAAGCTTTCTTTGGACAA	CAILRDNTEAFF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	10	0	7	2	6	0	27	34	-1	40	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAILRDNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATCCCAGGGACGGGTGGCTACACCTTCGGTTCG	CASSIPGTGGYTF	In	VDJ	1	119	3.30162112371646E-4	3.7222512425750474E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	0	7	7	7	3	27	38	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPGTGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGAGGCTGGCTACACCTTCGGTTCG	CASSIREAGYTF	In	VDJ	1	120	3.3293658390418085E-4	3.75353066478156E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	1	7	1	1	27	42	49	43	50			01,02										Vb 17	CASSIREAGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGACGGGGTCTCCTACGAGCAGTACTTCGGGCCG	CASTDGVSYEQYF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	3	0	4	1	27	37	46	41	47			01,02										Vb 17	CASTDGVSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSIGGSTEAFF	In	VDJ	1	123	3.412599985017854E-4	3.8473689314010994E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	6	1	4	0	2	27	-1	48	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACGGATCGATCCTGAAGCTTTCTTTGGACAA	CASSGRIDPEAFF	In	VDJ	1	123	3.412599985017854E-4	3.8473689314010994E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	1	7	6	0	9	27	-1	43	39	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGRIDPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTACAAAAGGGGTCCATACTAACTATGGCTACACCTTCGGTTCG	CASSPTKGVHTNYGYTF	In	VDJ	1	124	3.4403447003432023E-4	3.878648353607612E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	2	0	9	6	27	38	52	47	58			01,02										Vb 17	CASSPTKGVHTNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGCCGGGACAGGGGACAATCTTCCTATGGCTACACCTTCGGTTCG	CASSIGRDRGQSSYGYTF	In	VDJ	1	129	3.579068276969944E-4	4.035045464640177E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	4	5	9	27	41	56	46	65			01,02										Vb 17	CASSIGRDRGQSSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTGACGGCTTTATGGGTGGCTACACCTTCGGTTCG	CASSPDGFMGGYTF	In	VDJ	1	132	3.6623024229459893E-4	4.128883731259716E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	0	9	7	14	0	27	39	-1	53	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPDGFMGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGCTTAGCTACGAGCAGTACTTCGGGCCG	CASSIVLSYEQYF	In	VDJ	1	134	3.717791853596686E-4	4.1914425756727424E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	5	8	3	4	0	27	43	-1	47	50			01,02			01,02							Vb 17	CASSIVLSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTACTGCGGGAGGTGAGCCCAGATACGCAGTATTTTGGCCCA	CASSIVLREVSPDTQYF	In	VDJ	1	136	3.773281284247383E-4	4.254001420085768E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	1	4	4	6	27	43	55	47	61			01,02										Vb 17	CASSIVLREVSPDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGTCGGCGGGATAATTGATGAGCAGTTCTTCGGGCCA	CASSMRVGGIIDEQFF	In	VDJ	1	136	3.773281284247383E-4	4.254001420085768E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	3	8	8	6	27	41	55	49	61			01,02										Vb 17	CASSMRVGGIIDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGCTCATCGGGGRATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASAHRGISNQPQHF	In	VDJ	1	137	3.8010259995727315E-4	4.285280842292281E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	9	8	2	0	7	2	27	35	48	42	50			01,02										Vb 17	CASAHRGISNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGTCGGTGAGGTCTCTGGCTACACCTTCGGTTCG	CASVGEVSGYTF	In	VDJ	1	138	3.82877071489808E-4	4.3165602644987944E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	11	1	7	6	4	27	36	46	42	50			01,02										Vb 17	CASVGEVSGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCGGCTCGATAAGCTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	141	3.912004860874125E-4		50	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	9	0	4	4	10	27	41	48	45	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGGACAGGGGGTGTGAACACTGAAGCTTTCTTTGGACAA	CASSRGTGGVNTEAFF	In	VDJ	1	142	3.939749576199473E-4	4.4416779533248464E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	1	0	2	2	27	40	53	42	55			01,02										Vb 17	CASSRGTGGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAACCCCCCCTCTAGCGAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIKPPL*RGNTGELFF	Stop	VDJ	1	145	4.0229837221755185E-4		57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	6	1	12	3	24	38	56	50	59			01,02			01,02							Vb 17	CASSIKPPL*RGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCCCCGAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPRENTEAFF	In	VDJ	1	146	4.050728437500867E-4	4.5667956421508983E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	9	11	0	1	6	1	27	35	46	41	47			01,02										Vb 17	CASSPRENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCATCCCCTCGGGACAGGGGTGGCACTGAAGCTTTCTTTGGACAA	CASSSPRDRGGTEAFF	In	VDJ	1	150	4.161707298802261E-4	4.6919133309769503E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	2	4	10	3	27	36	56	46	59			01,02										Vb 17	CASSSPRDRGGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGATCGGGACAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASRIGTGGSYEQYF	In	VDJ	2	161	4.466899167381093E-4	5.035986975248593E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	0	4	0	27	38	-1	42	53			01,02										Vb 17	CASRIGTGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTGCAGCGGGGGTATTGTGGGCTTTCTTTGGACAA	CASSPAAGVLWAFF	In	VDJ	2	161	4.466899167381093E-4	5.035986975248593E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	6	2	11	5	8	27	39	52	44	60			01,02										Vb 17	CASSPAAGVLWAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGGGACTAGGTTTCTACGAGCAGTACTTCGGGCCG	CASSIAGLGFYEQYF	In	VDJ	2	169	4.68885688998388E-4	5.286222352900697E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	8	3	1	4	27	43	52	44	56			01,02			01,02							Vb 17	CASSIAGLGFYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTAGATTCATCGACAGGAGGCCTGCTGTTTTTTGGAGAA	CASSLDSSTGGLLFF	In	VDJ	2	177	4.910814612586668E-4	5.536457730552801E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	4	13	6	6	27	44	56	50	62			01,02										Vb 17	CASSLDSSTGGLLFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACGGGAGAAGCTACGAGCAGTACTTCGGGCCG	CASSDGRSYEQYF	In	VDJ	2	182	5.049538189213409E-4	5.692854841585366E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	2	3	2	3	27	39	47	41	50			01,02										Vb 17	CASSDGRSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCACGGAGGGGCAGTATCCCATACTCCGAGCAGTACTTCGGGCCG	CASSSRRGSIPYSEQYF	In	VDJ	2	183	5.077282904538758E-4	5.72413426379188E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	6	4	16	27	39	49	43	65			01,02										Vb 17	CASSSRRGSIPYSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAATCCCCCGGGTGAAAAACTGTTTTTTGGCAGT	CASRNPPGEKLFF	In	VDJ	2	184	5.105027619864106E-4	5.755413685998392E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	8	4	7	8	0	27	38	-1	46	50			01,02			01,02							Vb 17	CASRNPPGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCAGGCACGAGCAGTACTTCGGGCCG		Out	VDJ	2	185	5.132772335189455E-4		34	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	5	1	1	27	41	46	42	47			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGTGCTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSIRASGTDTQYF	In	VDJ	2	187	5.188261765840151E-4	5.849251952617931E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	6	1	5	0	27	41	-1	46	52			01,02			01,02							Vb 17	CASSIRASGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGTAGCGGGAGGGCGGGGTACGCAGTATTTTGGCCCA	CAVAGGRGTQYF	In	VDJ	2	187	5.188261765840151E-4	5.849251952617931E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	5	0	8	1	5	27	33	45	34	50			01,02										Vb 17	CAVAGGRGTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAAACAGGGACCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	190	5.271495911816197E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	3	5	3	4	27	37	46	40	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCACTATATCAGATACGCAGTATTTTGGCCCA	CASSFTISDTQYF	In	VDJ	2	192	5.326985342466894E-4	6.005649063650496E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	9	4	3	3	27	39	46	42	49			01,02			01,02							Vb 17	CASSFTISDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGGGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRVATNEKLFF	In	VDJ	2	194	5.382474773117591E-4	6.068207908063523E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	4	3	0	0	3	27	-1	40	35	43			01,02										Vb 17	CASRVATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAACTAACGGAACTAGCGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	196	5.437964203768288E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	3	4	5	12	0	27	34	-1	46	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGACAGGGCTACGGGCGAGCAGTACTTCGGGCCG	CASSMDRATGEQYF	In	VDJ	2	196	5.437964203768288E-4	6.130766752476548E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	6	0	7	27	-1	49	41	56			01,02										Vb 17	CASSMDRATGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGGGACAGCCACACAGATACGCAGTATTTTGGCCCA	CASSIRDSHTDTQYF	In	VDJ	2	205	5.687666641696423E-4	6.412281552335166E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	5	2	1	3	27	42	50	43	53			01,02										Vb 17	CASSIRDSHTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCAAGGGTTAGCACAGATACGCAGTATTTTGGCCCA	CASSISRVSTDTQYF	In	VDJ	2	211	5.854134933648514E-4	6.599958085574243E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	5	3	0	4	2	27	41	49	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISRVSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAGACCACGGGACTTGAGCAGTTCTTCGGGCCA	CASETTGLEQFF	In	VDJ	2	221	6.131582086901997E-4	6.912752307639373E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	10	9	8	0	27	36	-1	44	50			01,02			01,02							Vb 17	CASETTGLEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGGACCCAACAAGAAACCCAGTACTTCGGGCCA	CASSIEGTQQETQYF	In	VDJ	2	225	6.242560948203391E-4	7.037869996465425E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	0	7	8	1	10	27	44	50	45	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGTQQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTAGCGGGAGCGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	226	6.27030566352874E-4		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	4	2	3	0	3	27	-1	46	36	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTAACGACCATGAGCAGTTCTTCGGGCCA	CASTNDHEQFF	In	VDJ	2	238	6.60324224743292E-4	7.444502485150095E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	7	2	7	8	5	1	27	37	45	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTNDHEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACGAGGGGGGGGCTCCGGCCTGAAGCTTTCTTTGGACAA	CASTRGGLRPEAFF	In	VDJ	2	239	6.630986962758269E-4	7.475781907356607E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	9	9	0	6	5	8	27	35	47	40	55			01,02										Vb 17	CASTRGGLRPEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAAAGACGGCCGCGTAAATGAAAAACTGTTTTTTGGCAGT	CASSKDGRVNEKLFF	In	VDJ	2	247	6.852944685361056E-4	7.726017285008711E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	2	7	5	4	9	27	38	45	42	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKDGRVNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGCGGGACAGGGTGGTAACTGAAGCTTTCTTTGGACAA	CASTRDRVVTEAFF	In	VDJ	2	248	6.880689400686405E-4	7.757296707215224E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	5	3	5	27	37	49	40	54			01,02										Vb 17	CASTRDRVVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGTAGCGGGATCGAGCAGTTCTTCGGGCCA	CASSRSGIEQFF	In	VDJ	2	250	6.936178831337101E-4	7.81985555162825E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	10	2	2	27	39	49	41	51			01,02										Vb 17	CASSRSGIEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGTTGGGCAGGGAAGGTACGAGCAGTACTTCGGGCCG	CATVGQGRYEQYF	In	VDJ	2	257	7.13039183861454E-4	8.038811507073842E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	4	3	4	8	4	27	34	47	42	51			01,02										Vb 17	CATVGQGRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCATAACCGACGGTGAGGAAGCTTTCTTTGGACAA		Out	VDJ	2	257	7.13039183861454E-4		43	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	2	7	8	8	6	27	41	52	49	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCACCTCCTCCGATCAGCCCCAGCATTTTGGTGAT	CASSPTSSDQPQHF	In	VDJ	2	259	7.185881269265237E-4	8.101370351486867E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	6	3	7	5	4	8	27	38	44	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPTSSDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGAATAGGCGGGCCTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSTNRRASTNEKLFF	In	VDJ	3	269	7.46332842251872E-4	8.414164573551997E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	7	4	0	7	3	27	40	52	47	55			01,02			01,02							Vb 17	CASSTNRRASTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCGAGACAGGGGTGAACAGCCCCAGCATTTTGGTGAT	CASKRDRGEQPQHF	In	VDJ	3	282	7.82400972174825E-4	8.820797062236666E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	2	7	5	4	27	37	50	42	54			01,02										Vb 17	CASKRDRGEQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGCTAGCGGGAGGGGACATTCAGTACTTCGGCGCC	CASSRLAGGDIQYF	In	VDJ	3	286	7.934988583049643E-4	8.945914751062718E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	4	0	8	3	1	27	39	54	42	55			01,02										Vb 17	CASSRLAGGDIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGGGAACATTAACTATGGCTACACCTTCGGTTCG	CASTGNINYGYTF	In	VDJ	3	302	8.378904028255218E-4	9.446385506366926E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	8	3	1	0	5	27	-1	42	37	47			01,02										Vb 17	CASTGNINYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGATCTAGCGGGAGGCGAGCAGTACTTCGGGCCG	CASSMDLAGGEQYF	In	VDJ	3	308	8.545372320207308E-4	9.634062039606005E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	1	6	4	0	27	41	-1	45	56			01,02										Vb 17	CASSMDLAGGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGAGGCCCCGGGGACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	312	8.656351181508702E-4		47	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	0	7	6	11	0	27	41	-1	52	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGATTTAGGACAGGAAGATCAGCCCCAGCATTTTGGTGAT	CASKDLGQEDQPQHF	In	VDJ	3	323	8.961543050087534E-4	0.00101032533727037	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	4	5	8	3	27	37	52	45	55			01,02										Vb 17	CASKDLGQEDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTAGGACTAGCGGGAGGGAAATACGAGCAGTACTTCGGGCCG	CASSLGLAGGKYEQYF	In	VDJ	3	333	9.238990203341019E-4	0.0010416047594768829	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	2	0	4	0	3	27	-1	57	43	60			01,02										Vb 17	CASSLGLAGGKYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGGGCGCAGCTATGGCTACACCTTCGGTTCG	CASSIGGRSYGYTF	In	VDJ	3	347	9.627416217895896E-4	0.0010853959505660012	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	6	0	4	2	4	27	41	49	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGRSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACGCTGAGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSNAEGYNEQFF	In	VDJ	3	350	9.710650363871942E-4	0.001094779777227955	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	5	2	4	6	0	27	40	-1	46	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSNAEGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTTGGAGGCTATTACACTGAAGCTTTCTTTGGACAA	CASTLGGYYTEAFF	In	VDJ	4	392	0.0010875928407536575	0.0012261533504953097	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	1	3	5	5	27	37	47	42	52			01,02										Vb 17	CASTLGGYYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGCGAGACTAGCGGACTACAGTACTTCGGGCCG	CASSSETSGLQYF	In	VDJ	4	444	0.0012318653604454692	0.0013888063459691772	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	5	10	6	4	27	38	53	44	57			01,02			01,02							Vb 17	CASSSETSGLQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCCGGGATTGTCGGAGATACGCAGTATTTTGGCCCA	CASSISGIVGDTQYF	In	VDJ	5	537	0.0014898912129712094	0.0016797049724897482	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	3	5	3	7	27	41	49	44	56			01,02										Vb 17	CASSISGIVGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTCGGAGCACGGAACGAGCAGTACTTCGGGCCG	CASLGARNEQYF	In	VDJ	6	581	0.0016119679604027423	0.0018173344301984054	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	10	2	5	3	6	27	36	43	39	49			01,02										Vb 17	CASLGARNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGGGGACTATACCCCCAATGAGCAGTTCTTCGGGCCA	CASKGDYTPNEQFF	In	VDJ	6	590	0.0016369382041955558	0.0018454859101842672	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	9	6	3	6	27	37	47	40	53			01,02			01,02							Vb 17	CASKGDYTPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGATCTCAAGAACTATGGCTACACCTTCGGTTCG	CASSDLKNYGYTF	In	VDJ	6	670	0.001858895926798343	0.002095721287836371	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	2	8	2	1	7	27	38	41	39	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDLKNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTATGGCGGGGTCGGGTAGAGATACGCAGTATTTTGGCCCA	CATMAGSGRDTQYF	In	VDJ	8	811	0.0022500964128857556	0.0025367611409482043	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	7	3	5	5	8	27	34	45	39	53			01,02										Vb 17	CATMAGSGRDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTAGGGCGGGTGGCATTCCCATAATCAGCCCCAGCATTTTGGTGAT	CAS*GGWHSHNQPQHF	Stop	VDJ	11	1149	0.003187867790882532		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	8	7	4	4	4	12	27	36	45	40	57			01,02			01,02							Vb 17	CAS*GGWHSHNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCAACTAGCAGATACGCAGTATTTTGGCCCA	CASSQLADTQYF	In	VDJ	12	1221	0.00338762974122504	0.0038192174514152374	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	3	8	4	3	0	27	38	-1	41	46			01,02			01,02							Vb 17	CASSQLADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGAGACAGAATCAGCCCCAGCATTTTGGTGAT	CASSIWRQNQPQHF	In	VDJ	13	1411	0.00391477933240666	0.004413526473338984	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	4	5	0	27	41	-1	46	51			01,02										Vb 17	CASSIWRQNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACTCTGGTGAATGAGCAGTTCTTCGGGCCA	CASSTTLVNEQFF	In	VDJ	14	1415	0.003925877218536799	0.004426038242221589	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	7	1	6	27	40	45	41	51			01,02			01,02							Vb 17	CASSTTLVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTAGCTAGCGGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSIDLASGAYNEQFF	In	VDJ	14	1466	0.0040673752666960765	0.004585563295474806	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	4	5	2	27	44	58	49	60			01,02										Vb 17	CASSIDLASGAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAGGGTAGGGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CASEGRAGYNEQFF	In	VDJ	24	2524	0.007002766148117937	0.007894926164923882	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	7	4	3	9	0	27	36	-1	45	50			01,02			01,02							Vb 17	CASEGRAGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCGGGCAGGGGGCAGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	7.768520291097554E-5		46	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	8	5	4	23	38	51	43	55													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCACAGGGGAGCCCTTATGAAAAACTGTTTTTTGGCAGT	CASSAQGSPYEKLFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	2	6	1	7	23	36	44	37	51													Vb 11	CASSAQGSPYEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTCGTACGTGGGTCCTACGAGCAGTACTTCGGGCCG	CASSVVRGSYEQYF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	4	0	9	1	8	0	23	36	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSVVRGSYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCTCTTGGAGAAACTATGGCTACACCTTCGGTTCG	CASSWRNYGYTF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	10	2	2	4	1	23	32	40	36	41													Vb 11	CASSWRNYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCAAAAGGCAGATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQKADSYNEQFF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	45	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-01	01	5	4	5	1	7	2	23	35	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSQKADSYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCTGGACAGGGGGTGGGTGGCTACACCTTCGGTTCG	CASSAGQGVGGYTF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	1	7	2	4	23	36	48	38	52													Vb 11	CASSAGQGVGGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTCGTTACAGGGAAACACCGGAGAGCTGTTTTTTGGAGAA	CASSSLQGNTGELFF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	11	5	10	23	35	46	40	56													Vb 11	CASSSLQGNTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCCATGGGCTTTGGAACTGAAGCTTTCTTTGGACAA	CASSPMGFGTEAFF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	5	5	6	23	35	44	40	50													Vb 11	CASSPMGFGTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATTCGCGGGAGAGATTCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSEYSRERFGTGELFF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	54	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	7	2	4	3	8	23	40	50	43	58													Vb 11	CASSEYSRERFGTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTCCAGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSELQGNTGELFF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	2	3	1	23	38	46	41	47													Vb 11	CASSELQGNTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGAGGGACATACTCCTACGAGCAGTACTTCGGGCCG	CASRGTYSYEQYF	In	VDJ	1	88	2.4415349486306594E-4	2.752589154173144E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	0	1	2	23	34	41	35	43													Vb 11	CASRGTYSYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGTAGTGAAAGGGGACATCAAGAGACCCAGTACTTCGGGCCA	CASSERGHQETQYF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	6	2	2	1	23	38	46	40	47													Vb 11	CASSERGHQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCAATTTCCCGGGGAGCGATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	106	2.940939824486931E-4		49	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	3	4	8	5	23	36	49	44	54						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATAGAGGTTTACCGCCAGTTCTTCGGGCCA		Out	VDJ	1	135	3.7455365689220346E-4		38	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	1	13	0	8	23	-1	44	40	52													Vb 11	X+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGAGACAGTACAATCAGCCCCAGCATTTTGGTGAT	CASSERQYNQPQHF	In	VDJ	1	138	3.82877071489808E-4	4.3165602644987944E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	3	2	2	23	37	44	39	46													Vb 11	CASSERQYNQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTAAGACGATCTAAAGCGGTATGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	140	3.884260145548777E-4		52	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	5	0	12	4	23	35	52	47	56						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCGTCGCGGGGCTCAGATACGCAGTATTTTGGCCCA	CASSASRGSDTQYF	In	VDJ	1	143	3.9674942915248217E-4	4.472957375531359E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	4	4	2	23	36	46	40	48													Vb 11	CASSASRGSDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCTCCCCCGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSPGLNTEAFF	In	VDJ	1	150	4.161707298802261E-4	4.6919133309769503E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	8	8	0	0	6	0	23	32	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSPGLNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGCGACAGGCTTGGGGGAAAAACTGTTTTTTGGCAGT	CASSEATGLGEKLFF	In	VDJ	3	304	8.434393458905915E-4	9.508944350779952E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	4	8	2	7	23	38	46	40	53													Vb 11	CASSEATGLGEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTAGACTAGCGAGCACAGATACGCAGTATTTTGGCCCA	CATSSRLASTDTQYF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	6	0	2	0	18	32	-1	34	42						01,02								CATSSRLASTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATAGCGGGAGAGGAGCAGTTCTTCGGGCCA	CATSRIAGEEQFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	39	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	2	10	1	2	18	33	43	34	45														CATSRIAGEEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCCCTCCACGGGTAATGAAAAACTGTTTTTTGGCAGT	CATSSPSTGNEKLFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	8	4	4	8	0	18	32	-1	40	44						01,02								CATSSPSTGNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAACCCGGGAACCCTATGGCTACACCTTCGGTTCG	CATSRTREPYGYTF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	3	4	3	3	18	33	41	36	44														CATSRTREPYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATTCAGCGGGAGGGTAATGAGCAGTTCTTCGGGCCA	CATSIQREGNEQFF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	0	7	3	1	18	31	44	34	45														CATSIQREGNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCGAACTAGCGGGAGATAAGAGCGGGGAGCTGTTTTTTGGAGAA	CATELAGDKSGELFF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	3	2	7	2	7	18	27	40	29	47														CATELAGDKSGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTGGTCGGTCGACAGCGTTACAATGAGCAGTTCTTCGGGCCA	CASSLVGRQRYNEQFF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	5	4	10	3	18	30	45	40	48														CASSLVGRQRYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTATCCGGGAGAGATCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSRDYPGEISYNEQFF	In	VDJ	1	91	2.5247690946067047E-4	2.846427420792683E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	2	0	5	4	18	35	46	40	50														CATSRDYPGEISYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCTGACGACCCTCTCTATGGCTACACCTTCGGTTCG	CATSRADDPLYGYTF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	1	2	7	4	2	8	18	34	39	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRADDPLYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGACAGGGGTGACCTACAATGAGCAGTTCTTCGGGCCA	CATSRGTGVTYNEQFF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	2	1	3	18	32	43	33	46														CATSRGTGVTYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGCGCCCCCCCGGGACTAGCGGGACAAGAGACCCAGTACTTCGGGCCA	CATSGAPPGLAGQETQYF	In	VDJ	1	131	3.634557707620641E-4	4.0976043090532033E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	3	2	11	0	18	30	-1	41	54														CATSGAPPGLAGQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGAGGAGGGGGAGTACAAGAGAACCCAGTACTTCGGGCCA	CATSEEGEYKRTQYF	In	VDJ	1	139	3.8565154302234284E-4	4.347839686705307E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	5	5	1	8	4	11	18	30	40	34	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSEEGEYKRTQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCCCCACCGGACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CATSRAPTGLAGGETQYF	In	VDJ	1	152	4.2171967294529577E-4	4.754472175389976E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	1	1	4	8	0	18	34	-1	42	56														CATSRAPTGLAGGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGTAGACAGGGCACCAACGAGCAGTACTTCGGGCCG	CATSGRQGTNEQYF	In	VDJ	2	159	4.411409736730396E-4	4.973428130835568E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	5	4	5	18	30	41	34	46														CATSGRQGTNEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAATAGGCGAACAAGAGACCCAGTACTTCGGGCCA	CATSRIGEQETQYF	In	VDJ	2	173	4.799835751285274E-4	5.411340041726749E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	2	5	4	2	2	4	18	33	38	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRIGEQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCCCTACGGACTAGCGGGAAGGAGGTTGAAGACCCAGTACTTCGGGCCA	CATSSPYGLAGRRLKTQYF	In	VDJ	2	173	4.799835751285274E-4	5.411340041726749E-4	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	1	3	6	7	10	18	32	51	39	61														CATSSPYGLAGRRLKTQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCATAGCGGAATAGCCAAAAACATTCAGTACTTCGGCGCC	CATSRDHSGIAKNIQYF	In	VDJ	2	187	5.188261765840151E-4	5.849251952617931E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	5	5	0	3	3	18	35	44	38	47						01,02								CATSRDHSGIAKNIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAGGGACCAACTATGGCTACACCTTCGGTTCG	CATSREGTNYGYTF	In	VDJ	2	201	5.576687780395029E-4	6.287163863509113E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	0	0	7	2	1	1	18	35	41	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSREGTNYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGTGGCCGAACCTACGAGCAGTACTTCGGGCCG	CATSRGGRTYEQYF	In	VDJ	2	219	6.0760926562513E-4	6.850193463226348E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	2	0	8	18	-1	35	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGGRTYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGACGGGAGTAACGGCAGATACGCAGTATTTTGGCCCA	CATSRATGVTADTQYF	In	VDJ	2	238	6.60324224743292E-4	7.444502485150095E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	2	4	3	6	18	34	43	37	49														CATSRATGVTADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGTGCTAGCGGTTTATTACTCAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	257	7.13039183861454E-4		56	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	5	5	5	12	18	35	47	40	59						01,02								X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGTTTGGGGGGTTAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	266	7.380094276542675E-4		46	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	9	1	5	4	4	18	35	45	39	49														X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTCTCGGGACAGGAAATGAAAAACTGTTTTTTGGCAGT	CATSRGLGTGNEKLFF	In	VDJ	3	274	7.602051999145463E-4	8.570561684584562E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	4	5	5	1	18	34	47	39	48														CATSRGLGTGNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTTAGAACAGGGGGACTCCTACGAGCAGTACTTCGGGCCG	CATSLEQGDSYEQYF	In	VDJ	3	285	7.907243867724295E-4	8.914635328856205E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	1	0	5	1	18	30	43	35	44														CATSLEQGDSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGCCGGGCAGACAAACAATGAGCAGTTCTTCGGGCCA	CATSRDAGQTNNEQFF	In	VDJ	3	305	8.462138174231263E-4	9.540223772986465E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	2	6	5	9	1	18	35	48	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDAGQTNNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGACGTTTACAGATACGCAGTATTTTGGCCCA	CATSRDRTFTDTQYF	In	VDJ	3	330	9.155756057364974E-4	0.001032220932814929	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	0	1	7	3	2	4	18	35	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRTFTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGAGTGATCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	336	9.322224349317063E-4		46	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	2	1	2	4	18	35	41	37	45														X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACAGAAGGGACAGGGGGGTACGAGCAGTACTTCGGGCCG	CATSTEGTGGYEQYF	In	VDJ	3	365	0.0010126821093752168	0.0011416989105377244	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	4	1	1	18	35	47	36	48														CATSTEGTGGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAGTTGATAGGAGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	469	0.0013012271487588402		46	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	10	1	4	8	0	18	33	-1	41	46														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CATSREADTGELFF	In	VDJ	5	549	0.0015231848713616273	0.0017172402791375638	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	7	5	3	1	0	18	35	-1	36	40						01,02								CATSREADTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGACAGGTGAAGAAAAACTGTTTTTTGGCAGT	CATSRDRTGEEKLFF	In	VDJ	6	631	0.0017506915370294842	0.0019737315412309705	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	4	8	2	4	18	35	44	37	48														CATSRDRTGEEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGGAGTCGATGGGAAAACTGTTTTTTGGCAGT	CATSRDGESMGKLFF	In	VDJ	6	633	0.001756240480094554	0.001979987425672273	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	9	2	10	2	8	18	35	42	37	50														CATSRDGESMGKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGAGGACAGGCGCTTTACAATGAGCAGTTCTTCGGGCCA	CATSRDRGQALYNEQFF	In	VDJ	7	686	0.0019032874713189006	0.002145768363366792	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	4	4	5	18	35	46	39	51														CATSRDRGQALYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGAAGGTCCTCGTGGAGACCCAGTACTTCGGGCCA	CATSRKVLVETQYF	In	VDJ	7	695	0.001928257715111714	0.0021739198433526536	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	3	5	4	5	2	8	18	32	37	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRKVLVETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGGGGGGTAAGGGACTAGCGGGAGGCTACGAGCAGTACTTCGGGCCG	CATSRVGGKGLAGGYEQYF	In	VDJ	8	883	0.002449858363228264	0.002761972980835098	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	0	1	3	10	0	18	34	-1	44	59														CATSRVGGKGLAGGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCGGGGGAAGGCACTGAAGCTTTCTTTGGACAA	CATSRPGEGTEAFF	In	VDJ	12	1209	0.0033543360828346223	0.0037816821447674218	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	2	4	1	4	18	33	40	34	44														CATSRPGEGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGGGCATACAGGGAGCTGAAGCTTTCTTTGGACAA	CARSLGIQGAEAFF	In	VDJ	1	113	3.13515283176437E-4	3.534574709335969E-4	42	TCRBV05	TCRBV05-03		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	6	4	2	18	34	44	38	46			01,02											CARSLGIQGAEAFF+TCRBV05-03+TCRBJ01-01	TCRBV05-03	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGGCAGCCTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	9	901	0.0024997988508138913		43	TCRBV05	TCRBV05-03					TCRBJ01	TCRBJ01-05	01	0	4	5	0	0	2	18	-1	37	34	39			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-03+TCRBJ01-05	TCRBV05-03		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTCGAGACGAACACTGAAGCTTTCTTTGGACAA	CASSFETNTEAFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	3	2	7	1	3	0	18	32	-1	35	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFETNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCAAAGGGCCCTTCTATGGCTACACCTTCGGTTCG	CASSKGPFYGYTF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-02	01	5	5	3	4	2	5	18	30	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGPFYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGTAGGACAGAATTGGATCAACTTCGGGCCG	CASSLVGQNWINF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	14	2	10	18	34	42	36	52														CASSLVGQNWINF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCTGGGGTTTGGGATACGCAGTATTTTGGCCCA	CASSSGVWDTQYF	In	VDJ	2	209	5.798645502997817E-4	6.537399241161217E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-03	01	4	6	2	6	2	5	18	31	37	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGVWDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGCCCCAATCACATACTCTGGAAACACCATATATTTTGGAGAG	CASAPITYSGNTIYF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	3	6	0	9	2	18	27	39	36	41														CASAPITYSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTATTAGCGGGGGTCATCTACGAGCAGTACTTCGGGCCG	CASSLLAGVIYEQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	3	4	4	18	30	43	34	47														CASSLLAGVIYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGACCCAAATATACTACCCAATCAGCCCCAGCATTTTGGTGAT	CASSLDPNILPNQPQHF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	3	9	3	14	2	18	30	48	44	50						01,02								CASSLDPNILPNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCCCAGTGGTCGGGGAGCTGTTTTTTGGAGAA	CASSLSPVVGELFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	4	5	7	4	4	18	33	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSPVVGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACGGGGCCCATTCGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASNGAHSATNEKLFF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	7	7	0	0	2	8	18	28	35	30	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNGAHSATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGTTGAGGCTGGGCCTAGCGAGTTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	8.878308904111489E-5		59	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	6	1	15	4	18	33	54	48	58						01,02								X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCCATGGGACAGGCAAGAGACCCAGTACTTCGGGCCA	CASSSPWDRQETQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	4	2	6	0	18	31	-1	37	45														CASSSPWDRQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGTGACACACCAAGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	33	9.155756057364973E-5		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	6	5	3	7	18	31	38	34	45														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCGGCGACGGGAGTGGCTACACCTTCGGTTCG	CASSLGGDGSGYTF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	2	7	9	0	18	32	-1	41	47														CASSLGGDGSGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTTCTAGCGGGCCGGCGGAGTTCTTCGGGCCA	CASSLVSSGPAEFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	4	14	3	7	18	34	45	37	52						01,02								CASSLVSSGPAEFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGCCCTAGCGGGAGGTTCTACGAGCAGTACTTCGGGCCG	CASSPGPSGRFYEQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	1	3	7	2	18	30	48	37	50														CASSPGPSGRFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGTCCCGGGCCACTGAAGCTTTCTTTGGACAA	CASSLGQSRATEAFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	4	0	8	18	-1	39	32	47														CASSLGQSRATEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCGGGAGGGCGTGAGGACTGAAGCTTTCTTTGGACAA	CASTREGVRTEAFF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	8	0	5	2	7	18	28	38	30	45														CASTREGVRTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGAGGACTAGCGGGATCGGCAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	36	9.988097517125425E-5		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	1	3	4	4	6	18	30	46	34	52														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATCAGGGCCTCGGGACAGCATTCGGCGTCCTGACTTTCGGGGCC	CASSYQGLGTAFGVLTF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	5	12	11	7	18	31	49	42	56														CASSYQGLGTAFGVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACAGGGGATACAGTATGGCTACACCTTCGGTTCG	CASSSQGIQYGYTF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	5	1	6	18	31	39	32	45														CASSSQGIQYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTTCCCGACTAGCCCTTGAGCAGTTCTTCGGGCCA	CASSLGSRLALEQFF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	7	9	6	3	18	34	47	40	50						01,02								CASSLGSRLALEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGCTAGCGGGAGTTCGCGAGCAGTACTTCGGGCCG	CASSLRLAGVREQYF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	2	6	3	4	18	33	46	36	50														CASSLRLAGVREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTCGGGGAAATCAGCCCCAGCATTTTGGTGAT	CASSLSRGNQPQHF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	3	4	3	1	18	33	41	36	42														CASSLSRGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCTAGCGGGAAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	38	1.0542991823632394E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	4	3	1	2	1	18	34	45	36	46														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGCCGGGGACTAGCGGGAGGGCCTCAGGCAGATACGCAGTATTTTGGCCCA	CASSPRRGLAGGPQADTQYF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	0	4	8	7	18	30	54	38	61														CASSPRRGLAGGPQADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACCCGCCGGGGGACGAAACTATGGCTACACCTTCGGTTCG	CASSSPAGGRNYGYTF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	2	2	7	4	18	31	44	38	48														CASSSPAGGRNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGCGGAAAGCCTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	1.0820438976885877E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	5	6	0	7	18	-1	39	35	46						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTATGGGACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSMGQNTGELFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	6	1	3	0	18	29	-1	32	38														CASSMGQNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACCAGGGGGTTAATTTCTACGAGCAGTACTTCGGGCCG	CASSLDQGVNFYEQYF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	3	4	7	18	32	43	36	50														CASSLDQGVNFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAGGGGGTTTTCACTGAAGCTTTCTTTGGACAA	CASSPQGVFTEAFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	4	3	4	18	30	40	33	44														CASSPQGVFTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGACAGGATGCTTATGGGCTACACCTTCGGTTCG	CASSPDRMLMGYTF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	8	3	9	18	30	39	33	48														CASSPDRMLMGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGTTCGGGTCACAGATACGCAGTATTTTGGCCCA	CASSLVRVTDTQYF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	4	2	6	1	18	30	40	36	41						01,02								CASSLVRVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAATGACCCAGGGGACTTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	1.1652780436646329E-4		50	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	4	2	2	8	5	18	30	44	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGGGACAGGGGTACGAGAGACCCAGTACTTCGGGCCA	CASSAGTGVRETQYF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	4	3	4	18	30	43	33	47														CASSAGTGVRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCCAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQARNTGELFF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	4	5	2	5	1	18	30	38	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQARNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGGGTGGAGGTGAAAAACTGTTTTTTGGCAGT	CASSFGGGGEKLFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	2	7	0	6	18	-1	38	32	44														CASSFGGGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAACTAGCGGGAGAGGATGAGCAGTTCTTCGGGCCA	CASSLELAGEDEQFF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	3	2	8	0	3	18	-1	46	35	49														CASSLELAGEDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCGCAGGATACACTGAAGCTTTCTTTGGACAA	CASSLGAGYTEAFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	3	5	2	18	32	41	37	43														CASSLGAGYTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLRGAQETQYF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	5	1	1	0	2	18	-1	39	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCAGCCGCTAATGAAAAACTGTTTTTTGGCAGT	CASSFPAANEKLFF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	3	4	5	3	2	3	18	32	37	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPAANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTTCCAGCTGACTACAATGAGCAGTTCTTCGGGCCA	CASSFPADYNEQFF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	6	4	5	3	5	4	18	29	37	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPADYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAGCACTTCCCGTCGAGCAGTACTTCGGGCCG	CASSLGALPVEQYF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	2	6	0	10	18	-1	37	32	47														CASSLGALPVEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGATGGACAGGGCTGGATCAGTCCCAGCATTTTGGTGAT	CASSRWTGLDQSQHF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	11	4	10	18	30	42	34	52														CASSRWTGLDQSQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCAGGCGGACAGGGTTCTGAAAAACTGTTTTTTGGCAGT	CASSPSGGQGSEKLFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	3	7	9	3	18	30	47	39	50														CASSPSGGQGSEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGTCGGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGSGTSTDTQYF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	10	0	7	0	18	32	-1	39	45						01,02								CASSLGSGTSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGGTCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGSSNQPQHF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	1	0	3	18	-1	36	30	39														CASSQGSSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACTAGCGACAGAAGAGACCCAGTACTTCGGGCCA	CASSPGLATEETQYF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	6	3	2	4	18	30	42	32	46						01,02								CASSPGLATEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGACAGGGAATTTGGGATATGGCTACACCTTCGGTTCG	CASSLGGTGNLGYGYTF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	5	2	9	18	34	45	36	54														CASSLGGTGNLGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGGCATCTGATCAGCCCCAGCATTTTGGTGAT	CASSLVASDQPQHF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	9	0	5	3	5	18	32	38	35	43														CASSLVASDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGACTAGCGGGACTTCAGGATACGCAGTATTTTGGCCCA	CASSTGLAGLQDTQYF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	3	6	3	6	18	30	45	33	51														CASSTGLAGLQDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTAAGGGACAAGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRKGQASGANVLTF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	6	0	5	3	18	30	41	35	44														CASSRKGQASGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAACGCGGGGGGTCCTCCTACGAGCAGTACTTCGGGCCG	CASSLKRGGSSYEQYF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	1	0	4	2	18	33	45	37	47														CASSLKRGGSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGACTAGTTGGCACAGATACGCAGTATTTTGGCCCA	CASSQGLVGTDTQYF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	8	1	3	3	18	30	40	33	43						01,02								CASSQGLVGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGACAGTGATGAACACTGAAGCTTTCTTTGGACAA	CASSLTVMNTEAFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	0	3	3	18	29	37	32	40														CASSLTVMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTCGGGCTAGCGGGAGGGGGGCAGTACTTCGGGCCG	CASSFLGLAGGGQYF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	0	9	7	2	18	32	51	39	53														CASSFLGLAGGGQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCGGGACAGAAACTACGAGCAGTACTTCGGGCCG	CASSHRDRNYEQYF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	4	3	18	30	41	34	44														CASSHRDRNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAAACTGGGACTCTTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	60	1.6646829195209043E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	3	5	4	18	31	42	36	46						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCTACGGGACTAGCGTTAGATACGCAGTATTTTGGCCCA	CASSLATGLALDTQYF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	6	5	6	2	18	32	48	38	50						01,02								CASSLATGLALDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGACTAGCGGGAGCGGGTGAGCAGTTCTTCGGGCCA	CASSFGLAGAGEQFF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	1	2	9	1	4	18	32	46	33	50														CASSFGLAGAGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACACCGGGACTAGCGGATTACAATGAGCAGTTCTTCGGGCCA	CASSQTPGLADYNEQFF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	4	8	2	18	30	49	38	51						01,02								CASSQTPGLADYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTAGTGGAGTGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSSGVVYNEQFF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	2	3	4	4	18	29	37	33	41														CASSSGVVYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACAGACAGGCGACGGGTCTACGAGCAGTACTTCGGGCCG	CASTDRRRVYEQYF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	4	3	2	8	18	28	36	30	44														CASTDRRRVYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGAGATCGGAGCTGAACACTGAAGCTTTCTTTGGACAA	CASSQRSELNTEAFF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	0	8	1	18	30	42	38	43														CASSQRSELNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGGCAGGGGAGAATGCTGAAGCTTTCTTTGGACAA	CASSLWAGENAEAFF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	6	4	6	18	33	43	37	49														CASSLWAGENAEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATCTTCCCGGGACAGCATGAACACTGAAGCTTTCTTTGGACAA	CASRSSRDSMNTEAFF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	8	2	18	29	44	37	46														CASRSSRDSMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTCCCTCGCGGGCGGGGACGAGCAGTACTTCGGGCCG	CASSLGSLAGGDEQYF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	5	12	0	18	34	-1	46	52														CASSLGSLAGGDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAAGGGAAACGGGGTCAGCCCCAGCATTTTGGTGAT	CASSLKGKRGQPQHF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	6	10	0	18	32	-1	42	47														CASSLKGKRGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACCCCGGGACAGGGGAACTCAATGAGCAGTTCTTCGGGCCA	CASSNPGTGELNEQFF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	6	6	4	18	30	46	36	50														CASSNPGTGELNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGGTCGGGACTAGCATCAGATACGCAGTATTTTGGCCCA	CASSRGSGLASDTQYF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	7	4	8	2	18	30	47	38	49						01,02								CASSRGSGLASDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACGGGAGGGAAGAACTACGAGCAGTACTTCGGGCCG	CASRTGGKNYEQYF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	0	3	2	5	18	29	39	31	44														CASRTGGKNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCGGGACCGCGGGACCACTGAAGCTTTCTTTGGACAA	CASNRDRGTTEAFF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	7	3	4	9	1	18	28	43	37	44														CASNRDRGTTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAACCGGACCGGAGGACACTGAAGCTTTCTTTGGACAA	CASSQTGPEDTEAFF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	1	3	11	0	18	30	-1	41	46														CASSQTGPEDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATCAGGCCTCTCGGCCGCCCCAGCATTTTGGTGAT	CASSYQASRPPQHF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	4	9	2	10	18	31	37	33	47														CASSYQASRPPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGGGGGAATCAGATACGCAGTATTTTGGCCCA	CASSLGQGESDTQYF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	1	4	0	3	18	-1	43	32	46														CASSLGQGESDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACGATCGGGGGGAAGAACCAGAGCAGTACTTCGGGCCG	CASNDRGEEPEQYF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	1	7	5	8	18	28	40	33	48														CASNDRGEEPEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACAGGGGGTTCTCCTCCGCGGCTACACCTTCGGTTCG	CASSPGQGVLLRGYTF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	1	8	3	11	18	30	43	33	54														CASSPGQGVLLRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACCCATACTAGCACAGATACGCAGTATTTTGGCCCA	CASSFGTHTSTDTQYF	In	VDJ	1	67	1.858895926798343E-4	2.0957212878363712E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	0	7	0	1	7	18	32	38	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGTHTSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCCGGGAGGAGGGACCGCTGAGACCCAGTACTTCGGGCCA	CASSPPGGGTAETQYF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	1	5	4	10	18	30	41	34	51														CASSPPGGGTAETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTACCCCTACAGGGGAGGACGGGGAGCTGTTTTTTGGAGAA	CASSSTPTGEDGELFF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	2	7	8	4	18	31	46	39	50														CASSSTPTGEDGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGACAGGCCGCACTTCTTATGGCTACACCTTCGGTTCG	CASSWTGRTSYGYTF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	5	0	10	18	-1	38	31	48														CASSWTGRTSYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGGGGGAGGGCTACGAGCAGTACTTCGGGCCG	CASSLWGEGYEQYF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	0	3	5	0	18	32	-1	37	44														CASSLWGEGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACTTACCCCACAGGGCGGCAAAAACATTCAGTACTTCGGCGCC	CASSQLTPQGGKNIQYF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	3	3	11	3	18	30	47	41	50														CASSQLTPQGGKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACGACAGGGCGCACTGAAGCTTTCTTTGGACAA	CASSPTTGRTEAFF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	4	5	2	18	30	42	35	44														CASSPTTGRTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAGCGGGTCCGCGCACAGATACGCAGTATTTTGGCCCA	CASSLGAGPRTDTQYF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	4	1	3	5	18	32	41	35	46						01,02								CASSLGAGPRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCTATTCGCCGGGACAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLLFAGTGAGELFF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	2	6	10	0	18	32	-1	42	52														CASSLLFAGTGAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGCCGGGACAGGGTACGCTGAAGCTTTCTTTGGACAA	CASSQAGTGYAEAFF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	6	6	4	18	30	45	36	49														CASSQAGTGYAEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGGGGACTAGCGGGAAAGAATGAGCAGTTCTTCGGGCCA	CASGGLAGKNEQFF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	0	3	7	2	3	18	27	42	29	45														CASGGLAGKNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGGAAACCGCTGAAAAACTGTTTTTTGGCAGT	CASSLKETAEKLFF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	2	1	8	7	2	6	18	33	38	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKETAEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCTCTAATGAACACTGAAGCTTTCTTTGGACAA	CASSLPLMNTEAFF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	4	9	0	3	1	18	33	39	36	40						01,02								CASSLPLMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAACAGGGCTATGGAAACACCATATATTTTGGAGAG	CASSLEQGYGNTIYF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	3	3	0	3	18	-1	41	35	44														CASSLEQGYGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGATCGTACAGGTTACACTATGGCTACACCTTCGGTTCG	CASSLGSYRLHYGYTF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	4	3	8	4	18	32	45	40	49														CASSLGSYRLHYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACACCGGGAAAGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSDTGKGYTGELFF	In	VDJ	1	75	2.0808536494011304E-4	2.3459566654884752E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	3	3	5	6	18	30	40	35	46														CASSDTGKGYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACTCTACAGGACAGATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	77	2.136343080051827E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	1	10	1	18	30	46	40	47														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGCCGCCCAGCAAGAGACCCAGTACTTCGGGCCA	CASSLAAAQQETQYF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	5	2	10	0	18	32	-1	42	45														CASSLAAAQQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCCGGGACTGGGGTTTGTTGAGCAGTACTTCGGGCCG		Out	VDJ	1	77	2.136343080051827E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	7	4	10	18	29	39	33	49						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGGGCCGGCACCTACGAGCAGTACTTCGGGCCG	CASSLDGAGTYEQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	2	1	5	18	35	41	36	46														CASSLDGAGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCTCACAGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSAHRGGTGELFF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	2	4	4	3	18	30	41	34	44														CASSAHRGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGTCGGTAATAGGACTAGCGGGAGGAGATACGCAGTATTTTGGCCCA	CASSLRSVIGLAGGDTQYF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	1	1	5	12	0	18	33	-1	45	59														CASSLRSVIGLAGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGTCCAGCGGGAGGGCCGTATGAGCAGTTCTTCGGGCCA	CASSLSPAGGPYEQFF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	0	8	6	4	18	32	48	38	52														CASSLSPAGGPYEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGGCTACCGGAGTGGGGGAGGTGGACTGAAGCTTTCTTTGGACAA	CASGLPEWGRWTEAFF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	9	1	5	15	3	18	27	48	42	51														CASGLPEWGRWTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTATCCGGACTAGTTAGTTGCAGTTCTTCGGGCCA		Out	VDJ	1	86	2.3860455179799627E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	8	12	9	6	18	30	46	39	52						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCAGGATGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLRMGSTDTQYF	In	VDJ	1	87	2.4137902333053112E-4	2.721309731966631E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	4	4	0	2	6	18	30	36	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRMGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGAGTTAAGACTAGCGTCCACAGATACGCAGTATTTTGGCCCA	CASSLGELRLASTDTQYF	In	VDJ	1	87	2.4137902333053112E-4	2.721309731966631E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	6	2	11	2	18	32	51	43	53						01,02								CASSLGELRLASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAACTCGAATATAACTATGGCTACACCTTCGGTTCG	CASSLQLEYNYGYTF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	3	10	1	3	6	18	32	38	35	44						01,02								CASSLQLEYNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGAAGGGGTTGGGTTCTGGGAGCAGTACTTCGGGCCG	CASSPEGVGFWEQYF	In	VDJ	1	90	2.497024379281356E-4	2.81514799858617E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	7	5	11	18	30	40	35	51														CASSPEGVGFWEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTGGGACAGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	90	2.497024379281356E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	0	4	1	4	0	18	31	-1	35	43														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGACAGGGGGAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	91	2.5247690946067047E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	1	0	3	0	18	30	-1	33	43														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTAGCGGGATTGGATACGCAGTATTTTGGCCCA	CASSLGLAGLDTQYF	In	VDJ	1	91	2.5247690946067047E-4	2.846427420792683E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	0	3	6	0	3	18	-1	45	32	48														CASSLGLAGLDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCACCAACAGGGGGTAGGCGAGAGACCCAGTACTTCGGGCCA	CASSLSPTGGRRETQYF	In	VDJ	1	91	2.5247690946067047E-4	2.846427420792683E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	1	4	7	6	18	32	47	39	53														CASSLSPTGGRRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGTGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSPWTGNEKLFF	In	VDJ	1	92	2.552513809932053E-4	2.877706842999196E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	3	5	4	0	18	30	-1	34	42														CASSPWTGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCTATCTCTGGGGTCTCCTTAGGCGAGCAGTACTTCGGGCCG	CASSAISGVSLGEQYF	In	VDJ	1	92	2.552513809932053E-4	2.877706842999196E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	6	2	6	9	10	18	30	43	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAISGVSLGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTATCTCCGGGACAGGCTATTCTGGAGCTGTTTTTTGGAGAA	CASSVSPGQAILELFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	10	8	7	18	30	46	38	53														CASSVSPGQAILELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTAGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLGLAGYNEQFF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	4	3	0	0	18	-1	-1	32	44						01,02								CASSLGLAGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTGGACTAACGGGAGCGGCACACAATGAGCAGTTCTTCGGGCCA	CASSSGLTGAAHNEQFF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	9	5	2	13	18	31	39	33	52						01,02								CASSSGLTGAAHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTGGACAGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLSGQTNEKLFF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	5	2	3	0	18	33	-1	36	42														CASSLSGQTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTAGAGTTCTTTCTCCCTGGGGACGGTGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	97	2.6912373865587954E-4		59	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	0	0	7	4	14	4	18	35	54	49	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTAGCGGGGACTTACAATGAGCAGTTCTTCGGGCCA	CASSLLAGTYNEQFF	In	VDJ	1	98	2.718982101884144E-4	3.065383376238274E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	4	0	3	18	-1	42	33	45														CASSLLAGTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGACTAGCGTATCATTACAATGAGCAGTTCTTCGGGCCA	CASSPGLAYHYNEQFF	In	VDJ	1	102	2.829960963185537E-4	3.190501065064326E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	6	4	3	6	18	30	42	33	48						01,02								CASSPGLAYHYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGGTGATCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	103	2.8577056785108855E-4		41	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	0	9	5	3	7	18	30	36	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACTACTGGGACACACGCTCTGGAAACACCATATATTTTGGAGAG	CASSLDYWDTRSGNTIYF	In	VDJ	1	104	2.885450393836234E-4	3.2530599094773524E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	0	6	0	5	4	18	35	46	40	50														CASSLDYWDTRSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAATCCGGGACCGCAGTACCAAGAGACCCAGTACTTCGGGCCA	CASNPGPQYQETQYF	In	VDJ	1	105	2.9131951091615824E-4	3.284339331683865E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	7	0	7	0	4	6	18	28	37	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPGPQYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGGCAGGGGGGTGTTGACACTGAAGCTTTCTTTGGACAA	CASSPRQGGVDTEAFF	In	VDJ	1	106	2.940939824486931E-4	3.315618753890378E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	3	6	6	18	30	43	36	49														CASSPRQGGVDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTGGGGTCTAGCGGGAGTCACAGATACGCAGTATTTTGGCCCA	CASSLWGLAGVTDTQYF	In	VDJ	1	106	2.940939824486931E-4	3.315618753890378E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	2	2	7	1	18	32	49	39	50														CASSLWGLAGVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGTCAGGGGTGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLGSGVAQETQYF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	1	5	4	18	32	43	37	47														CASSLGSGVAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCCCCTACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSQAPTANTEAFF	In	VDJ	1	108	2.9964292551376277E-4	3.3781775983034043E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	1	9	1	18	30	43	39	44														CASSQAPTANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATATCAGGGGGAACTGAAGCTTTCTTTGGACAA	CASSLISGGTEAFF	In	VDJ	1	109	3.024173970462976E-4	3.409457020509917E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	1	5	4	1	18	33	44	37	45														CASSLISGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCGCAGACAGGAGAAGATAACTATGGCTACACCTTCGGTTCG	CASSSSQTGEDNYGYTF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	1	7	6	18	31	44	38	50														CASSSSQTGEDNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTGCAGTCTTTAACTATGGCTACACCTTCGGTTCG	CASSLSAVFNYGYTF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	5	1	4	4	18	33	40	37	44														CASSLSAVFNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTACGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLVTAQETQYF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	9	0	1	4	0	18	34	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVTAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCAGGGGGCATAGGGTATGGCTACACCTTCGGTTCG	CASSPSGGIGYGYTF	In	VDJ	1	113	3.13515283176437E-4	3.534574709335969E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	5	4	6	18	30	42	34	48														CASSPSGGIGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACTCGGGACGGACGTACGAGCAGTACTTCGGGCCG	CASSYSGRTYEQYF	In	VDJ	1	113	3.13515283176437E-4	3.534574709335969E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	0	7	4	4	5	18	31	40	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGRTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAACTTAGTGCGGGAGTGGGGAAAAACATTCAGTACTTCGGCGCC	CASSELSAGVGKNIQYF	In	VDJ	1	116	3.2183869777404147E-4	3.628412975955508E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	7	2	4	9	5	18	30	46	39	51														CASSELSAGVGKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAACGGGAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSSTGVTGELFF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	8	2	4	3	1	18	31	40	34	41														CASSSTGVTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAGGGACCGTCCCTACGAGCAGTACTTCGGGCCG	CASSPRDRPYEQYF	In	VDJ	1	120	3.3293658390418085E-4	3.75353066478156E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	0	7	2	4	4	18	30	39	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDRPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGCGCAGTTTTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLRAQFSTNEKLFF	In	VDJ	1	120	3.3293658390418085E-4	3.75353066478156E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	2	5	3	0	0	9	18	-1	37	33	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRAQFSTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGATCAGCATCACCGGGGAGCTGTTTTTTGGAGAA	CASSLISITGELFF	In	VDJ	1	121	3.357110554367157E-4	3.784810086988073E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	4	5	4	3	3	18	32	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLISITGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGGGAGGCACTAACTATGGCTACACCTTCGGTTCG	CASSLVGGTNYGYTF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	1	0	3	2	18	32	41	35	43														CASSLVGGTNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGACCGGGACAGGGGACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRPGQGTSYNEQFF	In	VDJ	1	126	3.495834130993899E-4	3.941207198020638E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	0	5	2	18	33	48	38	50														CASSLRPGQGTSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACACAGGTAGCGGGGGAAAAACTGTTTTTTGGCAGT	CASSLGTQVAGEKLFF	In	VDJ	1	128	3.5513235616445955E-4	4.003766042433664E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	5	3	8	11	0	18	32	-1	43	51														CASSLGTQVAGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTCAAGGGGGGGACAGGGGTGGGCTACGAGCAGTACTTCGGGCCG	CASSPLKGGTGVGYEQYF	In	VDJ	1	130	3.6068129922952924E-4	4.06632488684669E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	3	12	4	18	30	52	42	56														CASSPLKGGTGVGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATGGGACTAGCGGGCATGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASMGLAGMGVNEQFF	In	VDJ	1	132	3.6623024229459893E-4	4.128883731259716E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	4	6	1	9	18	28	41	29	50						01,02								CASMGLAGMGVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGGGCGCGGACAATGAGCAGTTCTTCGGGCCA	CASSPGGADNEQFF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	4	18	30	39	31	43														CASSPGGADNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACTAGCGGGAGAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSLTSGRGSYEQYF	In	VDJ	1	135	3.7455365689220346E-4	4.2227219978792553E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	2	2	1	0	4	18	-1	44	32	48														CASSLTSGRGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTATATGGGACTAGCAGTGATCACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	138	3.82877071489808E-4		55	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	7	3	5	7	18	32	46	37	53						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGACAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLETGAYNEQFF	In	VDJ	1	140	3.884260145548777E-4	4.37911910891182E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	2	2	0	0	18	-1	-1	35	43														CASSLETGAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCGGGCCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIGPSNQPQHF	In	VDJ	1	141	3.912004860874125E-4	4.410398531118333E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	8	0	0	3	1	18	30	37	33	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIGPSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCAAACTAGCGGGAGTTTGTTTGAGCAGTTCTTCGGGCCA	CASQTSGSLFEQFF	In	VDJ	1	141	3.912004860874125E-4	4.410398531118333E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	3	2	9	3	6	18	27	41	30	47														CASQTSGSLFEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGTGTTAGCGGGAGCGGGGATACGCAGTATTTTGGCCCA	CASSPGVSGSGDTQYF	In	VDJ	1	142	3.939749576199473E-4	4.4416779533248464E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	6	8	4	18	30	47	38	51														CASSPGVSGSGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATAGTGGGGGAATCTCCTACGAGCAGTACTTCGGGCCG	CASSYSGGISYEQYF	In	VDJ	1	142	3.939749576199473E-4	4.4416779533248464E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	6	1	0	5	3	18	31	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGGISYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTTAGAGGTAGGGGTCTATCAGCCCCAGCATTTTGGTGAT	CASTLEVGVYQPQHF	In	VDJ	1	144	3.99523900685017E-4	4.504236797737872E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	5	3	3	18	35	43	38	46														CASTLEVGVYQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGAACCGGGGACAGGGGTTGGAATGAGCAGTTCTTCGGGCCA	CASSFRTGDRGWNEQFF	In	VDJ	1	148	4.106217868151564E-4	4.629354486563924E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	7	8	4	18	32	50	40	54														CASSFRTGDRGWNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGCCGGGATCTGAGCTCCTACGAGCAGTACTTCGGGCCG	CASGRDLSSYEQYF	In	VDJ	1	150	4.161707298802261E-4	4.6919133309769503E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	8	3	0	3	6	18	27	35	30	41														CASGRDLSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTTTCCGGGACAGGAACACTGAAGCTTTCTTTGGACAA	CASSLIFRDRNTEAFF	In	VDJ	1	151	4.189452014127609E-4	4.723192753183463E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	1	7	0	18	33	-1	40	47														CASSLIFRDRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCTGGGGGACCAGCACAGATACGCAGTATTTTGGCCCA	CASSLVWGTSTDTQYF	In	VDJ	1	153	4.244941444778306E-4	4.7857515975964894E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	1	0	7	0	5	1	18	34	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVWGTSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGATAGGGGATTACACCGGGGAGCTGTTTTTTGGAGAA	CASRIGDYTGELFF	In	VDJ	1	155	4.3004308754290025E-4	4.848310442009515E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	5	2	3	3	3	18	29	37	32	40														CASRIGDYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCACCCCCCGGACTAGCGGGAGCGGATGAGCAGTTCTTCGGGCCA	CASSLPPPGLAGADEQFF	In	VDJ	1	157	4.3559203060796993E-4	4.910869286422541E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	1	2	8	9	3	18	33	55	42	58														CASSLPPPGLAGADEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCCAAGCGGGAGGGCCTGGAGATACGCAGTATTTTGGCCCA	CASSIQAGGPGDTQYF	In	VDJ	2	158	4.383665021405048E-4	4.942148708629054E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	0	5	5	5	18	30	45	35	50														CASSIQAGGPGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTTGACAGTGCAAGAGACCCAGTACTTCGGGCCA	CASSFLTVQETQYF	In	VDJ	2	162	4.4946438827064416E-4	5.067266397455106E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	2	3	2	18	32	40	35	42														CASSFLTVQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTCGGACAGGGCCCTACGAGCAGTACTTCGGGCCG	CASSRRTGPYEQYF	In	VDJ	2	164	4.5501333133571385E-4	5.129825241868132E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	4	1	18	30	42	34	43														CASSRRTGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGCACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLEGTSNQPQHF	In	VDJ	2	164	4.5501333133571385E-4	5.129825241868132E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	8	0	0	0	2	18	-1	39	35	41														CASSLEGTSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCACAAGGGAACTTCATGAACACTGAAGCTTTCTTTGGACAA	CASSFPQGNFMNTEAFF	In	VDJ	2	164	4.5501333133571385E-4	5.129825241868132E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	0	8	0	7	6	18	32	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPQGNFMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTACTAGCTCCCAAGAGACCCAGTACTTCGGGCCA	CASSLTSSQETQYF	In	VDJ	2	167	4.633367459333183E-4	5.223663508487672E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	7	1	3	2	18	30	39	33	41						01,02								CASSLTSSQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCCGGGACACTGTACAATGAGCAGTTCTTCGGGCCA	CASSSGTLYNEQFF	In	VDJ	2	167	4.633367459333183E-4	5.223663508487672E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	4	4	3	18	29	39	33	42														CASSSGTLYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCGGGAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLPGGGTGELFF	In	VDJ	2	168	4.6611121746585317E-4	5.254942930694184E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	0	4	1	2	18	33	42	34	44														CASSLPGGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTTCAGGAGGGATCCGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQVQEGSAGANVLTF	In	VDJ	2	171	4.744346320634577E-4	5.348781197313723E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	0	2	8	5	18	30	44	38	49														CASSQVQEGSAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGACAGGATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGQDYSNQPQHF	In	VDJ	2	173	4.799835751285274E-4	5.411340041726749E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	0	0	4	18	-1	37	30	41														CASSGQDYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGTCTCTCTAACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLGVSLTTNEKLFF	In	VDJ	2	175	4.855325181935971E-4	5.473898886139776E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	4	9	0	8	1	18	34	45	42	46						01,02								CASSLGVSLTTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAGAGGAGTAATGAAAAACTGTTTTTTGGCAGT	CASSLKRSNEKLFF	In	VDJ	2	178	4.938559327912016E-4	5.567737152759315E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	10	2	4	5	0	18	32	-1	37	41														CASSLKRSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACATGGGGCTAGCGGGAGTAGGGGTGGTTAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	180	4.994048758562712E-4		58	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	2	5	9	11	18	30	49	39	60														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACACGAATTCCGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLHEFRENTEAFF	In	VDJ	2	182	5.049538189213409E-4	5.692854841585366E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	3	1	9	0	18	33	-1	42	47														CASSLHEFRENTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCCAGGGAAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPRESNQPQHF	In	VDJ	2	184	5.105027619864106E-4	5.755413685998392E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	1	3	2	18	29	37	32	39														CASSPRESNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAAAAGACTCGTGGGTCTAGTAGGCGGGGAGCTGTTTTTTGGAGAA	CASKRLVGLVGGELFF	In	VDJ	2	191	5.299240627141545E-4	5.974369641443983E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	2	10	7	3	15	18	28	35	31	50						01,02								CASKRLVGLVGGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTAATTAGCGGGAGGAGATACGCAGTATTTTGGCCCA	CASSF*LAGGDTQYF	Stop	VDJ	2	201	5.576687780395029E-4		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	1	5	5	0	18	32	-1	37	47														CASSF*LAGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACGTTGGGAGTCCTACGAGCAGTACTTCGGGCCG	CASSPRWESYEQYF	In	VDJ	2	202	5.604432495720377E-4	6.318443285715626E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	2	1	7	0	18	30	-1	37	42														CASSPRWESYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTATCGTCAGCGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSSAGSSYNEQFF	In	VDJ	2	212	5.881879648973862E-4	6.631237507780756E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	3	0	8	2	18	30	45	38	47														CASSLSSAGSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCGGGACAGGTCAGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSSGQVRLNTEAFF	In	VDJ	2	214	5.937369079624559E-4	6.693796352193782E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	0	3	6	18	29	40	32	46														CASSSGQVRLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGAACATATTATAGCGGGAGTGGTCCCACCGGGGAGCTGTTTTTTGGAGAA	CASRTYYSGSGPTGELFF	In	VDJ	2	224	6.214816232878043E-4	7.006590574258913E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	5	2	4	11	6	18	27	47	38	53														CASRTYYSGSGPTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGACCGGGACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRTGTANTGELFF	In	VDJ	2	236	6.547752816782223E-4	7.381943640737068E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	0	6	0	18	30	-1	36	43														CASSRTGTANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGACCATAAGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	240	6.658731678083617E-4		41	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	2	7	18	30	37	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGGACTATTCCTACGAGCAGTACTTCGGGCCG	CASSQGDYSYEQYF	In	VDJ	2	242	6.714221108734314E-4	7.569620173976146E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	9	1	4	1	18	30	41	34	42						01,02								CASSQGDYSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAAGGGGGACAGAAGCCACAGATACGCAGTATTTTGGCCCA	CASSLRGTEATDTQYF	In	VDJ	2	248	6.880689400686405E-4	7.757296707215224E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	2	6	4	18	30	43	36	47														CASSLRGTEATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGGGACAGGGAAATACGAGCAGTACTTCGGGCCG	CASSLDGTGKYEQYF	In	VDJ	2	253	7.019412977313146E-4	7.913693818247789E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	4	4	3	18	32	45	36	48														CASSLDGTGKYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGYSNQPQHF	In	VDJ	2	254	7.047157692638494E-4	7.944973240454303E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	0	9	0	1	2	18	32	36	33	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTTCGGGACAGCCCTACGAGCAGTACTTCGGGCCG	CASSLSGQPYEQYF	In	VDJ	2	259	7.185881269265237E-4	8.101370351486867E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	5	1	18	30	42	35	43														CASSLSGQPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGTGGGTAGCGGTGGGAATGAGCAGTTCTTCGGGCCA	CASSLGVGSGGNEQFF	In	VDJ	2	261	7.241370699915934E-4	8.163929195899893E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	5	7	7	4	18	34	47	41	51						01,02								CASSLGVGSGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGGGGTCCGGGACAGCTAATGAAAAACTGTTTTTTGGCAGT	CASSTGSGTANEKLFF	In	VDJ	3	272	7.546562568494766E-4	8.508002840171536E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	3	9	0	18	30	-1	39	46														CASSTGSGTANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCAGATTGGCCCAGCACAGATACGCAGTATTTTGGCCCA	CASSSDWPSTDTQYF	In	VDJ	3	275	7.629796714470811E-4	8.601841106791075E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	5	0	2	8	18	29	34	31	42														CASSSDWPSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCACCCTCAAGGGACAGCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPPSRDSSSGANVLTF	In	VDJ	3	281	7.796265006422902E-4	8.789517640030154E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	5	0	11	3	18	29	47	40	50														CASSPPSRDSSSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATAGGACAGGGGGAGGAAGAGACCCAGTACTTCGGGCCA	CASSIGQGEEETQYF	In	VDJ	3	282	7.82400972174825E-4	8.820797062236666E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	1	3	0	3	18	-1	43	34	46														CASSIGQGEEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATTGACAGGCCCCGGAAACCCTAAGTGGCGAGCAGTACTTCGGGCCG		Out	VDJ	3	289	8.018222729025689E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	6	3	19	18	30	39	33	58														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGACAGGGATCCCTACAATGAGCAGTTCTTCGGGCCA	CASSADRDPYNEQFF	In	VDJ	3	299	8.295669882279173E-4	9.352547239747387E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	2	2	3	18	30	40	32	43														CASSADRDPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGGGCCGGAACTGAAGCTTTCTTTGGACAA	CASSLGGAGTEAFF	In	VDJ	3	306	8.489882889556612E-4	9.571503195192979E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	5	0	6	18	-1	39	32	45														CASSLGGAGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACAGGGAACAACAATCAGCCCCAGCATTTTGGTGAT	CASSLTGNNNQPQHF	In	VDJ	3	307	8.51762760488196E-4	9.602782617399491E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	3	3	0	5	18	-1	39	32	44														CASSLTGNNNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGGGTTTGGTCGATGAGCAGTTCTTCGGGCCA	CASSFGGLVDEQFF	In	VDJ	3	308	8.545372320207308E-4	9.634062039606005E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	6	1	8	1	8	18	32	38	33	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGLVDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTCCGGGACCGCCGTTAATGAGCAGTTCTTCGGGCCA	CASSLGSGTAVNEQFF	In	VDJ	4	421	0.0011680525151971678	0.0013168636748941973	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	0	7	7	5	7	18	34	44	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSGTAVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTGGACAGCACCGGGACTAGCGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSFWTAPGLAGGETQYF	In	VDJ	4	457	0.001267933490368422	0.0014294695948376443	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	0	0	5	12	0	18	32	-1	44	60														CASSFWTAPGLAGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGTGGAGGTGAAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	5	474	0.0013150995064215144		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	1	4	4	5	18	31	40	35	45														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGAGTATTCAGCCCCAGCATTTTGGTGAT	CASSLEGSIQPQHF	In	VDJ	5	525	0.0014565975545807912	0.0016421696658419326	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	9	2	6	1	3	18	35	41	36	44														CASSLEGSIQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTCGACAGCGAAGAATGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	556	0.0015426061720893714		56	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	5	0	4	9	18	33	42	37	51														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCGGACAAATGGACGAGCAGTACTTCGGGCCG	CASSLPGQMDEQYF	In	VDJ	5	572	0.0015869977166099287	0.0017891829502125437	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	6	5	3	5	18	33	41	36	46														CASSLPGQMDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGAGCTAGGGGGAGGAACATACAATGAGCAGTTCTTCGGGCCA	CASSTELGGGTYNEQFF	In	VDJ	6	591	0.0016397126757280907	0.0018486138524049184	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	5	1	4	8	7	18	30	44	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTELGGGTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGGCCGGGGGGCGAGCAGTACTTCGGGCCG	CASSLVGPGGEQYF	In	VDJ	6	594	0.0016480360903256951	0.0018579976790668723	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	1	6	6	0	18	34	-1	40	47														CASSLVGPGGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTGACAGGGGGAGTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	6	650	0.0018034064961476462		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	4	2	3	18	30	41	32	44														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGAGTTCTTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLGSSLAKNIQYF	In	VDJ	7	694	0.0019254832435791791	0.0021707919011320024	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	9	2	0	1	6	18	32	38	33	44														CASSLGSSLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTCGAGGGAGAAGCCTACGAGCAGTACTTCGGGCCG	CASSQVEGEAYEQYF	In	VDJ	7	773	0.0021446664946494316	0.002417899336563455	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	2	2	8	3	18	30	43	38	46														CASSQVEGEAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGACGGCAGGAACACTGAAGCTTTCTTTGGACAA	CASSLVDGRNTEAFF	In	VDJ	9	931	0.0025830329967899365	0.0029121142074263603	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	2	7	1	2	5	18	34	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVDGRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGGATAACCGAGACCCAGTACTTCGGGCCA	CASSLVGITETQYF	In	VDJ	9	989	0.002743952345676957	0.0030935348562241356	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	3	5	1	5	18	34	40	35	45														CASSLVGITETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGTAGGGGCACTGAAGCTTTCTTTGGACAA	CASSLGGRGTEAFF	In	VDJ	11	1105	0.003065791043450999	0.0034563761538196867	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	4	0	6	18	-1	38	32	44														CASSLGGRGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGCGCGGGTAGGCTCCCCGAAGCTTTCTTTGGACAA	CASSPGAGRLPEAFF	In	VDJ	13	1373	0.003809349414170336	0.004294664668954235	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	4	8	6	10	18	30	41	36	51						01,02								CASSPGAGRLPEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCCAGACAGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSAQTGANEKLFF	In	VDJ	22	2346	0.006508910215326735	0.0073381524496479505	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	3	5	0	18	30	-1	35	43														CASSAQTGANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGGCCCGGGGACATCCGGGGTGAGCAGTTCTTCGGGCCA	CASGPGDIRGEQFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	9	5	7	26	37	48	42	55														CASGPGDIRGEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAGCCACGTTTGGTGGAACCCAGGGACTCAGCTTGTATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG	CASGPGDNYGYTF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	5	4	4	1	1	3	42	54	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCCACGTTTGGTGGAACCCAGGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG	CASGPGDNYGYTF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	5	4	4	1	1	3	42	54	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCAGGGTCGCTACAATGAGCAGTTCTTCGGGCCA	CASGLQGRYNEQFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	3	0	3	26	-1	46	41	49														CASGLQGRYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAGGATAGCCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	43	1.1930227589899814E-4		40	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	12	5	7	2	9	1	26	31	44	40	45						01,02								X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCGCGGTCGATGGGGAAGAGACCCAGTACTTCGGGCCA	CASAAVDGEETQYF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	7	6	2	3	11	0	26	36	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAAVDGEETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAGCCACGTTTGGTGGAACCCAGGGACTAGCTGTGTATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG	CASGPGDNYGYTF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	5	4	4	1	1	3	42	54	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTTGGCCCGGGGAGCTGTTTTTTGGAGAA	CASGFWPGELFF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	9	0	6	2	0	26	40	-1	42	45														CASGFWPGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAGCCACGTTTGGTGGAACCCAGGGMTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG	CASGPGDNYGYTF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	5	4	4	1	1	3	42	54	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTATCCACGCGCAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	60	1.6646829195209043E-4		53	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	11	5	26	38	54	49	59														X+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCTTAGGACTAGCGGGAGGTGCCGAGCAGTACTTCGGGCCG	CASALGLAGGAEQYF	In	VDJ	1	102	2.829960963185537E-4	3.190501065064326E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	1	6	5	3	26	36	55	41	58														CASALGLAGGAEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCGGAGGGGGACGGAGACCCGTCCGGGCGAGCAGTTCTTCGGGCCA		Out	VDJ	1	107	2.968684539812279E-4		52	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	4	5	1	10	3	18	26	39	48	42	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCACGACTGAGGGACTGCTTTGGGGCTACACCTTCGGTTCG	CATTEGLLWGYTF	In	VDJ	1	113	3.13515283176437E-4	3.534574709335969E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	12	0	10	8	9	7	26	31	46	40	53						01,02								CATTEGLLWGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGTTAGTGGTCTAGGAGATAACTATGGCTACACCTTCGGTTCG	CVSGLGDNYGYTF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	4	8	1	0	4	26	-1	42	38	46						01,02								CVSGLGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGTAAACCGGCGGCAGGTTGCTTTCTTTGGACAA	CASVNRRQVAFF	In	VDJ	1	116	3.2183869777404147E-4	3.628412975955508E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	12	4	4	11	16	2	26	31	51	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVNRRQVAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTATAGGGGGACAGGGGGACACTGAAGCTTTCTTTGGACAA	CASGFIGGQGDTEAFF	In	VDJ	1	131	3.634557707620641E-4	4.0976043090532033E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	1	3	6	0	26	40	-1	46	57														CASGFIGGQGDTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAGCCACGTTTGGTGGAACCCAGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG	CASGPGDNYGYTF	In	VDJ	2	159	4.411409736730396E-4	4.973428130835568E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	5	4	4	1	1	3	42	54	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTTCCAGGACAGGGATCGCAGATACGCAGTATTTTGGCCCA	CASTSRTGIADTQYF	In	VDJ	2	183	5.077282904538758E-4	5.72413426379188E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	1	3	4	11	4	26	31	50	42	54														CASTSRTGIADTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGGGTTCTGGAAACACCATATATTTTGGAGAG	CASGLGGSGNTIYF	In	VDJ	2	220	6.103837371576649E-4	6.88147288543286E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	1	6	2	1	0	1	26	-1	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGGSGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAGTAAGGGTACGCAGTATTTTGGCCCA		Out	VDJ	2	225	6.242560948203391E-4		38	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	0	5	3	8	4	0	26	43	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAGCCACGTTTGGTGGAACCCAGGGACTCAGCTGTGTATTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	247	6.852944685361056E-4		38	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	17	4	4	1	12	3	43	43	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTAATAAACCGGTATCCCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	427	0.0011846993443923768		53	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	5	0	8	7	26	41	52	49	59						01,02								X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTAGGGCTCTCCTCCAATGAGCAGTTCTTCGGGCCA	CASGLGLSSNEQFF	In	VDJ	7	730	0.0020253642187504335	0.002283397821075449	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	3	5	3	6	0	8	26	-1	44	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGLSSNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG	CASGPGDNYGYTF	In	VDJ	370	38758	0.10753296765798534	0.12123278458800309	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	5	4	4	1	1	3	26	38	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAATTTCAGGGTGAGGGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	7.491073137844069E-5		43	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	7	4	3	3	4	8	20	30	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CACGGCACTGTATCTCTGCGCCAGCAGCCAGCATTCAGACGTTCGGACTAGCGGGTGGCCTAAGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	1.2207674743153297E-4		65	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	4	3	17	10	16	27	55	44	65						01,02								X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAGAGCGGGAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	66	1.8311512114729947E-4		41	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	6	2	6	2	0	20	37	-1	39	47														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACGCAGGGGCAGGGGATCCCCAGTACTTCGGGCCG		Out	VDJ	1	67	1.858895926798343E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	10	2	11	20	35	43	37	54														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAAAGTTTGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	93	2.5802585252574016E-4		46	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	0	8	1	8	0	20	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTATGTCAAAGGGGGCGCCACGTTGGCTACACCTTCGGTTCG	CASSLCQRGRHVGYTF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	0	7	8	7	20	33	48	41	55														CASSLCQRGRHVGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACAACCACAGGTCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	117	3.246131693065763E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	4	0	5	1	20	35	45	40	46														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAAAGCGGAACCAGTAGATGGGGCTTTCTTTGGACAA	CASKAEPVDGAFF	In	VDJ	1	119	3.30162112371646E-4	3.7222512425750474E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	6	5	11	1	14	20	30	36	31	50						01,02								CASKAEPVDGAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGATCCCGAGCTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	140	3.884260145548777E-4		46	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	6	7	2	7	1	20	37	47	44	48						01,02								X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTGAATAGCCGGGGAGACCCAGTACTTCGGGCCA	CASSQS*IAGETQYF	Stop	VDJ	1	151	4.189452014127609E-4		45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	7	5	5	4	20	37	46	42	50						01,02								CASSQS*IAGETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCTGTTGGGACAGTTGAGCAGTTCTTCGGGCCA	CASSPVGTVEQFF	In	VDJ	2	177	4.910814612586668E-4	5.536457730552801E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	9	5	1	20	33	45	38	46														CASSPVGTVEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGTCGGCAGGTGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	281	7.796265006422902E-4		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	4	4	5	3	20	36	45	41	48														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCGCGACAGGGACGGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	386	0.0010709460115584483		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	3	8	4	5	20	35	46	39	51														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCCCGCGGGACAGGGATAAAAATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	7.491073137844069E-5		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	6	8	6	23	35	52	43	58														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGGACAGGGGGGAGCTACGAGCAGTACTTCGGGCCG	CASSDRTGGSYEQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	1	3	4	3	23	35	49	39	52														CASSDRTGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATAGCGGAAAATACGAGCAGTACTTCGGGCCG	CASSDSGKYEQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	5	4	2	4	23	35	43	37	47						01,02								CASSDSGKYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAACGGAGATACGCAGTATTTTGGCCCA	CASSSNGDTQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	5	5	4	0	23	36	-1	40	43						01,02								CASSSNGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCGGCCGACAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASTPADRVNTEAFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	0	8	0	23	33	-1	41	48														CASTPADRVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCAGGGACACAGATACGCAGTATTTTGGCCCA	CASSGTSRDTDTQYF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	7	2	0	5	23	-1	44	35	49						01,02								CASSGTSRDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGATCTTCTATGGCTACACCTTCGGTTCG	CASSYGIFYGYTF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	8	4	0	4	23	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGIFYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGAAGCGGACAGGGGTGGAATCAGCCCCAGCATTTTGGTGAT	CAIRSGQGWNQPQHF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	4	4	3	23	34	47	38	50														CAIRSGQGWNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCTCGAGACTAGCGAGGGCAATGAGCAGTTCTTCGGGCCA	CASSDLETSEGNEQFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	6	6	8	4	23	35	51	43	55						01,02								CASSDLETSEGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCGAGCCGGGACAGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CAISPSRDSYSNQPQHF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	0	7	3	23	35	49	42	52														CAISPSRDSYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCAGGGGCGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASRSGAGGNQPQHF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	7	2	2	7	0	23	34	-1	41	48														CASRSGAGGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCCGTCGGTGGGCAGCCCCAGCATTTTGGTGAT	CASRAVGGQPQHF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	0	9	7	10	0	23	34	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAVGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTAGCGGGAGGGCCTTATACGAGCAGTACTTCGGGCCG	CASSRSGRALYEQYF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	0	4	2	5	23	35	48	37	53														CASSRSGRALYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTACCTAGCGGGAGGATCACAGATACGCAGTATTTTGGCCCA	CASSLPSGRITDTQYF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	1	2	4	2	23	35	50	39	52														CASSLPSGRITDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGGCCTCCTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYQGASSSGANVLTF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	4	0	0	0	6	23	-1	46	38	52														CASSYQGASSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGATTAGCGGGAGAGACAGACGAGCAGTACTTCGGGCCG	CAIRLAGETDEQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	2	5	2	6	23	34	45	36	51														CAIRLAGETDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTATCAGGGGAGTCAGCCCCAGCATTTTGGTGAT	CASTYQGSQPQHF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	6	5	2	23	33	44	38	46														CASTYQGSQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGGAACAGGGGGGATTGGCAGATACGCAGTATTTTGGCCCA	CAIREQGGLADTQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	4	3	6	23	34	45	37	51														CAIREQGGLADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGCTAGCGGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASSALAGGADTQYF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	4	3	2	23	35	49	38	51														CASSALAGGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGAACTACTCCGGGACTAGCGGGAGCAGATACGCAGTATTTTGGCCCA	CASSGTTPGLAGADTQYF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	2	4	11	0	23	35	-1	46	60														CASSGTTPGLAGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACCTACGGGGCTGAATATCAACGAGCAGTACTTCGGGCCG	CASSGPTGLNINEQYF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	7	0	5	8	9	23	35	48	43	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGPTGLNINEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGAATACAGGGGCCCTATCCTACGAGCAGTACTTCGGGCCG	CAISGNTGALSYEQYF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	1	6	5	23	35	48	41	53														CAISGNTGALSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGGTGGCCCCACACCATATATTTTGGAGAG		Out	VDJ	1	38	1.0542991823632394E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	6	9	0	8	7	3	23	34	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGAGCACAGATACGCAGTATTTTGGCCCA	CASSDRSTDTQYF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	4	0	0	0	23	-1	-1	35	41														CASSDRSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCCTAGCGGGAGAACCCTACGAGCAGTACTTCGGGCCG	CASRTLAGEPYEQYF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	2	2	4	3	23	34	48	38	51														CASRTLAGEPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTCTGGGGGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSFWGGTNTEAFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	1	5	3	23	34	46	39	49														CASSFWGGTNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCCTGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSSLLYNEQFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	7	4	0	6	23	-1	38	35	44						01,02								CASSSLLYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGACGGGACGGGGCTTTCTTTGGACAA	CASSYGRDGAFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	0	7	11	5	3	23	37	47	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGRDGAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACAAAGGGGATTGGTCTAGCAGCATAGCCAAAAACATTCAGTACTTTGGCGCC	CASNKGDWSSSIAKNIQYF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	57	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	7	5	2	22	4	38	23	33	42	37	80				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNKGDWSSSIAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGCCCCCGGGACTGGCGGTGGCTACACCTTCGGTTCG	CASRAPGTGGGYTF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	0	10	7	7	5	23	34	47	41	52						01,02								CASRAPGTGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACCGGGACTAGCGGGAGCGGTGAGCAGTTCTTCGGGCCA	CASSETGTSGSGEQFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	9	6	3	23	35	55	41	58														CASSETGTSGSGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTCAACGGGCCAGCACAGATACGCAGTATTTTGGCCCA	CASSFQRASTDTQYF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	4	8	0	0	6	1	23	36	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQRASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGGCTCCCGGGTAATGAGCAGTTCTTCGGGCCA	CASSPGLPGNEQFF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	7	0	7	3	8	23	34	42	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGLPGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCCTACCTTTGGGAATGAGCAGTTCTTCGGGCCA	CASSDPTFGNEQFF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	0	9	7	12	0	23	35	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPTFGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAAGAGGGCCGGCTCAGATACGCAGTATTTTGGCCCA	CASSDSKRAGSDTQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	11	0	4	3	6	23	40	48	43	54														CASSDSKRAGSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSGDSTDTQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	0	7	0	1	0	23	35	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAAGACATTTCCTACGAGCAGTACTTCGGGCCG	CASQDISYEQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	6	1	3	2	23	32	39	35	41														CASQDISYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGAGGGGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTRGGSYNEQFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	5	2	0	2	3	23	33	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRGGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGAGACAGGCTAGATACGCAGTATTTTGGCCCA	CASSRDRLDTQYF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	4	5	4	2	23	34	44	38	46														CASSRDRLDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCTCCGAAGTACGGGCCGACAATCAGCCCCAGCATTTTGGTGAT	CAISEVRADNQPQHF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	10	8	0	3	12	3	23	30	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEVRADNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACCGGGACCCGAGACGAACCATCGACCTCAACACCATATATTTTGGAGAG		Out	VDJ	1	44	1.2207674743153297E-4		59	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	5	0	7	7	6	21	22	34	45	40	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGCCAGGGTGCAAAGTGGCTACACCTTCGGTTCG		Out	VDJ	1	45	1.248512189640678E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	4	3	7	6	7	23	35	46	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGATCCTACGAGCAGTACTTCGGGCCG	CASSDRSYEQYF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	1	0	1	23	-1	40	35	41														CASSDRSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGAATTGAAGGGCGCCTACAATGAGCAGTTCTTCGGGCCA	CASTELKGAYNEQFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	5	3	2	9	2	23	33	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTELKGAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAGGGACTAGCGGCACACAATGAGCAGTTCTTCGGGCCA	CASRQGLAAHNEQFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	5	3	3	23	34	48	37	51						01,02								CASRQGLAAHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCTAGCGGGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDLAGANTGELFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	2	0	3	0	23	35	-1	38	48														CASSDLAGANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAAGAAGGGTTCGGGACTAGTAAGCAAGAGACCCAGTACTTCGGGCCA	CASSKEGFGTSKQETQYF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	8	2	12	4	23	35	55	47	59						01,02								CASSKEGFGTSKQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGACAGGGCGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	49	1.359491050942072E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	3	7	1	3	23	33	41	34	44														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGTAGCGGCCACAATGAGCAGTTCTTCGGGCCA	CASSDSGSGHNEQFF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	5	5	3	2	23	40	49	43	51						01,02								CASSDSGSGHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGCAGGGGTGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	49	1.359491050942072E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	2	2	2	2	23	39	47	41	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTACTAACGACAGGGGGTACGAGCAGTACTTCGGGCCG	CASSSTNDRGYEQYF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	4	8	0	23	36	-1	44	53														CASSSTNDRGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTATAGGGACTAGCGGGACTATGCTAGATAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	49	1.359491050942072E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	0	3	4	4	11	23	29	46	33	57														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAGGACTCAGGGGTTAGTCAGCCCCAGCATTTTGGTGAT	CASSKDSGVSQPQHF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	6	7	4	23	35	48	42	52														CASSKDSGVSQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCAGGCGTTCTTATAGCAATCAGCCTCAGCATTTTGGTGAT	CASSRRSYSNQPQHF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	8	4	4	13	2	21	23	32	38	34	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRSYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCATCACCGGGGAGCTGTTTTTTGGAGAA		Out	VJ	1	52	1.442725196918117E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	0	0	4	0	2	23	-1	40	-1	42														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACTAGCGGGAGTGGGGGAGACCCAGTACTTCGGGCCA	CASSLLAGVGETQYF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	3	2	5	1	5	23	36	48	37	53														CASSLLAGVGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACGCAGCCTATTCAGATACGCAGTATTTTGGCCCA	CASNAAYSDTQYF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	4	5	4	3	6	23	33	39	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNAAYSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACTAGCGGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSLLAGGYNEQFF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	1	4	1	1	23	36	49	37	50														CASSLLAGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTAACAGGGTCTCCACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFNRVSTGANVLTF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	3	2	3	6	23	36	45	39	51														CASSFNRVSTGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCATCTAGCGGGCAATTCTACGAGCAGTACTTCGGGCCG	CASSPSSGQFYEQYF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	4	3	4	5	23	35	47	39	52						01,02								CASSPSSGQFYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCAGGGGGACTATGGCTACACCTTCGGTTCG	CASRQGDYGYTF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	1	3	1	0	23	34	-1	35	42														CASRQGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACTGACTAGCGGAGCCTACGAGCAGTACTTCGGGCCG	CASKLTSGAYEQYF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	2	5	2	4	2	23	33	46	37	48						01,02								CASKLTSGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCTCCGGGACAGGAGCCTACGAGCAGTACTTCGGGCCG	CASSASGTGAYEQYF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	2	6	2	23	35	49	41	51														CASSASGTGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTGGACAGAGGAACACTGAAGCTTTCTTTGGACAA	CASSYRGQRNTEAFF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	1	3	2	23	38	47	41	49														CASSYRGQRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCAGGCCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSDQAGDTGELFF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	3	3	8	0	23	35	-1	43	48														CASSDQAGDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCACCAAAGCCAAGGGGATTAACTATGGCTACACCTTCGGTTCG	CATTKAKGINYGYTF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	5	2	1	12	2	23	30	47	42	49														CATTKAKGINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGGGCGTGGAGGCTACACCTTCGGTTCG	CASSYSRGRGGYTF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	0	8	1	5	23	40	48	41	53														CASSYSRGRGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCATCGACGGTTGGGGGCTACACCTTCGGTTCG	CASRPSTVGGYTF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	0	9	8	13	0	23	34	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPSTVGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACAGGGGGTCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASRDRGSSYNEQFF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	1	1	0	3	23	-1	44	34	47														CASRDRGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGGGACAGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSVGTGDYNEQFF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	3	3	1	23	35	48	38	49														CASSVGTGDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCGGAAGAGCGGGAGTGGTATGAGCAGTTCTTCGGGCCA	CASSEEREWYEQFF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	2	8	7	4	23	32	47	39	51														CASSEEREWYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAAACTTGGGACTAGCGTCCTACGAGCAGTACTTCGGGCCG	CASKNLGLASYEQYF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	6	1	7	0	23	33	-1	40	50						01,02								CASKNLGLASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTCGGGCCCCAGGGAATCAGCCCCAGCATTTTGGTGAT	CASIRAPGNQPQHF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	3	4	9	0	23	33	-1	42	47														CASIRAPGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGACAGTTGAACTACAATGAGCAGTTCTTCGGGCCA	CASSDGQLNYNEQFF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	5	3	3	5	23	35	44	38	49														CASSDGQLNYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTACTAGCGGGAGGTGGCACAGATACGCAGTATTTTGGCCCA	CASSVLAGGGTDTQYF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	1	1	2	2	23	35	49	37	51														CASSVLAGGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAAAGGACAGTCTCCTCTGGAAACACCATATATTTTGGAGAA	CASRQRTVSSGNTIYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	5	19	5	22	23	34	45	39	67														CASRQRTVSSGNTIYF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCAGGCGGGAGGAACAGATACGCAGTATTTTGGCCCA	CASSDQAGGTDTQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	1	3	6	1	23	35	49	41	50														CASSDQAGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCATTAAGAGACCTAACAGGGGGCTTCTGGCTACACCTTCGGTTCG	CAH*ET*QGASGYTF	Stop	VDJ	1	73	2.0253642187504335E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	3	0	7	14	3	23	29	52	43	55														CAH*ET*QGASGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGAGGGGGGAGGAGCGGGGAGACCCAGTACTTCGGGCCA	CASRGGGRSGETQYF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	0	5	0	12	23	-1	41	34	53														CASRGGGRSGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAAATACCGGGACAGGGGTTTCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	74	2.053108934075782E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	5	7	4	23	37	54	44	58														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAGATCTTTACAGGGGGCGTACGGATCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	77	2.136343080051827E-4		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	0	4	11	8	23	34	54	45	62														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGCCGCGGAGACACAGATACGCAGTATTTTGGCCCA	CASSRRGDTDTQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	5	2	4	3	23	35	43	39	46						01,02								CASSRRGDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCACAATCCCCGGGGACGCTATGGCTACACCTTCGGTTCG	CASHNPRGRYGYTF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	8	0	7	4	11	1	23	32	48	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHNPRGRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAGATAGGGGACTTCTCCATGGCTACACCTTCGGTTCG	CASTDRGLLHGYTF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	0	10	6	7	5	23	33	46	40	51						01,02								CASTDRGLLHGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTAAAGGGCAGGGGAGGAGGGCAGATACGCAGTATTTTGGCCCA	CASTKGQGRRADTQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	4	2	4	8	7	23	33	47	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTKGQGRRADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTACTCGCCTGGGCTGGCGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSDYSPGLAGGETQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	0	5	18	0	23	35	-1	53	62														CASSDYSPGLAGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGAAAGCGGGAGGGCTTCCTACGAGCAGTACTTCGGGCCG	CASSWESGRASYEQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	6	0	1	5	2	23	36	51	41	53														CASSWESGRASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGATGGTAACACTGAAGCTTTCTTTGGACAA	CASSSDGNTEAFF	In	VDJ	1	82	2.2750666566785692E-4	2.564912620934066E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	4	1	8	2	1	4	23	36	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAAAGGCGATTCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSKGDSDTGELFF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	5	4	3	3	8	23	34	40	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGDSDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGAGGGAGGGCCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDEGGPSNTGELFF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	0	0	5	4	23	35	47	40	51														CASSDEGGPSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGGGCGCGGGCGATGGCTACACCTTCGGTTCG	CASSDGGAGDGYTF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	6	0	6	3	7	23	35	44	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGGAGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTTCCATAGAGACCCAGTACTTCGGGCCA	CASSPSIETQYF	In	VDJ	1	85	2.3583008026546143E-4	2.6587508875536054E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	4	6	4	6	1	23	34	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSIETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGACTAGCGGATCCTTTTGGGTGAATGAGCAGTTCTTCGGGCCA	CASSPGTSGSFWVNEQFF	In	VDJ	1	86	2.3860455179799627E-4	2.690030309760118E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	7	4	13	23	34	49	38	62						01,02								CASSPGTSGSFWVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGACTAGCGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSPTSGASYEQYF	In	VDJ	1	86	2.3860455179799627E-4	2.690030309760118E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	0	3	1	23	34	48	37	49														CASSPTSGASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTAGCGGGAGGCGTCGGGGAGCTGTTTTTTGGAGAA	CASSYSVAGGVGELFF	In	VDJ	1	86	2.3860455179799627E-4	2.690030309760118E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	5	1	7	2	3	23	40	52	42	55														CASSYSVAGGVGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCTCGGCAGGGGGCGAGGCTACACCTTCGGTTCG	CASSTLGRGRGYTF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	8	8	2	23	35	51	43	53														CASSTLGRGRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCGGACAGTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	89	2.469279663956008E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	5	4	3	1	23	40	49	43	50														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTGACAGTTCTCCGTGGACCAAAAACATTCAGTACTTCGGCGCC	CATDSSPWTKNIQYF	In	VDJ	1	90	2.497024379281356E-4	2.81514799858617E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	2	5	2	2	11	23	30	37	32	48														CATDSSPWTKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGGGCAATCGTACGAGCAGTACTTCGGGCCG	CASNGQSYEQYF	In	VDJ	1	90	2.497024379281356E-4	2.81514799858617E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	8	0	4	2	5	23	33	39	35	44														CASNGQSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCAAAACGGCGCCTCGAACACTGAAGCTTTCTTTGGACAA	CASSQNGASNTEAFF	In	VDJ	1	91	2.5247690946067047E-4	2.846427420792683E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	9	0	1	9	5	23	32	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNGASNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGCGGGAGGGGGCGAAATCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGGEINTGELFF	In	VDJ	1	92	2.552513809932053E-4	2.877706842999196E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	0	2	1	9	23	34	47	35	56														CASSLAGGGEINTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCAGGGGGATAAGAGACTGTTTTTTGGCAGT	CASSYSQGDKRLFF	In	VDJ	1	92	2.552513809932053E-4	2.877706842999196E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	1	13	1	7	23	40	48	41	55														CASSYSQGDKRLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTCGGGGACTAGCGCGGTGCAGTACTTCGGGCCG	CASTSGTSAVQYF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	6	9	5	4	23	33	48	38	52						01,02								CASTSGTSAVQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGACTAGCGGGAGGGCCTACGAGCAGTACTTCGGGCCG	CASSYRTSGRAYEQYF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	1	0	2	1	0	23	38	-1	39	54														CASSYRTSGRAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTAGGGACAGGAGATAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	99	2.746726817209492E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	4	3	4	23	34	45	37	49														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTGTCCAAGTCTCCTAGTCGACAATGAAAAACTGTTTTTTGGCAGT	CASSDCPSLLVDNEKLFF	In	VDJ	1	99	2.746726817209492E-4	3.096662798444787E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	4	8	5	11	5	23	39	54	50	59						01,02								CASSDCPSLLVDNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCAAGTGGACTCTCCTACGAGCAGTACTTCGGGCCG	CAASGLSYEQYF	In	VDJ	1	99	2.746726817209492E-4	3.096662798444787E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	1	10	0	6	0	23	29	-1	35	40						01,02								CAASGLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCTCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTSYSNQPQHF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	9	0	5	0	23	35	-1	40	43						01,02								CASSTSYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGACTAGCGGGACGGCAGATACGCAGTATTTTGGCCCA	CASSVTSGTADTQYF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	3	4	2	3	23	35	48	37	51														CASSVTSGTADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTTAAGTTGGACAGGGGATTATGGCTACACCTTCGGTTCG	CASRLSWTGDYGYTF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	5	8	2	23	34	51	42	53														CASRLSWTGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACTTACACGACCAGAGCACTGAAGCTTTCTTTGGACAA	CASNLHDQSTEAFF	In	VDJ	1	103	2.8577056785108855E-4	3.221780487270839E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	2	7	4	8	5	23	33	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNLHDQSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGATCAGGGGGACACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDQGDTNTGELFF	In	VDJ	1	106	2.940939824486931E-4	3.315618753890378E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	0	4	3	23	34	45	38	48														CASSDQGDTNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGCGCGTTTGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSYSAFGATNEKLFF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	6	6	0	0	9	23	-1	42	38	51						01,02								CASSYSAFGATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTACGAGAGTCCCTACGAGCAGTACTTCGGGCCG	CASSYYESPYEQYF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	11	2	2	2	4	23	39	44	41	48														CASSYYESPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGAGGGGTCGGAAACACCATATATTTTGGAGAG	CASRGGVGNTIYF	In	VDJ	1	108	2.9964292551376277E-4	3.3781775983034043E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	9	0	4	0	3	23	-1	41	34	44														CASRGGVGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATAGTACAGGAATACACCGGGGAGCTGTTTTTTGGAGAA	CASRIVQEYTGELFF	In	VDJ	1	109	3.024173970462976E-4	3.409457020509917E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	4	3	6	3	23	34	45	40	48														CASRIVQEYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGTTACCAGGGACAGGGAGGCCGGTGGCTACACCTTCGGTTCG	CASRVTRDREAGGYTF	In	VDJ	1	111	3.079663401113673E-4	3.472015864922943E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	7	8	7	23	34	51	42	58														CASRVTRDREAGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACAGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASSDSTGGADTQYF	In	VDJ	1	111	3.079663401113673E-4	3.472015864922943E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	0	4	0	1	23	-1	50	40	51														CASSDSTGGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCACTAGCGGGAGGGAATGAGCAGTTCTTCGGGCCA	CASSDSLAGGNEQFF	In	VDJ	1	113	3.13515283176437E-4	3.534574709335969E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	3	0	7	0	0	23	-1	-1	40	53														CASSDSLAGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGGACATAACCTACGAGCAGTACTTCGGGCCG	CASGDITYEQYF	In	VDJ	1	113	3.13515283176437E-4	3.534574709335969E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	6	2	1	3	23	32	39	33	42														CASGDITYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSDSSGSTDTQYF	In	VDJ	1	115	3.1906422624150663E-4	3.5971335537489954E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	4	0	0	0	23	-1	-1	40	47						01,02								CASSDSSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAGAATACAATGAGCAGTTCTTCGGGCCA	CASSYGEYNEQFF	In	VDJ	1	116	3.2183869777404147E-4	3.628412975955508E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	2	4	0	2	23	-1	42	38	44														CASSYGEYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAACTAGCGGGAGGGAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	116	3.2183869777404147E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	3	0	4	2	2	23	40	55	42	57														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAACAGGGGTCCGAGCAGTACTTCGGGCCG	CASSQQGSEQYF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	6	3	2	23	34	44	37	46														CASSQQGSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCAACTAGCGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSDQLAGNNEQFF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	5	5	1	23	35	50	40	51														CASSDQLAGNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGCGGGAGGGCCAGATACGCAGTATTTTGGCCCA	CASSDSAGGPDTQYF	In	VDJ	1	120	3.3293658390418085E-4	3.75353066478156E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	6	0	4	0	1	23	-1	50	40	51														CASSDSAGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTTTATAACAGGGGATAAGAGCACTGAAGCTTTCTTTGGACAA	CASSYSFITGDKSTEAFF	In	VDJ	1	121	3.357110554367157E-4	3.784810086988073E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	2	4	7	7	23	40	54	47	61														CASSYSFITGDKSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAGGACAGGGGATACACCGGGGAGCTGTTTTTTGGAGAA	CASEDRGYTGELFF	In	VDJ	1	121	3.357110554367157E-4	3.784810086988073E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	2	3	2	2	23	32	43	34	45														CASEDRGYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGTAGGTCGGGACAGGGGAAGCGCGGGGAGCTGTTTTTTGGAGAA	CASSYSRRSGQGKRGELFF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	2	7	9	5	23	40	59	49	64														CASSYSRRSGQGKRGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGAGGGCTTACAGAGGGGAAGTACTTCGGGCCG	CAIRGLTEGKYF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	10	5	2	11	15	1	23	30	50	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRGLTEGKYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCATAGCGGGAAGGGTAGATACGCAGTATTTTGGCCCA	CASSAIAGRVDTQYF	In	VDJ	1	123	3.412599985017854E-4	3.8473689314010994E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	3	5	4	5	23	35	47	39	52														CASSAIAGRVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCACACCAGGTCGGCAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	124	3.4403447003432023E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	4	4	6	7	5	23	34	45	41	50														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCGAGGGACAGGGGGCTTAGGGAGACCCAGTACTTCGGGCCA	CASSSRDRGLRETQYF	In	VDJ	1	124	3.4403447003432023E-4	3.878648353607612E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	0	5	5	5	23	34	51	39	56														CASSSRDRGLRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGGTCACCCAGACGAACACTGAAGCTTTCTTTGGACAA	CASRVTQTNTEAFF	In	VDJ	1	127	3.523578846319247E-4	3.9724866202271513E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	8	4	1	0	10	23	-1	36	32	46						01,02								CASRVTQTNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGAACGCCTACGAGCAGTACTTCGGGCCG	CASSYGNAYEQYF	In	VDJ	1	128	3.5513235616445955E-4	4.003766042433664E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	0	8	2	0	3	23	-1	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGNAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATAAAGCCGGGACTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASNKAGTSGYNEQFF	In	VDJ	1	129	3.579068276969944E-4	4.035045464640177E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	5	4	8	1	23	33	52	41	53						01,02								CASNKAGTSGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCAGCGTCAATGAGCAGTTCTTCGGGCCA	CASSDSSVNEQFF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	6	6	1	1	23	40	45	41	46						01,02								CASSDSSVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGATCCGCTACGAGCAGTACTTCGGGCCG	CASSEIRYEQYF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	2	3	0	5	23	-1	38	35	43														CASSEIRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGACTGAGCCTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGLSLSYNEQFF	In	VDJ	1	134	3.717791853596686E-4	4.1914425756727424E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	10	1	4	7	23	34	43	38	50						01,02								CASSPGLSLSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGCGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDSAGSYNEQFF	In	VDJ	1	134	3.717791853596686E-4	4.1914425756727424E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	4	0	0	0	23	-1	-1	40	46						01,02								CASSDSAGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCCCCCGTTGCGACGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	134	3.717791853596686E-4		40	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	8	2	7	3	10	1	23	32	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGGGACAGAATTCCTACGAGCAGTACTTCGGGCCG	CASRPGQNSYEQYF	In	VDJ	1	135	3.7455365689220346E-4	4.2227219978792553E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	1	3	3	23	34	44	37	47														CASRPGQNSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTCCAAACCCTGATTAATGAGCAGTTCTTCGGGCCA	CASRVQTLINEQFF	In	VDJ	1	136	3.773281284247383E-4	4.254001420085768E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	0	10	7	0	14	23	-1	36	34	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVQTLINEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCCCTTGAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSDPLRAGANVLTF	In	VDJ	1	140	3.884260145548777E-4	4.37911910891182E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	11	0	2	8	0	23	35	-1	43	48														CASSDPLRAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTGGGACGACAGACACAGATACGCAGTATTTTGGCCCA	CASSDSGTTDTDTQYF	In	VDJ	1	143	3.9674942915248217E-4	4.472957375531359E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	0	7	2	1	6	23	40	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGTTDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGTGGGACTCGACCCCTACAATGAGCAGTTCTTCGGGCCA	CASSYEVGLDPYNEQFF	In	VDJ	1	144	3.99523900685017E-4	4.504236797737872E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	10	2	5	5	23	38	49	43	54						01,02								CASSYEVGLDPYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTCCAATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	148	4.106217868151564E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	4	6	4	4	1	23	35	41	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACAGGGGGCTGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSYRGLGNEKLFF	In	VDJ	1	149	4.1339625834769123E-4	4.6606339087704374E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	5	0	4	0	4	23	-1	45	38	49														CASSYRGLGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGGAGACAACAATGAGCAGTTCTTCGGGCCA	CASSAGDNNEQFF	In	VDJ	1	155	4.3004308754290025E-4	4.848310442009515E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	5	0	3	23	-1	42	35	45														CASSAGDNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTACAAGGGCTAACCGACGGGAGCAGTACTTCGGGCCG	CASSVTRANRREQYF	In	VDJ	1	157	4.3559203060796993E-4	4.910869286422541E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	5	3	7	6	11	23	35	45	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVTRANRREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAAAGGACAGTCTCCTCTGGAAACACCATATATTTTGGAGAG	CASRQRTVSSGNTIYF	In	VDJ	2	162	4.4946438827064416E-4	5.067266397455106E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	5	0	5	4	23	34	45	39	49														CASRQRTVSSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGCGGGAGTCGGCAATGAGCAGTTCTTCGGGCCA	CASSLAGVGNEQFF	In	VDJ	2	163	4.52238859803179E-4	5.098545819661619E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	6	0	4	23	-1	45	36	49														CASSLAGVGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGTAGTAGACACAGATACGCAGTATTTTGGCCCA	CASSYSTVVDTDTQYF	In	VDJ	2	164	4.5501333133571385E-4	5.129825241868132E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	5	2	0	7	23	-1	45	40	52														CASSYSTVVDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTCCGGACTATCCGAATACGCAGTATTTTGGCCCA	CASSDSPDYPNTQYF	In	VDJ	2	167	4.633367459333183E-4	5.223663508487672E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	9	7	3	5	23	40	49	43	54						01,02								CASSDSPDYPNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTAGAAGGACAGACCTACGAGCAGTACTTCGGGCCG	CASLEGQTYEQYF	In	VDJ	2	167	4.633367459333183E-4	5.223663508487672E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	5	2	6	1	23	32	44	38	45														CASLEGQTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCACTGCGCGGGGGGGCCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSPLRGGARSYEQYF	In	VDJ	2	170	4.7166016053092286E-4	5.317501775107211E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	0	7	4	23	35	51	42	55														CASSPLRGGARSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTTCACCGGGACAGGGGCACAATGAGCAGTTCTTCGGGCCA	CASSDSSPGQGHNEQFF	In	VDJ	2	175	4.855325181935971E-4	5.473898886139776E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	2	5	6	1	23	40	56	46	57														CASSDSSPGQGHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTTCCCCCGGCGGGGGAGAGCAGTTCTTCGGGCCA	CASISPGGGEQFF	In	VDJ	2	175	4.855325181935971E-4	5.473898886139776E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	7	2	10	9	1	23	33	49	42	50														CASISPGGGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCTGAGCCCAGGAACTAGCGGGATAGTAGATGAGCAGTTCTTCGGGCCA	CASRLSPGTSGIVDEQFF	In	VDJ	2	189	5.243751196490848E-4	5.911810797030958E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	3	8	13	6	23	34	57	47	63														CASRLSPGTSGIVDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGGCTGGTGGACTATGGCTACACCTTCGGTTCG	CASSWGLVDYGYTF	In	VDJ	2	190	5.271495911816197E-4	5.94309021923747E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	3	0	6	23	-1	42	36	48														CASSWGLVDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAGGGGACAGCGTTTCTTATGGCTACACCTTCGGTTCG	CASSRGDSVSYGYTF	In	VDJ	2	192	5.326985342466894E-4	6.005649063650496E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	5	4	7	23	35	46	39	53														CASSRGDSVSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCAAGGACTAGAGGCTTTAGATACGCAGTATTTTGGCCCA	CASTQGLEALDTQYF	In	VDJ	2	194	5.382474773117591E-4	6.068207908063523E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	8	5	5	7	23	33	45	38	52						01,02								CASTQGLEALDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSGDTGELFF	In	VDJ	2	198	5.493453634418984E-4	6.193325596889574E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	0	9	3	0	2	23	-1	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGCCCCACGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASCPTTGNEKLFF	In	VDJ	2	224	6.214816232878043E-4	7.006590574258913E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	2	3	5	8	0	23	32	-1	40	47														CASCPTTGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACAGGGGAGGTATCCGGGGAGCTGTTTTTTGGAGAA	CASSDSTGEVSGELFF	In	VDJ	2	229	6.353539809504785E-4	7.162987685291477E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	2	6	0	6	23	-1	48	40	54														CASSDSTGEVSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATAATACAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSYDNTAYNEQFF	In	VDJ	2	229	6.353539809504785E-4	7.162987685291477E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	5	2	6	0	23	38	-1	44	48														CASSYDNTAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGGGAGGGACCCAAAACATTCAGTACTTCGGCGCC	CASSGGGTQNIQYF	In	VDJ	2	230	6.381284524830133E-4	7.194267107497991E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	9	0	5	3	4	23	34	44	37	48														CASSGGGTQNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGCGAGCCACAAGAGACCCAGTACTTCGGGCCA	CASSGGEPQETQYF	In	VDJ	2	234	6.492263386131526E-4	7.319384796324042E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	6	0	2	0	6	23	-1	41	35	47														CASSGGEPQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTAGCGGGGGGATCTGGGAGCAGTACTTCGGGCCG	CASSYPSGGIWEQYF	In	VDJ	2	249	6.908434116011752E-4	7.788576129421738E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	1	7	1	6	23	38	50	39	56														CASSYPSGGIWEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGAGTAGCGGGAATAAATGAGCAGTTCTTCGGGCCA	CASSDGVAGINEQFF	In	VDJ	2	253	7.019412977313146E-4	7.913693818247789E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	7	7	3	23	35	50	42	53														CASSDGVAGINEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCATCGATCCCGGGACCTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASHRSRDLGANVLTF	In	VDJ	2	260	7.213625984590585E-4	8.13264977369338E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	8	0	7	3	10	2	23	32	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHRSRDLGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGACAGGGTCGAGCACTGAAGCTTTCTTTGGACAA	CASSSTGSSTEAFF	In	VDJ	3	263	7.296860130566631E-4	8.226488040312919E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	4	1	5	23	36	44	37	49														CASSSTGSSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSDTGELFF	In	VDJ	3	264	7.324604845891979E-4	8.257767462519432E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	0	10	3	0	0	23	-1	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCAGGGGATGGGGCCAACGTCCTGACTTTCGGGGCC	CASAGDGANVLTF	In	VDJ	3	264	7.324604845891979E-4	8.257767462519432E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	4	2	3	1	1	23	32	39	33	40														CASAGDGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACTAGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPTSGSSYEQYF	In	VDJ	3	272	7.546562568494766E-4	8.508002840171536E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	0	2	0	23	35	-1	37	49														CASSPTSGSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSDGSGSTDTQYF	In	VDJ	3	284	7.879499152398946E-4	8.883355906649693E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	0	5	0	23	35	-1	40	47						01,02								CASSDGSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGGGGGAGACAACACCGGGGAGCTGTTTTTTGGAGAA	CASS*GGDNTGELFF	Stop	VDJ	3	288	7.99047801370034E-4		45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	9	1	2	0	4	23	-1	43	37	47														CASS*GGDNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGACTAGCGGAGACAATGAGCAGTTCTTCGGGCCA	CASSDGTSGDNEQFF	In	VDJ	3	296	8.212435736303128E-4	9.258708973127848E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	5	3	2	23	35	49	38	51						01,02								CASSDGTSGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCCTTGCTATTTTACGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	296	8.212435736303128E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	9	4	6	8	23	38	47	44	55						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACCACCGGGGAGCTGTTTTTTGGAGAA	CASSDSTTGELFF	In	VDJ	3	300	8.323414597604522E-4	9.383826661953901E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	2	7	4	0	0	23	-1	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSTTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAACAGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSEQGHNEQFF	In	VDJ	3	303	8.406648743580566E-4	9.47766492857344E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	5	3	2	23	34	43	37	45														CASSEQGHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAACCAGACAGGAGATTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	3	313	8.684095896834051E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	4	4	5	6	23	40	51	45	57														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSDSTSGTDTQYF	In	VDJ	3	334	9.266734918666366E-4	0.0010447327016975343	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	6	1	0	0	23	-1	-1	40	48						01,02								CASSDSTSGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCGGGACAGCTACAATGAGCAGTTCTTCGGGCCA	CASSRDSYNEQFF	In	VDJ	3	340	9.433203210618457E-4	0.0010635003550214421	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	5	3	4	0	23	32	-1	36	43														CASSRDSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCGCGACCGGATAACAAGAACACTGAAGCTTTCTTTGGACAA	CATSRPDNKNTEAFF	In	VDJ	3	361	0.0010015842232450774	0.0011291871416551193	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	10	1	8	1	10	6	23	30	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRPDNKNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTGCAGGGGGCTCAGATACGCAGTATTTTGGCCCA	CASSDSAGGSDTQYF	In	VDJ	4	367	0.0010182310524402864	0.0011479547949790271	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	0	4	2	1	23	40	50	42	51														CASSDSAGGSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGTCAATCAGCCCCAGCATTTTGGTGAT	CASSYSGVNQPQHF	In	VDJ	4	377	0.001045975767765635	0.00117923421718554	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	6	1	3	0	1	23	-1	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGVNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTACGGATTGCCCTACGAGCAGTACTTCGGGCCG	CASSYYGLPYEQYF	In	VDJ	4	382	0.001059848125428309	0.0011948739282887967	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	1	1	8	2	2	4	23	39	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYGLPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGSNTGELFF	In	VDJ	4	405	0.0011236609706766103	0.0012668165993637765	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	4	0	0	1	23	-1	38	34	39						01,02								CASSGSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTCGGCAGGATGACAGATACGCAGTATTTTGGCCCA	CASVGRMTDTQYF	In	VDJ	4	405	0.0011236609706766103	0.0012668165993637765	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	4	3	5	3	23	32	41	37	44														CASVGRMTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCGGACTAGAGGCCGTCAATGAGCAGTTCTTCGGGCCA	CASSTGLEAVNEQFF	In	VDJ	4	411	0.0011403077998718195	0.0012855842526876844	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	8	6	4	7	23	34	45	38	52						01,02								CASSTGLEAVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGACACAGATACGCAGTATTTTGGCCCA	CASSDRDTDTQYF	In	VDJ	4	416	0.0011541801575344936	0.001301223963790941	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	2	0	1	23	-1	42	35	43														CASSDRDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGAGGACAGGGGTGACACCGGGGAGCTGTTTTTTGGAGAA	CATEDRGDTGELFF	In	VDJ	5	483	0.0013400697502143279	0.001510796092574578	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	1	2	3	4	2	23	30	43	34	45														CATEDRGDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGTGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGVSGANVLTF	In	VDJ	5	487	0.0013511676363444673	0.0015233078614571832	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	8	4	0	1	3	23	35	40	36	43						01,02								CASSPGVSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTAGCGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSASGSTGELFF	In	VDJ	5	558	0.001548155115154441	0.0017453917591234256	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	2	4	1	0	23	35	-1	36	46														CASSASGSTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTCACAGGGGGCTACAGATACGCAGTATTTTGGCCCA	CASSDSQGATDTQYF	In	VDJ	5	566	0.0015703508874147197	0.0017704152968886359	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	3	5	1	23	35	49	40	50														CASSDSQGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGTCCCAGCCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	5	573	0.0015897721881424636		37	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	0	9	6	0	9	23	-1	37	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAACTAGCGGGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASQLAGEYNEQFF	In	VDJ	6	641	0.0017784362523548328	0.002005010963437483	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	3	2	4	2	2	23	32	45	34	47														CASQLAGEYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCCCTACAGGGGACGGGCGAAAAACTGTTTTTTGGCAGT	CASSALQGTGEKLFF	In	VDJ	6	661	0.0018339256830055294	0.0020675698078505096	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	8	6	6	23	34	47	40	53														CASSALQGTGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAGACAGGGGCACTATGGCTACACCTTCGGTTCG	CASSYRQGHYGYTF	In	VDJ	7	695	0.001928257715111714	0.0021739198433526536	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	3	2	1	23	37	47	39	48														CASSYRQGHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGTGAGCTACGAGCAGTACTTCGGGCCG	CASSGVSYEQYF	In	VDJ	7	731	0.0020281386902829684	0.0022865257632961006	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	6	2	3	0	4	23	-1	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGVSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGTGTCCTACGAGCAGTACTTCGGGCCG	CASSGVSYEQYF	In	VDJ	7	775	0.0021502154377145014	0.002424155221004758	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	6	2	1	0	2	23	-1	39	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGVSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACTAGCGGGAGCAATGAGCAGTTCTTCGGGCCA	CASSDSTSGSNEQFF	In	VDJ	8	804	0.0022306751121580117	0.0025148655454036452	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	2	6	0	0	23	-1	-1	40	52														CASSDSTSGSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACAGGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	8	824	0.0022861645428087084		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	3	1	0	23	34	-1	35	43														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCGGACCCAAGCGTTACAAGAGACCCAGTACTTCGGGCCA	CASTRTQALQETQYF	In	VDJ	9	924	0.0025636116960621926	0.0028902186118818013	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	7	1	7	2	3	10	23	33	40	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRTQALQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTCAGGATCAACTAATGAAAAACTGTTTTTTGGCAGT	CASTSGSTNEKLFF	In	VDJ	23	2364	0.006558850702912363	0.0073944554096196735	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	4	0	3	2	23	33	40	36	42														CASTSGSTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACATGGGGGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPTWGNSGANVLTF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	51	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	2	6	1	0	4	2	24	39	48	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTWGNSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTGGACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	8.878308904111489E-5		40	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	2	1	8	0	2	0	24	39	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGGAGTATACAAGGCTACACCTTCGGTTCG	CASSQGSIQGYTF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	4	5	2	8	0	9	24	-1	42	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQGSIQGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCCGCTAGCGGATACTACGAGCAGTACTTCGGGCCG	CASSPAASGYYEQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	5	3	4	3	24	39	50	43	53						01,02							Vb 18	CASSPAASGYYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACTAGGGGACTGGCAGTTCTTCGGGCCA	CASSPGLGDWQFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	8	12	0	7	24	-1	46	38	53						01,02							Vb 18	CASSPGLGDWQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGAGCGGGAAAACCTACGAGCAGTACTTCGGGCCG	CASSPQSGKTYEQYF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	6	3	2	2	3	24	40	49	42	52													Vb 18	CASSPQSGKTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCACCGGACATTGGGGATGAAAAACTGTTTTTTGGCAGT	CASSSPDIGDEKLFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	6	6	0	6	24	-1	46	41	52													Vb 18	CASSSPDIGDEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCTAGCTCACCCTCCGACAGGGGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPSDRGGNQPQHF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	2	2	4	2	24	38	50	42	52													Vb 18	CASSPSDRGGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACCCTAAAGGGTGAGCAGTTCTTCGGGCCA	CASSPTLKGEQFF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	2	5	3	9	7	0	24	39	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTLKGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTCATCTCAAATGAAAAACTGTTTTTTGGCAGT	CASSPFISNEKLFF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	2	4	6	5	2	5	24	39	43	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPFISNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSPPGRNTEAFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	2	1	1	0	24	41	-1	42	47													Vb 18	CASSPPGRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACAGGGGGCAATGATGGCTACACCTTCGGTTCG	CASSPTGGNDGYTF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	0	6	1	4	24	38	48	39	52													Vb 18	CASSPTGGNDGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTCAGGGGTCGAATCAGCCCCAGCATTTTGGTGAT	CASSPPQGSNQPQHF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	4	1	3	24	41	48	42	51													Vb 18	CASSPPQGSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGAGATACGTAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	67	1.858895926798343E-4		44	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	8	2	4	1	8	24	38	45	39	53													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGCTTAGGGACAGAAAAGAGACCCAGTACTTCGGGCCA	CASSQLRDRKETQYF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	3	6	2	24	37	50	43	52													Vb 18	CASSQLRDRKETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACATCGGACAGGGTCAAGGGTAGAGACCCAGTACTTCGGGCCA	CASSHRTGSRVETQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	4	3	8	24	37	48	40	56													Vb 18	CASSHRTGSRVETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTTTTCGGGGAGCAGTTCTTCGGGCCA	CASSPVFGEQFF	In	VDJ	1	75	2.0808536494011304E-4	2.3459566654884752E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	4	10	5	0	24	39	-1	44	48						01,02							Vb 18	CASSPVFGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACCCGGACAGGGGAGAGAGATACGCAGTATTTTGGCCCA	CASTRTGERDTQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	2	5	4	4	24	33	46	37	50													Vb 18	CASTRTGERDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGCGACAGGGCCGCTAGGTCTGGAAACACCATATATTTTGGAGAG	CASSPRDRAARSGNTIYF	In	VDJ	1	82	2.2750666566785692E-4	2.564912620934066E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	3	1	2	8	24	40	49	42	57													Vb 18	CASSPRDRAARSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCCTCGGGGATAGGTGAGACCCAGTACTTCGGGCCA	CASSPSGIGETQYF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	3	5	5	6	24	35	45	40	51													Vb 18	CASSPSGIGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGGTGTTTGGCGAGCAGTTCTTCGGGCCA	CASSGVFGEQFF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	5	6	2	10	0	8	24	-1	40	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSGVFGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGGACACCGTGACACTGAAGCTTTCTTTGGACAA	CASSPRGHRDTEAFF	In	VDJ	1	97	2.6912373865587954E-4	3.034103954031761E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	3	2	5	24	39	47	41	52													Vb 18	CASSPRGHRDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATACGGAGGATCCTCCTACGAGCAGTACTTCGGGCCG	CASSPYGGSSYEQYF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	1	0	3	3	24	39	47	42	50													Vb 18	CASSPYGGSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGACAGGGTGTTAACATTCAGTACTTCGGCGCC	CASSPGQGVNIQYF	In	VDJ	1	104	2.885450393836234E-4	3.2530599094773524E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	1	3	7	0	4	24	-1	47	39	51													Vb 18	CASSPGQGVNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATTGGGTTGGACACTGAAGCTTTCTTTGGACAA	CASSPIGLDTEAFF	In	VDJ	1	112	3.1074081164390215E-4	3.5032952871294563E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	9	3	3	4	24	39	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPIGLDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTGACAGGTCCCAATCAGCCCCAGCATTTTGGTGAT	CASSPVTGPNQPQHF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	4	3	2	3	24	39	47	41	50													Vb 18	CASSPVTGPNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACAGGGGACCAACTAACTATGGCTACACCTTCGGTTCG	CASSDRGPTNYGYTF	In	VDJ	1	125	3.468089415668551E-4	3.909927775814125E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	0	0	5	24	-1	44	36	49													Vb 18	CASSDRGPTNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCCGGGACTAGCGGACAGTTGGAGCAGTTCTTCGGGCCA	CASSPGTSGQLEQFF	In	VDJ	1	129	3.579068276969944E-4	4.035045464640177E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	10	4	7	24	35	50	39	57						01,02							Vb 18	CASSPGTSGQLEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGACAGATTACACAAATACGCAGTATTTTGGCCCA	CASSPRTDYTNTQYF	In	VDJ	1	145	4.0229837221755185E-4	4.535516219944385E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	5	7	0	9	24	-1	46	40	55													Vb 18	CASSPRTDYTNTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCATAGCGGGAGCCGAAGATACGCAGTATTTTGGCCCA	CASSPIAGAEDTQYF	In	VDJ	1	157	4.3559203060796993E-4	4.910869286422541E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	5	2	4	24	38	49	40	53													Vb 18	CASSPIAGAEDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGGTACAAAACATTCAGTACTTCGGCGCC	CASSPAVQNIQYF	In	VDJ	2	171	4.744346320634577E-4	5.348781197313723E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	7	5	5	0	3	24	-1	43	39	46						01,02							Vb 18	CASSPAVQNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGCGCCCTGGCAGGGGGGTTCGACGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	184	5.105027619864106E-4		56	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	6	11	8	24	41	59	52	67													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTTGCGGGACCTCCGCTCTGAGCAGTTCTTCGGGCCA	CASLRDLRSEQFF	In	VDJ	2	194	5.382474773117591E-4	6.068207908063523E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	7	3	9	1	9	24	34	41	35	50													Vb 18	CASLRDLRSEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTTCGAGGAACCAGATACGCAGTATTTTGGCCCA	CASSPFEEPDTQYF	In	VDJ	2	203	5.632177211045726E-4	6.349722707922139E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	1	4	4	3	24	38	46	42	49													Vb 18	CASSPFEEPDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCCCACAGGGAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSPLPQGGSYEQYF	In	VDJ	2	224	6.214816232878043E-4	7.006590574258913E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	0	1	7	0	24	40	-1	47	54													Vb 18	CASSPLPQGGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCCCGGGACAGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLPGQGSGANVLTF	In	VDJ	2	231	6.409029240155482E-4	7.225546529704503E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	2	1	4	0	24	37	-1	41	51													Vb 18	CASSLPGQGSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACAGTCGCCAAAAACATTCAGTACTTCGGCGCC	CASSPTVAKNIQYF	In	VDJ	2	261	7.241370699915934E-4	8.163929195899893E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	3	5	1	1	2	24	38	43	39	45													Vb 18	CASSPTVAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGACAGGGGGTCCCTCTACGAGCAGTACTTCGGGCCG	CASSLDRGSLYEQYF	In	VDJ	3	268	7.435583707193372E-4	8.382885151345485E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	3	2	5	24	37	48	39	53													Vb 18	CASSLDRGSLYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCGGGACAGGGGGCGAGGGAGCAGTACTTCGGGCCG	CASSPPGQGAREQYF	In	VDJ	3	357	9.90486337114938E-4	0.0011166753727725142	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	0	7	3	4	24	38	53	41	57													Vb 18	CASSPPGQGAREQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGGGGGGGAGACACTGAAGCTTTCTTTGGACAA	CASSRGGDTEAFF	In	VDJ	4	416	0.0011541801575344936	0.001301223963790941	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	3	1	2	24	36	44	37	46													Vb 18	CASSRGGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGTGGACAGGGGACTCTACGAGCAGTACTTCGGGCCG	CASSVDRGLYEQYF	In	VDJ	7	736	0.0020420110479456425	0.0023021654743993567	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	3	2	3	24	36	47	38	50													Vb 18	CASSVDRGLYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGTCCAGACTTCGGGACAAAAAAGCATTCAGTACTTCGGCGCC	CASSVQTSGQKSIQYF	In	VDJ	8	859	0.002383271046447428	0.002686902367539467	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	6	9	11	6	24	36	53	47	59													Vb 18	CASSVQTSGQKSIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTCCCTGGACAGACCCCGAACACTGAAGCTTTCTTTGGACAA	CASSPLPGQTPNTEAFF	In	VDJ	18	1863	0.005168840465112408	0.005827356357073372	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	1	7	5	24	38	51	45	56													Vb 18	CASSPLPGQTPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGAACCGGGATACTCAAGAGACCCAGTACTTCGGGCCA	CSALNRDTQETQYF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	3	2	7	4	26	34	46	41	50		TCRBV20-01,TCRBV20-or09_02												CSALNRDTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGCCTCGGGACAGTTCTCTATGGCTACACCTTCGGTTCG	CSARRLGTVLYGYTF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	4	7	4	26	37	51	44	55		TCRBV20-01,TCRBV20-or09_02												CSARRLGTVLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAAAAACCGGGACTACCAACACAGATACGCAGTATTTTGGCCCA	CSAGKTGTTNTDTQYF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	2	9	4	26	35	51	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGKTGTTNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGGGACTCAGCTGTGTACTTCTGTACCAGCAGCCGCATGGACAGGAACACTGAAGCTTTCTTTGGACAA	CTSSRMDRNTEAFF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	1	6	0	22	33	-1	39	45		TCRBV12-03,TCRBV12-04												CTSSRMDRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGCAGGGGCGTTACACTGAAGCTTTCTTTGGACAA	CASSLQGRYTEAFF	In	VDJ	1	27	7.491073137844069E-5	8.445443995758511E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	3	1	4	18	32	39	33	43	TCRBV07,TCRBV11													CASSLQGRYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTACCCAGGTCCCTACGAGCAGTACTTCGGGCCG	CASSQDYPGPYEQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	2	5	2	23	40	49	45	51	TCRBV01,TCRBV04													CASSQDYPGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGACACATGGTCAGGGGGGCAGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	7.768520291097554E-5		49				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	1	5	9	5	24	35	51	44	56	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGATACGGGAGCACGCAGTATTTTGGCCCA	CASSQEGYGSTQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	2	9	6	1	26	43	55	49	56		TCRBV03-01,TCRBV03-02												CASSQEGYGSTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGKGACTCKGCYSTSTATYTCTGTGCCAGCAGCTTAGGGGGAAGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGRGSYNEQFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	1	2	7	26	38	46	40	53	TCRBV03,TCRBV05													CASSLGGRGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAAACAGGGGTCGGTGGCTACACCTTCGGTTCG	CASSQTGVGGYTF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	7	0	4	26	-1	48	41	52		TCRBV03-01,TCRBV03-02												CASSQTGVGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAGGGCCTAGCGGGAGGGCAAATACGCACAGATACGCAGTATTTTGGCCCA	CSAEGLAGGQIRTDTQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	0	1	7	7	26	34	53	41	60		TCRBV20-01,TCRBV20-or09_02												CSAEGLAGGQIRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTACAGGGCTATGGCTACACCTTCGGTTCG	CSAVQGYGYTF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	4	3	0	26	34	-1	37	43		TCRBV20-01,TCRBV20-or09_02												CSAVQGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGGACAGCATTTCCTATGGCTACACCTTCGGTTCG	CSAREGDSISYGYTF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	4	2	6	26	40	49	42	55		TCRBV20-01,TCRBV20-or09_02												CSAREGDSISYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCACAGGAACACTGAAGCTTTCTTTGGACAA	CSASHRNTEAFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	1	2	0	26	37	-1	39	43		TCRBV20-01,TCRBV20-or09_02												CSASHRNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATTTCCCTGACCCCTACGAGCAGTACTTCGGGCCG	CASSQDFPDPYEQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	45	unresolved						TCRBJ02	TCRBJ02-07	01	0	2	7	2	7	1	23	40	50	47	51	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDFPDPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAAAGGACCCCGTGGCTATGGCTACACCTTCGGTTCG	CASKGPRGYGYTF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	7	1	7	4	2	7	22	32	38	34	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKGPRGYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGCCCAAGAGACAGGGGTCTAATGAGCAGTTCTTCGGGCCA	CASRPKRQGSNEQFF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	2	7	8	3	22	33	49	41	52	TCRBV02,TCRBV12													CASRPKRQGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAAAACAGGACGCTATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	28	7.768520291097554E-5		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	4	6	3	5	24	38	46	41	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGGGGGGGGCCGCTACGAGCAGTACTTCGGGCCG	CASSQGGGRYEQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	0	3	3	4	19	31	41	34	45	TCRBV07,TCRBV11													CASSQGGGRYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACTGGCCAGGGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSQDWPGGSYEQYF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	1	5	1	18	35	47	40	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDWPGGSYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GAGACWCGGCMMTGTATCKCTGYGCCAGCAGCTTAATACCGACTAGCCCTCCAGAGGTCTTCGGGCCA	CASSLIPTSPPEVF	In	VDJ	1	28	7.768520291097554E-5	8.758238217823641E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	7	17	9	10	20	31	47	40	57	TCRBV07,TCRBV23					01,02								CASSLIPTSPPEVF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GCCACGTTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTTTCGGTCAGTCTATGGGGCCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	7.768520291097554E-5		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	24	7	0	6	29	1	40	30	64	59	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCATCAGCCGGACAGGGACAAATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	29	8.045967444351037E-5		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	3	0	2	6	24	35	45	37	51	TCRBV06,TCRBV10													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGGGACAGAACACTGAAGCTTTCTTTGGACAA	CASSAGQNTEAFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	5	0	6	1	2	0	26	38	-1	40	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGQNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGTTCGCGGGACGTACAGATACGCAGTATTTTGGCCCA	CSARDRFAGRTDTQYF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	3	3	7	3	26	40	53	47	56		TCRBV20-01,TCRBV20-or09_02												CSARDRFAGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTTAATCGATGGCGGCCCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	8.045967444351037E-5		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	7	5	5	7	5	23	38	49	45	54	TCRBV06,TCRBV27					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGGATCAACCGGGACAAGGGGACGATAAGCAATCAGCCCCAGCATTTTGGTGAT	CASRINRDKGTISNQPQHF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	6	1	8	11	23	34	48	42	59	TCRBV06,TCRBV24													CASRINRDKGTISNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCGGACTAACTCAGGGTTTCGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	8.045967444351037E-5		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	1	9	4	2	13	18	31	39	33	52	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAATTCGGCAGGGCGAGACCCAGTACTTCGGGCCA	CASSLIRQGETQYF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	5	6	1	18	33	44	39	45	TCRBV07,TCRBV11													CASSLIRQGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCAAACTCACAGGGGGTTCTGAAGCTTTCTTTGGACAA	CASSKLTGGSEAFF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	6	6	2	19	31	45	37	47	TCRBV05,TCRBV11													CASSKLTGGSEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGTTCCGGTCCCAGTCGGAGATCAGCCCCAGCATTTTGGTGAT	CASSLVPVPVGDQPQHF	In	VDJ	1	29	8.045967444351037E-5	9.07103243988877E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	2	5	17	0	22	35	-1	52	56	TCRBV07,TCRBV11													CASSLVPVPVGDQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTTTCGGTCAGTCTATGGGGCCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	8.045967444351037E-5		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	21	7	0	6	26	1	32	25	56	51	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGCAGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSAGTSTDTQYF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	0	2	0	24	37	-1	39	45	TCRBV06,TCRBV10					01,02								CASSAGTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTATCAAGAGCAGTACTTCGGGCCG	CSAREYQEQYF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	4	6	7	4	1	26	40	46	44	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREYQEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCTTGGGATGGGCAGATACGCAGTATTTTGGCCCA	CATSALGWADTQYF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	5	0	8	4	4	4	24	37	45	41	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSALGWADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACAGCGTACCTACAATGAGCAGTTCTTCGGGCCA	CASSLQRTYNEQFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	42	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	3	5	2	2	4	24	36	42	38	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQRTYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCCGGGAGGAACAATGAGCAGTTCTTCGGGCCA	CASSLAGRNNEQFF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	1	5	0	1	18	-1	42	35	43	TCRBV07,TCRBV11													CASSLAGRNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGAGGAAGCGGACTAGCGGGAGGAGGAGCAGATACGCAGTATTTTGGCCCA	CASRGSGLAGGGADTQYF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	1	4	7	5	19	30	51	37	56	TCRBV05,TCRBV11													CASRGSGLAGGGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGAACAGGGGGCCGGAGGCTACACCTTCGGTTCG	CASSLEQGAGGYTF	In	VDJ	1	30	8.323414597604521E-5	9.3838266619539E-5	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	8	1	4	19	35	45	36	49		TCRBV05-06,TCRBV05-07												CASSLEQGAGGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTKGGKGACTYKGCTGTGTATYTCTGTGCCAGCAGCTTAGATCTAGGAGGGAGATTGGAAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	30	8.323414597604521E-5		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	0	5	8	10	22	35	49	43	59	TCRBV03,TCRBV07													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTACGAGGACTAGCGGAGCTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	8.600861750858006E-5		50	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	5	2	4	5	26	38	52	42	57		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTACGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSQDLRGMNTEAFF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	48	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	7	0	0	5	1	26	43	53	48	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLRGMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACTAGGTACGGACCTAGTAATGAAAAACTGTTTTTTGGCAGT	CASTRYGPSNEKLFF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	45	unresolved						TCRBJ01	TCRBJ01-04	01	7	1	7	4	8	4	22	32	44	40	48	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRYGPSNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGAGGCATTTTAGGGTCGGGGTCAGGAGAAAAACTGTTTTTTGGCAGT	CASSEGGILGSGSGEKLFF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	57	TCRBV25			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	3	8	16	6	23	38	59	54	65		TCRBV25-01,TCRBV25-or09_02				01,02								CASSEGGILGSGSGEKLFF+TCRBV25-X+TCRBJ01-04	TCRBV25	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGATCGTCCTTGGCAGGGGAAAATGAAAAACTGTTTTTTGGCAGT	CASRSSLAGENEKLFF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	4	2	5	14	2	19	27	47	41	49	TCRBV07,TCRBV11													CASRSSLAGENEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGGCCGGGACAGTAAACACTGAAGCTTTCTTTGGACAA	CASSPAGTVNTEAFF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	2	6	2	18	30	43	36	45	TCRBV07,TCRBV11													CASSPAGTVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGATGGGGACCCGGCAGATACGCAGTATTTTGGCCCA	CASSLDGDPADTQYF	In	VDJ	1	31	8.600861750858006E-5	9.69662088401903E-5	45	unresolved						TCRBJ02	TCRBJ02-03	01	0	0	7	4	2	4	18	35	42	37	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGDPADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCACAGGGGGCGGGTATCAGCCCCAGCATTTTGGTGAT	CASSTGGGYQPQHF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	0	5	1	4	26	37	47	38	51	TCRBV09,TCRBV12													CASSTGGGYQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTCCGGGGAGCGGGATCCTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	8.878308904111489E-5		49	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	3	2	10	5	26	34	51	44	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCTTCTAGGTTCGGTGAGCAGTTCTTCGGGCCA	CSARDSSRFGEQFF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	8	9	5	6	26	40	49	45	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSSRFGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CSARGQGDYNEQFF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	1	3	0	1	26	-1	48	39	49		TCRBV20-01,TCRBV20-or09_02												CSARGQGDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATACGGGGGAGGAGAAAAACTGTTTTTTGGCAGT	CASSEYGGGEKLFF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	42	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	2	8	2	4	23	38	46	40	50		TCRBV06-01,TCRBV06-08				01,02								CASSEYGGGEKLFF+TCRBV06-X+TCRBJ01-04	TCRBV06	TCRBD02-01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGGCCTCCAGGGTTACGGCGGGGAGCTGTTTTTTGGAGAA	CASSQGLQGYGGELFF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	7	9	6	19	31	45	40	51	TCRBV07,TCRBV11													CASSQGLQGYGGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACAGGGACGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGTGTSNQPQHF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	3	1	0	3	18	-1	42	34	45	TCRBV07,TCRBV11													CASSLGTGTSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGCCCGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CASSLGPTSGYEQYF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	5	3	4	0	18	34	-1	38	47	TCRBV07,TCRBV11					01,02								CASSLGPTSGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGAGCCAGGGTGCTGAACACTGAAGCTTTCTTTGGACAA	CASRARVLNTEAFF	In	VDJ	1	32	8.878308904111489E-5	1.000941510608416E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	0	3	3	23	34	42	37	45	TCRBV02,TCRBV09													CASRARVLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCCACGGACGGCTACGAGCAGTACTTCGGGCCG	CASRPTDGYEQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	6	1	7	3	6	2	26	37	47	43	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPTDGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCCGGGACAGGGGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASRSGTGADTGELFF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	2	3	4	3	26	37	51	41	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSGTGADTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGGAAAATGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGKMGNTGELFF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	45	TCRBV12						TCRBJ02	TCRBJ02-02	01	5	0	8	1	0	7	26	-1	42	38	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGKMGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGATCTTCAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	9.155756057364973E-5		47	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	1	8	1	0	6	26	-1	46	43	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGATCTCAGGGAGAGATGGCTACACCTTCGGTTCG	CSALISGRDGYTF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	4	3	6	8	4	26	34	47	42	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALISGRDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGGTCTGTCTAAGGACTACGAGCAGTACTTCGGGCCG	CSAKGLSKDYEQYF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	1	8	3	13	0	26	36	-1	49	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGLSKDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGGCAGAGCTAAATCAGCCCCAGCATTTTGGTGAT	CSASRAELNQPQHF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	8	0	4	2	7	26	37	43	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRAELNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTCTCCGGGGGCTAGCGGGAGCGGGATACAATGAGCAGTTCTTCGGGCCA	CSALLRGLAGAGYNEQFF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	4	12	5	26	35	57	47	62		TCRBV20-01,TCRBV20-or09_02												CSALLRGLAGAGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGCGCACAGGGGAATTTCAGCCCCAGCATTTTGGTGAT	CASRRTGEFQPQHF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	2	6	4	4	22	33	44	37	48		TCRBV12-03,TCRBV12-04												CASRRTGEFQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGTCGTGGGCGGAAACACTGAAGCTTTCTTTGGACAA	CASSVVGGNTEAFF	In	VDJ	1	33	9.155756057364973E-5	1.032220932814929E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	8	0	2	5	3	18	30	39	35	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVGGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCGAGCGGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASTRAGSGELFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	6	3	6	4	1	26	36	47	40	48		TCRBV03-01,TCRBV03-02												CASTRAGSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGCAATTGATAACCAGGACAGATACGCAGTATTTTGGCCCA	CASSQGQLITRTDTQYF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	3	0	14	26	-1	45	40	59		TCRBV03-01,TCRBV03-02												CASSQGQLITRTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGCGGTGCAAATCAGCCCCAGCATTTTGGTGAT	CSATGGANQPQHF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	7	5	4	3	4	26	36	43	39	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSATGGANQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCCAGAGCACTCCACCGAGGTTCAGCCCCAGCATTTTGGTGAT	CSARGPEHSTEVQPQHF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	1	6	17	1	26	39	60	56	61		TCRBV20-01,TCRBV20-or09_02												CSARGPEHSTEVQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCGGACCGGAGGGCCTCCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASGPEGLPSYNEQFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	10	0	0	5	6	33	42	53	47	59	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASGPEGLPSYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATCCATTTTTAGCGACCGCCTACAATGAGCAGTTCTTCGGGCCA	CASNPFLATAYNEQFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	5	6	2	12	4	24	31	48	43	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASNPFLATAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAACCCCTCGGAGTGAAGCTTTCTTTGGACAA	CASSPTPRSEAFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	2	7	10	0	24	36	-1	46	50		TCRBV24-01,TCRBV24-or09_02												CASSPTPRSEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTAAAAGAACCGGGACAGGGTTAACAATGAGCAGTTCTTCGGGCCA	CASS*KNRDRVNNEQFF	Stop	VDJ	1	34	9.433203210618458E-5		51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	5	10	3	24	36	55	46	58		TCRBV24-01,TCRBV24-or09_02												CASS*KNRDRVNNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGAAGCTKGAGGAYTCAGCMRTGTAYTTYTGTGCCAGCAGCGTAGGTGGTTGGGGGAGATTCAGAAACACCATATATTTTGGAGAG	CASSVGGWGRFRNTIYF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	51	unresolved						TCRBJ01	TCRBJ01-03	01	5	6	1	5	10	7	29	41	56	51	63	TCRBV02,TCRBV16			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGGWGRFRNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCGGCTAGCGGGCCTATCCGAGCGGGTGAGCAGTTCTTCGGGCCA	CASSLAASGPIRAGEQFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	4	9	2	14	18	35	45	37	59	TCRBV07,TCRBV11					01,02								CASSLAASGPIRAGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTCGGGACACACTACAATGAGCAGTTCTTCGGGCCA	CASSFGTHYNEQFF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	3	1	2	18	32	39	33	41	TCRBV07,TCRBV11													CASSFGTHYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCTTAAACCGGACAGCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	9.433203210618458E-5		44				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	2	4	2	18	33	43	37	45	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTTTAGGACAGACTGGAAACACCATATATTTTGGAGAG	CASSLGQTGNTIYF	In	VDJ	1	34	9.433203210618458E-5	1.063500355021442E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	2	4	1	23	34	44	38	45	TCRBV02,TCRBV09													CASSLGQTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAATTTTTCGGGCAGGAACACTGAAGCTTTCTTTGGACAA	CASNFSGRNTEAFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	8	0	1	3	2	26	40	47	43	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNFSGRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAACAGGCTGAACCCAGGAACTAGCGGGATAGTAGATGAGCAGTTCTTCGGGCCA	CANRLNPGTSGIVDEQFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	3	8	13	6	24	35	58	48	64	TCRBV06,TCRBV10													CANRLNPGTSGIVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTYRGKGACTCWGCTGTGTAYTTCTGTGCCAGCAGACGAGGTAGCCTAGCGGGCAGCTACGAGCAGTACTTCGGGCCG	CASRRGSLAGSYEQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	4	3	10	3	26	37	55	47	58	TCRBV03,TCRBV12					01,02								CASRRGSLAGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAATCGGACAGCCTCTTAAACTATGGCTACACCTTCGGTTCG	CASSQQSDSLLNYGYTF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	5	2	5	7	26	41	52	46	59		TCRBV03-01,TCRBV03-02												CASSQQSDSLLNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCACCTTAGACTAGCGACCCAAGAGACCCAGTACTTCGGGCCA	CSASHLRLATQETQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	6	1	8	2	26	37	53	45	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSASHLRLATQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGAACCCAGGACGGCCTTTTTGGCAGT	CSASGTQDGLF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	33	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	1	7	18	9	4	26	37	50	46	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGTQDGLF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCTTGGACTAGCGGGAGGGCGTGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	35	9.710650363871942E-5		53	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	0	4	4	5	26	36	55	40	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTGGGACTAGCGGGAGTAAAGCAGATACGCAGTATTTTGGCCCA	CSAIGTSGSKADTQYF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	2	4	2	5	26	36	52	38	57		TCRBV20-01,TCRBV20-or09_02												CSAIGTSGSKADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCGGGGGACAGGGGACGGGGCGCTGAAGCTTTCTTTGGACAA	CASSPGDRGRGAEAFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	6	4	8	22	34	48	38	56		TCRBV12-03,TCRBV12-04												CASSPGDRGRGAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGTTCACCTACCGGGATAGGGGTTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	35	9.710650363871942E-5		58	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	5	2	2	20	3	23	35	60	55	63		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGATGGTGATCCTGGTGAGCAGTTCTTCGGGCCA	CASSDGDPGEQFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	5	0	10	9	3	9	23	35	40	38	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGDPGEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGAGGTGGGAGGGTTTGAGCAGTTCTTCGGGCCA	CASSLEVGGFEQFF	In	VDJ	1	35	9.710650363871942E-5	1.094779777227955E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	9	3	2	18	35	45	38	47	TCRBV07,TCRBV11													CASSLEVGGFEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTTCAGCGGGAGGGCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	9.710650363871942E-5		47				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	0	5	3	3	18	35	48	38	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCGGACAGACCTATGGCTACACCTTCGGTTCG	CASSPGQTYGYTF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	4	2	2	23	36	44	38	46	TCRBV01,TCRBV04													CASSPGQTYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCTGGCGATTAATGAAAAACTGTTTTTTGGCAGT	CASSLAINEKLFF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	39							TCRBJ01	TCRBJ01-04	01	5	9	0	4	2	3	24	36	41	38	44	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAINEKLFF+X+TCRBJ01-04			TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAGGAGTGCGCATCGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	9.988097517125425E-5		37	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	1	6	0	11	26	-1	39	34	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCAGGTTCCCACGAGCAGTACTTCGGGCCG	CSARPGSHEQYF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	4	5	1	5	26	38	43	39	48		TCRBV20-01,TCRBV20-or09_02												CSARPGSHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGCAGCGGCAGTCTATGGCTACACCTTCGGTTCG	CASSEAAAVYGYTF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	5	4	5	4	22	34	44	39	48	TCRBV09,TCRBV12					01,02								CASSEAAAVYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCGGGTCTCAAGGCTCTGGAAACACCATATATTTTGGAGAG	CAGSQGSGNTIYF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	39	TCRBV12						TCRBJ01	TCRBJ01-03	01	11	0	9	0	0	8	22	-1	31	28	39		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGSQGSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCACACCCCAGGGGGTTAGCGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTPQGVSGYSNQPQHF	In	VDJ	1	36	9.988097517125425E-5	1.126059199434468E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	4	1	0	8	10	24	31	46	39	56	TCRBV06,TCRBV24													CASTPQGVSGYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAACGTCTCCAAGGTATATCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	36	9.988097517125425E-5		52	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	5	4	0	12	5	24	36	51	48	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCACCGGACTAGAGGCCGTCAATGAGTAGTTCTTCGGGCCA	CASSTGLEAVNE*FF	Stop	VDJ	1	36	9.988097517125425E-5		45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	8	14	4	15	23	34	45	38	60	TCRBV06,TCRBV10					01,02								CASSTGLEAVNE*FF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCCAAATTTGGGCGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	36	9.988097517125425E-5		49				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	8	0	0	8	1	18	31	43	39	44	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCGGGACAGGGAATACACTTCGGGCCG		Out	VDJ	1	37	1.026554467037891E-4		38	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	14	3	5	26	42	54	45	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGACTAGCGGCAGATACGCAGTATTTTGGCCCA	CSARLAADTQYF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	5	4	0	0	26	-1	-1	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLAADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGTCGACTAGCGGGCCCGCTGAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	37	1.026554467037891E-4		50	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	4	5	5	9	26	37	52	42	61		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGTTTGACTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLTSSYNEQFF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	8	0	2	0	24	36	-1	38	44	TCRBV22,TCRBV24					01,02								CASSLTSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAAATACTTCCGTGGACCGCGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASKYFRGPRSSYNEQFF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	54	unresolved						TCRBJ02	TCRBJ02-01	01	6	1	7	0	11	7	19	29	44	40	51	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKYFRGPRSSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCAGGGATTTTTTGTACAATGAGCAGTTCTTCGGGCCA	CASSPRDFLYNEQFF	In	VDJ	1	37	1.026554467037891E-4	1.157338621640981E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	4	2	8	19	31	38	33	46		TCRBV05-06,TCRBV05-07												CASSPRDFLYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCAGGGACAGGGGTTTTACCTCTGGAAACACCATATATTTTGGAGAG	CASSLRDRGFTSGNTIYF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	2	0	3	6	26	39	52	42	58		TCRBV03-01,TCRBV03-02												CASSLRDRGFTSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTGGGGGGTCGGGGAGCTGTTTTTTGGAGAA	CASWGVGELFF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	33	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	9	1	7	1	1	26	35	42	36	43		TCRBV03-01,TCRBV03-02												CASWGVGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGACAGGGGTAACTGAAGCTTTCTTTGGACAA	CSARDPTGVTEAFF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	5	3	2	26	40	51	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDPTGVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGGACAGGGGGAGGTCAGTCCCCAGCATTTTGGTGAT	CSARDLGQGEVSPQHF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	1	10	3	8	26	40	54	43	62		TCRBV20-01,TCRBV20-or09_02												CSARDLGQGEVSPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGGGTTACTATGGCTATACCTTCGGTTCG	CSASQGYYGYTF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	14	1	13	26	37	43	38	56		TCRBV20-01,TCRBV20-or09_02												CSASQGYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTGGACAGGGGGCCGGACTGAAGCTTTCTTTGGACAA	CASSWTGGRTEAFF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	0	5	0	3	18	-1	42	31	45	TCRBV07,TCRBV11													CASSWTGGRTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGACCCTAACTGAAGCTTTCTTTGGACAA	CASSVGTLTEAFF	In	VDJ	1	38	1.0542991823632394E-4	1.188618043847494E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	0	1	7	5	0	4	23	-1	43	39	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGTLTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGACAGGCATACGAGCAGTACTTCGGGCCG	CASSQGQAYEQYF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	4	0	2	23	-1	45	39	47	TCRBV01,TCRBV04													CASSQGQAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAACGACAGGGTTTTCGAATCAGCCCCAGCATTTTGGTGAT	CASRTTGFSNQPQHF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	4	3	6	24	35	45	38	51		TCRBV24-01,TCRBV24-or09_02												CASRTTGFSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCATATACCCCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSIYPGGYNEQFF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	2	3	8	0	18	30	-1	38	44	TCRBV07,TCRBV11													CASSIYPGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCGGGGGGCGGGCTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASGGRASSTDTQYF	In	VDJ	1	39	1.0820438976885877E-4	1.219897466054007E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	8	6	0	0	1	8	23	32	39	33	47	TCRBV02,TCRBV21			TCRBD01,TCRBD02										CASGGRASSTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGACAGGGATGTGTCTTTCTTTGGACAA	CASRDRDVSFF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	33	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	12	1	6	26	37	45	38	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRDRDVSFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCGCGGGTAGGTAGCGGGAGGGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	1.1097886130139362E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	5	0	5	13	2	26	31	55	44	57	TCRBV09,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGCGGGAGAGACAGATACGCAGTATTTTGGCCCA	CASSAGETDTQYF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	8	2	3	0	2	24	-1	43	37	45	TCRBV06,TCRBV10													CASSAGETDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCAGAGGATTCAGCCCCAGCATTTTGGTGAT	CASSQDQRIQPQHF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	11	1	6	3	2	26	43	50	46	52		TCRBV03-01,TCRBV03-02												CASSQDQRIQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCTCGGGGAGCTGTTTTTTGGAGAA	CASSHLGELFF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	10	7	1	0	26	40	-1	41	43		TCRBV03-01,TCRBV03-02				01,02								CASSHLGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGGCAGATTCACTGAAGCTTTCTTTGGACAA	CSARDQGRFTEAFF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	4	1	6	26	40	46	41	52		TCRBV20-01,TCRBV20-or09_02												CSARDQGRFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTGATGGGACGTCACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSAVMGRHSGANVLTF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	48	TCRBV20						TCRBJ02	TCRBJ02-06	01	5	0	7	0	5	4	26	35	45	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAVMGRHSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTCGTTCGGGGGCAGCCCCGTATTTTGGCCCA	CATSDFRSGAAPYF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	1	6	0	14	6	6	24	41	53	47	59		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFRSGAAPYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCCTAATTAAGACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	1.1097886130139362E-4		40	TCRBV24						TCRBJ02	TCRBJ02-05	01	11	2	7	1	11	0	24	31	-1	42	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAACCAGGGGGCTTTTGGCGGAAACACCATATATTTTGGAGAG	CASNQGAFGGNTIYF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	4	0	4	2	7	23	33	43	35	50	TCRBV06,TCRBV10													CASNQGAFGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTGGAGGGCTGCTCGGCTACACCTTCGGTTCG	CASSVGGLLGYTF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	0	8	3	6	24	36	45	39	51	TCRBV09,TCRBV21													CASSVGGLLGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCTACTCACGCGGGACACTGAAGCTTTCTTTGGACAA	CASSLLTRDTEAFF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	7	4	3	9	0	24	35	-1	44	49	TCRBV12,TCRBV21					01,02								CASSLLTRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTTATTATCGGGACCGGCGGATGGCTACACCTTCGGTTCG	CASSLLSGPADGYTF	In	VDJ	1	40	1.1097886130139362E-4	1.25117688826052E-4	45							TCRBJ01	TCRBJ01-02	01	6	0	7	6	9	6	23	34	48	43	54	TCRBV02,TCRBV13	TCRBV02-01,TCRBV13-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLSGPADGYTF+X+TCRBJ01-02			TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCTGGGACTAGCGGGTTTTCCGAGCAGTACTTCGGGCCG	CASSLAGTSGFSEQYF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	4	6	1	5	26	43	56	44	61		TCRBV12-03,TCRBV12-04				01,02								CASSLAGTSGFSEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCAGACAGGGGGAGCGGAAGAGACCCAGTACTTCGGGCCA	CASSHQTGGAEETQYF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	1	3	3	5	26	40	52	43	57		TCRBV03-01,TCRBV03-02												CASSHQTGGAEETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGCGGGGGGACTAAGAAGACCCAGTACTTCGGGCCA	CSARSGGTKKTQYF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	1	6	1	7	26	37	47	38	54		TCRBV20-01,TCRBV20-or09_02												CSARSGGTKKTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTATAGCGGGAGGGCCGGATGACGAGCAGTACTTCGGGCCG	CSASGIAGGPDDEQYF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	0	5	5	7	26	37	53	42	60		TCRBV20-01,TCRBV20-or09_02												CSASGIAGGPDDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATACTCCACACTGAAGCTTTCTTTGGACAA	CSAILHTEAFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	3	10	3	1	2	26	36	40	37	42		TCRBV20-01,TCRBV20-or09_02				01,02								CSAILHTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAAGCCACGTTTGGTGGAACCCAGGGACTCAGCTGTGATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	1.1375333283392846E-4		38	TCRBV12						TCRBJ01	TCRBJ01-02	01	23	4	4	1	18	3	43	37	59	55	62		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACGGGCACGGACGACTACAATGAGCAGTTCTTCGGGCCA	CATGTDDYNEQFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	10	1	7	3	7	2	23	30	41	37	43	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGTDDYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGGCGGACAGGGTCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSGGQGRTGELFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	5	3	4	18	30	41	33	45	TCRBV07,TCRBV11													CASSGGQGRTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGGTTGAAGTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRLKSSSYNEQFF	In	VDJ	1	41	1.1375333283392846E-4	1.282456310467033E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	6	11	2	0	9	0	18	29	-1	38	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASRLKSSSYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACCCGACAGGGGCCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	42	1.1652780436646329E-4		43	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	6	4	2	26	38	50	42	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACAGGGTAGCGACACCGGGGAGCTGTTTTTTGGAGAA	CSAKQGSDTGELFF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	3	1	5	26	36	43	37	48		TCRBV20-01,TCRBV20-or09_02												CSAKQGSDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGGGACTGCGATTAAAGAGACCCAGTACTTCGGGCCA	CSATGTAIKETQYF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	3	2	7	26	36	44	38	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSATGTAIKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACGGTTATCGGGAGGAAACCCCTACGAGCAGTACTTCGGGCCG	CSAGRLSGGNPYEQYF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	1	2	10	5	26	35	52	45	57		TCRBV20-01,TCRBV20-or09_02												CSAGRLSGGNPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGACGGGACAGGGGACGAGCAGTACTTCGGGCCG	CASSDGTGDEQYF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	5	3	0	22	34	-1	37	47	TCRBV02,TCRBV12													CASSDGTGDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAAGGGACAGGGGAGTATCAGCCCCAGCATTTTGGTGAT	CASKGTGEYQPQHF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	2	5	5	3	24	31	46	36	49		TCRBV24-01,TCRBV24-or09_02												CASKGTGEYQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAAAAACAGGGGGCCGATGTCCAATGAAAAACTGTTTTTTGGCAGT	CAKNRGPMSNEKLFF	In	VDJ	1	42	1.1652780436646329E-4	1.313735732673546E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	3	0	5	3	8	23	30	42	33	50	TCRBV06,TCRBV24													CAKNRGPMSNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCACTCATGAGCAGTTCTTCGGGCCA	CASSSTHEQFF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	10	8	2	1	26	39	44	41	45		TCRBV12-03,TCRBV12-04				01,02								CASSSTHEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCCGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	43	1.1930227589899814E-4		34	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	5	4	4	0	26	37	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCACCAAACTCAGGGTGGCGACTGAAGCTTTCTTTGGACAA	CATKLRVATEAFF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	4	3	5	7	5	22	29	41	36	46	TCRBV09,TCRBV12													CATKLRVATEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCATCCGGACTAGCTTTGGGGAGACCCAGTACTTCGGGCCA	CAIRTSFGETQYF	In	VDJ	1	43	1.1930227589899814E-4	1.345015154880059E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	1	7	5	3	6	22	29	40	32	46	TCRBV02,TCRBV12					01,02								CAIRTSFGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGGCGGACAGCATAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDGGQHNTGELFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	5	2	4	3	26	43	53	47	56		TCRBV03-01,TCRBV03-02												CASSQDGGQHNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTAAACGGGGGGGTACAGATACGCAGTATTTTGGCCCA	CSAPKRGGTDTQYF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	3	7	1	26	34	49	41	50		TCRBV20-01,TCRBV20-or09_02												CSAPKRGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGATTCAGGGGGCCTATGGCTACACCTTCGGTTCG	CASSEQIQGAYGYTF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	0	4	6	0	23	38	-1	44	52		TCRBV06-01,TCRBV06-08												CASSEQIQGAYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTRCCARCCTTCGGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CXXLRGNTGELFF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	8	3	2	3	1	23	32	40	35	41	TCRBV06,TCRBV10													CXXLRGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCCCGGCGGGGGGGTATGGCTACACCTTCGGTTCG	CASSPAGGYGYTF	In	VDJ	1	44	1.2207674743153297E-4	1.376294577086572E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	7	0	5	3	0	18	30	-1	33	42	TCRBV05,TCRBV07													CASSPAGGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGGAGGGCCCGGCAGATACGCAGTATTTTGGCCCA	CASSDSEGPADTQYF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	0	4	3	5	24	38	47	41	52	TCRBV06,TCRBV10													CASSDSEGPADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATTTGTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	1.248512189640678E-4		37	TCRBV03						TCRBJ02	TCRBJ02-03	01	7	4	6	5	5	4	26	36	43	41	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTGCAGGGTAGAGGAGAGACCCAGTACTTCGGGCCA	CSAVQGRGETQYF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	4	4	6	26	34	43	38	49		TCRBV20-01,TCRBV20-or09_02												CSAVQGRGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTGGAAGTGGGCTGTCCTATGGCTACACCTTCGGTTCG	CASSFGSGLSYGYTF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	4	7	4	22	36	47	43	51		TCRBV12-03,TCRBV12-04												CASSFGSGLSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTACTAGCGGGGGCCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	1.248512189640678E-4		46	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	2	1	3	24	36	48	37	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATTCCAGGACTAGCGGGCGCTAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	45	1.248512189640678E-4		52	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	1	4	2	5	5	24	34	50	39	55		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCTACCAGTGCCTCACGCGGGGGATTTGGAGAGACCCAGTACTTCGGGCCA	CATSASRGGFGETQYF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	2	4	6	6	24	37	50	43	56		TCRBV24-01,TCRBV24-or09_02												CATSASRGGFGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCTGCTAGCGGGACAGATACGCAGTATTTTGGCCCA	CASSDSASGTDTQYF	In	VDJ	1	45	1.248512189640678E-4	1.407573999293085E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	4	3	2	0	23	40	-1	42	50	TCRBV06,TCRBV10					01,02								CASSDSASGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTACAGACAGGGCCCTACGAGCAGTACTTCGGGCCG	CASSVQTGPYEQYF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	2	6	1	26	37	50	43	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVQTGPYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCCGCAGTTCCATTTCTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	1.2762569049660266E-4		49	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	4	5	5	5	15	26	38	46	43	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCGACCAAAAAACCGACTAGCGGGATCAAATGAGCAGTTCTTCGGGCCA	CSRPKNRLAGSNEQFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	2	3	7	13	3	26	32	56	45	59		TCRBV20-01,TCRBV20-or09_02												CSRPKNRLAGSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCAGGACTAGCGGGAGGGCCCTTTACAATGAGCAGTTCTTCGGGCCA	CSARVRTSGRALYNEQFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	0	4	3	5	26	39	57	42	62		TCRBV20-01,TCRBV20-or09_02												CSARVRTSGRALYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGTCTGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASRSASSYNEQFF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	6	0	7	2	26	37	47	44	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRSASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGTACAGGGGGCCCTAAGCAATCAGCCCCAGCATTTTGGTGAT	CSVVQGALSNQPQHF	In	VDJ	1	46	1.2762569049660266E-4	1.438853421499598E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	0	1	4	4	26	33	46	37	50		TCRBV20-01,TCRBV20-or09_02												CSVVQGALSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGATTCGTGCGGGACTAGCCACCGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	1.2762569049660266E-4		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	7	6	8	5	24	35	52	43	57		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACACGGACAGTCGAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	1.2762569049660266E-4		47	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	5	2	4	5	23	38	48	42	53		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTATAGCGGGAGCTCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	46	1.2762569049660266E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	2	5	3	3	18	30	42	33	45	TCRBV05,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGAGGCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CSARREAGTGELFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	1	5	0	5	26	-1	45	38	50		TCRBV20-01,TCRBV20-or09_02												CSARREAGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTAGTCGGGAGAACAATGAGCAGTTCTTCGGGCCA	CSARGSRENNEQFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	2	5	5	1	26	39	50	44	51		TCRBV20-01,TCRBV20-or09_02												CSARGSRENNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCCAAAATTTTCAGCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	47	1.304001620291375E-4		47							TCRBJ01	TCRBJ01-03	01	5	4	5	0	9	1	18	30	42	39	43	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-03			TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGCCGGCCTCCTTAACGAGCCCCAGCATTTTGGTGAT	CASSAGLLNEPQHF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	4	9	0	8	3	10	19	31	37	34	47	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGLLNEPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAAAGATCAATGAGCAGTTCTTCGGGCCA	CASSEKINEQFF	In	VDJ	1	47	1.304001620291375E-4	1.470132843706111E-4	36	unresolved						TCRBJ02	TCRBJ02-01	01	2	2	8	6	2	1	23	38	42	40	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEKINEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAACGGACAGGGGGTTGCCGGGGAGCTGTTTTTTGGAGAA	CASSFNGQGVAGELFF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	1	6	4	3	26	40	54	44	57		TCRBV12-03,TCRBV12-04												CASSFNGQGVAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTGGGCGACAGGGCCGGCAATCAGCCCCAGCATTTTGGTGAT	CSASLGDRAGNQPQHF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	3	2	7	3	26	37	51	44	54		TCRBV20-01,TCRBV20-or09_02												CSASLGDRAGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACGGACGGAAGTTTACAATGAGCAGTTCTTCGGGCCA	CASSLRTEVYNEQFF	In	VDJ	1	48	1.3317463356167235E-4	1.501412265912624E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	2	1	7	4	1	7	18	33	38	34	45	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRTEVYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCCTCCTCGCTTGGCTACACCTTCGGTTCG	CASSQDPSSLGYTF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	10	0	7	9	1	26	43	54	52	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPSSLGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGTTCTCGGAGTAGCGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSQDVLGVAGGNEQFF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	6	11	0	26	43	-1	54	64		TCRBV03-01,TCRBV03-02												CASSQDVLGVAGGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCTCTGGGACAACGATCAGCCCCAGCATTTTGGTGAT	CSAILWDNDQPQHF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	6	5	6	3	26	36	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSAILWDNDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTGGGGTGACTACGAGCAGTACTTCGGGCCG	CASSQDWGDYEQYF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	42							TCRBJ02	TCRBJ02-07	01	0	6	2	3	2	3	18	35	41	37	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWGDYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTACGGGAGGTCGAGTACTGAAGCTTTCTTTGGACAA	CASSYGRSSTEAFF	In	VDJ	1	49	1.359491050942072E-4	1.532691688119137E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	1	5	1	6	18	31	39	32	45	TCRBV05,TCRBV11													CASSYGRSSTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRGSYNEQFF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	5	0	3	0	26	39	-1	42	46		TCRBV03-01,TCRBV03-02				01,02								CASSLRGSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGATCCTCCGTTACCGGGGAGCTGTTTTTTGGAGAA	CSARRSSVTGELFF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	42	TCRBV20						TCRBJ02	TCRBJ02-02	01	2	2	8	5	1	9	26	38	41	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRSSVTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGCTTAGCGGCGGGTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSRLAAGDTGELFF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	5	5	3	3	6	23	36	45	39	51	TCRBV01,TCRBV04					01,02								CASSRLAAGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACACCAGGTACGACAGGCCCTTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	50	1.3872357662674203E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	4	2	9	6	24	32	47	41	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCCTCGACGGATTTGGGACTGAAGCTTTCTTTGGACAA	CASSPLDGFGTEAFF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	9	5	15	0	18	30	-1	45	48	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLDGFGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGTGGGACTCTTGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	50	1.3872357662674203E-4		43	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	2	10	1	0	4	19	-1	39	35	43		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTGGGGACAAATCCAGAGCAATGAGCAGTTCTTCGGGCCA	CASSWGQIQSNEQFF	In	VDJ	1	50	1.3872357662674203E-4	1.5639711103256502E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	6	1	9	19	32	39	33	48	TCRBV05,TCRBV11													CASSWGQIQSNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGGTTACGGTGGCTACACCTTCGGTTCG	CASSQDRGYGGYTF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	7	1	6	26	43	49	44	55		TCRBV03-01,TCRBV03-02												CASSQDRGYGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGAAACGACCCACTCCTACGAGCAGTACTTCGGGCCG	CASSQDETTHSYEQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	48	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	2	7	0	6	3	26	43	52	49	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDETTHSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGCGGGAACCGTACGAGCAGTACTTCGGGCCG	CSARDKREPYEQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	3	4	2	4	26	40	49	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDKREPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCACCGGTATGGGGGATCCTCCTACGAGCAGTACTTCGGGCCG	CASSHRYGGSSYEQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	48	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	6	1	0	9	3	24	36	50	45	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRYGGSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCGGCTGTGGGTGGGCCGGACACCCGGAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	51	1.4149804815927685E-4		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	1	6	5	17	6	23	30	52	47	58	TCRBV06,TCRBV10													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTGGCTTCTGGAGATACGCAGTATTTTGGCCCA	CASSLVASGDTQYF	In	VDJ	1	51	1.4149804815927685E-4	1.595250532532163E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	9	0	5	1	6	18	34	38	35	44	TCRBV07,TCRBV11													CASSLVASGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGTTTCCGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CASSVSGTGDTEAFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	3	7	0	26	37	-1	44	54	TCRBV03,TCRBV12													CASSVSGTGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGATCGACGTATGGCTACACCTTCGGTTCG	CASSQGSTYGYTF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	0	8	5	0	6	26	-1	44	40	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSTYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGACAGGGCTTACAGATACGCAGTATTTTGGCCCA	CSATGTGLTDTQYF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	3	2	3	26	36	47	38	50		TCRBV20-01,TCRBV20-or09_02												CSATGTGLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTTGGGCCAGGAGAGACCCAGTACTTCGGGCCA	CSARFGPGETQYF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	4	4	7	0	26	38	-1	45	49		TCRBV20-01,TCRBV20-or09_02												CSARFGPGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MSCWMCCAGACAKCTSTKTACTTCTGTGCCAGCAGTCAACACGGACTAGCGGTGTACAATGAGCAGTTCTTCGGGCCA	CASSQHGLAVYNEQFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	5	4	6	2	24	36	52	42	54	TCRBV06,TCRBV10,TCRBV24					01,02								CASSQHGLAVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCCCCCCGGGGCACTGAAGCTTTCTTTGGACAA	CASSPPRGTEAFF	In	VDJ	1	52	1.442725196918117E-4	1.6265299547386762E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	4	6	0	24	36	-1	42	47	TCRBV24,TCRBV27													CASSPPRGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGATAGACTGGTTTGGTGGTGGAGCAGTACTTCGGGCCG		Out	VDJ	1	52	1.442725196918117E-4		44				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	7	4	12	18	30	38	34	50	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03				01,02								X+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCTGGGGGAGCTGTTTTTTGGAGAA	CASSRLGELFF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	33	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	10	0	8	0	3	26	-1	41	39	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRLGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGATCGCCAGGGGGCGCGGGCAATGAGCAGTTCTTCGGGCCA	CSAGSPGGAGNEQFF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	6	7	5	26	35	50	42	55		TCRBV20-01,TCRBV20-or09_02												CSAGSPGGAGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGACAGAGCGGTGGCGAGCAGTACTTCGGGCCG	CASSPGQSGGEQYF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	6	3	8	18	30	39	33	47	TCRBV07,TCRBV11													CASSPGQSGGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAGAGTTTCGGGGGGAGCGCCTACAATGAGCAGTTCTTCGGGCCA	XASSQSFGGSAYNEQFF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	2	6	4	22	36	49	42	53	TCRBV04,TCRBV07,TCRBV17													XASSQSFGGSAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGCTAGCGGGGATACCACGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSVGASGDTTSSYEQYF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	0	7	10	24	36	52	43	62	TCRBV09,TCRBV21													CASSVGASGDTTSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAATTATGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSELWGNTEAFF	In	VDJ	1	53	1.4704699122434654E-4	1.657809376945189E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	2	6	2	1	4	0	23	38	-1	42	46	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELWGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTKGGKGACTCWGCTGTGTATYTCTGTGCCAGCAGCCTGGACAGTTTGGGCGAGCAGTACTTCGGGCCG	CASSLDSLGEQYF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	6	1	6	26	39	46	40	52	TCRBV03,TCRBV07													CASSLDSLGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGYGACTCKGCTGTGTATYTCTGTGCCAGCAGCTTAGGCCTAGCGGGAGTCAATGAGCAGTTCTTCGGGCCA	CASSLGLAGVNEQFF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	6	6	1	26	38	54	44	55	TCRBV03,TCRBV07													CASSLGLAGVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCATAGTGACCAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	54	1.4982146275688139E-4		47	unresolved						TCRBJ02	TCRBJ02-06	01	1	2	7	5	1	7	18	34	38	35	45	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGCGGGAGAGAATACAATGAGCAGTTCTTCGGGCCA	CASSLGGREYNEQFF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	2	4	0	4	18	-1	41	34	45	TCRBV05,TCRBV11													CASSLGGREYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCTGGTTTTCGAGCGGGAGGGCATCGGCCCAGTCTGATACGCAGTATTTTGGCCCA	CASWFSSGRASAQSDTQYF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	6	0	6	9	14	23	32	51	41	65	TCRBV02,TCRBV09													CASWFSSGRASAQSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGGGACAGGGGACCTATGGCTACACCTTCGGTTCG	CASSVEGQGTYGYTF	In	VDJ	1	54	1.4982146275688139E-4	1.6890887991517022E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	4	1	2	23	39	50	40	52	TCRBV09,TCRBV21													CASSVEGQGTYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCCTAGTTAAGGACGAGCAGTACTTCGGGCCG	CASSQTLVKDEQYF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	8	5	3	6	26	41	48	44	54		TCRBV03-01,TCRBV03-02				01,02								CASSQTLVKDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTTTAGCGGAAGGGCCGTCCTACGAGCAGTACTTCGGGCCG	CSARDPLAEGPSYEQYF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	5	1	5	8	26	40	51	45	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPLAEGPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTACGGGACAGGGGCTCTCGAGCAGTACTTCGGGCCG	CSASYGTGALEQYF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	6	4	4	26	37	51	41	55		TCRBV20-01,TCRBV20-or09_02												CSASYGTGALEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACTAGCGGGAGCCGAATTAATGGAAGAGACCCAGTACTTCGGGCCA	CSARDQLAGAELMEETQYF	In	VDJ	1	55	1.5259593428941623E-4	1.720368221358215E-4	57	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	2	3	3	12	24	38	52	41	64		TCRBV20-01,TCRBV20-or09_02												CSARDQLAGAELMEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGGCGGGGACAAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	55	1.5259593428941623E-4		49	unresolved						TCRBJ02	TCRBJ02-06	01	0	0	6	4	5	1	23	39	50	44	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCCAGTTCAGTGCCGGGGAGCTGTTTTTTGGAGAA	CASQFSAGELFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	5	6	0	7	26	-1	38	35	45	TCRBV03,TCRBV09													CASQFSAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAACTGAAGCTTTCTTTGGACAA	CSARGTTEAFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	5	0	0	26	-1	-1	39	44		TCRBV20-01,TCRBV20-or09_02												CSARGTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGGTGGGTGCAGAACACTGAAGCTTTCTTTGGACAA	CASSRWVQNTEAFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	9	1	4	4	18	30	37	34	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRWVQNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCTGGGGGGGCCGGGGATACGCAGTATTTTGGCCCA	CASSPGGAGDTQYF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	9	0	6	3	5	18	30	40	33	45	TCRBV07,TCRBV11													CASSPGGAGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGGGGACTCAGCTKTGTATYTCTGTGCCAGCAGCTCAGGACCGGCGCGTGAGCAGTTCTTCGGGCCA	CASSSGPAREQFF	In	VDJ	1	56	1.5537040582195107E-4	1.7516476435647281E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	4	1	7	9	2	7	22	35	41	37	48	TCRBV07,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGPAREQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCATCAAAGCCGGGGCATATGGCTACACCTTCGGTTCG	CIKAGAYGYTF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	10	7	0	5	8	1	26	30	43	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CIKAGAYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTGACTAGCACGTATGAGCAGTTCTTCGGGCCA	CATSDLTSTYEQFF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	7	8	3	4	24	38	48	41	52		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLTSTYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCACCCTTTCGGCCGGGCGGGGAACTGAAGCTTTCTTTGGACAA	CASTLSAGRGTEAFF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	7	3	5	13	1	18	28	47	41	48	TCRBV07,TCRBV11													CASTLSAGRGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTACCTTGGACAAATTAAGAGACCCAGTACTTCGGGCCA	CASSLPWTN*ETQYF	Stop	VDJ	1	57	1.581448773544859E-4		45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	6	3	7	4	19	31	43	38	47	TCRBV05,TCRBV11													CASSLPWTN*ETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCAATGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSAQWGNTEAFF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	6	2	1	7	0	24	36	-1	43	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAQWGNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGACCGTCTGCTGAAAAACTGTTTTTTGGCAGT	CASSGPSAEKLFF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	39	unresolved						TCRBJ01	TCRBJ01-04	01	5	1	7	7	0	7	24	-1	40	36	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGPSAEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCTTAAAGAGTGGGGGCGCAGAGACCCAGTACTTCGGGCCA	CASLKSGGAETQYF	In	VDJ	1	57	1.581448773544859E-4	1.782927065771241E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	6	0	4	11	2	24	31	48	42	50	TCRBV09,TCRBV21													CASLKSGGAETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCGGGGGACCTAAGCGGTGGACTGTTTTTTGGCAGT	CASSPPGDLSGGLFF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	2	13	3	13	26	39	48	42	61		TCRBV03-01,TCRBV03-02												CASSPPGDLSGGLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTCCTTACCGGCAGACCCCCGTGCCGGCTACACCTTCGGTTCG	CSSLPADPRAGYTF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	9	2	7	8	13	9	26	31	47	44	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSSLPADPRAGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGATACAGGACAGGAATCTAGCACAGATACGCAGTATTTTGGCCCA	CSARDDTGQESSTDTQYF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	4	0	7	5	26	40	54	47	59		TCRBV20-01,TCRBV20-or09_02												CSARDDTGQESSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCACGCGGGTTCGGGACTAGCGGGAGCGAGCAGTACTTCGGGCCG	CSARDSRGFGTSGSEQYF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	0	2	6	13	0	26	40	-1	53	67		TCRBV20-01,TCRBV20-or09_02												CSARDSRGFGTSGSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTATCCGGACAGGGGGCGAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	58	1.6091934888702074E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	0	4	4	1	23	35	50	39	51	TCRBV06,TCRBV24													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGAGGCAGGGGGCGACGAAAAACTGTTTTTTGGCAGT	CASSLEAGGDEKLFF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	0	8	3	3	18	34	45	37	48	TCRBV05,TCRBV07													CASSLEAGGDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGTCAGAAGCCCACATGGCGACAGGACGCAGGGGTATGGCTACACCTTCGGTTCG	CVRSPHGDRTQGYGYTF	In	VDJ	1	58	1.6091934888702074E-4	1.814206487977754E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	5	9	9	18	30	45	39	54	TCRBV07,TCRBV12	TCRBV07-05,TCRBV12-02												CVRSPHGDRTQGYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGAGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPRGENTEAFF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	2	1	4	1	26	39	48	43	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTCAGTTCCCGCGACAGGAGAAACAAGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	59	1.6369382041955558E-4		53	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	4	0	12	11	26	31	49	43	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGCGGAGCCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	59	1.6369382041955558E-4		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	4	1	4	26	39	44	40	48		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGCTCGGGGTTCGAATCAGCCCCAGCATTTTGGTGAT	CASSEARGSNQPQHF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	4	6	4	22	34	45	40	49	TCRBV02,TCRBV12													CASSEARGSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGTGGGGGTACGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	59	1.6369382041955558E-4		46	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	6	1	2	5	4	24	36	46	41	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAAAACAGAACTACGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLKQNYDSNQPQHF	In	VDJ	1	59	1.6369382041955558E-4	1.845485910184267E-4	51	unresolved						TCRBJ01	TCRBJ01-05	01	2	3	5	0	2	8	18	33	39	35	47	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKQNYDSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGGACCTTGGGGCGGGAGAATCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	59	1.6369382041955558E-4		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	2	2	14	3	23	34	55	48	58	TCRBV09,TCRBV12													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCTAAGCGGGAGTCACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGSHTGELFF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	2	3	3	2	36	48	59	51	61	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSLSGSHTGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCGACAGAACAGTGGACTGTATGGCTACACCTTCGGTTCG	CASSRQNSGLYGYTF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	5	2	5	5	1	12	18	30	36	31	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRQNSGLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGTCGGGGGTGGAAACACCATATATTTTGGAGAG	CASSLVGGGNTIYF	In	VDJ	1	60	1.6646829195209043E-4	1.87676533239078E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	2	3	3	0	18	32	-1	35	41	TCRBV07,TCRBV11													CASSLVGGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCAGCCCCCCCGGGCTAGCGGGTCATAACGAGCAGTACTTCGGGCCG	CSARVSPPGLAGHNEQYF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	4	5	14	5	26	39	61	53	66		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVSPPGLAGHNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACCGACAGGGGTATAAAAACATTCAGTACTTCGGCGCC	CSASDRQGYKNIQYF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	2	2	4	5	3	26	37	50	42	53		TCRBV20-01,TCRBV20-or09_02												CSASDRQGYKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGGTTGAGCACAGATACGCAGTATTTTGGCCCA	CASSLGLSTDTQYF	In	VDJ	1	61	1.6924276348462527E-4	1.908044754597293E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	6	2	0	2	3	24	36	42	38	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGTATTACGGGACTAGCGTGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	62	1.7201723501716011E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	6	7	6	3	23	39	55	45	58	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGGGGACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	62	1.7201723501716011E-4		35	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	7	6	0	0	24	-1	-1	37	42	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTGGGATGTCCATTTCATACATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	62	1.7201723501716011E-4		55	TCRBV03						TCRBJ01	TCRBJ01-06	01	5	0	8	5	2	17	26	38	44	40	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCAGGACAGGCGATAGCTCCTACGAGCAGTACTTCGGGCCG	CSAIRTGDSSYEQYF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	0	3	6	26	36	46	39	52		TCRBV20-01,TCRBV20-or09_02												CSAIRTGDSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCGCCAGGGCGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSRQGGVYNEQFF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	3	7	1	23	35	48	42	49	TCRBV06,TCRBV10													CASSRQGGVYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAACGCAGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSENAGSGANVLTF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	4	3	1	4	0	23	38	-1	42	47		TCRBV06-01,TCRBV06-08												CASSENAGSGANVLTF+TCRBV06-X+TCRBJ02-06	TCRBV06	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTTTCAGGGCTTGGGGGCACTGAAGCTTTCTTTGGACAA	CASSFSGLGGTEAFF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	4	4	3	4	3	8	23	36	44	39	52	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSGLGGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAAAGCGCCTGGGGCTAGCGGGACAAGAGACCCAGTACTTCGGGCCA	CASSLKRLGLAGQETQYF	In	VDJ	1	62	1.7201723501716011E-4	1.939324176803806E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	3	2	12	0	18	33	-1	45	54	TCRBV07,TCRBV11													CASSLKRLGLAGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACTCTAAGTCCCATCATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	63	1.7479170654969496E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	3	10	5	0	15	26	-1	41	38	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01	TCRBJ01-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATATGGGGATGGGCTACGAGCAGTACTTCGGGCCG	CSANMGMGYEQYF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	0	8	3	5	4	26	36	45	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANMGMGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGACGGTAATCAGCCCCAGCATTTTGGTGAT	CSATDGNQPQHF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	4	2	7	4	2	3	26	36	41	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATDGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGGGAGCGGGATATTACAGATACGCAGTATTTTGGCCCA	CSARRGERDITDTQYF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	3	3	7	4	26	38	52	45	56		TCRBV20-01,TCRBV20-or09_02												CSARRGERDITDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGCTAGCGGGAGTGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDWASGSASYNEQFF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	2	1	5	4	26	40	55	45	59		TCRBV20-01,TCRBV20-or09_02												CSARDWASGSASYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATATTCCGGGACAGGGGCTACGAGCAGTACTTCGGGCCG	CSAIFRDRGYEQYF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	3	6	0	26	36	-1	42	52		TCRBV20-01,TCRBV20-or09_02												CSAIFRDRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGATCGGTCGGGGTACAAAAACATTCAGTACTTCGGCGCC	CSAPDRSGYKNIQYF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	8	3	3	10	2	26	35	50	45	52		TCRBV20-01,TCRBV20-or09_02												CSAPDRSGYKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTAACTTACGATTCGAAGGTCTACACCTTCGGTTCG	CSALTYDSKVYTF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	5	5	4	10	16	1	26	35	54	51	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALTYDSKVYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGGACTGAGCTCTGGGGTCAACGTCCTGACTTTCGGGGCC	CSAGGLSSGVNVLTF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	45	TCRBV20						TCRBJ02	TCRBJ02-06	01	1	6	2	9	11	1	26	39	54	50	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGGLSSGVNVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCCGGACAGGGGGAGGTTTGAGCAGTTCTTCGGGCCA	CASSQDPDRGRFEQFF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	1	9	3	5	23	40	53	43	58	TCRBV01,TCRBV04													CASSQDPDRGRFEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAGGTTATCGGGAATGAGCAGTTCTTCGGGCCA	CASKVIGNEQFF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	8	4	7	10	0	24	31	-1	41	45		TCRBV24-01,TCRBV24-or09_02				01,02								CASKVIGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCCTGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDPDSGANVLTF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	48							TCRBJ02	TCRBJ02-06	01	0	2	8	0	4	0	18	35	-1	39	41	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPDSGANVLTF+X+TCRBJ02-06			TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCGCCCCGGGGTTCAATGACTATGGCTACACCTTCGGTTCG	CASAPGFNDYGYTF	In	VDJ	1	63	1.7479170654969496E-4	1.970603599010319E-4	42	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	8	3	3	4	7	19	28	37	32	44		TCRBV05-06,TCRBV05-07												CASAPGFNDYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTCTTCTCCTGGACAGGGTCACCCACGGGGAGCTGTTTTTTGGAGAA	CASSQVLLLDRVTHGELFF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	3	7	10	7	24	40	58	50	65		TCRBV03-01,TCRBV03-02												CASSQVLLLDRVTHGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGAGGCCTTGCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGLANTGELFF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	11	1	2	0	7	18	-1	38	34	45	TCRBV07,TCRBV11													CASSLGGLANTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCATCTCTCCTACTCTAGCGGACTTACGCAGTATTTTGGCCCA	CASSHLSYSSGLTQYF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	48	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	8	13	3	19	31	51	44	54		TCRBV05-06,TCRBV05-07				01,02								CASSHLSYSSGLTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TTTCTGTGCCAGCAGCGTAGGCCCGTTCCTGGGACTAGCGGGAGGCGATCACTACAATGAGCAGTTCTTCGGGCCA	CASSVGPFLGLAGGDHYNEQFF	In	VDJ	1	64	1.7756617808222978E-4	2.001883021216832E-4	66	TCRBV21			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	1	3	14	6	4	16	45	30	51		TCRBV21-or09_02,TCRBV21-01												CASSVGPFLGLAGGDHYNEQFF+TCRBV21-X+TCRBJ02-01	TCRBV21	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCTAATTTTCAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSFLIFRGNEQFF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	6	9	0	26	40	-1	49	55		TCRBV12-03,TCRBV12-04												CASSFLIFRGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGGGACACAACCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDGGHNPSTDTQYF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	6	0	3	7	26	43	52	46	59		TCRBV03-01,TCRBV03-02												CASSQDGGHNPSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTACCCCCACCGACCCTTTCTTTGGACAA	CSARVTPTDPFF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	2	7	12	11	1	26	39	53	50	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVTPTDPFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAACAGACTAGACACAGATACGCAGTATTTTGGCCCA	CASNRLDTDTQYF	In	VDJ	1	65	1.8034064961476462E-4	2.033162443423345E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	11	2	8	2	6	1	24	31	43	37	44		TCRBV24-01,TCRBV24-or09_02				01,02								CASNRLDTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	65	1.8034064961476462E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	3	2	0	0	23	-1	-1	35	40	TCRBV06,TCRBV10													X+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGGGGAATGAAGCTTTCTTTGGACAA	CASSRGNEAFF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	7	0	2	26	-1	44	38	46		TCRBV03-01,TCRBV03-02												CASSRGNEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCGAAGTGGGCGGGAGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLRSGREGGTGELFF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	7	0	4	10	3	26	39	58	49	61		TCRBV03-01,TCRBV03-02												CASSLRSGREGGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTTTAGCGGGAGGTGGCTACGAGCAGTACTTCGGGCCG	CSAPLAGGGYEQYF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	1	3	5	3	26	34	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSAPLAGGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCATAAACCCGGGACTAGCGGCTAGAGCTAGGGACGAGCAGTACTTCGGGCCG	CASSINPGLAARARDEQYF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	5	5	8	12	19	31	50	39	62	TCRBV07,TCRBV11					01,02								CASSINPGLAARARDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCCCCGGCTTCCGCTTAGTTTCACTGAAGCTTTCTTTGGACAA	CASSPRLPLSFTEAFF	In	VDJ	1	66	1.8311512114729947E-4	2.064441865629858E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	5	9	0	4	4	13	18	30	37	34	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRLPLSFTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACTGAGGGACAGGCGCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	67	1.858895926798343E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	4	4	4	3	26	41	53	45	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCCGACTAGCGGGAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSFRLAGGQETQYF	In	VDJ	1	67	1.858895926798343E-4	2.0957212878363712E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	0	2	4	0	26	38	-1	42	56		TCRBV03-01,TCRBV03-02												CASSFRLAGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGGGTGACGGGACTAGCGGGAAGCGATGAGCAGTTCTTCGGGCCA	CSARVGVTGLAGSDEQFF	In	VDJ	1	67	1.858895926798343E-4	2.0957212878363712E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	0	3	8	10	4	26	39	62	49	66		TCRBV20-01,TCRBV20-or09_02												CSARVGVTGLAGSDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGTTCACCGCCGGGGCCCCAGCATTTTGGTGAT	CSARRSPPGPQHF	In	VDJ	1	67	1.858895926798343E-4	2.0957212878363712E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	4	9	11	0	26	37	-1	48	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRSPPGPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCCTGGGGGGTTCGAGCAGTTCTTCGGGCCA	CASSFPGGFEQFF	In	VDJ	1	67	1.858895926798343E-4	2.0957212878363712E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	9	1	10	6	3	24	36	48	42	51		TCRBV24-01,TCRBV24-or09_02												CASSFPGGFEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTACTGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSFTGASTDTQYF	In	VDJ	1	67	1.858895926798343E-4	2.0957212878363712E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	7	0	0	6	1	24	36	47	42	48		TCRBV24-01,TCRBV24-or09_02												CASSFTGASTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCYAGCAGCTTAAGGGCAAGTGTTGAGCCCCAGCATTTTGGTGAT	CASSLRASVEPQHF	In	VDJ	1	67	1.858895926798343E-4	2.0957212878363712E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	1	5	3	8	0	9	19	-1	38	34	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRASVEPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGGGGGACTCTCAGCGAAAAACTGTTTTTTGGCAGT	CASSFGGTLSEKLFF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	8	0	9	26	-1	47	40	56		TCRBV12-03,TCRBV12-04												CASSFGGTLSEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTTACGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQELRSNTGELFF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	5	0	4	1	26	43	50	47	51		TCRBV03-01,TCRBV03-02				01,02								CASSQELRSNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGGACAGCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSQDLDSLQETQYF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	1	5	1	3	3	26	43	52	46	55		TCRBV03-01,TCRBV03-02												CASSQDLDSLQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCACCAGGGCTGCCACTGAAGCTTTCTTTGGACAA	CASSQATRAATEAFF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	4	4	4	26	42	51	46	55		TCRBV03-01,TCRBV03-02												CASSQATRAATEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGCCGGGACAGATACAAGAGACCCAGTACTTCGGGCCA	CSAPPGQIQETQYF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	2	6	3	26	34	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSAPPGQIQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGGACAGGGGGGAGTAGGCTACACCTTCGGTTCG	CSAPGQGGVGYTF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	1	8	3	5	26	35	48	38	53		TCRBV20-01,TCRBV20-or09_02												CSAPGQGGVGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTCATCGGACATTGCCCGGCTACACCTTCGGTTCG	CATSDSHRTLPGYTF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	6	8	6	6	24	40	51	46	57		TCRBV24-01,TCRBV24-or09_02												CATSDSHRTLPGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCGGGACAGGGGTACACAGATACGCAGTATTTTGGCCCA	CASSPGQGYTDTQYF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	2	2	2	18	30	42	32	44	TCRBV05,TCRBV11													CASSPGQGYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGTCTAGGCAGTACTCAAGAGACCCAGTACTTCGGGCCA	CASSLGSTQETQYF	In	VDJ	1	68	1.8866406421236915E-4	2.127000710042884E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	8	2	1	8	18	29	34	30	42	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02				01,02								CASSLGSTQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGATACGCAGTATTTTGGCCCA	CASSQGDTQYF	In	VJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	0	0	5	0	1	26	-1	42	-1	43		TCRBV03-01,TCRBV03-02												CASSQGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGAAATCAGCCCCAGCATTTTGGTGAT	CSARDGNQPQHF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	1	8	4	1	0	26	40	-1	41	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTATCGACGGGGGGGAATGTACGAGCAGTACTTCGGGCCG	CSARDYRRGGMYEQYF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	0	4	7	4	26	40	55	47	59		TCRBV20-01,TCRBV20-or09_02												CSARDYRRGGMYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCAAAGCGGGAGGAGTGCCTACGAGCAGTACTTCGGGCCG	CASSQSGRSAYEQYF	In	VDJ	1	69	1.91438535744904E-4	2.1582801322493972E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	1	2	3	4	18	30	42	33	46	TCRBV07,TCRBV11													CASSQSGRSAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTCCTTAACTATGGCTACACCTTCGGTTCG	CSASVLNYGYTF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	4	10	1	4	0	26	37	-1	41	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSASVLNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTCGACCCCGGGACTAGCGGGAGTTGAGCAGTACTTCGGGCCG	CASSSTPGLAGVEQYF	In	VDJ	1	70	1.9421300727743884E-4	2.18955955445591E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	2	7	8	2	24	36	58	44	60	TCRBV06,TCRBV24													CASSSTPGLAGVEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACGGCGGTCTAACTATGGCTACACCTTCGGTTCG	CASSQGRRSNYGYTF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	7	5	0	4	1	26	42	50	46	51		TCRBV03-01,TCRBV03-02				01,02								CASSQGRRSNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCATCGGGACAGGATGAACACTGAAGCTTTCTTTGGACAA	CASSHRDRMNTEAFF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	0	4	1	24	36	48	40	49		TCRBV24-01,TCRBV24-or09_02												CASSHRDRMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAAACCAACAGGGCCTGAAGCTTTCTTTGGACAA	CASKPTGPEAFF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	6	5	1	23	33	44	38	45	TCRBV06,TCRBV10													CASKPTGPEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCGGACAGAATACAATGAGCAGTTCTTCGGGCCA	CASRTEYNEQFF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	1	5	4	1	2	23	32	39	33	41	TCRBV06,TCRBV10													CASRTEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTCGAGGGAGGGGGAGGAAACACCATATATTTTGGAGAG	CASSLEGGGGNTIYF	In	VDJ	1	71	1.9698747880997366E-4	2.2208389766624232E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	9	0	4	5	3	18	30	42	35	45	TCRBV05,TCRBV11													CASSLEGGGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACACCGGGGTCCACTGAAGCTTTCTTTGGACAA	CASSQTPGSTEAFF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	4	4	2	26	41	50	45	52		TCRBV03-01,TCRBV03-02												CASSQTPGSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCCTACTAGCGGGATACTACAATGAGCAGTTCTTCGGGCCA	CSARSLLAGYYNEQFF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	3	3	5	2	26	38	53	43	55		TCRBV20-01,TCRBV20-or09_02												CSARSLLAGYYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGGACAGGGAAGGAGGGGACCTAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	72	1.997619503425085E-4		55	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	0	2	15	26	35	46	37	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTTATGGACTAGCGGGGATGAGCAGTTCTTCGGGCCA	CASSLWTSGDEQFF	In	VDJ	1	72	1.997619503425085E-4	2.252118398868936E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	8	4	0	24	36	-1	40	52	TCRBV09,TCRBV21													CASSLWTSGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCCCAGCTATCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	72	1.997619503425085E-4		40	unresolved						TCRBJ02	TCRBJ02-06	01	10	4	5	1	3	3	24	31	37	34	40	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT	CASHFWHHQPQHF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	9	0	5	7	3	26	35	45	42	48		TCRBV03-01,TCRBV03-02												CASHFWHHQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTCGGCGGGAGGATTACGAGCAGTACTTCGGGCCG	CSARGRREDYEQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	1	4	6	2	26	37	51	43	53		TCRBV20-01,TCRBV20-or09_02												CSARGRREDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCACCCGGGAACGACCTACGAGCAGTACTTCGGGCCG	CASSQDHPGTTYEQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	2	5	4	23	40	50	45	54	TCRBV01,TCRBV04													CASSQDHPGTTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCTCCCCTAGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSSPSGSYNEQFF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	5	0	5	0	24	35	-1	40	47		TCRBV24-01,TCRBV24-or09_02				01,02								CATSSPSGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTCGGGAAAGCACAGATACGCAGTATTTTGGCCCA	CASRESTDTQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	8	3	0	1	1	23	31	37	32	38	TCRBV06,TCRBV10													CASRESTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATACCAGAAGGGGCTAGCGGGAGGGCCAGAGACCCAGTACTTCGGGCCA	CASSQYQKGLAGGPETQYF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	57	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	0	4	12	2	24	39	63	51	65		TCRBV03-01,TCRBV03-02												CASSQYQKGLAGGPETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGAGGGGGACAGGGACCATTGGCTATGGCTACACCTTCGGTTCG	CASSVRGTGTIGYGYTF	In	VDJ	1	73	2.0253642187504335E-4	2.2833978210754492E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	4	4	8	23	37	50	41	58	TCRBV09,TCRBV21													CASSVRGTGTIGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCTACGGGAGGGAACACTGAAGCTTTCTTTGGACAA	CASSVATGGNTEAFF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	1	1	8	0	26	37	-1	45	52	TCRBV09,TCRBV12													CASSVATGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTTTCGGGACAGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	74	2.053108934075782E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	4	5	0	26	37	-1	42	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CSARATGELFF	In	VDJ	1	74	2.053108934075782E-4	2.314677243281962E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	9	0	4	0	0	26	-1	-1	37	40		TCRBV20-01,TCRBV20-or09_02												CSARATGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCAGGAATGTTTTATGAAAAACTGTTTTTTGGCAGT	CASSQDSGMFYEKLFF	In	VDJ	1	75	2.0808536494011304E-4	2.3459566654884752E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	4	6	2	8	26	43	49	45	57		TCRBV03-01,TCRBV03-02												CASSQDSGMFYEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAGAATGGGGGAGGCCTCAAGATACGCAGTATTTTGGCCCA	CSAREWGRPQDTQYF	In	VDJ	1	75	2.0808536494011304E-4	2.3459566654884752E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	1	5	4	5	26	40	50	44	55		TCRBV20-01,TCRBV20-or09_02												CSAREWGRPQDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGACTGGACCTGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSASGDWTWSNQPQHF	In	VDJ	1	75	2.0808536494011304E-4	2.3459566654884752E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	0	10	1	2	8	26	37	45	39	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGDWTWSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCAAAAGGGACAGGTCGAGCAGTACTTCGGGCCG	CASSQKGQVEQYF	In	VDJ	1	75	2.0808536494011304E-4	2.3459566654884752E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	6	6	1	22	33	47	39	48		TCRBV12-03,TCRBV12-04												CASSQKGQVEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTATAGTACAGCTTATGGCTACACCTTCGGTTCG	CASSYSTAYGYTF	In	VDJ	1	76	2.1085983647264788E-4	2.377236087694988E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	5	5	5	2	26	39	48	44	50		TCRBV12-03,TCRBV12-04												CASSYSTAYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCGAGGGGGCTAGCGGACTACGAGCAGTACTTCGGGCCG	CSPRGLADYEQYF	In	VDJ	1	76	2.1085983647264788E-4	2.377236087694988E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	9	5	0	3	4	7	26	31	42	35	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSPRGLADYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGCCCGTGCGGGGATCGTACCCGGGGAGCTGTTTTTTGGAGAA	CASSQEARAGIVPGELFF	In	VDJ	1	76	2.1085983647264788E-4	2.377236087694988E-4	54				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	7	3	6	7	7	18	35	48	42	55	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEARAGIVPGELFF+X+TCRBJ02-02		TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAAACTGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQTGGNQPQHF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	5	6	2	2	6	0	26	38	-1	44	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTGGNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAACCGGGACAGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARTGTVSYNEQFF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	0	6	1	26	35	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSARTGTVSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGTTAGCGGGAGGGCTGGATACAATGAGCAGTTCTTCGGGCCA	CASSFVSGRAGYNEQFF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	0	4	5	5	24	36	52	41	57		TCRBV24-01,TCRBV24-or09_02												CASSFVSGRAGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATAGCGGGCCCACCGGGGAGCTGTTTTTTGGAGAA	CAISDSGPTGELFF	In	VDJ	1	77	2.136343080051827E-4	2.4085155099015011E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	4	4	2	2	23	35	44	37	46	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03				01,02								CAISDSGPTGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACGACAGCCCGGAACACTGAAGCTTTCTTTGGACAA	CASSTTARNTEAFF	In	VDJ	1	78	2.1640877953771754E-4	2.439794932108014E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	1	2	4	26	38	45	40	49		TCRBV12-03,TCRBV12-04												CASSTTARNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGGGGTCCCTACGAGCAGTACTTCGGGCCG	CASSFGGPYEQYF	In	VDJ	1	78	2.1640877953771754E-4	2.439794932108014E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	2	2	2	2	24	36	44	38	46		TCRBV24-01,TCRBV24-or09_02												CASSFGGPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGGGGGCGAGCAGTACTTCGGGCCG	CASSQAGGEQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	6	0	0	26	-1	-1	42	49		TCRBV03-01,TCRBV03-02												CASSQAGGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTGAAACTAGCGGGAGATTTGGGTGGGCAGTTCTTCGGGCCA	CSALKLAGDLGGQFF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	12	6	10	26	34	51	40	61		TCRBV20-01,TCRBV20-or09_02												CSALKLAGDLGGQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATTACCTCGTTGTCGCGTACTTCGGGCCG		Out	VDJ	1	79	2.191832510702524E-4		35	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	3	7	12	3	11	26	38	43	41	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CSARTGDTEAFF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	3	0	0	26	-1	-1	37	45		TCRBV20-01,TCRBV20-or09_02												CSARTGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGGGGCAGGCTACGAGCAGTACTTCGGGCCG	CASSLSGAGYEQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	42							TCRBJ02	TCRBJ02-07	01	6	7	0	3	6	3	24	36	47	42	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGAGYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGGAGTGAAGGACTATGGCTACACCTTCGGTTCG	CASSFGVKDYGYTF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	2	3	3	6	24	36	43	39	49		TCRBV24-01,TCRBV24-or09_02												CASSFGVKDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTGGGACTAGCAGAGCTTCGACCGAGCAGTACTTCGGGCCG	CASSFGTSRASTEQYF	In	VDJ	1	79	2.191832510702524E-4	2.471074354314527E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	7	6	1	11	18	32	42	33	53	TCRBV07,TCRBV11					01,02								CASSFGTSRASTEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAACCGGCGGCGGGCTCTACGAGCAGTACTTCGGGCCG	CASSRTGGGLYEQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	7	4	3	9	2	26	39	53	48	55		TCRBV03-01,TCRBV03-02				01,02								CASSRTGGGLYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTGGCACCTAGGCCCCCCCGGGAGACCCAGTACTTCGGGCCA	CASSLAVAPRPPRETQYF	In	VDJ	1	80	2.2195772260278723E-4	2.50235377652104E-4	54				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	8	5	8	10	18	35	47	43	57	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAVAPRPPRETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTAGCGGGAGGGTGGGAAGAGACCCAGTACTTCGGGCCA	CASSLAGGWEETQYF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	4	0	3	1	4	24	35	48	36	52		TCRBV24-01,TCRBV24-or09_02												CASSLAGGWEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGACCGGGACAGGGACGAGCAGTACTTCGGGCCG	CASRDRDRDEQYF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	5	5	0	24	35	-1	40	49		TCRBV24-01,TCRBV24-or09_02												CASRDRDRDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACGACAGGCTCTGTCTATGGCTACACCTTCGGTTCG	CASTTGSVYGYTF	In	VDJ	1	81	2.2473219413532208E-4	2.533633198727553E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	4	4	1	6	23	33	40	34	46	TCRBV02,TCRBV09													CASTTGSVYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGACTAGCGGGAGGGGTACGCAGTATTTTGGCCCA	CASRTSGRGTQYF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	2	0	8	0	1	26	-1	51	37	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRTSGRGTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGCTAGCGGGAGGGCGCGCGAGCAGTACTTCGGGCCG	CASSRASGRAREQYF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	0	6	3	4	26	39	54	42	58		TCRBV03-01,TCRBV03-02												CASSRASGRAREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGGGCCGGGACCGCGTTCCCAAACATTCAGTACTTCGGCGCC	CASRAGTAFPNIQYF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	45	unresolved						TCRBJ02	TCRBJ02-04	01	6	0	7	6	4	9	18	29	38	33	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAGTAFPNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGGGGTGTGGTTCCCGGACTAGCGGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASRGVVPGLAGGGETQYF	In	VDJ	1	83	2.3028113720039177E-4	2.596192043140579E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	1	0	4	13	2	18	29	57	42	59	TCRBV05,TCRBV11													CASRGVVPGLAGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGTATCGTAGGACTAGCGGGAAGAGAGACCCAGTACTTCGGGCCA	CSAREGIVGLAGRETQYF	In	VDJ	1	84	2.3305560873292658E-4	2.627471465347092E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	1	3	4	10	2	26	40	62	50	64		TCRBV20-01,TCRBV20-or09_02												CSAREGIVGLAGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCACAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSHRGNTGELFF	In	VDJ	1	85	2.3583008026546143E-4	2.6587508875536054E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	1	2	0	26	37	-1	39	46		TCRBV03-01,TCRBV03-02												CASSHRGNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAATATGGCTCCCGCGGGGCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	85	2.3583008026546143E-4		46	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	6	13	2	26	37	56	50	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTTACAGGGACTATGGCTACACCTTCGGTTCG	CSGYRDYGYTF	In	VDJ	1	85	2.3583008026546143E-4	2.6587508875536054E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	3	3	3	0	26	33	-1	36	42		TCRBV20-01,TCRBV20-or09_02												CSGYRDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTATCCGGGATTCTCCTACGAGCAGTACTTCGGGCCG	CASSQDYPGFSYEQYF	In	VDJ	1	85	2.3583008026546143E-4	2.6587508875536054E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	0	5	2	23	40	50	45	52	TCRBV01,TCRBV04													CASSQDYPGFSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGAAGTCAACCTGGGCGGTTGACCATATATTTTGGAGAG		Out	VDJ	1	85	2.3583008026546143E-4		46	unresolved						TCRBJ01	TCRBJ01-03	01	3	8	0	10	11	5	23	37	52	48	57	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCCTGGGGTTATCCCTACGAGCAGTACTTCGGGCCG	CASSSWGYPYEQYF	In	VDJ	1	85	2.3583008026546143E-4	2.6587508875536054E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	4	6	2	2	3	5	18	31	38	34	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWGYPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTACTAGCGGGAGGGAATCGTCCAGATACGCAGTATTTTGGCCCA	CASSLLAGGNRPDTQYF	In	VDJ	1	85	2.3583008026546143E-4	2.6587508875536054E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	0	4	0	7	18	-1	45	33	52	TCRBV07,TCRBV11													CASSLLAGGNRPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCTTAGGCAGGGCGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	85	2.3583008026546143E-4		43							TCRBJ01	TCRBJ01-01	01	1	4	3	3	1	4	18	34	40	35	44	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01			TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATTGGGATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLLGSGANVLTF	In	VDJ	1	86	2.3860455179799627E-4	2.690030309760118E-4	45	unresolved						TCRBJ02	TCRBJ02-06	01	2	0	8	1	2	0	18	33	-1	35	39	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGTATTTCGCAGGGTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVFRRVNTGELFF	In	VDJ	1	86	2.3860455179799627E-4	2.690030309760118E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	2	9	2	18	32	46	41	48	TCRBV07,TCRBV11													CASSLVFRRVNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTAGGCCGGGAGACCCAGTACTTCGGGCCA	CSARDLGRETQYF	In	VDJ	1	87	2.4137902333053112E-4	2.721309731966631E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	8	5	1	5	26	40	45	41	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGTATGAGGGACTAACTGCGAACACTGAAGCTTTCTTTGGACAA	CSARDQYEGLTANTEAFF	In	VDJ	1	87	2.4137902333053112E-4	2.721309731966631E-4	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	0	9	1	9	5	26	40	56	49	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDQYEGLTANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTCGGCGACGCTGAAGCTTTCTTTGGACAA	CSARFGDAEAFF	In	VDJ	1	87	2.4137902333053112E-4	2.721309731966631E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	2	7	6	6	1	26	38	47	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARFGDAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAAGACAGGTTTCGCGAACGAGAACACTGAAGCTTTCTTTGGACAA	CASSHKTGFANENTEAFF	In	VDJ	1	88	2.4415349486306594E-4	2.752589154173144E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	1	3	12	26	40	49	43	61		TCRBV03-01,TCRBV03-02												CASSHKTGFANENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATCGACGGGACTAGCGCCTACAATGAGCAGTTCTTCGGGCCA	CSARDIDGTSAYNEQFF	In	VDJ	1	88	2.4415349486306594E-4	2.752589154173144E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	6	2	7	0	26	40	-1	47	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDIDGTSAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGTAGCGGGCTTGAGCAGTTCTTCGGGCCA	CSASGSGLEQFF	In	VDJ	1	88	2.4415349486306594E-4	2.752589154173144E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	4	9	3	2	26	37	47	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGSGLEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATAATGGGGCAGGAGAGACCCAGTACTTCGGGCCA	CASSQDNGAGETQYF	In	VDJ	1	88	2.4415349486306594E-4	2.752589154173144E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	7	0	4	4	3	23	40	49	44	52	TCRBV01,TCRBV04													CASSQDNGAGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGTGAGTAGGGACACTGAAGCTTTCTTTGGACAA	CASSLVSRDTEAFF	In	VDJ	1	88	2.4415349486306594E-4	2.752589154173144E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	5	3	3	5	0	22	38	-1	43	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSRDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGACCGAACCTCCGGGCCCCCAAAACTGTTTTTTGGCAGT	CASSDRTSGPPKLFF	In	VDJ	1	88	2.4415349486306594E-4	2.752589154173144E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	5	8	0	10	12	4	18	30	46	42	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDRTSGPPKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTTTCCATTGGGCCTAAACGGGGAGACCCAGTACTTCGGGCCA	CSAREFPLGLNGETQYF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	51	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	8	0	5	9	9	26	40	53	49	62		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREFPLGLNGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCGCGGGGACTCTAGGGGACACAGATACGCAGTATTTTGGCCCA	CATAGTLGDTDTQYF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	0	10	2	5	8	23	30	41	35	49	TCRBV06,TCRBV10					01,02								CATAGTLGDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCGGTGGGGCTAGCGGGAGGAATTACAATGAGCAGTTCTTCGGGCCA	CATGGASGRNYNEQFF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	4	1	4	9	3	23	30	50	39	53	TCRBV06,TCRBV10													CATGGASGRNYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCTTTGTCCGGGGAGCTGAAGCTTTCTTTGGACAA	CASSFVRGAEAFF	In	VDJ	1	89	2.469279663956008E-4	2.7838685763796573E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	3	6	7	2	23	34	46	41	48	TCRBV06,TCRBV10					01,02								CASSFVRGAEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGACAGCGCTAGAAGCTTTCTTTGGACAA	CSATTALEAFF	In	VDJ	1	90	2.497024379281356E-4	2.81514799858617E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	8	1	5	26	36	42	37	47		TCRBV20-01,TCRBV20-or09_02												CSATTALEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
YRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTATTTCGGGGCATCGGCCTATCACAGACACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	90	2.497024379281356E-4		58	unresolved						TCRBJ02	TCRBJ02-07	01	5	7	0	3	7	18	23	35	47	42	65	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACGAGGGGTATGAGACCCAGTACTTCGGGCCA	CASSYEGYETQYF	In	VDJ	1	90	2.497024379281356E-4	2.81514799858617E-4	39	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	5	2	5	4	3	24	36	45	40	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYEGYETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTACTGACGGAAATTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	90	2.497024379281356E-4		46	unresolved						TCRBJ02	TCRBJ02-07	01	2	1	8	0	5	4	18	33	41	38	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCACGCCGTTCCCTCTCACAGATACGCAGTATTTTGGCCCA	CASTPFPLTDTQYF	In	VDJ	1	91	2.5247690946067047E-4	2.846427420792683E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	11	3	7	2	2	12	24	31	35	33	47	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPFPLTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTCTCGGGCTTGTGCGGGAGGCCTTCCAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	91	2.5247690946067047E-4		58	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	1	3	11	8	18	32	51	43	59	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGGGACTAGCGGGAGGGCCGCCTACGAGCAGTACTTCGGGCCG	CASSGTSGRAAYEQYF	In	VDJ	1	92	2.552513809932053E-4	2.877706842999196E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	1	0	2	0	3	23	-1	51	36	54	TCRBV09,TCRBV12													CASSGTSGRAAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGGGACTAGCGTCCCCCAGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CSARDLGTSVPQGGYNEQFF	In	VDJ	1	93	2.5802585252574016E-4	2.9089862652057093E-4	60	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	6	3	4	13	15	29	43	33	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGTSVPQGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGACTCCGGGACGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSDSGTVSYEQYF	In	VDJ	1	93	2.5802585252574016E-4	2.9089862652057093E-4	45	TCRBV24						TCRBJ02	TCRBJ02-07	01	4	0	7	0	4	3	24	38	47	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGTVSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAATTGGGGAAAAACTGTTTTTTGGCAGT	CASSLIGEKLFF	In	VDJ	1	93	2.5802585252574016E-4	2.9089862652057093E-4	36	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	0	9	8	6	0	24	36	-1	42	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGTGGGAGCGTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLVGASTGELFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	9	2	4	3	4	26	40	48	43	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLVGASTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACCCCCGGTTCCCACGAGCAGTACTTCGGGCCG	CSARTPGSHEQYF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	1	7	5	2	11	26	34	40	36	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTPGSHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFSNTGELFF	In	VJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	39	TCRBV12						TCRBJ02	TCRBJ02-02	01	3	0	0	0	0	2	22	-1	36	-1	38		TCRBV12-03,TCRBV12-04												CASSFSNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGAAGGACACGATTCTACGAGCAGTACTTCGGGCCG	CASRRTRFYEQYF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	6	3	2	5	24	35	42	37	47	TCRBV24,TCRBV27													CASRRTRFYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGGGGACTAGCGGGTACGAGCAGTACTTCGGGCCG	CASSPGTSGYEQYF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	4	4	3	0	24	36	-1	39	51		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPGTSGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTACTACGGGCGGGGTAAGCGCTACAATGAGCAGTTCTTCGGGCCA	CASSYYGRGKRYNEQFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	3	3	9	6	18	29	44	38	50	TCRBV07,TCRBV11													CASSYYGRGKRYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCAGGCCACGTGGGCGGCACTGAAGCTTTCTTTGGACAA	CASSPGHVGGTEAFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	5	4	4	4	1	12	18	30	35	31	47	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGHVGGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAAGGCCCCTTCGCGTGAAAAACTGTTTTTTGGCAGT	CASKAPSREKLFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	39	unresolved						TCRBJ01	TCRBJ01-04	01	7	5	4	7	0	10	23	-1	36	33	46	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKAPSREKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCCCTTTTCGGGGAAGCGGCCTTGGAGGCGGGGAGCTGTTTTTTGGAGAA	CASSPFRGSGLGGGELFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	6	5	7	13	9	23	34	52	47	61	TCRBV02,TCRBV12					01,02								CASSPFRGSGLGGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAGTCCAGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSESRATNEKLFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	0	3	0	23	37	-1	40	45	TCRBV02,TCRBV09													CASSESRATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCTCAAGGAGTAACACTAATGAAAAACTGTTTTTTGGCAGT	CASRSNTNEKLFF	In	VDJ	1	95	2.6357479559080985E-4	2.971545109618735E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	11	10	2	2	4	4	23	29	37	33	41	TCRBV02,TCRBV12													CASRSNTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCAAATAGGGACAGGGGAGGGGTCACTGAAGCTTTCTTTGGACAA	CATSDPNRDRGGVTEAFF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	4	7	6	24	39	56	46	62		TCRBV24-01,TCRBV24-or09_02												CATSDPNRDRGGVTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTGGGGACAGGGGGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGDRGFSGANVLTF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	11	0	1	0	3	2	24	31	45	34	47		TCRBV24-01,TCRBV24-or09_02												CASGDRGFSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCCCGTTATGAGCAGTTCTTCGGGCCA	CASSLSRYEQFF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	9	8	0	7	23	-1	38	36	45	TCRBV06,TCRBV24,TCRBV27					01,02								CASSLSRYEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCGCGACTAGCGGGATTCGGGGAGCTGTTTTTTGGAGAA	CASSSRLAGFGELFF	In	VDJ	1	96	2.663492671233447E-4	3.002824531825248E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	2	3	7	4	2	24	36	51	40	53	TCRBV09,TCRBV21													CASSSRLAGFGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGTACGAGCAGTACTTCGGGCCG	CSARDRYEQYF	In	VDJ	1	98	2.718982101884144E-4	3.065383376238274E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	5	4	1	0	26	40	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGCCGGGACAGGGGTACACCTACGAGCAGTACTTCGGGCCG	CSARRPGQGYTYEQYF	In	VDJ	1	99	2.746726817209492E-4	3.096662798444787E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	2	5	4	26	38	53	43	57		TCRBV20-01,TCRBV20-or09_02												CSARRPGQGYTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCTGGACAGAGTCCCAAGAGACCCAGTACTTCGGGCCA	CASSSWTESQETQYF	In	VDJ	1	99	2.746726817209492E-4	3.096662798444787E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	5	1	3	4	18	31	40	34	44	TCRBV07,TCRBV11													CASSSWTESQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTAGATAATACTAGCGAAGCCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	99	2.746726817209492E-4		52	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	6	4	9	6	19	31	47	40	53	TCRBV05,TCRBV11					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGCAGCGGGAGGCCCGACGTAGCACAGATACGCAGTATTTTGGCCCA	CASSEQREARRSTDTQYF	In	VDJ	1	99	2.746726817209492E-4	3.096662798444787E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	1	0	2	8	23	37	48	39	56	TCRBV02,TCRBV12													CASSEQREARRSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGATCCGGGACAGGGGTTTTGCTGAAGCTTTCTTTGGACAA	CSAEIRDRGFAEAFF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	6	8	5	26	34	52	42	57		TCRBV20-01,TCRBV20-or09_02												CSAEIRDRGFAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGGACGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDRTGSYNEQFF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	48							TCRBJ02	TCRBJ02-01	01	0	1	7	1	2	4	18	35	41	37	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRTGSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCGCACTAGCGGGAGGCTCAAATGAGCAGTTCTTCGGGCCA	CASSALAGGSNEQFF	In	VDJ	1	100	2.7744715325348407E-4	3.1279422206513004E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	1	7	2	4	18	30	44	32	48	TCRBV07,TCRBV11													CASSALAGGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAAGATTTTTATGGCTACACCTTCGGTTCG	CASSQGQDFYGYTF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	6	5	0	7	26	-1	46	42	53		TCRBV03-01,TCRBV03-02												CASSQGQDFYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGCGGGACAGGGGGCTGTTTTAGTGGGGACAGATACGCAGTATTTTGGCCCA	CRAGQGAVLVGTDTQYF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	0	0	3	3	13	26	31	46	34	59		TCRBV20-01,TCRBV20-or09_02												CRAGQGAVLVGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATGGGAAGGGCCTGAACACTGAAGCTTTCTTTGGACAA	CSAYGKGLNTEAFF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	8	0	3	6	26	35	42	38	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYGKGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATACTAGCGGCCAATACGAGCAGTACTTCGGGCCG	CASSQDTSGQYEQYF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	5	4	1	4	23	40	49	41	53	TCRBV01,TCRBV04					01,02								CASSQDTSGQYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTCAGGGTATGGCTACACCTTCGGTTCG	CATSDLSGYGYTF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	5	1	0	24	42	-1	43	48		TCRBV24-01,TCRBV24-or09_02												CATSDLSGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGTTTAGGGACATCGCCTACGAGCAGTACTTCGGGCCG	CATSGFRDIAYEQYF	In	VDJ	1	101	2.8022162478601886E-4	3.159221642857813E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	2	6	3	24	37	49	43	52		TCRBV24-01,TCRBV24-or09_02												CATSGFRDIAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTCTAGCGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CSARRSSGNTGELFF	In	VDJ	1	102	2.829960963185537E-4	3.190501065064326E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	5	2	4	1	26	38	49	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRSSGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGGACTACCTTTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	102	2.829960963185537E-4		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	1	9	2	3	5	26	37	46	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCGGACAGTGAACTATGGCTACACCTTCGGTTCG	CSAPRTVNYGYTF	In	VDJ	1	103	2.8577056785108855E-4	3.221780487270839E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	2	5	2	26	34	45	39	47		TCRBV20-01,TCRBV20-or09_02												CSAPRTVNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACGGACTAGCGGGACCCCTGAGCACAGATACGCAGTATTTTGGCCCA	CSADGLAGPLSTDTQYF	In	VDJ	1	103	2.8577056785108855E-4	3.221780487270839E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	3	0	4	6	26	34	50	38	56		TCRBV20-01,TCRBV20-or09_02												CSADGLAGPLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAAAGATGATATATGGCTACACCTTCGGTTCG	CSAGKMIYGYTF	In	VDJ	1	103	2.8577056785108855E-4	3.221780487270839E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	5	1	8	5	0	9	26	-1	38	35	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGKMIYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATTCATGAATGGGTCGAACAGATACGCAGTATTTTGGCCCA	CASNS*MGRTDTQYF	Stop	VDJ	1	103	2.8577056785108855E-4		45	TCRBV24						TCRBJ02	TCRBJ02-03	01	11	0	9	3	13	4	24	31	47	44	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNS*MGRTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATACTTGGGGAGTGTTTACAATGAGCAGTTCTTCGGGCCA	CASSLYLGSVYNEQFF	In	VDJ	1	103	2.8577056785108855E-4	3.221780487270839E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	2	4	9	4	24	36	50	45	54		TCRBV24-01,TCRBV24-or09_02												CASSLYLGSVYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGGGGGAGGAATCAGCCCCAGCATTTTGGTGAT	CASSWGGRNQPQHF	In	VDJ	1	104	2.885450393836234E-4	3.2530599094773524E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	9	0	4	0	4	26	-1	46	39	50		TCRBV12-03,TCRBV12-04												CASSWGGRNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTCACCTCCTATTCGCGGGCTACACCTTCGGTTCG	CSASHLLFAGYTF	In	VDJ	1	104	2.885450393836234E-4	3.2530599094773524E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	4	5	8	0	16	26	-1	37	34	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASHLLFAGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCTCCGAGGGGCCTTCCTACGAGCAGTACTTCGGGCCG	CASSQDPSEGPSYEQYF	In	VDJ	1	105	2.9131951091615824E-4	3.284339331683865E-4	51	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	5	2	1	8	3	26	43	56	51	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPSEGPSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCACGGAATGGGGGGCTGGAAACACCATATATTTTGGAGAG	CSAATEWGAGNTIYF	In	VDJ	1	105	2.9131951091615824E-4	3.284339331683865E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	9	1	2	11	0	26	34	-1	45	51		TCRBV20-01,TCRBV20-or09_02												CSAATEWGAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGATAGCGGCAATGAGCAGTTCTTCGGGCCA	CASSLADSGNEQFF	In	VDJ	1	106	2.940939824486931E-4	3.315618753890378E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	5	5	6	3	0	18	35	-1	38	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLADSGNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCTTGAGGGAGACTAGCGGCCTAAAAAGACCCAGTACTTCGGGCCA		Out	VDJ	1	106	2.940939824486931E-4		43	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	11	2	5	6	8	7	23	28	45	36	52	TCRBV09,TCRBV21					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCACAGGTTTCTGGGGAGCTGTTTTTTGGAGAA	CASSSQVSGELFF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	4	8	1	5	26	39	45	40	50		TCRBV12-03,TCRBV12-04												CASSSQVSGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACGACTAGCGGGAGTCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSRRLAGVDTGELFF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	2	2	3	3	3	26	39	54	42	57		TCRBV03-01,TCRBV03-02												CASSRRLAGVDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGAATCCGACAGGGGGTATGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	107	2.968684539812279E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	2	1	5	7	5	26	31	47	38	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTGGACAGATAGAAAATGAAAAACTGTTTTTTGGCAGT	CASSFGQIENEKLFF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	5	5	1	6	18	32	39	33	45	TCRBV07,TCRBV11													CASSFGQIENEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCTAACACAGGGAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTQGGSNQPQHF	In	VDJ	1	107	2.968684539812279E-4	3.346898176096891E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	0	1	9	0	20	31	-1	40	47	TCRBV01,TCRBV23													CASSLTQGGSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCACTAGCGAAGGGCGGCGAGCAGTACTTCGGGCCG	CSASLAKGGEQYF	In	VDJ	1	108	2.9964292551376277E-4	3.3781775983034043E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	6	6	2	8	26	35	44	37	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLAKGGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAACGGGACAGGGTCACTATGGCTACACCTTCGGTTCG	CSARATGQGHYGYTF	In	VDJ	1	109	3.024173970462976E-4	3.409457020509917E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	3	4	2	26	39	52	43	54		TCRBV20-01,TCRBV20-or09_02												CSARATGQGHYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAACTTAACTCGGACCGCTGAAGCTTTCTTTGGACAA	CASSNLTRTAEAFF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	1	7	6	11	2	26	37	52	48	54		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNLTRTAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGGVSNQPQHF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	9	1	1	0	2	26	-1	48	42	50		TCRBV03-01,TCRBV03-02												CASSQGGVSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCGACTAGCGGGATGAATGTCGAGCAGTACTTCGGGCCG	CSPTSGMNVEQYF	In	VDJ	1	110	3.0519186857883246E-4	3.44073644271643E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	2	3	6	2	7	26	32	45	34	52		TCRBV20-01,TCRBV20-or09_02												CSPTSGMNVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCGCCTCCCATCATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	111	3.079663401113673E-4		50	TCRBV03						TCRBJ01	TCRBJ01-06	01	3	4	6	5	9	5	26	40	51	49	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGACTAGCGGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGLAGNTGELFF	In	VDJ	1	111	3.079663401113673E-4	3.472015864922943E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	4	2	0	1	26	-1	49	38	50		TCRBV03-01,TCRBV03-02				01,02								CASSGLAGNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACGGACTAGCGGTTCTCAATGAGCAGTTCTTCGGGCCA	CSAHGLAVLNEQFF	In	VDJ	1	111	3.079663401113673E-4	3.472015864922943E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	5	6	4	4	26	34	48	38	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAHGLAVLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	111	3.079663401113673E-4		37	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	0	10	0	1	1	26	39	42	40	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGGCAGCTACGAGCAGTACTTCGGGCCG	CASSQGGSYEQYF	In	VDJ	1	111	3.079663401113673E-4	3.472015864922943E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	7	0	3	0	2	23	-1	44	39	46	TCRBV01,TCRBV04													CASSQGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCGGGACTAGCGAACTCCGAGCAGTACTTCGGGCCG	CASSQPGLANSEQYF	In	VDJ	1	112	3.1074081164390215E-4	3.5032952871294563E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	6	6	2	5	26	41	53	43	58		TCRBV03-01,TCRBV03-02				01,02								CASSQPGLANSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCTATACGGGACTTCGAGAGACCCAGTACTTCGGGCCA	CASSPYTGLRETQYF	In	VDJ	1	112	3.1074081164390215E-4	3.5032952871294563E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	4	8	3	18	30	44	38	47	TCRBV05,TCRBV11					01,02								CASSPYTGLRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTAGGGAGCGCAGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	113	3.13515283176437E-4		34	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	9	2	6	1	6	26	32	38	33	44		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGGTGCCGACAGCGGAAACTATGGCTACACCTTCGGTTCG	CASSQGGADSGNYGYTF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	51	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	2	5	2	8	4	26	42	55	50	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGADSGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACGAACGCGGGTGGAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSATNAGGDSGANVLTF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	7	4	0	7	6	26	34	46	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSATNAGGDSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTTCCCGGGAGTCTCCTACGAGCAGTACTTCGGGCCG	CASSQDFPGVSYEQYF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	2	0	5	1	18	35	46	40	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDFPGVSYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTGAYTAGCGGGAGGGCCAATGAGCAGTTCTTCGGGCCA	CASSLXSGRANEQFF	In	VDJ	1	114	3.162897547089718E-4	3.565854131542482E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	0	6	3	1	22	36	50	39	51	TCRBV07,TCRBV11													CASSLXSGRANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCGGGGGTCACAGATACGCAGTATTTTGGCCCA	CSARGAGVTDTQYF	In	VDJ	1	115	3.1906422624150663E-4	3.5971335537489954E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	2	2	2	1	26	39	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSARGAGVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTCGGGTTTAATGAGCAGTTCTTCGGGCCA	CSASFGFNEQFF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	4	7	3	3	26	37	44	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSASFGFNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAGACCACCCCGGGACTTCCTACGAGCAGTACTTCGGGCCG	CASSQDHPGTSYEQYF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	10	1	7	0	18	35	-1	42	48	TCRBV04,TCRBV05,TCRBV11					01,02								CASSQDHPGTSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCATGACAGGGTTAGCGACGAGCAGTACTTCGGGCCG	XASSHDRVSDEQYF	In	VDJ	1	117	3.246131693065763E-4	3.659692398162021E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	5	1	6	22	36	44	37	50	TCRBV04,TCRBV07,TCRBV17													XASSHDRVSDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAGGCAGGGGTAGAAAAACTGTTTTTTGGCAGT	CASSQAGVEKLFF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	2	8	5	2	26	37	48	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSQAGVEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGACTAGCGGGAGTTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGLAGVDTGELFF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	0	2	3	0	3	26	-1	54	40	57		TCRBV03-01,TCRBV03-02												CASSQGLAGVDTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGGCCCCGGGACCGCTAACTATGGCTACACCTTCGGTTCG	CSAGPGTANYGYTF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	0	7	0	7	2	26	34	46	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGPGTANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAACCGGGACCAAGACTTCTACGAGCAGTACTTCGGGCCG	CASNRDQDFYEQYF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	7	0	7	3	3	8	19	29	37	32	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNRDQDFYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGAGGGGTAGCGGGAGGTCTTGGTTACGGGGAGCTGTTTTTTGGAGAA	CASRGVAGGLGYGELFF	In	VDJ	1	118	3.2738764083911116E-4	3.690971820368534E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	5	1	7	5	9	23	34	49	39	58	TCRBV02,TCRBV12													CASRGVAGGLGYGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCAGCGGGAGGGCACACGAGCAGTACTTCGGGCCG	CASSPSGRAHEQYF	In	VDJ	1	119	3.30162112371646E-4	3.7222512425750474E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	0	5	3	3	26	38	51	41	54		TCRBV12-03,TCRBV12-04												CASSPSGRAHEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACTCTGGGCTGTTTCGAAAGACCTATGGCTCGGTTCG		Out	VDJ	1	119	3.30162112371646E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	18	6	20	26	35	45	41	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTGGTCGGCGGGAGGGATAGAGAGACCCAGTACTTCGGGCCA	CSARLVGGRDRETQYF	In	VDJ	1	120	3.3293658390418085E-4	3.75353066478156E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	7	0	4	7	4	26	38	54	45	58		TCRBV20-01,TCRBV20-or09_02												CSARLVGGRDRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSPTGGTDTQYF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	0	3	3	0	26	39	-1	42	50		TCRBV03-01,TCRBV03-02												CASSPTGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAAGCAGAAGGGACAGTCGATGGCTACACCTTCGGTTCG	CASSEAEGTVDGYTF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	6	9	3	22	34	50	43	53	TCRBV09,TCRBV12													CASSEAEGTVDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCTCCGTGGGACAGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSVGQGPYEQYF	In	VDJ	1	122	3.3848552696925054E-4	3.816089509194586E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	3	2	5	2	23	32	46	37	48	TCRBV02,TCRBV12													CASSVGQGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACGAATCCGACAGGGCGGTATCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	122	3.3848552696925054E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	4	7	6	23	33	47	40	53	TCRBV02,TCRBV09													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGCGGACAGGGGGCCGAGCAGTACTTCGGGCCG	CASSRGQGAEQYF	In	VDJ	1	123	3.412599985017854E-4	3.8473689314010994E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	0	6	4	0	26	37	-1	41	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRGQGAEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTAAGAGACACGCTCTCTCCTACGACCGAGCAGTACTTCGGGCCG	CSAVRDTLSPTTEQYF	In	VDJ	1	123	3.412599985017854E-4	3.8473689314010994E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	6	6	7	16	26	34	45	41	61		TCRBV20-01,TCRBV20-or09_02												CSAVRDTLSPTTEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCCCGGGGTTGGACACTGAAGCTTTCTTTGGACAA	CSASSPGLDTEAFF	In	VDJ	1	123	3.412599985017854E-4	3.8473689314010994E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	3	5	4	26	37	47	42	51		TCRBV20-01,TCRBV20-or09_02												CSASSPGLDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCGGGACTAGCGATCTACAATGAGCAGTTCTTCGGGCCA	CSASSGLAIYNEQFF	In	VDJ	1	123	3.412599985017854E-4	3.8473689314010994E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	6	3	3	2	26	37	50	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSGLAIYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGAACAGGGTCCGTAGATGAGCAGTTCTTCGGGCCA	CASGTGSVDEQFF	In	VDJ	1	124	3.4403447003432023E-4	3.878648353607612E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	3	3	8	5	7	24	31	42	36	49	TCRBV06,TCRBV10													CASGTGSVDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TATTTCTGTGCCAGCAGCGCGATTTCCCAGGACTAGCTATTTGGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSAISQD*LFGSNTGELFF	Stop	VDJ	1	124	3.4403447003432023E-4		63	TCRBV21			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	7	0	11	9	6	18	37	29	46		TCRBV21-or09_02,TCRBV21-01				01,02								CASSAISQD*LFGSNTGELFF+TCRBV21-X+TCRBJ02-02	TCRBV21	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGTTAGCTAGCGGGAGAACCAATGAGCAGTTCTTCGGGCCA	CSATLASGRTNEQFF	In	VDJ	1	125	3.468089415668551E-4	3.909927775814125E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	6	8	3	26	34	52	42	55		TCRBV20-01,TCRBV20-or09_02												CSATLASGRTNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGGGCGAGTACCGGGGAGCTGTTTTTTGGAGAA	CSARVGASTGELFF	In	VDJ	1	125	3.468089415668551E-4	3.909927775814125E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	6	0	5	1	4	26	39	46	40	50		TCRBV20-01,TCRBV20-or09_02												CSARVGASTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGGTCAACGGGAGACCCAGTACTTCGGGCCA	CSAPGQRETQYF	In	VDJ	1	125	3.468089415668551E-4	3.909927775814125E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	5	5	2	7	26	35	40	37	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPGQRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGTAGCCATTTGACAGGGCTATTTTCGTGGGAGACCCAGTACTTCGGGCCA	CASSHLTGLFSWETQYF	In	VDJ	1	125	3.468089415668551E-4	3.909927775814125E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	5	3	12	23	37	47	40	59	TCRBV01,TCRBV04													CASSHLTGLFSWETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGCGGGCAGGGGGCGGCTTCCGGGGAGCTGTTTTTTGGAGAA	CASRGQGAASGELFF	In	VDJ	1	125	3.468089415668551E-4	3.909927775814125E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	0	6	6	5	18	27	41	33	46	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CASRGQGAASGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTAAACCGGGACTAGCGGGAGGCGATACCGGGGAGCTGTTTTTTGGAGAA	CSASKPGLAGGDTGELFF	In	VDJ	1	129	3.579068276969944E-4	4.035045464640177E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	1	5	9	4	26	34	58	43	62		TCRBV20-01,TCRBV20-or09_02												CSASKPGLAGGDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCGACAGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	129	3.579068276969944E-4		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	5	3	0	26	37	-1	40	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGAGCACGGACTAGCGGGAGGAGTCCAGATACGCAGTATTTTGGCCCA	CATSGARTSGRSPDTQYF	In	VDJ	1	129	3.579068276969944E-4	4.035045464640177E-4	54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	1	4	6	4	24	37	57	43	61		TCRBV24-01,TCRBV24-or09_02												CATSGARTSGRSPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCTCTTTAGCGGGAGCTGTGTATGAGCAGTTCTTCGGGCCA	CASSASLAGAVYEQFF	In	VDJ	1	129	3.579068276969944E-4	4.035045464640177E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	2	8	7	6	24	36	52	43	58	TCRBV09,TCRBV21													CASSASLAGAVYEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTATGGAGTTTATCGGGAGGGTGTAGACGAGCAGTTCTTCGGGCCA	CSAYGVYREGVDEQFF	In	VDJ	1	131	3.634557707620641E-4	4.0976043090532033E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	10	13	7	26	34	55	47	62		TCRBV20-01,TCRBV20-or09_02												CSAYGVYREGVDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACTAGCGGGAAAACCTACGAGCAGTACTTCGGGCCG	CSASTSGKTYEQYF	In	VDJ	1	131	3.634557707620641E-4	4.0976043090532033E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	3	3	2	1	3	26	37	48	38	51		TCRBV20-01,TCRBV20-or09_02												CSASTSGKTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACCCTCTCGGGGGACAGGTACAATGAGCAGTTCTTCGGGCCA	CASTLSGDRYNEQFF	In	VDJ	1	132	3.6623024229459893E-4	4.128883731259716E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	4	4	9	0	23	33	-1	42	50	TCRBV02,TCRBV09													CASTLSGDRYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGGGCGGGAGGTCCACGAGCAGTACTTCGGGCCG	CSARDEGREVHEQYF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	1	5	6	3	26	40	54	46	57		TCRBV20-01,TCRBV20-or09_02												CSARDEGREVHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAAGTCGAGGACGGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASKSRTVSSYNEQFF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	48	unresolved						TCRBJ02	TCRBJ02-01	01	7	1	7	0	6	6	23	33	43	39	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKSRTVSSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGGAGCGGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGSGTSTDTQYF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	5	0	4	4	18	32	41	36	45	TCRBV07,TCRBV11					01,02								CASSLGSGTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGTAGCGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGVAGYTGELFF	In	VDJ	1	133	3.690047138271338E-4	4.160163153466229E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	5	3	3	3	1	23	39	50	42	51	TCRBV09,TCRBV21													CASSVGVAGYTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAAGGGTAGCTCCCGCACCGGGGAGCTGTTTTTTGGAGAA	CSASKGSSRTGELFF	In	VDJ	1	134	3.717791853596686E-4	4.1914425756727424E-4	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	3	5	3	4	2	9	26	37	43	39	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASKGSSRTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGGCCRTGTATSKCTGTGCCAGCAGCTTGGAGTACAGCAAGATCGTACAACTCATCATCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	134	3.717791853596686E-4		67	unresolved						TCRBJ01	TCRBJ01-03	01	3	3	5	0	5	22	14	28	37	33	59	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGCTATACGAGCAGTTCTTCGGGCCA	CSARDELYEQFF	In	VDJ	1	135	3.7455365689220346E-4	4.2227219978792553E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	9	10	4	3	26	40	47	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDELYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGGATACAGGGGGCGTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	136	3.773281284247383E-4		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	3	0	3	6	1	26	43	58	49	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGGGCGGAGGCAGATACGCAGTATTTTGGCCCA	CSAREGAEADTQYF	In	VDJ	1	136	3.773281284247383E-4	4.254001420085768E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	4	0	5	26	-1	46	40	51		TCRBV20-01,TCRBV20-or09_02												CSAREGAEADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTTACCGGGACCAGGGGTTGGCTTGGGGGCACAATGAGCAGTTCTTCGGGCCA	CASSLVYRDQGLAWGHNEQFF	In	VDJ	1	136	3.773281284247383E-4	4.254001420085768E-4	63				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	5	13	13	18	32	51	45	64	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												CASSLVYRDQGLAWGHNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCCCTCTAACTAGCGGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSSPLTSGTSTDTQYF	In	VDJ	1	137	3.8010259995727315E-4	4.285280842292281E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	5	0	8	4	18	31	47	39	51	TCRBV05,TCRBV11					01,02								CASSSPLTSGTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTATCCGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSQDYPGPYEQYF	In	VDJ	1	138	3.82877071489808E-4	4.3165602644987944E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	0	8	0	2	6	1	23	40	50	46	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDYPGPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCAATATGGTCCGGGGACTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSNMVRGLAGGETQYF	In	VDJ	1	138	3.82877071489808E-4	4.3165602644987944E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	1	4	11	0	18	30	-1	41	56	TCRBV05,TCRBV11													CASSNMVRGLAGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGATGTGGGGGACGACTGAAGCTTTCTTTGGACAA	CASSQMWGTTEAFF	In	VDJ	1	140	3.884260145548777E-4	4.37911910891182E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	3	0	7	5	7	1	26	40	52	47	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQMWGTTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGAGAGGGAGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSEREGAYNEQFF	In	VDJ	1	140	3.884260145548777E-4	4.37911910891182E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	9	0	2	3	2	26	33	43	36	45		TCRBV20-01,TCRBV20-or09_02												CSEREGAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCCCAGTCTAGATGAGCAGTTCTTCGGGCCA	CSATPSLDEQFF	In	VDJ	1	140	3.884260145548777E-4	4.37911910891182E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	8	8	8	0	26	36	-1	44	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSATPSLDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCAGGCTTGGGGGTCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSESGLGVLQETQYF	In	VDJ	1	140	3.884260145548777E-4	4.37911910891182E-4	51	TCRBV06						TCRBJ02	TCRBJ02-05	01	2	6	1	1	8	4	23	38	51	46	55		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESGLGVLQETQYF+TCRBV06-X+TCRBJ02-05	TCRBV06		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGGGCGGACAGGCGATGAAAAACTGTTTTTTGGCAGT	CASSLGRTGDEKLFF	In	VDJ	1	141	3.912004860874125E-4	4.410398531118333E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	4	6	3	2	18	34	44	37	46	TCRBV05,TCRBV07													CASSLGRTGDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGCACCGACTACGAGCAGTACTTCGGGCCG	CASSQRTDYEQYF	In	VDJ	1	142	3.939749576199473E-4	4.4416779533248464E-4	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	2	2	8	3	6	0	26	41	-1	47	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRTDYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGACAGTGTCGTGGACTGAAGCTTTCTTTGGACAA	CASSPTVSWTEAFF	In	VDJ	1	143	3.9674942915248217E-4	4.472957375531359E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	5	1	8	26	39	45	40	53		TCRBV03-01,TCRBV03-02												CASSPTVSWTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGAGTCACCCCCGATGCGGTTCTTCGGGCCA		Out	VDJ	1	144	3.99523900685017E-4		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	6	15	17	0	24	38	-1	55	58	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGACGCCTACGAGCAGTACTTCGGGCCG	CSARVDAYEQYF	In	VDJ	1	144	3.99523900685017E-4	4.504236797737872E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	1	7	2	1	1	26	39	44	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVDAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGCCTAGCGGGAGGTGATGGTGAGCAGTTCTTCGGGCCA	CASSSLAGGDGEQFF	In	VDJ	1	144	3.99523900685017E-4	4.504236797737872E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	1	9	3	6	24	36	50	39	56		TCRBV24-01,TCRBV24-or09_02												CASSSLAGGDGEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGAAAGCAGTATGAACACTGAAGCTTTCTTTGGACAA	CASSLESSMNTEAFF	In	VDJ	1	144	3.99523900685017E-4	4.504236797737872E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	3	1	8	0	0	8	18	-1	35	32	43	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLESSMNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGGACAGTAGCACAGATACGCAGTATTTTGGCCCA	CASSPDSSTDTQYF	In	VDJ	1	145	4.0229837221755185E-4	4.535516219944385E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	5	0	1	1	23	36	43	37	44	TCRBV01,TCRBV04													CASSPDSSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGTGCCGGGATTAGGACAGATACGCAGTATTTTGGCCCA	CASSLGAGIRTDTQYF	In	VDJ	1	146	4.050728437500867E-4	4.5667956421508983E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	3	3	6	5	18	32	43	38	48	TCRBV07,TCRBV11													CASSLGAGIRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGAGGGGGCGGGTGAAAAACTGTTTTTTGGCAGT	CASSQDEGAGEKLFF	In	VDJ	1	147	4.0784731528262154E-4	4.598075064357411E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	0	7	2	3	23	40	49	42	52	TCRBV01,TCRBV04													CASSQDEGAGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAAAGGGATTGATGAAAAACTGTTTTTTGGCAGT	CASKGIDEKLFF	In	VDJ	1	148	4.106217868151564E-4	4.629354486563924E-4	36	unresolved						TCRBJ01	TCRBJ01-04	01	7	0	8	6	2	3	23	33	39	35	42	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKGIDEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCCCGGAGAGAGGGAACGAGCAGTACTTCGGGCCG	CASSPPERGNEQYF	In	VDJ	1	149	4.1339625834769123E-4	4.6606339087704374E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	5	9	1	23	36	50	45	51	TCRBV01,TCRBV04													CASSPPERGNEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTTGCGTCTAAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSATLRLSSGANVLTF	In	VDJ	1	150	4.161707298802261E-4	4.6919133309769503E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	4	9	0	8	2	26	36	47	44	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSATLRLSSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGACAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	150	4.161707298802261E-4		40	TCRBV24						TCRBJ01	TCRBJ01-05	01	2	2	7	1	0	0	24	-1	-1	40	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTAGGACTAGCACAATCGAGCAGTACTTCGGGCCG	CSARGRTSTIEQYF	In	VDJ	1	151	4.189452014127609E-4	4.723192753183463E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	7	6	5	5	26	37	50	42	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGRTSTIEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGAGAGGAAAGGACTAGCGGGAGTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	152	4.2171967294529577E-4		49	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	2	7	12	1	26	34	59	46	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCGGGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CATSDPGTGSYEQYF	In	VDJ	1	153	4.244941444778306E-4	4.7857515975964894E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	1	3	0	24	39	-1	42	51		TCRBV24-01,TCRBV24-or09_02												CATSDPGTGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAAACAGGGGAAGATACGCAGTATTTTGGCCCA	CSARKTGEDTQYF	In	VDJ	1	154	4.272686160103654E-4	4.8170310198030023E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	2	5	4	1	26	37	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSARKTGEDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGGAGGGGAGTTGGCCAGATACGCAGTATTTTGGCCCA	CASSWEGSWPDTQYF	In	VDJ	1	154	4.272686160103654E-4	4.8170310198030023E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	0	4	1	8	24	36	44	37	52		TCRBV24-01,TCRBV24-or09_02												CASSWEGSWPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCCTCCCAGCGGACCTGGATCTTAGCGAGCAGTACTTCGGGCCG	CASLPADLDLSEQYF	In	VDJ	1	154	4.272686160103654E-4	4.8170310198030023E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	6	5	6	5	13	23	32	42	37	55	TCRBV09,TCRBV12					01,02								CASLPADLDLSEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACAGGTTTCACTGAAGCTTTCTTTGGACAA	CSARTGFTEAFF	In	VDJ	1	155	4.3004308754290025E-4	4.848310442009515E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	4	4	0	3	26	-1	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSARTGFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGTCGCCAGGGGGAAGCTACGAGCAGTACTTCGGGCCG	CASSQESPGGSYEQYF	In	VDJ	1	156	4.328175590754351E-4	4.879589864216028E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	3	5	3	18	35	47	40	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQESPGGSYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACCTTAGCGGGAGGGAGTACTCCTACGAGCAGTACTTCGGGCCG	CSADLSGREYSYEQYF	In	VDJ	1	157	4.3559203060796993E-4	4.910869286422541E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	0	0	5	4	26	35	51	40	55		TCRBV20-01,TCRBV20-or09_02												CSADLSGREYSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTCCCCAGCGGGCGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSPAGGSGANVLTF	In	VDJ	2	158	4.383665021405048E-4	4.942148708629054E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	4	6	4	0	5	3	23	35	46	40	49	TCRBV09,TCRBV12					01,02								CASSSPAGGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGGGGTGAACTCGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CARRGELASYNEQFF	In	VDJ	2	160	4.4391544520557447E-4	5.00470755304208E-4	45							TCRBJ02	TCRBJ02-01	01	5	0	9	0	0	9	18	-1	32	29	41	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARRGELASYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGTGAAGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	161	4.466899167381093E-4		41	TCRBV24						TCRBJ01	TCRBJ01-01	01	1	2	8	3	3	2	24	41	46	44	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGGATAAACAGGGTGGAGACCCAGTACTTCGGGCCA	CASRINRVETQYF	In	VDJ	2	161	4.466899167381093E-4	5.035986975248593E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	5	5	2	23	34	45	39	47	TCRBV09,TCRBV12													CASRINRVETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATAATCGCTCCCATTTGCAGAAAAAACATTCAGTACTTCGGCGCC	CASSIIAPICRKNIQYF	In	VDJ	2	162	4.4946438827064416E-4	5.067266397455106E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	5	4	17	1	26	38	58	55	59		TCRBV03-01,TCRBV03-02												CASSIIAPICRKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGCAGATATGAACACTGAAGCTTTCTTTGGACAA	CSARRADMNTEAFF	In	VDJ	2	162	4.4946438827064416E-4	5.067266397455106E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	8	0	0	1	5	26	38	43	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRADMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTATAGGGGACAGTCAGCCCCAGCATTTTGGTGAT	CSARDLIGDSQPQHF	In	VDJ	2	163	4.52238859803179E-4	5.098545819661619E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	5	6	8	0	26	40	-1	48	55		TCRBV20-01,TCRBV20-or09_02												CSARDLIGDSQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CSARGTGDTEAFF	In	VDJ	2	163	4.52238859803179E-4	5.098545819661619E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	2	3	0	0	26	-1	-1	39	48		TCRBV20-01,TCRBV20-or09_02												CSARGTGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCAACCCGGGACGACGAATGAAAAACTGTTTTTTGGCAGT	CASSQPGTTNEKLFF	In	VDJ	2	163	4.52238859803179E-4	5.098545819661619E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	2	0	7	5	3	4	23	38	46	41	50	TCRBV04,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGTTNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCTGGGGCTAGCGGGAAAGAGACCCAGTACTTCGGGCCA	CASSPGASGKETQYF	In	VDJ	2	163	4.52238859803179E-4	5.098545819661619E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	3	3	7	0	18	30	-1	37	46	TCRBV07,TCRBV11													CASSPGASGKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGTACAAGTAACAATCAGCCCCAGCATTTTGGTGAT	CASSRTSNNQPQHF	In	VDJ	2	164	4.5501333133571385E-4	5.129825241868132E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	6	3	4	5	26	37	44	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRTSNNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGATTTGCTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSQGFASGSYEQYF	In	VDJ	2	164	4.5501333133571385E-4	5.129825241868132E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	2	3	6	0	26	42	-1	48	58		TCRBV03-01,TCRBV03-02												CASSQGFASGSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MCCARCCARACAGCTYTKTACTTCTGTGCCAGCAGTTTCCTGTCTAGCGGGAGCTTATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFLSSGSLSGANVLTF	In	VDJ	2	164	4.5501333133571385E-4	5.129825241868132E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	4	2	1	7	4	24	36	53	43	57	TCRBV22,TCRBV24													CASSFLSSGSLSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTGGTGGCGGGACTACAATGAGCAGTTCTTCGGGCCA	CSARWWRDYNEQFF	In	VDJ	2	165	4.577878028682487E-4	5.161104664074645E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	3	3	6	0	26	37	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSARWWRDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCAAAATCCCATTCAAAGAAAAAACATTCAGTACTTCGGCGCC	CASSRQNPIQRKNIQYF	In	VDJ	2	167	4.633367459333183E-4	5.223663508487672E-4	51	TCRBV03						TCRBJ02	TCRBJ02-04	01	4	2	8	4	18	0	26	39	-1	57	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRQNPIQRKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACATCTACAATCAGCCCCAGCATTTTGGTGAT	CSAYIYNQPQHF	In	VDJ	2	168	4.6611121746585317E-4	5.254942930694184E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	5	3	6	3	1	4	26	35	39	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYIYNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGACAGTATACAATGAGCAGTTCTTCGGGCCA	CSAPTVYNEQFF	In	VDJ	2	169	4.68885688998388E-4	5.286222352900697E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	5	4	2	2	26	35	42	37	44		TCRBV20-01,TCRBV20-or09_02												CSAPTVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGGTGACCGGGGAGCTGTTTTTTGGAGAA	CASSLVTGELFF	In	VDJ	2	169	4.68885688998388E-4	5.286222352900697E-4	36	unresolved						TCRBJ02	TCRBJ02-02	01	6	0	10	5	2	2	24	36	40	38	42	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCTCACGGTGGCAGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASRWQGMNTEAFF	In	VDJ	2	169	4.68885688998388E-4	5.286222352900697E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	4	2	0	9	1	24	30	45	39	46		TCRBV24-01,TCRBV24-or09_02												CASRWQGMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTGGGACTAGCGGGAGTAGCGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLVGLAGVARTGELFF	In	VDJ	2	170	4.7166016053092286E-4	5.317501775107211E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	0	2	5	1	8	18	34	49	35	57	TCRBV07,TCRBV11													CASSLVGLAGVARTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCATACCGACAGGGGTCACACTGAAGCTTTCTTTGGACAA	CSAHTDRGHTEAFF	In	VDJ	2	171	4.744346320634577E-4	5.348781197313723E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	3	6	2	26	35	49	41	51		TCRBV20-01,TCRBV20-or09_02												CSAHTDRGHTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTCCGTTGGTGGGGCCAACGTCCTGACTTTCGGGGCC	CSSVGGANVLTF	In	VDJ	2	173	4.799835751285274E-4	5.411340041726749E-4	36	TCRBV20						TCRBJ02	TCRBJ02-06	01	9	0	10	3	7	0	26	31	-1	38	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSSVGGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGACTGAACACTGAAGCTTTCTTTGGACAA	CSARDRGLNTEAFF	In	VDJ	2	175	4.855325181935971E-4	5.473898886139776E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	0	7	0	3	0	26	40	-1	43	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACATCCGGGACACATTACGAGCAGTACTTCGGGCCG	CASTSGTHYEQYF	In	VDJ	2	175	4.855325181935971E-4	5.473898886139776E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	0	6	4	8	3	24	31	45	39	48		TCRBV24-01,TCRBV24-or09_02												CASTSGTHYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQISSYEQYF	In	VDJ	2	177	4.910814612586668E-4	5.536457730552801E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	5	0	2	0	26	41	-1	43	46		TCRBV03-01,TCRBV03-02												CASSQISSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAGGGACTAGCGGGCTACGAGCAGTACTTCGGGCCG	CSAEGLAGYEQYF	In	VDJ	2	178	4.938559327912016E-4	5.567737152759315E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	4	3	3	0	26	34	-1	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEGLAGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAAGGAACTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASKELATNEKLFF	In	VDJ	2	178	4.938559327912016E-4	5.567737152759315E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	7	1	8	0	1	5	23	33	37	34	42	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKELATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGGACGGCATTTAACTATGGCTACACCTTCGGTTCG	CASSPGTAFNYGYTF	In	VDJ	2	179	4.966304043237365E-4	5.599016574965827E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	0	7	1	2	6	26	39	46	41	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTAFNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGGGATCTCACAATGAGCAGTTCTTCGGGCCA	CSARGQGSHNEQFF	In	VDJ	2	181	5.021793473888061E-4	5.661575419378854E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	3	5	0	5	26	-1	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGQGSHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCACCCCGGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASTPDLAKNIQYF	In	VDJ	2	182	5.049538189213409E-4	5.692854841585366E-4	42	unresolved						TCRBJ02	TCRBJ02-04	01	11	1	8	0	7	3	24	31	41	38	44	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPDLAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGCGGGAACCTCTATGGCTACACCTTCGGTTCG	CASSLSGNLYGYTF	In	VDJ	2	182	5.049538189213409E-4	5.692854841585366E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	6	3	4	3	4	24	36	46	39	50		TCRBV24-01,TCRBV24-or09_02												CASSLSGNLYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAGATTGGGCGGGAGGGTGACGAGCAGTACTTCGGGCCG	CASSEIGREGDEQYF	In	VDJ	2	184	5.105027619864106E-4	5.755413685998392E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	5	8	2	24	36	53	44	55	TCRBV09,TCRBV21													CASSEIGREGDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTAACTAGCGGGAGACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	185	5.132772335189455E-4		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	2	0	3	1	26	36	50	39	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGAGCGGAGTCAGAGACCCAGTACTTCGGGCCA	CSARAGAESETQYF	In	VDJ	2	185	5.132772335189455E-4	5.786693108204905E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	2	4	0	7	26	-1	45	39	52		TCRBV20-01,TCRBV20-or09_02												CSARAGAESETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTCTCCGGGACCCTACGAGCAGTACTTCGGGCCG	CASSQDSPGPYEQYF	In	VDJ	2	187	5.188261765840151E-4	5.849251952617931E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	0	0	7	2	6	0	23	40	-1	46	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSPGPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCTAACCAGGAGCTATGGCTACACCTTCGGTTCG	CASSLTRSYGYTF	In	VDJ	2	190	5.271495911816197E-4	5.94309021923747E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	7	4	4	4	6	2	24	35	45	41	47	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTRSYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTCGGGGTTTTGTGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSFRGFVGGETQYF	In	VDJ	2	192	5.326985342466894E-4	6.005649063650496E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	9	1	4	12	0	19	33	-1	45	51	TCRBV05,TCRBV11													CASSFRGFVGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCGGGACCGGCAACTATGGCTACACCTTCGGTTCG	CSARGTGNYGYTF	In	VDJ	2	194	5.382474773117591E-4	6.068207908063523E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	7	3	2	2	5	26	34	42	36	47		TCRBV20-01,TCRBV20-or09_02												CSARGTGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCAAAGGGGAATGAGCAGTTCTTCGGGCCA	CSASKGNEQFF	In	VDJ	2	194	5.382474773117591E-4	6.068207908063523E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	7	4	0	26	35	-1	39	44		TCRBV20-01,TCRBV20-or09_02												CSASKGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCGGGGAGCGCTCCAAGAGACCCAGTACTTCGGGCCA	CASSHRGALQETQYF	In	VDJ	2	195	5.410219488442939E-4	6.099487330270035E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	3	1	1	6	26	40	46	41	52		TCRBV03-01,TCRBV03-02				01,02								CASSHRGALQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGTCAACGGGACTAGCGGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	195	5.410219488442939E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	4	1	0	23	38	-1	39	52	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTGGCGGGGGATTACAATGAGCAGTTCTTCGGGCCA	CSARLAGDYNEQFF	In	VDJ	2	196	5.437964203768288E-4	6.130766752476548E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	2	4	3	2	26	38	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSARLAGDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCGAAGAATATACCAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	196	5.437964203768288E-4		55	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	14	5	24	37	54	51	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTTCTCAAGAGACGGATCCTACGAGCAGTACTTCGGGCCG	CASSFSRDGSYEQYF	In	VDJ	2	196	5.437964203768288E-4	6.130766752476548E-4	45	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	1	8	1	13	0	24	35	-1	48	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSRDGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTAGCGGGAGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	197	5.465708919093636E-4		50	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	3	5	0	0	0	0	26	-1	-1	40	51		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAGACCCCGGTAGAGGAAAAACTGTTTTTTGGCAGT	CSAKTPVEEKLFF	In	VDJ	2	197	5.465708919093636E-4	6.162046174683062E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	2	7	8	3	10	26	34	40	37	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKTPVEEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTAATTCCCTTGCTTCTAAGACAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	199	5.521198349744332E-4		59	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	1	19	0	22	36	-1	55	62		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTTGCAGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLAGGSNQPQHF	In	VDJ	2	204	5.659921926371074E-4	6.381002130128652E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	1	0	3	0	23	36	-1	39	46	TCRBV01,TCRBV04													CASSLAGGSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCTAGCGGGAGGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	204	5.659921926371074E-4		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	0	2	1	1	24	39	52	40	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTAGGGGCGGGCAACTCTGGAAACACCATATATTTTGGAGAG	CASSPLGAGNSGNTIYF	In	VDJ	2	206	5.715411357021771E-4	6.443560974541678E-4	51	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	5	2	0	4	7	26	39	48	43	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGAGNSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCCCCGACAGGAGCTCAGCTCTGGAAACACCATATATTTTGGAGAG	CSAPPRQELSSGNTIYF	In	VDJ	2	207	5.74315607234712E-4	6.474840396748191E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	4	0	8	7	26	34	48	42	55		TCRBV20-01,TCRBV20-or09_02												CSAPPRQELSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGTCGGGTACTGAAGCTTTCTTTGGACAA	CSARDPSGTEAFF	In	VDJ	2	207	5.74315607234712E-4	6.474840396748191E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	5	5	1	26	40	49	45	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPSGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCATCGCCGGGATCCCTACCTACGAGCAGTACTTCGGGCCG	CSARSIAGIPTYEQYF	In	VDJ	2	209	5.798645502997817E-4	6.537399241161217E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	3	2	8	6	26	38	51	46	57		TCRBV20-01,TCRBV20-or09_02												CSARSIAGIPTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTCGTCTAGCGGGAACCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDSSSGNLNTGELFF	In	VDJ	2	210	5.826390218323165E-4	6.56867866336773E-4	57				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	4	3	1	5	4	18	35	49	40	53	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDSSSGNLNTGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCAGTCCAGGGAAAGACCCAGTACTTCGGGCCA	CSARDSVQGKTQYF	In	VDJ	2	219	6.0760926562513E-4	6.850193463226348E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	6	7	2	26	40	52	47	54		TCRBV20-01,TCRBV20-or09_02												CSARDSVQGKTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTAGAACCGGGCCAAACTCTGGAAACACCATATATTTTGGAGAG	CASSRRTGPNSGNTIYF	In	VDJ	2	223	6.187071517552694E-4	6.975311152052399E-4	51	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	8	0	0	8	4	26	39	51	47	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRTGPNSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCAGGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CASSPGTSGYEQYF	In	VDJ	2	224	6.214816232878043E-4	7.006590574258913E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	5	3	4	0	24	35	-1	39	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPGTSGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTGAAGACTAGCGGGATAACCCAAGAGACCCAGTACTTCGGGCCA	CSALKTSGITQETQYF	In	VDJ	2	228	6.325795094179436E-4	7.131708263084964E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	3	1	6	4	26	34	51	40	55		TCRBV20-01,TCRBV20-or09_02												CSALKTSGITQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTGGTTCCGTCCGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSFGSVRAGELFF	In	VDJ	2	228	6.325795094179436E-4	7.131708263084964E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	6	10	0	19	33	-1	43	47	TCRBV05,TCRBV11					01,02								CASSFGSVRAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCGAACGTAGCGGGAGGGCCCGGATACGCAGTATTTTGGCCCA		Out	VDJ	2	229	6.353539809504785E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	0	6	7	4	24	36	54	43	58	TCRBV09,TCRBV21													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAAACTCCGGGACAGGGAGCTACAGATACGCAGTATTTTGGCCCA	CASSLETPGQGATDTQYF	In	VDJ	2	230	6.381284524830133E-4	7.194267107497991E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	3	7	4	26	42	58	49	62		TCRBV12-03,TCRBV12-04												CASSLETPGQGATDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCCCCTAAACTTTACACCGGGGCGAAGCTTTCTTTGGACAA	CASP*TLHRGEAFF	Stop	VDJ	2	231	6.409029240155482E-4		42	unresolved						TCRBJ01	TCRBJ01-01	01	8	7	0	8	16	0	18	27	-1	43	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASP*TLHRGEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTATTTGATGGGACAATTCTTCGGGCCA	CASSQDYLMGQFF	In	VDJ	2	232	6.436773955480829E-4	7.256825951911017E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	6	16	9	1	26	43	58	52	59		TCRBV03-01,TCRBV03-02												CASSQDYLMGQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAACCGGGACACATCCCTGGCTGCCTACAATGAGCAGTTCTTCGGGCCA	CSANRDTSLAAYNEQFF	In	VDJ	2	232	6.436773955480829E-4	7.256825951911017E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	2	5	12	26	34	45	39	57		TCRBV20-01,TCRBV20-or09_02												CSANRDTSLAAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCAGGCAGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSQDQAGGNEKLFF	In	VDJ	2	234	6.492263386131526E-4	7.319384796324042E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	1	4	5	0	18	35	-1	40	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDQAGGNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTTGGGGAACCCAAGAGACCCAGTACTTCGGGCCA	CASSQGWGTQETQYF	In	VDJ	2	237	6.575497532107572E-4	7.413223062943581E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	1	0	8	1	4	2	23	39	47	43	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGWGTQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCAGTTCGGGACCCTCAACTACAATGAGCAGTTCTTCGGGCCA	CATSQFGTLNYNEQFF	In	VDJ	2	238	6.60324224743292E-4	7.444502485150095E-4	48	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	0	7	3	6	6	24	36	47	42	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSQFGTLNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCCCCGGGGCAGGGAAAGAGACCCAGTACTTCGGGCCA	CSATPGAGKETQYF	In	VDJ	2	240	6.658731678083617E-4	7.50706132956312E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	6	4	3	3	11	1	26	34	50	45	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPGAGKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTGTCCGGGCCTATCGTGAAGCTTTCTTTGGACAA	CATSVVRAYREAFF	In	VDJ	2	240	6.658731678083617E-4	7.50706132956312E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	5	8	0	7	6	6	24	37	47	43	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSVVRAYREAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCCGGACTAGCGGGGGGCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	241	6.686476393408965E-4		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	1	4	2	2	18	31	47	33	49	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGGGAGACTACGAGCAGTACTTCGGGCCG	CSARGQGDYEQYF	In	VDJ	2	242	6.714221108734314E-4	7.569620173976146E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	3	0	3	26	-1	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSARGQGDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAATGTGGAGGGACACCAGACAGATACGCAGTATTTTGGCCCA	CATSDLNVEGHQTDTQYF	In	VDJ	2	244	6.769710539385011E-4	7.632179018389172E-4	54	TCRBV24						TCRBJ02	TCRBJ02-03	01	0	0	6	3	8	4	24	42	56	50	60		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLNVEGHQTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATGTTGGAGAGGAGGGAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	257	7.13039183861454E-4		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	10	0	6	11	0	26	34	-1	45	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAAAGCTAGCGGGAGGAAGTGGGTACAATGAGCAGTTCTTCGGGCCA	CASSEKLAGGSGYNEQFF	In	VDJ	2	260	7.213625984590585E-4	8.13264977369338E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	1	4	3	7	23	38	52	41	59	TCRBV02,TCRBV12													CASSEKLAGGSGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGCCGGGGGGACTGGCTACACCTTCGGTTCG	CASSLSAGGTGYTF	In	VDJ	3	262	7.269115415241282E-4	8.195208618106407E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	7	8	2	24	36	51	44	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSAGGTGYTF+X+TCRBJ01-02		TCRBD02-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGAAGCGGGAGACACTTCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	263	7.296860130566631E-4		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	2	6	4	6	26	35	47	39	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGACTATCCTAGCAATGAGCAGTTCTTCGGGCCA	CASSPDYPSNEQFF	In	VDJ	3	267	7.407838991868023E-4	8.351605729138971E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	9	6	1	6	26	39	46	40	52		TCRBV03-01,TCRBV03-02				01,02								CASSPDYPSNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCTTGTAACCGGGACAGGGGTACGTGGCTACACCTTCGGTTCG	CASSFLVTGTGVRGYTF	In	VDJ	3	267	7.407838991868023E-4	8.351605729138971E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	7	12	4	24	36	58	48	62		TCRBV24-01,TCRBV24-or09_02												CASSFLVTGTGVRGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGATCACGGGGTGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRSRGANTGELFF	In	VDJ	3	268	7.435583707193372E-4	8.382885151345485E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	3	0	4	2	24	35	44	39	46		TCRBV24-01,TCRBV24-or09_02												CASRSRGANTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCTTTGGACTAGCGGGAGGGCCAAACGGGGAGCTGTTTTTTGGAGAA	CASSFGLAGGPNGELFF	In	VDJ	3	269	7.46332842251872E-4	8.414164573551997E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	1	0	7	4	5	22	33	52	37	57		TCRBV12-03,TCRBV12-04												CASSFGLAGGPNGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTTGGATAACTGTGCCAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	280	7.768520291097554E-4		53	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	1	8	0	4	13	26	37	44	41	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGAGGGGTACCAAGGATGAAAAACTGTTTTTTGGCAGT	CSAMRGTKDEKLFF	In	VDJ	3	280	7.768520291097554E-4	8.75823821782364E-4	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	4	5	2	6	2	8	26	36	43	38	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMRGTKDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGATGACCCGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSQDDPGPYEQYF	In	VDJ	3	284	7.879499152398946E-4	8.883355906649693E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	3	7	0	2	9	0	23	37	-1	46	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDDPGPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGGACAGATACGCAGTATTTTGGCCCA	CASSQVGTDTQYF	In	VDJ	3	293	8.129201590327083E-4	9.164870706508309E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	8	4	3	1	0	26	42	-1	43	47		TCRBV03-01,TCRBV03-02				01,02								CASSQVGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGACTCTAGCGGGAGTTACTCCTACGAGCAGTACTTCGGGCCG	CASSLDSSGSYSYEQYF	In	VDJ	3	293	8.129201590327083E-4	9.164870706508309E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	0	5	3	18	32	47	37	50	TCRBV07,TCRBV11													CASSLDSSGSYSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTTACTAGCGGCAAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	305	8.462138174231263E-4		47	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	5	4	3	4	24	38	49	41	53		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGTAAACAGGGTGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	309	8.573117035532657E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	0	5	3	26	35	46	40	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACCAGCCAGGGGAATTGTACGAGCAGTACTTCGGGCCG	CASSQDQPGELYEQYF	In	VDJ	3	311	8.628606466183354E-4	9.727900306225544E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	4	5	5	18	35	46	40	51	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDQPGELYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACCGGGGGCTAGTGAAGCTTTCTTTGGACAA		Out	VDJ	3	312	8.656351181508702E-4		34	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	6	0	7	4	3	26	34	44	38	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGGGGGGACTAGCGGGGGCCGGTAAGCAGTTCTTCGGGCCA	CASSPGGLAGAGKQFF	In	VDJ	3	319	8.850564188786141E-4	9.978135683877648E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	11	5	6	18	30	49	35	55	TCRBV07,TCRBV11													CASSPGGLAGAGKQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGAAGCTTGGAGGGGATGCCAACGTCCTGACTTTCGGGGCC	CASRKLGGDANVLTF	In	VDJ	3	322	8.933798334762186E-4	0.0010071973950497187	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	10	0	7	7	3	22	33	46	40	49	TCRBV02,TCRBV12													CASRKLGGDANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTCGGGGCACCACATATGGCTACACCTTCGGTTCG	CSARDPRGTTYGYTF	In	VDJ	3	330	9.155756057364974E-4	0.001032220932814929	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	7	0	5	5	6	26	40	50	45	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPRGTTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAAGGGTGGGACCAAGCGGTACCGGGGAGCTGTTTTTTGGAGAA	CSARGRVGPSGTGELFF	In	VDJ	3	332	9.211245488015671E-4	0.0010384768172562316	51	TCRBV20						TCRBJ02	TCRBJ02-02	01	1	0	7	5	7	8	26	39	51	46	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGRVGPSGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGAAGGTGAGCGGGAGTCCAGAGACCCAGTACTTCGGGCCA	CASRKVSGSPETQYF	In	VDJ	3	339	9.405458495293109E-4	0.0010603724128007907	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	6	2	4	7	3	24	35	50	42	53		TCRBV24-01,TCRBV24-or09_02												CASRKVSGSPETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTTAGGCGGGGATACAGATACGCAGTATTTTGGCCCA	CSARELGGDTDTQYF	In	VDJ	3	345	9.5719267872452E-4	0.0010791400661246985	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	3	5	2	26	40	51	45	53		TCRBV20-01,TCRBV20-or09_02												CSARELGGDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSERENTEAFF	In	VDJ	3	346	9.599671502570548E-4	0.0010822680083453497	39	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	3	1	0	0	23	-1	-1	38	43		TCRBV06-01,TCRBV06-08												CASSERENTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD02-01*02	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGACTAGTGGCTACGAGCAGTACTTCGGGCCG	CASSPGTSGYEQYF	In	VDJ	3	351	9.73839507919729E-4	0.0010979077194486063	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	8	3	3	3	24	36	47	39	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPGTSGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGTCAACCACGTCGGGCTAGACAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	353	9.793884509847986E-4		50	unresolved						TCRBJ02	TCRBJ02-01	01	6	2	6	5	17	1	22	33	54	50	55	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCGACGGAGCGATACCAATCCAAGAGACCCAGTACTTCGGGCCA	CSARDLDGAIPIQETQYF	In	VDJ	3	355	9.849373940498684E-4	0.0011104194883312115	54	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	6	6	1	9	8	26	40	53	49	61		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLDGAIPIQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCCTCCGGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CSSSGTSGYEQYF	In	VDJ	4	369	0.0010237799955053562	0.0011542106794203298	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	5	3	6	0	26	32	-1	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSSSGTSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAACACTGGGACGGCCTACGAGCAGTACTTCGGGCCG	CASSNTGTAYEQYF	In	VDJ	4	371	0.0010293289385704257	0.0011604665638616323	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	0	7	2	6	2	26	38	49	44	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNTGTAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCCCTACACTAGCGGCTTGAGCACAGATACGCAGTATTTTGGCCCA	CASSPYTSGLSTDTQYF	In	VDJ	4	379	0.0010515247108307045	0.0011854901016268428	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	5	0	6	4	22	34	48	40	52	TCRBV02,TCRBV12					01,02								CASSPYTSGLSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTGGGGGCGGAGCAGTTCTTCGGGCCA	CASSLLGAEQFF	In	VDJ	4	380	0.0010542991823632394	0.001188618043847494	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	10	5	1	24	36	47	41	48		TCRBV24-01,TCRBV24-or09_02												CASSLLGAEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAACAGGGACCCTCCTACGAGCAGTACTTCGGGCCG	CASSEQGPSYEQYF	In	VDJ	4	385	0.0010681715400259137	0.0012042577549507506	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	5	3	3	0	2	3	22	34	42	36	45	TCRBV02,TCRBV12			TCRBD01,TCRBD02										CASSEQGPSYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCCCGGACACTATCGATGAGCAGTTCTTCGGGCCA	CSARSPDTIDEQFF	In	VDJ	4	387	0.0010737204830909832	0.001210513639392053	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	6	8	5	6	26	38	48	43	54		TCRBV20-01,TCRBV20-or09_02												CSARSPDTIDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGACGGCTAGCGGGAGGGCTTACCGGGGAGCTGTTTTTTGGAGAA	CSARRLAGGLTGELFF	In	VDJ	4	392	0.0010875928407536575	0.0012261533504953097	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	4	0	5	3	3	26	38	53	41	56		TCRBV20-01,TCRBV20-or09_02												CSARRLAGGLTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGATTACTCTGGAAACACCATATATTTTGGAGAG	CASSLDYSGNTIYF	In	VDJ	4	394	0.001093141783818727	0.0012324092349366123	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	5	9	0	1	0	18	35	-1	36	38	TCRBV07,TCRBV11					01,02								CASSLDYSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATGTCGTCGTATGGCAGTACCTACAATGAGCAGTTCTTCGGGCCA	CASMSSYGSTYNEQFF	In	VDJ	4	408	0.0011319843852742148	0.0012762004260257304	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	4	5	2	16	2	24	31	50	47	52		TCRBV24-01,TCRBV24-or09_02												CASMSSYGSTYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCGTTACTCTCGGGACAGATTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLLSGQINTGELFF	In	VDJ	4	412	0.0011430822714043542	0.0012887121949083356	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	2	11	3	24	36	54	47	57	TCRBV24,TCRBV27													CASSPLLSGQINTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGACTAGCGGGAGATCGGGAGTTCTTCGGGCCA	CASSQEGLAGDREFF	In	VDJ	4	427	0.0011846993443923768	0.0013356313282181051	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	2	14	0	6	26	-1	57	43	63		TCRBV03-01,TCRBV03-02												CASSQEGLAGDREFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTGGGGTTTGGGGAGACCCAGTACTTCGGGCCA	CSARDVGFGETQYF	In	VDJ	4	438	0.00121521853125026	0.0013700386926452696	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	6	2	5	3	6	26	40	47	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDVGFGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAAGCGGGGGTTCGCACAGATACGCAGTATTTTGGCCCA	CASSVEAGVRTDTQYF	In	VDJ	4	450	0.0012485121896406782	0.001407573999293085	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	2	1	1	3	23	39	48	40	51	TCRBV09,TCRBV21													CASSVEAGVRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCACCCCAGGGCTTAGGGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	4	467	0.0012956782056937706		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	4	3	3	3	7	22	29	37	32	44	TCRBV09,TCRBV12													X+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGGGGCAGGGGAGAGAAGCTTTCTTTGGACAA	CSALGQGREAFF	In	VDJ	4	470	0.001304001620291375	0.0014701328437061111	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	8	7	3	26	34	47	41	50		TCRBV20-01,TCRBV20-or09_02												CSALGQGREAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGGGGGGATCCAGAGAGACCCAGTACTTCGGGCCA	CASSVEGGSRETQYF	In	VDJ	5	494	0.0013705889370722111	0.0015452034570017422	45	unresolved						TCRBJ02	TCRBJ02-05	01	0	5	1	4	0	7	23	-1	45	39	52	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGGSRETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTCGGACAGGGCTAACTACAATGAGCAGTTCTTCGGGCCA	CATSESDRANYNEQFF	In	VDJ	5	511	0.0014177549531253035	0.0015983784747528144	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	3	3	4	24	38	49	41	53		TCRBV24-01,TCRBV24-or09_02												CATSESDRANYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGGACAGGGGAAGCGGGTGGCTACACCTTCGGTTCG		Out	VDJ	5	516	0.0014316273107879776		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	7	2	7	26	35	46	37	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCGGGGAGGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	522	0.0014482741399831868		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	1	2	5	2	26	37	48	42	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGGGTTTAGCGGGAGAAACAGATACGCAGTATTTTGGCCCA	CASSEGLAGETDTQYF	In	VDJ	5	552	0.001531508285959232	0.0017266241057995178	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	3	5	2	23	37	51	42	53	TCRBV02,TCRBV12													CASSEGLAGETDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACAGGGTAAGATACGCAGTATTTTGGCCCA		Out	VDJ	6	582	0.0016147424319352772		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	5	2	2	26	35	43	37	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACCTAAATCAACCCCAGCATTTTGGTGAT	CSASDLNQPQHF	In	VDJ	6	671	0.001861670398330878	0.0020988492300570223	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	2	7	10	1	9	26	37	41	38	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASDLNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGACAGACAGGGTTACATGGCTACACCTTCGGTTCG	CSATRQTGLHGYTF	In	VDJ	7	738	0.0020475599910107123	0.0023084213588406596	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	6	7	4	26	36	50	43	54		TCRBV20-01,TCRBV20-or09_02												CSATRQTGLHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCGAGGGGGGACAGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSEGGQGKETQYF	In	VDJ	7	752	0.0020864025924662	0.0023522125499297777	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	3	6	1	23	34	50	40	51	TCRBV02,TCRBV12													CASSEGGQGKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGAGCGGGACGGTAGGGTCCTACGAGCAGTACTTCGGGCCG	CSARDLSGTVGSYEQYF	In	VDJ	8	838	0.002325007144264196	0.0026212155809057897	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	3	1	4	8	26	40	51	44	59		TCRBV20-01,TCRBV20-or09_02												CSARDLSGTVGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGAACTGATCGGGGAGCTGTTTTTTGGAGAA	CASELIGELFF	In	VDJ	8	844	0.0023416539734594055	0.002639983234229697	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	3	10	7	2	3	26	35	40	37	43		TCRBV03-01,TCRBV03-02				01,02								CASELIGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGGGAGCTGTTTTTTGGAGAA	CASSQVGELFF	In	VJ	8	854	0.0023693986887847536	0.0026712626564362103	33	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	0	0	7	0	1	26	-1	42	-1	43		TCRBV03-01,TCRBV03-02												CASSQVGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGAATGATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGNDGANVLTF	In	VDJ	9	939	0.0026052287690502152	0.002937137745191571	45	TCRBV03						TCRBJ02	TCRBJ02-06	01	3	0	8	3	1	4	26	40	45	41	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGNDGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTTCCCGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSQDFPGPYEQYF	In	VDJ	10	1007	0.0027938928332625844	0.003149837816195859	45	unresolved						TCRBJ02	TCRBJ02-07	01	0	8	0	2	6	1	23	40	50	46	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDFPGPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGCTTCGACAGAGGCGCAATGAGCAGTTCTTCGGGCCA	CSARGLRQRRNEQFF	In	VDJ	10	1055	0.0029270674668242565	0.0032999790427871217	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	6	8	5	26	37	50	45	55		TCRBV20-01,TCRBV20-or09_02												CSARGLRQRRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGAGGGGGAGGGAAAACTGTTTTTTGGCAGT	CSAIEGEGKLFF	In	VDJ	10	1072	0.002974233482877349	0.003353154060538194	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	9	0	10	2	0	26	40	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSAIEGEGKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATCCTACGACAGGGGGCAAACCTACGAGCAGTACTTCGGGCCG	CASSQSYDRGQTYEQYF	In	VDJ	10	1076	0.002985331369007488	0.003365665829420799	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	0	2	6	3	23	38	54	44	57	TCRBV01,TCRBV04													CASSQSYDRGQTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGTTTGGAGTATCCGGGTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLEYPGSSYEQYF	In	VDJ	10	1098	0.0030463697427232546	0.0034344805582751277	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	4	0	11	3	23	34	49	45	52	TCRBV01,TCRBV04					01,02								CASSLEYPGSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTTAATCTGGACAGGGGAGGTTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	11	1101	0.0030546931573208593		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	1	2	2	8	5	24	31	48	39	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGTGAAACCGGGGATAGGCACTGAAGCTTTCTTTGGACAA	CASSVKPGIGTEAFF	In	VDJ	11	1114	0.003090761287243812	0.0034845276338055483	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	4	7	5	23	35	47	42	52	TCRBV01,TCRBV04													CASSVKPGIGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAACCCCCCGGAACACTGAAGCTTTCTTTGGACAA	CASSETPRNTEAFF	In	VDJ	11	1153	0.003198965677012671	0.003606517380410949	42	unresolved						TCRBJ01	TCRBJ01-01	01	2	3	7	1	0	6	23	-1	40	38	46	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETPRNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGCGGCCCGACAAGAGACCCAGTACTTCGGGCCA	CASSAARQETQYF	In	VDJ	11	1193	0.0033099445383140648	0.003731635069237001	39	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	4	9	0	2	1	4	23	36	40	37	44	TCRBV02,TCRBV12			TCRBD01,TCRBD02										CASSAARQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGAGGCGCCAACAGGGTCTCGGCACAGATACGCAGTATTTTGGCCCA	CASSERRQQGLGTDTQYF	In	VDJ	13	1354	0.003756634455052174	0.00423523376676186	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	1	9	5	23	37	52	46	57	TCRBV02,TCRBV12													CASSERRQQGLGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTACCCGGGAGTGAGCTACGAGCAGTACTTCGGGCCG	CASSQDYPGVSYEQYF	In	VDJ	13	1395	0.0038703877878861026	0.004363479397808564	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	2	3	5	4	18	35	46	40	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDYPGVSYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCTCTTTTCTTGGTTCTTCGGGCCA	CASSQGLFSWFF	In	VDJ	14	1431	0.003970268763057357	0.004476085317752011	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	10	15	2	9	26	42	46	44	55		TCRBV03-01,TCRBV03-02				01,02								CASSQGLFSWFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAATTAAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSELSSSYNEQFF	In	VDJ	14	1437	0.003986915592252565	0.004494852971075918	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	8	0	5	0	23	38	-1	43	46	TCRBV02,TCRBV12					01,02								CASSELSSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGTACCGGTAGGCTAGCGGGATTTAACGAGCAGTACTTCGGGCCG		Out	VDJ	15	1551	0.004303205346961538		53	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	3	5	12	4	26	40	61	52	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTTGCTGTAACGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLAVTSNQPQHF	In	VDJ	15	1603	0.004447477866653349	0.005014091379704034	45	unresolved						TCRBJ01	TCRBJ01-05	01	4	3	7	1	8	1	23	36	46	44	47	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAVTSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGCCAGCGAGGGGGCCCAGTACTTCGGGCCA	CASSLAASEGAQYF	In	VDJ	16	1623	0.004502967297304046	0.00507665022411706	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	9	8	0	18	35	-1	43	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAASEGAQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGACTCCGAGCAGTACTTCGGGCCG	CASSLDSEQYF	In	VDJ	18	1834	0.0050883807906688975	0.005736646032674484	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	6	2	1	26	39	45	41	46		TCRBV03-01,TCRBV03-02				01,02								CASSLDSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTGGGCCGAGTAGATACGCAGTATTTTGGCCCA	CSASLGRVDTQYF	In	VDJ	19	1969	0.005462934447561101	0.00615891823246241	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	5	3	5	26	37	44	40	49		TCRBV20-01,TCRBV20-or09_02												CSASLGRVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACCCAAGAGACCCAGTACTTCGGGCCA	CASSETQETQYF	In	VDJ	21	2149	0.005962339323417372	0.006721947832179644	36	TCRBV06						TCRBJ02	TCRBJ02-05	01	2	3	7	1	0	0	23	-1	-1	38	40		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETQETQYF+TCRBV06-X+TCRBJ02-05	TCRBV06		TCRBJ02-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTCTGGACCGATGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSGPMSSYEQYF	In	VDJ	25	2665	0.00739396663420535	0.008335966018035715	45	unresolved						TCRBJ02	TCRBJ02-07	01	6	1	7	0	4	7	18	29	37	33	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGPMSSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTCGGTCAGTCTATGGGGCCCAATGAGCAGTTCTTCGGGCCA	CSFGQSMGPNEQFF	In	VDJ	46	4791	0.013292493112374421	0.014985971179140379	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	7	0	6	14	1	26	32	51	46	52		TCRBV20-01,TCRBV20-or09_02												CSFGQSMGPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCATAACAGGGTCCTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSITGSSSNQPQHF	In	VDJ	65	6810	0.018894151136562263	0.021301286522635354	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	0	3	5	23	35	44	38	49	TCRBV01,TCRBV04													CASSITGSSSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3915	3472	406	36	0	1887	1607	260	20	0	360429	319699	37380	3350	0	0.166562244	8.87624073	0.152734891	9.21983624				150147	0.0239169914	0.121232785	0.107532971	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:47	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8868454776926916	MSKCC- Snyder- P01-02		3591.0	
